data_2l66_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l66 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.055 0.455 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.77 156.25 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 0.0 109.759 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -145.52 147.05 31.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.531 -0.73 . . . . 0.0 110.598 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -137.81 164.05 29.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.752 -0.593 . . . . 0.0 109.912 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.95 137.93 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.657 -0.652 . . . . 0.0 110.519 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.15 165.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.575 -0.703 . . . . 0.0 109.736 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 tttp -137.07 138.35 40.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.351 -0.843 . . . . 0.0 110.517 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.45 124.96 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.597 -0.689 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 m -168.65 42.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.437 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -139.59 -66.04 0.46 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.605 -0.684 . . . . 0.0 109.457 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.08 46.29 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.752 -0.592 . . . . 0.0 109.995 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' B' ' 29' ' ' GLU . 15.2 m-85 53.42 57.42 6.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 110.803 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 174.71 13.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.463 -0.773 . . . . 0.0 110.81 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.52 145.53 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.753 -0.592 . . . . 0.0 109.693 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 p -110.95 -8.47 14.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 111.368 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.8 mt 59.51 111.6 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.304 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.53 -168.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.039 1.02 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.04 -33.85 26.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 0.0 111.519 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -56.34 -52.43 64.6 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.234 -0.916 . . . . 0.0 110.862 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.22 -47.7 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.393 -0.817 . . . . 0.0 109.593 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -58.63 -28.77 65.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.99 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -45.06 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 109.486 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.64 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.598 -0.688 . . . . 0.0 109.952 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.12 169.92 5.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.402 -0.811 . . . . 0.0 110.817 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.47 -73.43 0.38 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.692 -0.63 . . . . 0.0 110.733 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mm 55.12 93.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 139.16 47.79 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.0 110.365 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' HB2' ' CZ ' ' B' ' 13' ' ' TYR . 5.4 tt0 -67.58 112.15 4.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.543 -0.723 . . . . 0.0 110.154 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.73 35.44 4.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.73 163.98 18.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.579 -0.954 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.3 tp -93.71 107.25 19.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.645 -0.66 . . . . 0.0 110.289 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.9 t -98.72 141.18 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.667 -0.645 . . . . 0.0 109.585 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.75 142.21 46.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.548 -0.72 . . . . 0.0 110.346 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 p -131.37 134.27 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.665 -0.647 . . . . 0.0 109.779 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.1 p -134.25 146.03 49.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.74 . . . . 0.0 111.208 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -104.16 130.56 51.91 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.47 148.1 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 110.556 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.21 38.92 1.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.632 -0.668 . . . . 0.0 110.226 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -144.28 -52.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.92 -30.56 26.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.482 -0.761 . . . . 0.0 110.024 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 39.26 29.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.89 158.27 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.921 . . . . 0.0 109.684 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 61.6 t -98.68 130.48 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 109.504 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -110.08 127.21 54.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.877 -0.514 . . . . 0.0 110.415 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.432 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.4 pt -121.98 146.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.403 -0.811 . . . . 0.0 110.92 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -143.89 -169.58 3.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.871 -0.518 . . . . 0.0 110.186 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.135 0.493 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.75 156.3 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -145.47 147.13 31.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.484 -0.76 . . . . 0.0 110.59 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -137.95 163.88 30.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.683 -0.636 . . . . 0.0 109.903 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.84 137.89 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.688 -0.632 . . . . 0.0 110.582 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 10.2 p -146.14 165.17 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 0.0 109.725 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -137.03 138.4 40.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.433 -0.792 . . . . 0.0 110.518 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.46 125.17 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 109.54 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -168.75 42.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.475 -0.765 . . . . 0.0 110.43 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -139.61 -65.99 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.24 46.25 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 29' ' ' GLU . 15.2 m-85 53.44 57.57 6.05 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.492 -0.755 . . . . 0.0 110.814 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 174.78 13.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.451 -0.78 . . . . 0.0 110.822 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.64 145.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.843 -0.536 . . . . 0.0 109.666 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -110.78 -8.56 14.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 111.476 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt 59.55 111.69 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.248 -0.907 . . . . 0.0 110.592 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.76 -168.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.089 1.047 . . . . 0.0 111.324 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.78 -33.72 27.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.654 -0.654 . . . . 0.0 111.6 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -56.62 -52.15 65.96 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.14 -0.975 . . . . 0.0 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.44 -47.63 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.384 -0.823 . . . . 0.0 109.43 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -58.74 -28.78 66.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 109.938 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -45.11 80.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.459 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.61 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.13 169.87 5.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.451 -0.781 . . . . 0.0 110.827 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.41 -73.5 0.38 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.7 -0.625 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mm 55.2 93.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.234 -0.916 . . . . 0.0 110.337 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 139.21 47.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 110.339 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 5.5 tt0 -67.59 112.18 4.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.515 -0.74 . . . . 0.0 110.144 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.61 4.9 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.75 163.89 18.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.715 -0.874 . . . . 0.0 110.047 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.5 107.19 19.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.614 -0.679 . . . . 0.0 110.354 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.85 141.25 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.485 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 142.03 46.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.558 -0.714 . . . . 0.0 110.28 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.28 134.31 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 24.0 p -134.22 146.12 49.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -104.12 130.46 51.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.26 148.18 24.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.428 -0.795 . . . . 0.0 110.634 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.27 38.86 1.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.656 -0.652 . . . . 0.0 110.284 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -144.1 -52.78 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 110.07 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.82 -30.68 26.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 0.0 110.048 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.9 39.21 28.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.99 158.14 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.789 -0.83 . . . . 0.0 109.635 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 61.4 t -98.54 130.35 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.314 -0.866 . . . . 0.0 109.555 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -110.02 127.21 54.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.702 -0.624 . . . . 0.0 110.38 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.443 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.4 pt -121.75 146.93 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.423 -0.798 . . . . 0.0 110.917 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -143.91 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 0.0 110.197 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 110.319 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.182 0.515 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.47 134.91 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 109.97 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.76 153.39 39.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.74 . . . . 0.0 110.582 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.04 162.6 41.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.647 . . . . 0.0 109.746 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 6' ' ' ILE . 15.3 tt -134.93 154.9 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.566 -0.709 . . . . 0.0 110.703 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.36 159.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 109.973 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -156.32 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.72 . . . . 0.0 110.275 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 1.122 ' O ' ' N ' ' B' ' 30' ' ' GLY . 49.0 t -143.59 126.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.87 -169.21 3.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 56.88 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.8 -0.562 . . . . 0.0 111.313 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -152.42 57.73 0.82 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.975 -1.078 . . . . 0.0 110.835 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.944 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 80.3 m-85 50.8 37.38 16.83 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.327 -0.858 . . . . 0.0 111.346 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.45 173.98 6.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.453 -0.78 . . . . 0.0 110.242 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -169.5 141.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.791 . . . . 0.0 110.624 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -108.04 174.47 5.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 109.405 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.9 mm -108.54 133.47 20.6 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.386 -0.821 . . . . 0.0 110.38 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.36 157.32 57.02 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 O-C-N 123.171 1.09 . . . . 0.0 110.195 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.99 57.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 110.612 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -70.86 -53.49 15.01 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.372 -0.83 . . . . 0.0 110.466 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.8 t -59.95 -43.95 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.258 -0.901 . . . . 0.0 109.32 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -59.95 -31.48 69.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.61 -52.57 50.96 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.445 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.53 -68.64 0.67 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.626 -0.671 . . . . 0.0 110.383 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.713 ' CE1' HG22 ' B' ' 44' ' ' VAL . 13.5 t80 -57.96 134.87 56.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.536 -0.728 . . . . 0.0 111.029 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -81.97 123.09 28.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.671 -0.643 . . . . 0.0 109.783 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.9 tt -166.85 85.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.182 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.979 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.4 OUTLIER -95.83 178.28 5.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.294 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -66.62 135.28 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.65 -0.656 . . . . 0.0 110.606 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 1.127 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 61.16 48.66 84.65 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.473 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -106.68 -176.22 3.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -1.019 . . . . 0.0 110.165 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.9 78.84 3.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.792 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.806 HG23 ' CG2' ' B' ' 9' ' ' VAL . 63.7 t -85.6 116.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.35 142.32 32.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.669 -0.644 . . . . 0.0 109.836 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.08 122.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.56 -0.712 . . . . 0.0 109.878 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.3 p -140.55 146.79 38.53 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.311 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.421 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 12.0 t80 -105.03 142.54 34.64 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.36 145.07 27.76 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.135 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.56 32.69 2.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.007 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.63 -59.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.588 -0.695 . . . . 0.0 110.077 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -79.99 -30.02 39.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.666 . . . . 0.0 110.163 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.6 43.06 7.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.5 m -137.82 156.44 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.679 -0.894 . . . . 0.0 110.33 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.737 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 57.6 t -107.34 121.86 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 1.2 ttpt -103.67 136.96 42.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.684 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.76 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 42.9 pt -127.5 149.31 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.934 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -151.79 175.1 12.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.504 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 0.0 110.713 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.099 0.476 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.55 134.91 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.543 -0.723 . . . . 0.0 110.022 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.62 153.42 39.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.558 -0.714 . . . . 0.0 110.653 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.14 162.46 41.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.719 -0.613 . . . . 0.0 109.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.413 HG22 HD12 ' B' ' 6' ' ' ILE . 15.4 tt -134.85 154.85 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 110.783 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.33 159.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.686 -0.634 . . . . 0.0 109.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.31 -156.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.516 -0.74 . . . . 0.0 110.275 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 1.127 ' O ' ' N ' ' A' ' 30' ' ' GLY . 49.2 t -143.6 126.34 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.78 -169.18 3.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.611 -0.68 . . . . 0.0 110.404 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 56.87 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.657 -0.652 . . . . 0.0 111.309 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -152.23 57.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.102 -0.999 . . . . 0.0 110.842 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.979 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 81.6 m-85 50.8 37.37 16.8 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 0.0 111.397 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.4 174.13 6.02 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.439 -0.788 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.83 141.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.383 -0.823 . . . . 0.0 110.54 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -108.03 174.33 5.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.644 -0.66 . . . . 0.0 109.388 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.446 HG22 HD13 ' B' ' 17' ' ' ILE . 42.5 mm -108.35 133.47 20.56 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -71.53 157.19 56.74 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 O-C-N 123.304 1.16 . . . . 0.0 110.155 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.72 54.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -71.05 -53.41 14.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.363 -0.836 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 86.7 t -59.94 -43.96 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -60.03 -31.38 69.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.77 -0.581 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.55 -52.56 51.53 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.705 -0.622 . . . . 0.0 109.481 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -68.4 0.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.639 -0.663 . . . . 0.0 110.482 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.694 ' CE1' HG22 ' A' ' 44' ' ' VAL . 13.8 t80 -58.21 135.02 57.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.951 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -81.99 123.03 28.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.644 -0.66 . . . . 0.0 109.815 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 7.0 tt -166.74 85.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.271 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . 0.944 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -0.843 . . . . 0.0 110.311 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.678 ' HA ' HG11 ' A' ' 9' ' ' VAL . 3.5 mt-10 -66.56 135.33 54.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.669 -0.644 . . . . 0.0 110.538 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . 1.122 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 61.25 48.67 84.31 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.446 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -106.7 -176.14 2.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -1.009 . . . . 0.0 110.177 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.98 78.86 3.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.589 -0.695 . . . . 0.0 109.852 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.548 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 64.3 t -85.52 116.98 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.643 -0.661 . . . . 0.0 110.145 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.37 142.53 32.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 109.779 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.3 122.12 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.395 -0.815 . . . . 0.0 109.73 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 70.5 p -140.54 146.85 38.64 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -0.823 . . . . 0.0 111.269 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.425 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 11.9 t80 -105.11 142.55 34.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 145.02 27.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.405 -0.809 . . . . 0.0 110.184 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.6 32.6 2.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.706 . . . . 0.0 109.957 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.61 -59.32 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.702 -0.624 . . . . 0.0 110.065 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -80.11 -30.05 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 110.105 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.67 42.97 7.5 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.422 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 34.7 m -137.68 156.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.584 -0.95 . . . . 0.0 110.295 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.76 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 57.5 t -107.38 121.64 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -103.49 136.8 42.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.687 -0.633 . . . . 0.0 110.665 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.737 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 42.5 pt -127.28 149.35 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.767 -0.583 . . . . 0.0 109.99 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -151.66 175.13 12.68 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 0.0 110.495 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.599 -0.688 . . . . 0.0 110.723 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.163 0.506 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.75 139.8 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.666 -0.647 . . . . 0.0 109.968 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.14 150.4 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.6 -0.688 . . . . 0.0 110.168 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -156.81 161.88 39.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.624 -0.673 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.4 mt -131.25 136.61 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.585 -0.697 . . . . 0.0 110.216 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.69 170.07 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.748 -0.595 . . . . 0.0 109.785 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.69 152.16 35.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.424 -0.798 . . . . 0.0 110.772 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.977 HG13 ' O ' ' B' ' 28' ' ' LYS . 62.7 t -101.71 136.31 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.74 -0.6 . . . . 0.0 109.591 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.6 p -157.15 -47.01 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.524 -0.735 . . . . 0.0 110.411 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -147.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.652 -0.655 . . . . 0.0 110.182 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.97 60.98 1.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 111.1 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.928 ' CD2' ' O ' ' B' ' 27' ' ' ILE . 27.1 m-85 50.59 32.16 6.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.38 -0.825 . . . . 0.0 111.826 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -88.42 174.64 8.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.299 -0.876 . . . . 0.0 110.101 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.11 135.5 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.022 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.2 m -100.61 150.51 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 110.364 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.434 HD12 ' O ' ' B' ' 13' ' ' TYR . 89.3 mt -101.7 128.95 27.68 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.584 -0.698 . . . . 0.0 109.67 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.1 158.44 25.66 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.121 1.063 . . . . 0.0 110.72 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.14 77.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.639 -0.663 . . . . 0.0 109.874 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.49 -51.91 56.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.643 -0.661 . . . . 0.0 109.571 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.77 -39.26 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.05 -30.07 70.53 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.68 25.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.603 -0.686 . . . . 0.0 109.433 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -79.62 -63.34 1.44 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.684 -0.635 . . . . 0.0 109.846 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HD1' ' CD1' ' B' ' 37' ' ' PHE . 6.4 t80 -53.53 115.24 1.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.268 -0.895 . . . . 0.0 110.695 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -73.77 131.17 41.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.558 -0.714 . . . . 0.0 110.358 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.946 ' O ' ' CD2' ' B' ' 13' ' ' TYR . 6.8 tt -167.56 91.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.64 0.733 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 1.013 ' O ' HG13 ' B' ' 9' ' ' VAL . 8.3 tttt -99.1 -179.65 4.32 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.262 -0.899 . . . . 0.0 110.997 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -75.48 127.08 32.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.973 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.842 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 90.97 26.39 22.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.706 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -103.74 149.55 24.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.538 -0.978 . . . . 0.0 109.776 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.3 mt -101.43 74.59 1.55 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.695 . . . . 0.0 110.708 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.32 151.09 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.426 -0.796 . . . . 0.0 109.569 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -106.61 154.95 20.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.836 . . . . 0.0 111.145 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.21 125.83 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.0 p -130.98 146.95 52.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.865 . . . . 0.0 111.508 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 40.0 t80 -106.49 149.97 26.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -110.07 -167.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.13 -38.71 1.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.7 . . . . 0.0 110.597 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.97 -40.11 12.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 110.598 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -81.66 -37.2 27.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.697 . . . . 0.0 110.537 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.07 72.11 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.862 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 24.7 m -121.21 149.77 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.447 -1.031 . . . . 0.0 109.661 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.891 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 90.3 t -103.62 129.28 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.418 -0.802 . . . . 0.0 109.675 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.909 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 3.8 ttpm? -109.07 130.96 55.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.217 0.532 . . . . 0.0 109.737 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.892 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 10.8 pt -126.53 145.14 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.73 -0.606 . . . . 0.0 110.086 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.96 171.08 16.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 110.303 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.899 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.05 0.452 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.57 139.95 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.642 -0.661 . . . . 0.0 109.982 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.2 150.57 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.711 -0.618 . . . . 0.0 110.137 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -156.97 161.85 39.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.745 -0.597 . . . . 0.0 109.589 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.26 136.62 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -126.9 169.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.692 -0.63 . . . . 0.0 109.71 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.61 152.04 35.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.518 -0.739 . . . . 0.0 110.787 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 1.013 HG13 ' O ' ' A' ' 28' ' ' LYS . 62.8 t -101.59 136.26 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.665 . . . . 0.0 109.61 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.4 p -157.23 -46.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.746 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.72 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.657 -0.652 . . . . 0.0 110.222 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.9 60.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.093 -1.005 . . . . 0.0 111.213 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.946 ' CD2' ' O ' ' A' ' 27' ' ' ILE . 27.0 m-85 50.61 32.09 6.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.364 -0.835 . . . . 0.0 111.902 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -88.43 174.56 8.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.99 135.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.46 -0.775 . . . . 0.0 109.918 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 m -100.58 150.53 22.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 110.299 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 89.5 mt -101.67 129.0 27.61 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.22 158.52 25.91 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.115 1.061 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.0 77.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -51.65 58.18 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.574 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 83.7 t -62.04 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -66.01 -30.18 70.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.59 26.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.708 -0.62 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.61 -63.37 1.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.741 -0.599 . . . . 0.0 109.887 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.587 ' CE1' HG21 ' A' ' 44' ' ' VAL . 6.3 t80 -53.45 115.21 1.82 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -73.83 131.29 41.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.648 -0.658 . . . . 0.0 110.309 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . 0.928 ' O ' ' CD2' ' A' ' 13' ' ' TYR . 6.8 tt -167.64 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.548 0.69 . . . . 0.0 109.557 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . 0.977 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 tttt -98.99 -179.77 4.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 111.005 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.41 127.12 32.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.638 . . . . 0.0 109.961 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 91.02 26.36 22.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.692 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -103.78 149.44 25.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.972 . . . . 0.0 109.825 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 74.53 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.656 -0.652 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.44 151.19 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.517 -0.739 . . . . 0.0 109.516 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -106.79 154.93 20.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.337 -0.852 . . . . 0.0 111.141 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.17 125.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -130.99 146.97 52.56 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.591 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.569 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 39.8 t80 -106.46 149.95 26.56 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.9 -167.21 1.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.642 -0.661 . . . . 0.0 110.272 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.03 -38.64 1.42 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.633 -0.667 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.05 -40.08 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -0.8 . . . . 0.0 110.604 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -81.77 -37.2 27.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 110.446 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.87 26.29 71.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.909 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 25.5 m -121.32 149.58 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -1.047 . . . . 0.0 109.686 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.892 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 92.3 t -103.62 129.19 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 109.773 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.862 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 3.8 ttpm? -109.09 130.85 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.783 -0.573 . . . . 0.0 109.833 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.891 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 10.8 pt -126.25 145.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.788 -0.57 . . . . 0.0 110.178 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.514 ' HB3' HG11 ' A' ' 43' ' ' VAL . 3.9 pt20 -149.01 171.02 17.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.247 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tp . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 109.721 179.84 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.166 0.508 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.5 t -122.36 150.69 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.55 -0.719 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -156.27 142.94 18.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.491 -0.756 . . . . 0.0 110.736 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.61 166.86 29.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.8 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.0 mt -119.65 126.4 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.478 -0.764 . . . . 0.0 110.226 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.46 167.3 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.56 -0.712 . . . . 0.0 110.072 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -116.29 138.18 51.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.479 -0.763 . . . . 0.0 110.43 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -78.04 167.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 109.483 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' B' ' 29' ' ' GLU . 11.5 t -170.2 -66.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.33 -0.856 . . . . 0.0 111.164 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -58.08 -166.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.612 -0.68 . . . . 0.0 110.765 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -66.56 76.01 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.674 -0.641 . . . . 0.0 110.801 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 51.84 30.0 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.262 -0.899 . . . . 0.0 111.521 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -89.29 150.61 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.46 -0.775 . . . . 0.0 109.946 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.3 t -121.72 142.56 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 110.693 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.66 132.77 55.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 109.573 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.57 131.25 28.62 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.43 -0.794 . . . . 0.0 109.829 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.04 150.16 74.89 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.044 1.023 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.61 63.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.548 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -67.29 -45.75 75.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.542 -0.724 . . . . 0.0 109.839 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.8 -41.05 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -65.48 -33.6 76.32 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -42.14 96.77 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -80.45 -68.79 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE1' HG22 ' B' ' 44' ' ' VAL . 2.5 t80 -64.17 126.1 26.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.721 -0.612 . . . . 0.0 110.596 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.5 112.06 17.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.581 -0.699 . . . . 0.0 109.294 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.3 tt -154.04 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.73 0.776 . . . . 0.0 109.452 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -101.51 -170.9 1.89 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.429 -0.794 . . . . 0.0 111.438 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' B' ' 10' ' ' SER . 5.2 tt0 -74.21 139.84 44.67 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.279 0.562 . . . . 0.0 110.785 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.68 28.22 65.67 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.5 159.72 15.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -1.028 . . . . 0.0 110.283 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 64.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 110.054 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.01 150.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.743 . . . . 0.0 110.265 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -127.87 136.12 50.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 110.297 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.69 129.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.665 -0.647 . . . . 0.0 109.824 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.4 p -137.88 147.45 44.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.757 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -115.21 144.72 43.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.676 -0.64 . . . . 0.0 109.332 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.35 -174.22 2.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.44 42.01 2.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.561 -0.712 . . . . 0.0 110.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.36 -52.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 110.56 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -115.41 -61.61 1.72 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.745 . . . . 0.0 110.344 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.32 59.18 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.78 149.54 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.569 -0.959 . . . . 0.0 110.145 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.512 HG22 ' CE1' ' B' ' 25' ' ' PHE . 51.1 t -103.28 133.17 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.392 -0.817 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -109.42 136.63 48.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.727 -0.608 . . . . 0.0 110.036 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.471 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 5.3 pt -131.45 150.25 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.401 -0.812 . . . . 0.0 111.21 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -145.35 -167.9 2.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 0.0 109.594 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.256 -0.903 . . . . 0.0 111.191 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.026 0.441 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 66.4 t -122.13 150.98 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.654 -0.654 . . . . 0.0 109.652 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -156.65 142.77 18.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.722 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -151.46 166.93 29.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.588 -0.695 . . . . 0.0 109.837 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.1 mt -119.58 126.62 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.513 -0.742 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.64 167.06 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.558 -0.714 . . . . 0.0 110.171 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -116.28 138.13 51.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.527 -0.733 . . . . 0.0 110.468 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -78.1 167.67 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.471 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' SER . . . . . 0.511 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 11.2 t -170.21 -65.96 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -58.01 -166.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -66.52 76.0 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.66 . . . . 0.0 110.871 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 51.93 29.89 6.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.433 -0.792 . . . . 0.0 111.52 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -89.07 150.64 22.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.99 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.91 142.5 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.618 -0.676 . . . . 0.0 110.676 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.61 132.78 55.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.731 -0.606 . . . . 0.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 59.4 mt -96.62 131.19 28.69 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.585 -0.697 . . . . 0.0 109.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.79 150.07 73.5 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.079 1.042 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.67 -30.68 63.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.474 -0.766 . . . . 0.0 110.496 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -67.3 -45.74 75.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.514 -0.741 . . . . 0.0 109.773 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 65.5 t -62.83 -41.17 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.469 -0.769 . . . . 0.0 109.001 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -65.26 -33.72 76.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.696 -0.627 . . . . 0.0 109.365 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -80.47 -68.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.512 ' CE1' HG22 ' A' ' 44' ' ' VAL . 2.5 t80 -64.42 126.21 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.688 -0.633 . . . . 0.0 110.524 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 112.09 17.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 109.327 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 tt -154.16 91.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.76 0.79 . . . . 0.0 109.509 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -101.49 -170.92 1.9 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 111.543 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 10' ' ' SER . 5.2 tt0 -74.07 139.75 44.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.799 -0.563 . . . . 0.0 110.868 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.48 28.54 65.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.61 159.76 15.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -1.0 . . . . 0.0 110.238 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.46 64.78 1.88 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.06 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 10.1 p -75.12 150.74 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.618 -0.676 . . . . 0.0 110.25 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 31.9 tttt -127.82 136.01 50.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.66 130.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.827 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 65.5 p -137.96 147.32 44.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 110.894 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -115.06 144.67 43.27 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.24 -174.13 2.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 110.303 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.47 42.05 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.448 -0.782 . . . . 0.0 110.056 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.4 -52.13 1.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.526 -0.734 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -115.61 -61.79 1.69 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.558 -0.714 . . . . 0.0 110.241 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.35 59.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 32.7 m -140.72 149.46 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.621 -0.929 . . . . 0.0 110.13 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.535 HG22 ' CE1' ' A' ' 25' ' ' PHE . 50.4 t -103.2 132.98 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 110.119 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -109.26 136.52 48.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.658 -0.651 . . . . 0.0 110.135 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.458 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 5.3 pt -131.29 150.11 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.455 -0.778 . . . . 0.0 111.261 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -145.1 -167.8 2.77 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.585 -0.697 . . . . 0.0 109.654 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.238 -0.914 . . . . 0.0 111.337 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.146 0.498 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.2 m -123.64 152.7 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.554 -0.716 . . . . 0.0 109.572 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -144.06 153.91 42.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.783 . . . . 0.0 111.046 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -134.06 147.16 50.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.403 HG23 HD22 ' B' ' 32' ' ' LEU . 89.3 mt -111.28 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 110.677 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.17 151.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.65 12.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.526 -0.733 . . . . 0.0 110.72 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.763 HG21 ' O ' ' B' ' 31' ' ' ASP . 76.4 t -75.45 142.29 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.758 -0.589 . . . . 0.0 109.916 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -172.78 3.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 110.0 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 56.58 -86.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.712 -0.617 . . . . 0.0 110.526 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.1 78.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.926 -1.109 . . . . 0.0 109.043 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.79 14.62 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.368 -0.833 . . . . 0.0 109.83 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.06 157.16 26.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.604 -0.685 . . . . 0.0 110.823 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.94 138.47 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.655 -0.653 . . . . 0.0 109.385 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -120.78 152.81 37.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.497 -0.752 . . . . 0.0 110.886 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -97.3 119.59 62.73 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.708 -0.62 . . . . 0.0 109.5 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.21 -174.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.067 1.035 . . . . 0.0 110.622 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.49 25.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.564 -0.71 . . . . 0.0 110.44 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -48.4 42.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 109.982 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.24 -41.63 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.655 -0.653 . . . . 0.0 109.426 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.74 -38.29 81.33 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -36.02 81.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.596 -0.69 . . . . 0.0 109.757 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -76.45 -69.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.67 ' CE2' HG21 ' B' ' 44' ' ' VAL . 0.4 OUTLIER -65.02 149.9 49.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.645 -0.66 . . . . 0.0 109.923 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.88 -80.25 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.752 . . . . 0.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 94.9 mt 50.18 88.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.144 -0.972 . . . . 0.0 110.947 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.436 ' O ' HG11 ' B' ' 9' ' ' VAL . 11.7 tptt -109.34 168.09 9.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.589 -0.694 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HA ' HG13 ' B' ' 9' ' ' VAL . 27.7 mt-10 -69.35 123.7 21.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.587 -0.696 . . . . 0.0 110.024 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.464 ' H ' ' HB ' ' B' ' 9' ' ' VAL . . . 85.47 37.51 9.63 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.877 ' O ' HG21 ' B' ' 9' ' ' VAL . 2.6 m-20 -115.53 133.03 56.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.528 -0.984 . . . . 0.0 110.193 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.577 HD22 HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -69.19 112.25 5.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.598 HG21 HG22 ' B' ' 9' ' ' VAL . 59.9 t -107.62 151.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.593 -0.692 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -125.0 128.09 48.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.21 128.79 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.2 p -136.65 153.0 51.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.257 -0.902 . . . . 0.0 111.872 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 36.6 t80 -124.95 143.79 50.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -117.55 155.96 28.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.438 -0.789 . . . . 0.0 110.894 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -101.37 19.92 16.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.78 -0.575 . . . . 0.0 110.703 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -118.61 -28.48 5.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 110.601 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -105.41 -58.89 1.84 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.402 -0.811 . . . . 0.0 110.296 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.84 33.17 2.68 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.48 162.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.676 -0.896 . . . . 0.0 109.938 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.845 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 37.0 t -112.04 123.85 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.33 -0.856 . . . . 0.0 109.981 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 1.5 ttpm? -105.39 150.37 25.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.837 -0.54 . . . . 0.0 109.813 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.869 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.7 pp -136.98 155.86 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.833 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -154.98 -174.78 5.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.904 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.492 -0.755 . . . . 0.0 110.68 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.155 0.502 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.64 152.73 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.51 -0.744 . . . . 0.0 109.552 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -144.1 153.81 42.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.386 -0.821 . . . . 0.0 111.009 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.87 147.14 51.12 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.577 HG22 HD22 ' A' ' 32' ' ' LEU . 89.2 mt -111.24 116.03 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.739 . . . . 0.0 110.679 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.29 151.15 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.63 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.877 HG21 ' O ' ' A' ' 31' ' ' ASP . 69.0 t -75.43 142.18 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.754 -0.591 . . . . 0.0 109.981 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.9 t -159.22 -172.71 3.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.694 . . . . 0.0 109.93 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 56.46 -86.39 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.686 -0.634 . . . . 0.0 110.52 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.19 78.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.045 -1.035 . . . . 0.0 109.17 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.76 14.68 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.344 -0.848 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -117.08 157.15 26.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.582 -0.699 . . . . 0.0 110.786 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -137.9 138.28 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.746 -0.596 . . . . 0.0 109.459 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.5 p -120.62 152.74 37.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 0.0 110.916 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -97.21 119.56 62.93 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.791 -0.568 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.16 -174.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.06 1.031 . . . . 0.0 110.591 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.56 25.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.704 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -48.18 44.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.49 -41.5 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.555 -0.715 . . . . 0.0 109.466 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.64 -38.28 80.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.564 -0.71 . . . . 0.0 109.712 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -36.08 82.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.57 -0.706 . . . . 0.0 109.639 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -76.51 -69.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.781 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.786 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -65.33 150.0 49.02 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 109.887 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.96 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.538 -0.726 . . . . 0.0 109.906 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 94.9 mt 50.14 88.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.262 -0.899 . . . . 0.0 110.97 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -109.4 168.05 9.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.601 -0.687 . . . . 0.0 110.071 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.697 ' HA ' HG11 ' A' ' 9' ' ' VAL . 27.4 mt-10 -69.37 123.75 22.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.738 . . . . 0.0 110.077 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . 0.452 ' H ' ' HB ' ' A' ' 9' ' ' VAL . . . 85.64 37.32 9.62 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.763 ' O ' HG21 ' A' ' 9' ' ' VAL . 2.6 m-20 -115.61 132.9 56.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.588 -0.948 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.403 HD22 HG23 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -69.01 112.41 5.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.522 -0.737 . . . . 0.0 110.022 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.429 HG23 HG21 ' A' ' 9' ' ' VAL . 61.6 t -107.59 151.15 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -124.96 127.8 47.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.324 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -114.99 128.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 71.3 p -136.53 152.94 51.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 111.863 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.62 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 37.1 t80 -124.83 143.62 50.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -117.43 155.84 28.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.482 -0.761 . . . . 0.0 110.868 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -101.46 19.97 16.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.736 -0.603 . . . . 0.0 110.69 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -118.57 -28.7 5.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.358 -0.839 . . . . 0.0 110.616 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -105.36 -58.75 1.85 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.504 -0.747 . . . . 0.0 110.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.77 33.22 2.69 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -141.48 162.69 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.954 . . . . 0.0 109.831 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.869 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 37.8 t -112.11 123.67 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 0.0 109.922 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.5 ttpm? -105.45 150.08 25.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.713 -0.617 . . . . 0.0 109.874 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.845 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.7 pp -136.6 155.96 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.56 -0.713 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -154.92 -174.73 5.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.79 -0.569 . . . . 0.0 110.042 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.436 -0.79 . . . . 0.0 110.713 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.121 0.486 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.96 126.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.596 -0.69 . . . . 0.0 109.848 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.87 147.57 51.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.616 -0.678 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.17 146.38 18.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.708 . . . . 0.0 110.311 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 pt -112.62 150.35 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.63 -0.669 . . . . 0.0 110.218 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.6 m -136.52 150.6 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.625 -0.672 . . . . 0.0 110.267 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -94.06 138.04 32.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.136 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.49 HG11 ' O ' ' B' ' 28' ' ' LYS . 60.6 t -77.04 145.05 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 110.096 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -158.1 -55.4 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.579 -0.701 . . . . 0.0 110.219 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -168.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.666 -0.646 . . . . 0.0 110.033 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -77.93 67.84 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.51 -0.744 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.714 ' HH ' ' HG3' ' B' ' 29' ' ' GLU . 93.7 m-85 53.29 45.33 28.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -0.771 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.03 174.24 6.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.488 -0.758 . . . . 0.0 109.53 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.36 153.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.678 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -150.18 115.31 5.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.829 -0.545 . . . . 0.0 109.536 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.1 mt -71.73 143.01 86.55 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.545 -0.722 . . . . 0.0 110.204 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -61.23 -175.81 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.001 0 O-C-N 123.201 1.106 . . . . 0.0 110.216 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.07 -29.96 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 110.199 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.54 -48.26 49.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.539 -0.726 . . . . 0.0 110.012 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.43 -45.42 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.55 -0.719 . . . . 0.0 109.477 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.66 -32.31 73.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.513 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -63.61 -36.12 82.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 109.535 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -78.86 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.794 -0.566 . . . . 0.0 109.767 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.864 ' CE2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.47 159.58 6.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -80.72 -82.82 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.379 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.415 ' O ' ' HE2' ' B' ' 13' ' ' TYR . 45.3 mt 51.28 87.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.167 -0.958 . . . . 0.0 110.519 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 29.8 mtmt -107.05 -171.45 1.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.525 -0.734 . . . . 0.0 110.515 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.644 ' HA ' HG13 ' B' ' 9' ' ' VAL . 23.9 mt-10 -79.67 137.01 36.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.47 ' N ' ' HB ' ' B' ' 9' ' ' VAL . . . 58.45 44.09 95.51 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.953 . . . . 0.0 110.113 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.77 2.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 110.609 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.26 133.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 109.218 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -125.07 129.25 49.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.452 -0.78 . . . . 0.0 110.975 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t -123.72 129.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -138.17 148.38 44.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.375 -0.828 . . . . 0.0 111.235 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.87 ' CE1' ' CE2' ' B' ' 25' ' ' PHE . 47.9 t80 -113.92 135.65 53.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.32 162.7 12.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.762 . . . . 0.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.37 32.62 4.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.3 p -118.7 -60.69 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 110.102 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -87.03 -50.14 6.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 0.0 110.151 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.61 36.5 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.775 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 35.2 m -133.27 159.68 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -1.01 . . . . 0.0 110.342 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.989 ' HB ' ' CG2' ' B' ' 46' ' ' ILE . 45.6 t -103.23 127.51 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.667 . . . . 0.0 109.403 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.81 ' CD ' HG22 ' B' ' 43' ' ' VAL . 14.5 ttmt -112.13 125.54 54.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.632 . . . . 0.0 110.571 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 1.015 ' CG2' ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -113.04 138.66 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.687 . . . . 0.0 109.489 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.771 ' HG3' HG13 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -151.08 171.86 16.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.708 -0.62 . . . . 0.0 109.971 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.175 0.512 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.76 126.43 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.531 -0.731 . . . . 0.0 109.957 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -129.9 147.63 51.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.23 146.22 18.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.321 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.45 150.2 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.567 -0.708 . . . . 0.0 110.195 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.41 150.56 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.488 -0.757 . . . . 0.0 110.254 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.98 138.02 32.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.683 . . . . 0.0 110.2 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 29' ' ' GLU . 59.7 t -77.0 144.93 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.576 -0.703 . . . . 0.0 110.175 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -157.99 -55.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.591 -0.693 . . . . 0.0 110.278 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -168.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 0.0 110.112 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -78.08 67.92 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.717 . . . . 0.0 110.107 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.497 ' HH ' ' HG3' ' A' ' 29' ' ' GLU . 93.8 m-85 53.29 45.4 28.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 111.184 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.18 174.16 6.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.26 153.16 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.401 -0.812 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.2 t -150.22 115.22 5.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.68 -0.638 . . . . 0.0 109.508 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 80.9 mt -71.74 143.11 86.65 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.504 -0.748 . . . . 0.0 110.224 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.3 -175.91 0.15 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 O-C-N 123.1 1.053 . . . . 0.0 110.055 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.08 -29.74 24.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.582 -0.698 . . . . 0.0 110.242 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.65 -48.16 49.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.535 -0.728 . . . . 0.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.43 -45.48 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 0.0 109.492 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -65.71 -32.23 73.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.635 . . . . 0.0 109.562 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -63.62 -36.09 82.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.679 . . . . 0.0 109.474 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -79.03 -62.62 1.64 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.722 -0.611 . . . . 0.0 109.774 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.73 159.57 6.6 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.735 . . . . 0.0 110.015 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -80.69 -82.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.483 -0.76 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 45.5 mt 51.25 87.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.063 -1.023 . . . . 0.0 110.486 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . 0.49 ' O ' HG11 ' A' ' 9' ' ' VAL . 29.8 mtmt -107.19 -171.35 1.87 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.578 -0.702 . . . . 0.0 110.497 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.714 ' HG3' ' HH ' ' A' ' 13' ' ' TYR . 23.6 mt-10 -79.69 136.98 36.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . 0.478 ' N ' ' HB ' ' A' ' 9' ' ' VAL . . . 58.44 44.15 95.45 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.944 . . . . 0.0 110.142 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.57 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 110.684 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 9' ' ' VAL . 62.1 t -66.95 133.71 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.486 -0.758 . . . . 0.0 109.344 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -125.16 129.27 49.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -0.758 . . . . 0.0 111.04 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.74 129.28 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -138.19 148.42 44.82 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.402 -0.811 . . . . 0.0 111.272 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 25' ' ' PHE . 48.2 t80 -113.92 135.62 53.78 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.34 162.62 13.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.596 -0.69 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.34 32.6 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.627 -0.671 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.7 p -118.6 -60.62 1.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.619 -0.676 . . . . 0.0 110.069 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.15 -50.1 6.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.41 2.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.81 HG22 ' CD ' ' A' ' 45' ' ' LYS . 35.3 m -133.25 159.7 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.536 -0.979 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 1.015 ' HB ' ' CG2' ' A' ' 46' ' ' ILE . 45.9 t -103.26 127.51 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.527 -0.733 . . . . 0.0 109.409 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.775 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 14.8 ttmt -112.08 125.32 53.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.671 -0.643 . . . . 0.0 110.552 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.989 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -112.79 138.6 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.654 -0.654 . . . . 0.0 109.542 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.742 ' HG3' HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -151.04 171.86 16.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.203 0.525 . . . . 0.0 109.916 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.417 ' HB2' ' OD1' ' B' ' 38' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.79 119.83 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -0.75 . . . . 0.0 109.559 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -120.35 126.61 50.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 0.0 110.876 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.58 152.15 45.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.666 -0.646 . . . . 0.0 109.334 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.93 134.01 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.443 -0.786 . . . . 0.0 110.526 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.49 148.91 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 0.0 109.42 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.59 179.99 3.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 110.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.874 HG23 ' HB3' ' B' ' 31' ' ' ASP . 57.6 t -106.75 165.43 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.614 -0.679 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.1 p -102.87 -163.64 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.516 -0.74 . . . . 0.0 110.249 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.7 ' HG2' ' OE2' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -102.02 -25.34 13.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.748 . . . . 0.0 110.337 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.93 29.85 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 0.0 110.442 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.54 ' HE1' ' HA ' ' B' ' 28' ' ' LYS . 64.4 m-85 52.39 25.81 3.72 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.443 -0.786 . . . . 0.0 110.983 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -104.33 151.28 23.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.515 -0.741 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.93 146.07 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.594 -0.691 . . . . 0.0 110.114 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.5 p -110.72 123.94 51.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.689 -0.632 . . . . 0.0 109.756 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.7 mt -66.39 116.34 32.93 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.743 . . . . 0.0 109.711 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.3 169.17 4.11 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.156 1.082 . . . . 0.0 110.477 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.14 68.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.572 -0.705 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.85 -59.83 4.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.431 -0.793 . . . . 0.0 110.312 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.91 -40.78 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.379 -0.826 . . . . 0.0 109.22 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.32 -29.97 68.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.717 -0.614 . . . . 0.0 109.549 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -45.66 56.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.65 -69.13 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.661 -0.649 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.685 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.3 OUTLIER -73.44 151.3 41.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 109.659 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -81.37 -81.28 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.209 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.5 mt 54.49 93.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HA ' ' HE1' ' B' ' 13' ' ' TYR . 0.2 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 0.0 110.453 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.704 ' OE2' ' HG2' ' B' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.82 27.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.711 . . . . 0.0 110.411 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.34 50.9 4.87 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.907 ' HB3' HG22 ' B' ' 9' ' ' VAL . 3.2 t70 -110.06 155.68 21.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.487 -1.008 . . . . 0.0 110.266 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.29 52.34 0.84 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 109.706 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -61.12 170.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 0.0 110.404 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.3 122.03 7.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.69 144.31 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 109.141 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.9 p -138.79 150.53 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.218 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.7 t80 -134.46 147.13 50.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' OD1' ' HB2' ' B' ' 2' ' ' ALA . 2.2 t70 -122.04 178.45 4.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -0.785 . . . . 0.0 110.457 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.01 44.26 2.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.9 p -147.18 -52.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.017 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -40.43 21.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.732 -0.605 . . . . 0.0 109.754 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 32.96 17.51 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.729 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 33.0 m -131.61 156.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.745 ' HB ' ' CG2' ' B' ' 46' ' ' ILE . 56.3 t -104.2 133.81 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.506 -0.746 . . . . 0.0 109.455 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.742 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 0.2 OUTLIER -112.47 129.49 56.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.754 -0.591 . . . . 0.0 110.263 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.761 ' CG2' ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -123.51 139.44 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 109.861 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -158.62 -175.33 5.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 110.139 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.19 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . 0.434 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.202 0.525 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.85 119.9 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -120.43 126.59 50.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.477 -0.764 . . . . 0.0 110.979 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.51 152.08 45.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.674 -0.641 . . . . 0.0 109.303 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.82 134.04 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.531 -0.731 . . . . 0.0 110.537 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.9 t -137.44 148.96 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.714 -0.616 . . . . 0.0 109.485 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.76 179.9 3.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.431 -0.793 . . . . 0.0 110.326 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.907 HG22 ' HB3' ' A' ' 31' ' ' ASP . 58.0 t -106.77 165.55 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.586 -0.696 . . . . 0.0 110.182 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 78.0 p -102.92 -163.67 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.537 -0.727 . . . . 0.0 110.237 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.704 ' HG2' ' OE2' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -102.05 -25.33 13.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.611 -0.681 . . . . 0.0 110.255 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.92 29.8 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.456 -0.778 . . . . 0.0 110.374 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.567 ' HE1' ' HA ' ' A' ' 28' ' ' LYS . 64.5 m-85 52.35 25.74 3.65 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.463 -0.773 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.23 151.32 23.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.687 . . . . 0.0 109.883 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.99 146.07 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.601 -0.687 . . . . 0.0 110.159 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -110.77 123.95 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.36 116.28 32.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.29 169.03 4.21 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.143 1.075 . . . . 0.0 110.545 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.08 68.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 0.0 110.227 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -59.88 4.72 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.498 -0.751 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 109.229 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.27 -29.97 67.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -45.69 56.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.69 -68.97 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.635 -0.666 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.687 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -73.68 151.34 40.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.613 -0.679 . . . . 0.0 109.572 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -81.31 -81.4 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 111.22 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 15.5 mt 54.66 93.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.044 -1.035 . . . . 0.0 110.049 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . 0.54 ' HA ' ' HE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.612 -0.68 . . . . 0.0 110.436 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.7 ' OE2' ' HG2' ' A' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.79 27.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 110.358 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.45 50.88 4.86 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.874 ' HB3' HG23 ' A' ' 9' ' ' VAL . 3.2 t70 -110.13 155.64 21.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -1.034 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.25 52.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.489 -0.757 . . . . 0.0 109.865 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.9 170.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.605 -0.685 . . . . 0.0 110.481 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.18 122.19 7.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.685 -0.635 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 62.8 t -98.85 144.25 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.488 -0.758 . . . . 0.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -138.75 150.66 46.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.419 -0.8 . . . . 0.0 111.151 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.685 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 35.8 t80 -134.64 147.05 50.09 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 2' ' ' ALA . 2.2 t70 -121.92 178.54 4.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.457 -0.777 . . . . 0.0 110.485 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.1 44.33 2.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.169 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 85.6 p -147.32 -52.12 0.2 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.971 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.44 -40.45 21.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.85 17.71 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.742 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 32.9 m -131.53 156.95 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -1.041 . . . . 0.0 110.337 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.761 ' HB ' ' CG2' ' A' ' 46' ' ' ILE . 53.4 t -104.17 133.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.495 -0.753 . . . . 0.0 109.525 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.729 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -112.42 129.34 56.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 -179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.745 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.25 139.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.575 -0.703 . . . . 0.0 109.921 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -158.73 -175.46 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.171 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.2 0.524 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.8 164.87 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.451 -0.781 . . . . 0.0 110.498 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -131.76 146.74 52.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.809 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.33 162.17 39.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.21 136.23 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.639 . . . . 0.0 109.861 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.68 157.49 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 150.4 44.3 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.736 -0.602 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.416 HG21 ' O ' ' B' ' 31' ' ' ASP . 59.8 t -85.85 163.54 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.434 -0.791 . . . . 0.0 109.656 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.86 170.27 10.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.504 -0.748 . . . . 0.0 109.695 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -39.71 77.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -96.85 41.61 1.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.501 -0.749 . . . . 0.0 110.812 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 59.4 m-85 51.35 24.84 2.28 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.387 -0.821 . . . . 0.0 111.476 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -78.84 159.57 27.76 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.423 -0.798 . . . . 0.0 109.231 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.63 155.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.417 -0.802 . . . . 0.0 110.681 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.7 m -141.32 113.55 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -78.25 130.79 70.93 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.723 . . . . 0.0 110.03 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -55.79 -173.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.101 1.053 . . . . 0.0 110.605 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.48 -28.41 16.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.539 -0.726 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -59.24 3.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.53 -0.731 . . . . 0.0 110.915 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 22' ' ' ARG . 27.0 m -63.6 -33.76 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' N ' HG22 ' A' ' 21' ' ' VAL . 18.0 ttm180 -61.97 -37.29 84.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -68.9 -35.26 76.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.576 -0.702 . . . . 0.0 109.232 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -73.33 0.15 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.905 ' HD2' ' CD1' ' B' ' 37' ' ' PHE . 0.7 OUTLIER -60.5 158.63 11.83 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.592 -0.693 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -81.01 -84.12 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.394 -0.816 . . . . 0.0 110.855 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt 53.17 92.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.013 -1.054 . . . . 0.0 110.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -104.13 -170.53 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.695 -0.628 . . . . 0.0 110.818 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.59 126.49 35.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.738 -0.601 . . . . 0.0 110.164 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.1 45.36 15.85 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -112.67 142.93 44.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.988 . . . . 0.0 110.232 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.82 62.86 4.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.608 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -53.32 155.88 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.43 -0.794 . . . . 0.0 110.567 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -110.23 103.06 11.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.69 -0.631 . . . . 0.0 110.66 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.02 110.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.773 . . . . 0.0 108.933 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.2 p -128.14 150.42 49.99 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.562 0.696 . . . . 0.0 111.696 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.912 ' CD1' ' HD2' ' B' ' 25' ' ' PHE . 27.4 t80 -124.63 122.53 37.78 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.8 151.41 24.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 110.361 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.29 20.08 9.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.684 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -46.83 7.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.78 -30.27 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 109.859 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . . . 93.06 47.62 3.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.738 HG11 ' CG ' ' B' ' 47' ' ' GLN . 33.1 m -140.58 159.63 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.538 -0.978 . . . . 0.0 110.368 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.916 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 31.2 t -100.55 133.97 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.42 123.28 49.07 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.132 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.943 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.9 pt -109.17 134.16 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.752 ' HG3' HG11 ' B' ' 43' ' ' VAL . 54.0 tt0 -149.28 165.81 30.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.504 -0.747 . . . . 0.0 110.52 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.208 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.106 0.479 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -132.64 164.94 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.54 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -131.82 146.69 52.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.66 -0.65 . . . . 0.0 109.87 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.25 162.01 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.456 -0.778 . . . . 0.0 110.47 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.11 136.21 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.688 -0.632 . . . . 0.0 109.871 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -148.6 157.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.453 -0.78 . . . . 0.0 110.56 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 150.42 44.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 110.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -85.85 163.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 109.657 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.76 170.14 11.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.582 -0.699 . . . . 0.0 109.813 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -39.78 78.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.702 . . . . 0.0 110.502 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -96.84 41.61 1.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.468 -0.77 . . . . 0.0 110.92 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' B' ' 13' ' ' TYR . 58.5 m-85 51.49 24.7 2.34 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.442 -0.786 . . . . 0.0 111.499 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -78.88 159.41 27.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.396 -0.815 . . . . 0.0 109.094 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.59 155.85 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 0.0 110.687 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.5 m -141.3 113.53 8.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.09 130.99 70.74 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.541 -0.724 . . . . 0.0 110.109 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -56.19 -173.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.196 0 O-C-N 123.115 1.061 . . . . 0.0 110.436 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.35 -28.52 16.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.718 . . . . 0.0 110.878 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -59.25 3.03 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.489 -0.757 . . . . 0.0 110.887 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.65 -33.58 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -62.1 -37.11 83.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.203 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -69.08 -35.12 76.16 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -73.29 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.912 ' HD2' ' CD1' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -60.58 158.64 11.99 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -81.02 -84.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.362 -0.836 . . . . 0.0 110.856 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 88.0 mt 53.13 92.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.023 -1.048 . . . . 0.0 110.129 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -104.25 -170.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 110.821 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -88.51 126.54 35.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.825 -0.547 . . . . 0.0 110.185 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 45.26 15.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.416 ' O ' HG21 ' A' ' 9' ' ' VAL . 23.7 t70 -112.62 142.83 44.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.95 . . . . 0.0 110.24 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.85 62.95 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.744 -0.597 . . . . 0.0 109.495 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.5 155.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.479 -0.763 . . . . 0.0 110.583 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -110.33 102.95 11.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 110.591 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.84 110.75 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 49.6 p -128.12 150.62 49.9 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.645 0.736 . . . . 0.0 111.678 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.905 ' CD1' ' HD2' ' A' ' 25' ' ' PHE . 27.4 t80 -124.77 122.55 37.77 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.81 151.39 24.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.462 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.25 19.97 9.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.72 -46.57 7.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.98 -30.23 7.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.701 -0.624 . . . . 0.0 109.785 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . 0.568 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 93.11 47.49 3.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.752 HG11 ' HG3' ' A' ' 47' ' ' GLN . 33.1 m -140.65 159.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.56 -0.965 . . . . 0.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.943 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 32.4 t -100.49 133.81 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.16 123.23 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 111.317 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.916 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.9 pt -109.3 134.19 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.256 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.738 ' CG ' HG11 ' A' ' 43' ' ' VAL . 54.1 tt0 -149.26 165.81 30.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.683 -0.636 . . . . 0.0 110.611 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.566 -0.709 . . . . 0.0 110.142 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.18 150.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 110.139 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.95 157.34 44.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.604 -0.685 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.56 143.43 20.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.81 119.78 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.557 -0.714 . . . . 0.0 110.544 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.1 -176.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.474 -0.766 . . . . 0.0 110.139 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.71 163.73 29.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.484 -0.76 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.06 166.08 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.56 -0.712 . . . . 0.0 109.928 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' B' ' 29' ' ' GLU . 15.5 m -107.61 -156.64 0.59 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.468 -0.77 . . . . 0.0 110.514 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -79.09 -52.38 8.28 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.473 -0.767 . . . . 0.0 110.722 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.41 40.07 1.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 110.802 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.747 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 94.2 m-85 50.73 40.14 23.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.345 -0.847 . . . . 0.0 111.227 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.38 153.96 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.19 132.68 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 0.0 110.246 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.49 85.16 2.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.647 . . . . 0.0 109.631 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.0 145.42 89.34 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.62 -0.675 . . . . 0.0 110.273 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -61.9 -159.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.0 0 O-C-N 123.338 1.178 . . . . 0.0 110.367 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.11 -21.09 16.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.0 -55.84 29.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -0.882 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.22 -39.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.594 -0.691 . . . . 0.0 109.683 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -63.82 -32.31 73.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.661 -0.65 . . . . 0.0 109.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -54.1 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.56 -60.82 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.647 -0.658 . . . . 0.0 109.641 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.5 OUTLIER -74.07 128.18 34.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.54 -0.725 . . . . 0.0 110.355 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -78.58 96.97 5.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.517 -0.74 . . . . 0.0 110.104 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.5 mt -132.04 78.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.58 -0.7 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.768 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.3 OUTLIER -87.32 -158.67 0.46 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.653 -0.655 . . . . 0.0 110.606 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' B' ' 10' ' ' SER . 37.1 tt0 -87.41 91.62 8.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.696 -0.628 . . . . 0.0 110.31 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.99 47.24 0.31 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.985 . . . . 0.0 110.352 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mp -75.19 81.42 2.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.989 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -87.21 154.0 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.97 131.79 41.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.616 -0.677 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.91 131.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.532 -0.73 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.55 147.96 48.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.414 -0.804 . . . . 0.0 111.22 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.513 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 29.6 t80 -119.63 141.43 49.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -110.71 154.12 24.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.756 . . . . 0.0 110.733 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.41 29.11 7.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.024 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 p -117.91 -35.21 3.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.713 . . . . 0.0 110.305 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.29 -65.82 1.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.493 -0.754 . . . . 0.0 110.26 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.32 42.6 0.27 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.718 ' HB ' ' CG ' ' B' ' 45' ' ' LYS . 34.6 m -133.9 156.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.971 . . . . 0.0 109.665 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.811 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 29.2 t -116.36 115.4 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.838 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.732 ' CG ' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -99.94 146.82 26.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.735 -0.603 . . . . 0.0 109.997 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.811 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 12.9 pt -128.74 155.81 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.679 -0.638 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.471 ' HB2' HG12 ' B' ' 43' ' ' VAL . 38.9 tt0 -159.95 160.82 33.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.646 -0.659 . . . . 0.0 110.105 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 O-C-N 121.591 -0.693 . . . . 0.0 109.994 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.19 150.9 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 110.113 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.85 157.41 44.39 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.549 -0.72 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.62 143.48 20.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.244 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.79 119.97 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.559 -0.713 . . . . 0.0 110.477 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.35 -177.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.72 163.71 29.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.497 -0.752 . . . . 0.0 110.507 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.2 t -74.07 166.13 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.599 -0.688 . . . . 0.0 109.904 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 15.4 m -107.69 -156.67 0.59 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.44 -0.787 . . . . 0.0 110.449 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -79.05 -52.46 8.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.47 -0.769 . . . . 0.0 110.663 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.3 39.98 1.11 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.768 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 94.2 m-85 50.86 40.04 23.88 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.321 -0.862 . . . . 0.0 111.218 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.35 154.0 19.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.22 132.78 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.573 -0.704 . . . . 0.0 110.205 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.6 85.17 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 109.609 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.01 145.44 89.36 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.647 -0.658 . . . . 0.0 110.204 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.02 -159.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.986 0 O-C-N 123.347 1.183 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.12 -21.19 16.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.714 -0.616 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.02 -56.01 27.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.339 -0.851 . . . . 0.0 110.366 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -62.06 -39.1 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.576 -0.703 . . . . 0.0 109.7 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -63.89 -32.23 73.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.621 -0.674 . . . . 0.0 109.927 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -54.1 25.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.717 . . . . 0.0 109.645 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.42 -60.95 2.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.614 -0.679 . . . . 0.0 109.654 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.513 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -74.03 128.09 34.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.662 -0.649 . . . . 0.0 110.34 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -78.51 97.05 5.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.559 -0.713 . . . . 0.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . 0.406 HD11 HG23 ' B' ' 27' ' ' ILE . 88.6 mt -132.14 78.51 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.572 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . 0.747 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -87.37 -158.58 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.763 -0.586 . . . . 0.0 110.553 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 10' ' ' SER . 37.1 tt0 -87.51 91.81 8.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.648 -0.657 . . . . 0.0 110.238 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.76 47.38 0.32 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.12 133.9 53.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.971 . . . . 0.0 110.32 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.15 81.53 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.708 -0.62 . . . . 0.0 110.028 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -87.23 153.97 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.563 -0.711 . . . . 0.0 110.392 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.98 131.78 41.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.576 -0.703 . . . . 0.0 110.21 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.95 131.93 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.583 -0.698 . . . . 0.0 109.566 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.69 148.01 48.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 111.237 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 29.8 t80 -119.69 141.41 49.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -110.75 154.04 24.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.29 29.0 7.19 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.626 -0.672 . . . . 0.0 110.094 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 5.4 p -117.79 -35.23 3.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.28 -65.83 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.23 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.28 42.43 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.732 ' HB ' ' CG ' ' A' ' 45' ' ' LYS . 34.6 m -133.78 156.9 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.977 . . . . 0.0 109.704 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.811 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 30.8 t -116.48 115.28 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.291 -0.881 . . . . 0.0 109.986 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.718 ' CG ' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -99.86 146.78 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.811 -0.556 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.811 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 12.7 pt -128.68 155.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.709 -0.62 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -159.88 160.83 34.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.691 -0.63 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.469 ' N ' ' OE1' ' B' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.063 0.459 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.8 150.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.571 -0.706 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -147.99 116.0 6.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 109.937 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.52 173.96 8.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.47 -0.769 . . . . 0.0 110.641 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.424 HG21 ' HE2' ' B' ' 34' ' ' LYS . 26.8 pt -120.53 130.92 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.685 -0.635 . . . . 0.0 109.894 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.559 HG21 ' O ' ' B' ' 33' ' ' VAL . 33.1 m -131.37 146.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.576 -0.703 . . . . 0.0 110.265 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -103.58 154.21 19.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.39 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 1.032 ' O ' ' HA2' ' B' ' 30' ' ' GLY . 58.2 t -109.91 142.46 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.584 -0.697 . . . . 0.0 109.58 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.9 p -169.83 -170.52 1.04 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 111.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.93 -86.77 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.697 -0.627 . . . . 0.0 110.984 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.76 55.52 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.061 -1.024 . . . . 0.0 110.579 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.456 ' HE1' ' C ' ' B' ' 28' ' ' LYS . 71.9 m-85 49.33 47.43 22.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.457 -0.777 . . . . 0.0 111.048 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -112.25 154.15 26.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 110.13 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.92 135.85 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 110.391 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.4 p -108.2 106.87 17.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.782 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.41 126.96 93.0 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.688 . . . . 0.0 109.584 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.86 -77.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.06 1.032 . . . . 0.0 110.645 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.11 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.48 -0.763 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.77 -46.79 86.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.726 -0.609 . . . . 0.0 110.156 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.73 -43.69 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.698 . . . . 0.0 109.343 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.87 -27.66 68.3 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.612 -0.68 . . . . 0.0 110.164 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.04 -39.19 42.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.985 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -79.46 -70.37 0.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.648 . . . . 0.0 109.969 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.632 ' CD2' ' CG2' ' B' ' 44' ' ' VAL . 0.5 OUTLIER -65.65 133.59 51.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.516 -0.74 . . . . 0.0 110.57 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -81.84 87.92 6.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.59 76.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.593 -0.692 . . . . 0.0 109.481 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' C ' ' HE1' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -58.65 168.86 1.07 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.782 -0.574 . . . . 0.0 110.633 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' CE1' ' B' ' 13' ' ' TYR . 0.5 OUTLIER -74.87 72.66 2.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.73 -0.606 . . . . 0.0 110.139 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 1.03 ' HA2' ' O ' ' B' ' 9' ' ' VAL . . . 137.54 45.17 0.08 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.491 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 2.9 m-20 -105.42 147.54 28.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.613 -0.934 . . . . 0.0 110.323 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.32 76.8 5.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.461 -0.774 . . . . 0.0 110.064 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' HG21 ' B' ' 7' ' ' VAL . 59.0 t -86.65 143.23 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.525 -0.734 . . . . 0.0 110.082 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' B' ' 6' ' ' ILE . 0.6 OUTLIER -111.73 130.59 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.723 . . . . 0.0 110.166 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.95 130.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.625 -0.672 . . . . 0.0 109.498 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 p -129.02 145.01 51.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.54 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 49.8 t80 -121.09 129.73 53.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -107.47 146.9 31.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.426 -0.796 . . . . 0.0 110.774 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 2' ' ' ALA . 28.0 mt-10 -97.94 30.36 3.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.669 -0.644 . . . . 0.0 110.045 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.88 -34.47 3.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.638 -0.664 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -114.66 -42.08 3.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.531 -0.731 . . . . 0.0 110.281 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.52 37.43 4.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.61 152.31 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.73 -0.864 . . . . 0.0 109.645 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.834 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 56.3 t -99.2 127.35 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 2.1 ttpp -108.5 124.37 50.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.831 -0.543 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.818 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 9.1 pt -117.02 148.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.752 . . . . 0.0 110.447 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -161.53 -171.67 3.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.572 -0.705 . . . . 0.0 110.599 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.061 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . 0.476 ' N ' ' OE1' ' A' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.07 0.462 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.79 150.26 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.589 -0.694 . . . . 0.0 110.09 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -148.16 116.01 6.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.677 -0.639 . . . . 0.0 109.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.65 174.06 8.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.714 . . . . 0.0 110.554 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.437 HG23 HD13 ' B' ' 6' ' ' ILE . 27.6 pt -120.57 130.73 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.686 -0.634 . . . . 0.0 109.899 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 33' ' ' VAL . 33.3 m -131.25 146.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.533 -0.729 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -103.5 154.22 19.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 1.03 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 57.7 t -109.95 142.45 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.695 -0.628 . . . . 0.0 109.6 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 84.7 p -169.78 -170.5 1.04 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 0.0 111.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.9 -86.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.721 -0.612 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.7 55.49 1.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.04 -1.038 . . . . 0.0 110.564 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.476 ' HE1' ' C ' ' A' ' 28' ' ' LYS . 71.4 m-85 49.34 47.36 22.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.439 -0.788 . . . . 0.0 111.08 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -112.21 154.22 25.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.161 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.97 135.98 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.624 -0.673 . . . . 0.0 110.314 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 40.5 p -108.31 106.86 17.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.739 -0.601 . . . . 0.0 109.773 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.48 126.91 92.93 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.7 -78.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.091 1.048 . . . . 0.0 110.648 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.74 -37.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.752 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.57 -46.9 85.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.625 -0.672 . . . . 0.0 110.123 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.71 -43.63 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.362 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.94 -27.68 68.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.653 -0.654 . . . . 0.0 110.049 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.05 -39.21 42.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.533 -0.729 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -79.54 -70.32 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.591 -0.693 . . . . 0.0 109.968 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.626 ' CD2' ' CG2' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -65.55 133.52 51.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -0.756 . . . . 0.0 110.563 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -81.88 88.05 6.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.522 -0.736 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.71 76.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 0.0 109.472 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . 0.456 ' C ' ' HE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -58.54 168.74 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.75 -0.594 . . . . 0.0 110.65 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.448 ' N ' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -74.79 72.53 2.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.607 -0.683 . . . . 0.0 110.138 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . 1.032 ' HA2' ' O ' ' A' ' 9' ' ' VAL . . . 137.81 44.85 0.08 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.486 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 3.0 m-20 -105.3 147.54 28.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.405 -1.056 . . . . 0.0 110.362 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.35 76.82 5.91 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.519 -0.738 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.559 ' O ' HG21 ' A' ' 7' ' ' VAL . 57.4 t -86.52 143.13 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.512 -0.742 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HE2' HG21 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -111.7 130.57 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.86 130.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 61.2 p -129.1 144.9 51.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.417 -0.802 . . . . 0.0 111.354 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.552 ' CD1' ' CD2' ' A' ' 25' ' ' PHE . 50.1 t80 -121.11 129.86 53.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -107.54 146.88 31.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.656 -0.653 . . . . 0.0 110.823 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 2' ' ' ALA . 28.1 mt-10 -97.99 30.47 3.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.609 -0.682 . . . . 0.0 110.107 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 -34.58 3.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 110.243 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -114.53 -42.17 3.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.501 -0.749 . . . . 0.0 110.319 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.76 37.19 4.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.64 152.08 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.824 -0.809 . . . . 0.0 109.676 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.818 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.0 t -98.95 127.21 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.715 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.2 ttpp -108.26 124.27 50.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.834 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.9 pt -116.92 148.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.535 -0.728 . . . . 0.0 110.464 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -161.18 -171.74 3.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.706 -0.622 . . . . 0.0 110.742 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.672 . . . . 0.0 110.104 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.236 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.77 148.71 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.581 -0.699 . . . . 0.0 109.596 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -140.31 140.2 35.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.898 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.44 161.18 41.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.633 -0.667 . . . . 0.0 109.637 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.23 160.58 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.432 -0.793 . . . . 0.0 110.738 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.45 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.677 -0.64 . . . . 0.0 109.75 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -110.08 151.64 26.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 0.0 110.46 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.08 145.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.647 -0.658 . . . . 0.0 109.649 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 t -172.14 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.535 -0.728 . . . . 0.0 110.741 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.16 -78.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.36 -0.837 . . . . 0.0 111.201 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -162.14 69.18 0.28 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.37 -0.831 . . . . 0.0 110.343 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 52.42 23.94 2.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.271 -0.893 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.9 169.84 8.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.48 -0.762 . . . . 0.0 109.629 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -146.21 135.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.477 -0.764 . . . . 0.0 110.539 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.35 -174.69 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.617 . . . . 0.0 109.525 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.29 138.48 22.86 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -60.3 -164.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.163 1.086 . . . . 0.0 110.271 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.82 -26.41 13.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -65.87 -62.6 1.41 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.498 -0.751 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 22' ' ' ARG . 9.0 p -60.46 -36.18 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 109.609 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' N ' HG12 ' A' ' 21' ' ' VAL . 25.2 ttm180 -64.54 -30.16 71.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.62 -0.675 . . . . 0.0 109.255 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -45.41 82.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -68.76 -71.99 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.671 -0.643 . . . . 0.0 109.27 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -63.12 141.09 58.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.474 -0.766 . . . . 0.0 109.577 179.209 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.39 -83.64 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 110.376 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 25' ' ' PHE . 85.5 mt 51.07 77.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.032 -1.042 . . . . 0.0 110.857 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -105.6 177.25 4.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.449 -0.782 . . . . 0.0 110.205 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.83 77.33 0.88 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.573 -0.704 . . . . 0.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.91 56.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.32 170.38 16.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.94 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.56 103.6 7.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.595 -0.69 . . . . 0.0 110.197 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -95.08 157.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 110.482 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -108.29 131.28 54.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.608 -0.682 . . . . 0.0 110.191 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.4 t -122.43 136.63 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.741 . . . . 0.0 109.317 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 p -141.85 147.48 37.25 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.425 -0.797 . . . . 0.0 111.596 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' B' ' 24' ' ' LYS . 27.1 t80 -106.38 137.16 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.51 175.92 6.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 110.9 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.21 36.64 4.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 110.088 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -127.53 -67.02 0.85 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.621 -0.674 . . . . 0.0 110.023 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.6 -38.58 13.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.21 55.87 0.85 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.48 161.63 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.601 -0.941 . . . . 0.0 110.309 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.629 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 60.3 t -116.08 120.26 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.519 -0.738 . . . . 0.0 109.514 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 17.9 ttmt -109.92 151.53 26.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.752 -0.593 . . . . 0.0 110.799 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.627 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 7.8 pt -134.56 159.58 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.617 -0.677 . . . . 0.0 110.615 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -152.81 164.0 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 110.111 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.457 -0.777 . . . . 0.0 111.237 -179.421 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.202 0.525 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.78 148.65 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.24 140.22 35.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.447 -0.783 . . . . 0.0 110.924 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.43 161.2 41.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.755 -0.591 . . . . 0.0 109.575 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.2 160.59 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.433 -0.792 . . . . 0.0 110.708 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.43 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.642 -0.661 . . . . 0.0 109.663 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -110.06 151.6 27.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.743 . . . . 0.0 110.479 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.08 145.39 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.656 -0.652 . . . . 0.0 109.71 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.9 t -172.13 -37.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.17 -78.11 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.455 -0.778 . . . . 0.0 111.241 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.16 69.02 0.27 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 110.376 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 52.62 23.9 2.86 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.343 -0.848 . . . . 0.0 111.003 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.86 169.78 8.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.644 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -146.21 135.49 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.38 -174.64 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 109.517 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.401 ' CG2' HG11 ' B' ' 21' ' ' VAL . 4.2 mp -138.43 138.5 22.58 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -60.19 -164.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.151 1.079 . . . . 0.0 110.355 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.85 -26.5 13.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.573 -0.704 . . . . 0.0 110.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -65.79 -62.57 1.43 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.41 HG11 ' N ' ' B' ' 22' ' ' ARG . 9.2 p -60.45 -36.25 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.41 ' N ' HG11 ' B' ' 21' ' ' VAL . 25.1 ttm180 -64.5 -30.15 71.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -45.38 81.91 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.408 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 19.7 mmtm -68.77 -71.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.646 -0.659 . . . . 0.0 109.296 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -63.1 141.05 58.91 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -72.38 -83.62 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.402 -0.812 . . . . 0.0 110.428 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 85.6 mt 51.05 77.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.055 -1.028 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -105.58 177.27 4.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.182 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.93 77.41 0.9 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.534 -0.729 . . . . 0.0 110.139 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.84 56.88 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.46 170.4 16.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.577 -0.955 . . . . 0.0 110.103 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.46 103.59 7.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.573 -0.705 . . . . 0.0 110.299 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -95.01 157.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.638 -0.664 . . . . 0.0 110.461 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -108.38 131.23 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.649 -0.657 . . . . 0.0 110.14 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.5 136.56 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.705 . . . . 0.0 109.326 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 8.5 p -141.79 147.52 37.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.396 -0.815 . . . . 0.0 111.479 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -106.39 137.03 45.1 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.39 175.84 6.1 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.279 -0.888 . . . . 0.0 110.993 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.11 36.51 4.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 110.064 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -127.53 -66.88 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.573 -0.704 . . . . 0.0 110.025 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -90.55 -38.61 13.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.578 -0.701 . . . . 0.0 110.072 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.17 55.92 0.85 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.493 HG23 ' HD3' ' A' ' 45' ' ' LYS . 34.1 m -136.54 161.48 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.529 -0.983 . . . . 0.0 110.214 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.627 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.5 t -115.92 120.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.424 -0.798 . . . . 0.0 109.566 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 17.9 ttmt -109.75 151.37 27.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.677 -0.639 . . . . 0.0 110.921 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.629 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 7.8 pt -134.41 159.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.722 -0.611 . . . . 0.0 110.671 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -152.69 164.09 38.41 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 110.123 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.498 1.962 0 O-C-N 121.391 -0.818 . . . . 0.0 111.31 -179.476 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.182 0.515 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.96 147.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.593 -0.692 . . . . 0.0 110.152 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -125.79 135.48 52.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.697 -0.627 . . . . 0.0 109.786 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.69 164.5 38.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.0 110.776 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.35 133.16 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.652 -0.655 . . . . 0.0 109.521 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.37 159.32 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -113.09 158.17 20.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.695 -0.628 . . . . 0.0 109.693 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.444 HG22 ' O ' ' B' ' 31' ' ' ASP . 69.9 t -94.18 147.91 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.54 -0.725 . . . . 0.0 110.172 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.7 t -171.05 -168.81 0.68 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.571 -0.705 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.57 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.717 -0.614 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.14 79.5 0.16 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.01 -1.057 . . . . 0.0 111.563 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 53.14 56.99 6.74 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.314 -0.866 . . . . 0.0 111.433 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -130.26 153.33 48.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.82 . . . . 0.0 110.495 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -123.87 101.48 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.703 -0.623 . . . . 0.0 110.074 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -74.87 153.99 38.42 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.543 -0.723 . . . . 0.0 110.077 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -98.91 130.99 26.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.564 -0.71 . . . . 0.0 109.789 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.99 -167.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.042 1.022 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.52 -36.51 17.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 110.221 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.55 -43.17 85.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 110.103 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.32 -38.47 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.714 . . . . 0.0 109.64 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -67.87 -41.47 82.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.168 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -67.55 -45.19 76.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 109.916 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.2 -68.68 0.64 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.704 -0.622 . . . . 0.0 109.999 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -70.87 119.78 15.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.594 -0.691 . . . . 0.0 110.272 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.04 108.68 13.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.706 -0.621 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.65 76.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.472 -0.767 . . . . 0.0 109.981 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -97.23 175.35 6.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.632 -0.668 . . . . 0.0 110.011 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.26 125.62 24.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.52 -0.737 . . . . 0.0 109.997 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 20.4 12.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -111.83 114.8 27.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 95.93 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.624 . . . . 0.0 110.728 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.13 133.13 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.655 -0.653 . . . . 0.0 109.403 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 165.78 11.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.501 -0.749 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.68 136.15 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.658 -0.651 . . . . 0.0 109.873 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.3 p -141.87 146.41 35.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 110.904 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -103.64 140.28 37.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.732 -0.605 . . . . 0.0 109.539 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.33 173.39 6.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.645 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.71 33.97 5.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 110.059 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.5 t -121.65 -63.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 0.0 110.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.37 -35.9 10.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 110.58 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.82 56.97 0.88 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.25 166.92 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.631 -0.923 . . . . 0.0 110.053 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.505 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 47.4 t -119.71 116.6 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.358 -0.839 . . . . 0.0 109.833 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -98.96 139.93 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 110.44 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.502 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.4 pt -131.72 157.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.561 -0.712 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -161.26 168.71 23.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.461 -0.775 . . . . 0.0 110.464 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.539 -0.726 . . . . 0.0 109.568 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.225 0.536 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.03 147.17 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.563 -0.71 . . . . 0.0 110.178 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -125.64 135.6 52.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.69 -0.631 . . . . 0.0 109.75 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.76 164.53 38.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.728 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.437 HD13 HG21 ' B' ' 6' ' ' ILE . 87.8 mt -132.49 133.13 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 109.495 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.33 159.31 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.326 -0.859 . . . . 0.0 110.783 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -113.06 158.11 20.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.727 -0.608 . . . . 0.0 109.78 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 73.4 t -94.18 147.83 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 110.185 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -171.04 -168.75 0.68 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.361 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.6 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.674 -0.641 . . . . 0.0 110.831 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.13 79.47 0.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.965 -1.084 . . . . 0.0 111.559 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 53.07 57.15 6.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.301 -0.874 . . . . 0.0 111.459 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -130.47 153.23 49.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.332 -0.855 . . . . 0.0 110.586 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.9 t -123.78 101.4 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.763 -0.586 . . . . 0.0 110.082 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -74.83 153.9 38.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 110.075 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 34.1 mt -98.84 130.93 26.59 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.83 -167.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.161 1.085 . . . . 0.0 110.347 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.51 -36.47 17.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.63 -43.05 85.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.607 -0.683 . . . . 0.0 110.168 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.4 -38.44 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.573 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -67.9 -41.52 82.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.736 -0.603 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -67.5 -45.13 76.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.941 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.36 -68.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 109.971 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -70.87 119.78 15.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.7 -0.625 . . . . 0.0 110.227 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.09 108.75 13.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.627 -0.671 . . . . 0.0 110.327 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.63 76.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -97.25 175.39 6.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.659 -0.651 . . . . 0.0 110.018 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.37 125.74 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 110.017 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 20.42 12.24 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.444 ' O ' HG22 ' A' ' 9' ' ' VAL . 4.9 m-20 -111.77 114.87 28.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.7 95.82 1.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.606 -0.684 . . . . 0.0 110.76 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 64.2 t -94.11 133.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.501 -0.749 . . . . 0.0 109.374 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.37 165.83 11.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.492 -0.755 . . . . 0.0 110.356 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.69 136.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 109.775 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -141.91 146.42 35.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.456 -0.778 . . . . 0.0 110.979 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -103.67 140.36 37.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.481 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.34 173.44 6.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.525 -0.734 . . . . 0.0 110.618 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.7 33.76 5.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.675 -0.641 . . . . 0.0 110.027 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 36.9 t -121.48 -63.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.565 -0.71 . . . . 0.0 110.441 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.3 -35.96 10.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.525 -0.734 . . . . 0.0 110.498 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.85 56.87 0.88 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -133.25 166.75 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.654 -0.909 . . . . 0.0 110.066 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.502 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 47.3 t -119.61 116.64 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.315 -0.865 . . . . 0.0 109.868 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -99.0 139.84 34.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.578 -0.701 . . . . 0.0 110.419 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.505 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.4 pt -131.65 156.86 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 110.384 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -161.0 168.85 23.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.506 -0.746 . . . . 0.0 110.459 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.639 -0.663 . . . . 0.0 109.555 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.046 0.45 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.38 138.18 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.27 152.11 51.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.562 -0.712 . . . . 0.0 109.9 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.25 152.12 32.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.496 -0.753 . . . . 0.0 110.367 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.8 mt -120.11 125.4 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.634 -0.666 . . . . 0.0 109.567 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.54 155.91 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.498 -0.751 . . . . 0.0 110.59 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.46 145.1 38.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.688 -0.632 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.27 130.74 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.605 -0.684 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -170.85 -157.04 0.13 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.498 -0.751 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 mtt85 55.74 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.727 -0.608 . . . . 0.0 111.075 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -150.83 56.39 0.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.096 -1.002 . . . . 0.0 110.561 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.95 38.25 19.73 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.304 -0.873 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.57 176.94 6.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.25 128.58 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.46 -21.49 21.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.331 -0.856 . . . . 0.0 111.49 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.3 mt 59.87 115.32 0.02 OUTLIER Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.718 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.67 175.18 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 122.858 0.925 . . . . 0.0 110.775 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.59 -27.13 61.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.615 -0.678 . . . . 0.0 110.568 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -54.32 46.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.493 -0.754 . . . . 0.0 110.521 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.53 -45.63 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.38 -0.825 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -60.0 -31.39 69.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -48.42 64.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.629 -0.669 . . . . 0.0 109.502 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.437 ' HB3' ' CD2' ' B' ' 37' ' ' PHE . 0.0 OUTLIER -65.12 -65.29 0.69 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.686 -0.633 . . . . 0.0 109.514 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.499 ' CD1' ' CE1' ' B' ' 37' ' ' PHE . 0.6 OUTLIER -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.666 -0.646 . . . . 0.0 110.151 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -73.55 -74.95 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.566 -0.709 . . . . 0.0 109.912 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 27' ' ' ILE . 47.4 mm 52.95 84.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.396 -0.815 . . . . 0.0 110.608 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.35 148.57 37.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.632 -0.668 . . . . 0.0 110.379 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -61.69 109.44 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.586 -0.696 . . . . 0.0 110.134 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 55.22 1.31 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -126.92 158.38 36.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 0.0 110.274 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -92.78 82.95 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.502 HG22 ' CG2' ' B' ' 9' ' ' VAL . 61.2 t -86.81 156.45 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.825 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' B' ' 5' ' ' GLU . 5.1 tttt -134.17 147.14 50.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 110.25 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.81 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 0.0 109.664 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.7 p -134.51 155.84 49.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.987 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE1' ' CD1' ' B' ' 25' ' ' PHE . 26.3 t80 -133.97 121.85 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.708 -0.62 . . . . 0.0 109.536 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -99.97 168.8 9.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 110.174 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.53 32.12 5.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 110.009 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 p -117.61 -48.83 2.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 110.139 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.65 -29.64 12.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 110.163 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.91 39.62 11.54 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.3 155.14 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.888 . . . . 0.0 110.327 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.628 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 40.2 t -103.01 115.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -100.63 130.01 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.844 -0.535 . . . . 0.0 110.165 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.64 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 8.7 pt -124.45 151.44 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.521 -0.737 . . . . 0.0 110.959 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -159.3 -168.98 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.675 -0.641 . . . . 0.0 110.071 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.078 0.466 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.46 138.27 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.573 -0.704 . . . . 0.0 109.998 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -133.3 152.16 51.92 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.649 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.638 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.5 mp0 -151.29 152.15 32.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 mt -120.08 125.43 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.592 -0.692 . . . . 0.0 109.647 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.51 155.84 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.752 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.4 145.2 37.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.653 . . . . 0.0 110.036 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.502 ' CG2' HG22 ' A' ' 33' ' ' VAL . 64.9 t -79.27 130.87 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.569 -0.707 . . . . 0.0 109.991 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -171.09 -157.08 0.12 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.611 -0.68 . . . . 0.0 110.089 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 39.5 mtt85 55.75 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.646 -0.659 . . . . 0.0 111.131 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.82 56.36 0.91 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.067 -1.021 . . . . 0.0 110.518 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.9 38.3 19.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.263 -0.898 . . . . 0.0 110.857 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.6 176.95 6.83 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.52 -0.738 . . . . 0.0 111.179 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.24 128.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.52 -21.44 21.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.492 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 68.5 mt 59.85 115.35 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -57.8 175.19 0.47 Allowed 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 122.893 0.944 . . . . 0.0 110.819 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.07 61.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -54.26 47.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.56 -45.69 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -59.85 -31.56 69.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -48.32 64.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.685 -0.634 . . . . 0.0 109.563 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -65.25 -65.19 0.71 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.629 -0.669 . . . . 0.0 109.484 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.505 ' CD1' ' CE1' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -65.82 164.94 13.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.682 -0.636 . . . . 0.0 110.123 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.59 -74.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.607 -0.683 . . . . 0.0 109.914 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 47.6 mm 52.85 84.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.445 -0.784 . . . . 0.0 110.584 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.39 148.77 37.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.555 -0.716 . . . . 0.0 110.281 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -61.84 109.49 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.594 -0.691 . . . . 0.0 110.098 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 55.15 1.33 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -126.91 158.41 36.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.598 -0.942 . . . . 0.0 110.303 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -92.79 82.92 4.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.8 156.43 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 0.0 109.918 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 5.4 tttt -134.16 147.09 50.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.546 -0.721 . . . . 0.0 110.28 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 47.7 t -127.69 136.11 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.634 -0.666 . . . . 0.0 109.704 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -134.54 155.85 49.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.442 -0.786 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.499 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 26.4 t80 -134.03 121.94 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.705 -0.622 . . . . 0.0 109.468 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -100.07 168.79 9.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.728 -0.607 . . . . 0.0 110.182 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.52 31.97 5.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 74.6 p -117.55 -48.77 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.148 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.67 -29.56 12.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.68 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.82 39.79 11.46 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.31 155.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.744 -0.857 . . . . 0.0 110.343 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.64 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 41.1 t -103.1 115.39 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -100.22 129.8 46.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.761 -0.587 . . . . 0.0 110.342 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.628 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.8 pt -124.1 151.49 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.518 -0.739 . . . . 0.0 110.983 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -159.38 -168.96 2.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.783 -0.573 . . . . 0.0 110.348 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 109.958 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.053 0.454 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.99 112.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.067 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.38 160.51 14.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.543 -0.723 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.39 148.76 28.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.2 mt -120.32 147.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.638 -0.664 . . . . 0.0 109.777 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 p -168.18 161.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.512 -0.743 . . . . 0.0 110.365 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.86 -170.73 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 110.144 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.77 156.01 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.754 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.8 p -168.95 -176.93 2.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.764 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.94 -157.51 0.15 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.521 -0.737 . . . . 0.0 110.765 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -87.98 65.54 8.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.695 . . . . 0.0 110.271 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.41 33.03 14.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.468 -0.77 . . . . 0.0 111.042 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.86 151.37 25.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.702 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.04 140.03 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 t -144.77 110.59 5.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 109.891 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 88.3 mt -71.26 142.26 86.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.069 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -69.16 179.88 3.09 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.345 1.182 . . . . 0.0 110.465 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.43 43.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.7 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.65 -50.77 72.16 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.11 -36.18 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.267 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.94 -47.67 65.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.312 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -69.33 0.29 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.683 -0.636 . . . . 0.0 109.355 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.3 OUTLIER -66.41 156.25 35.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.579 -0.701 . . . . 0.0 109.719 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.77 -81.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.494 -0.754 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.6 mt 50.63 87.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.191 -0.943 . . . . 0.0 110.895 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -124.77 173.0 8.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.727 . . . . 0.0 109.917 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.86 5.66 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 0.0 110.266 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.27 61.6 1.55 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -133.96 138.08 45.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.522 -0.987 . . . . 0.0 110.152 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.81 90.78 8.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.543 -0.723 . . . . 0.0 110.325 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -97.21 152.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.629 -0.669 . . . . 0.0 109.789 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 151.59 48.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.541 -0.724 . . . . 0.0 110.627 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.0 127.57 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.7 p -127.37 150.11 49.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.497 -0.752 . . . . 0.0 111.367 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.1 t80 -136.23 125.33 24.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.51 -177.68 3.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 0.0 110.532 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -124.24 24.21 8.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.713 -0.617 . . . . 0.0 110.461 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.6 t -119.45 -40.36 2.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 110.072 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.61 -49.6 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 110.128 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.31 43.78 2.49 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.554 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 34.9 m -141.41 156.23 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.576 -0.955 . . . . 0.0 110.032 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' B' ' 46' ' ' ILE . 46.6 t -106.23 125.5 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.956 -0.697 . . . . 0.0 109.925 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.546 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -107.83 128.28 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.665 -0.647 . . . . 0.0 110.259 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG12 ' HB ' ' B' ' 44' ' ' VAL . 22.1 pt -116.76 153.56 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.735 . . . . 0.0 110.356 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -156.26 162.76 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.578 -0.701 . . . . 0.0 110.428 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 110.166 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.047 0.451 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.95 112.78 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.678 . . . . 0.0 110.03 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.4 160.54 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.44 148.68 28.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.545 -0.722 . . . . 0.0 110.43 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 23.3 mt -120.31 147.73 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.643 -0.661 . . . . 0.0 109.757 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.25 161.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.423 -0.798 . . . . 0.0 110.356 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.77 -170.65 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 156.03 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.109 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -169.02 -177.02 2.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.482 -0.761 . . . . 0.0 110.454 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.97 -157.54 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.454 -0.779 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -88.02 65.66 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.226 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.5 32.74 14.69 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.0 111.083 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.7 151.41 25.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.553 -0.717 . . . . 0.0 109.759 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.09 140.03 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -144.67 110.5 5.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.609 -0.682 . . . . 0.0 109.936 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 88.7 mt -71.37 142.33 86.68 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.475 -0.765 . . . . 0.0 110.046 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -69.31 179.95 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.393 1.207 . . . . 0.0 110.419 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.34 43.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.107 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -60.8 -50.6 72.8 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.602 -0.687 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.05 -36.3 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.671 -0.643 . . . . 0.0 109.267 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -64.03 -31.97 73.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.641 -0.662 . . . . 0.0 109.587 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -47.54 65.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.668 . . . . 0.0 109.299 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -69.42 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.292 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -66.37 156.14 35.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.638 -0.664 . . . . 0.0 109.778 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.66 -81.74 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.53 -0.731 . . . . 0.0 110.035 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 61.8 mt 50.59 87.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.138 -0.977 . . . . 0.0 110.87 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -124.73 172.99 8.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.597 -0.689 . . . . 0.0 109.925 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.82 5.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.5 -0.75 . . . . 0.0 110.314 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 61.45 1.56 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -133.84 138.22 45.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 0.0 110.146 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.9 90.83 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 110.343 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.24 152.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.0 109.821 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 151.58 48.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 110.669 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.06 127.53 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 18.5 p -127.46 150.04 49.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.818 . . . . 0.0 111.369 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 34.8 t80 -136.25 125.39 24.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.43 -177.74 3.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 110.57 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.28 24.31 8.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.384 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -119.44 -40.51 2.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.48 -49.67 4.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.647 -0.658 . . . . 0.0 110.154 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.41 43.63 2.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.546 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 34.8 m -141.31 156.13 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.6 -0.941 . . . . 0.0 110.12 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.468 ' HB ' HG12 ' A' ' 46' ' ' ILE . 46.2 t -106.09 125.54 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.554 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -107.86 128.36 54.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.485 HG12 ' HB ' ' A' ' 44' ' ' VAL . 22.2 pt -116.76 153.57 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.583 -0.698 . . . . 0.0 110.321 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -156.34 162.64 40.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.658 -0.651 . . . . 0.0 110.414 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.654 -0.654 . . . . 0.0 110.175 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.101 0.476 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.47 144.38 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.657 -0.652 . . . . 0.0 109.755 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.6 131.08 14.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.508 -0.745 . . . . 0.0 110.306 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.44 173.26 11.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.575 -0.703 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 pt -121.77 159.5 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.642 -0.661 . . . . 0.0 110.286 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -147.42 153.12 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.658 -0.651 . . . . 0.0 110.204 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 172.24 6.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.83 149.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.472 -0.767 . . . . 0.0 110.213 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -171.8 -167.65 0.52 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.542 -0.724 . . . . 0.0 110.799 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.81 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.684 -0.635 . . . . 0.0 111.465 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.36 73.94 0.94 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.949 -1.094 . . . . 0.0 111.181 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 49.2 29.08 2.44 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.37 -0.831 . . . . 0.0 111.427 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.01 153.6 21.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.637 -0.664 . . . . 0.0 110.409 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -126.33 151.58 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.61 -0.681 . . . . 0.0 109.842 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -148.15 127.1 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.645 -0.659 . . . . 0.0 110.147 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.6 mt -81.26 145.38 55.82 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 0.0 109.942 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -58.12 -166.18 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.344 1.181 . . . . 0.0 110.617 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.93 -43.33 8.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.595 -0.691 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -63.71 -44.09 94.63 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.642 -0.661 . . . . 0.0 110.33 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.0 -41.71 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.528 -0.732 . . . . 0.0 109.603 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -65.54 -31.68 72.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.499 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -40.4 75.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.675 -0.641 . . . . 0.0 109.272 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -72.98 -74.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.615 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.3 154.01 14.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.593 -0.692 . . . . 0.0 109.975 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -84.88 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.73 . . . . 0.0 109.853 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.0 mt 49.6 86.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.972 . . . . 0.0 110.902 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.25 -177.22 3.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -0.769 . . . . 0.0 110.596 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -83.15 117.57 22.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 0.0 110.104 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.38 38.01 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.27 170.01 9.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.936 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -117.17 72.24 0.83 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.746 . . . . 0.0 110.136 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -64.65 149.37 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 110.398 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.45 156.95 18.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.67 -0.644 . . . . 0.0 110.329 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.33 133.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.4 p -141.57 145.86 35.6 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.156 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 44.4 t80 -111.47 140.18 46.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -132.81 155.7 48.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 0.0 110.948 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.77 20.02 12.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.239 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -100.94 -27.78 13.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.285 -0.884 . . . . 0.0 109.909 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -127.2 -49.27 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.637 -0.664 . . . . 0.0 110.24 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.42 35.31 3.37 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.602 HG11 ' HB2' ' B' ' 47' ' ' GLN . 35.3 m -136.89 163.12 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.523 -0.987 . . . . 0.0 110.236 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.789 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 59.5 t -105.0 127.61 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.346 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 27.3 ttmt -112.22 133.71 54.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.771 -0.581 . . . . 0.0 110.217 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.796 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 5.3 pt -125.75 158.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.631 -0.668 . . . . 0.0 110.194 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.561 ' CD ' ' CG1' ' B' ' 43' ' ' VAL . 5.0 tt0 -153.72 161.31 42.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.668 -0.645 . . . . 0.0 110.351 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.578 -0.701 . . . . 0.0 110.056 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.138 0.494 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.45 144.33 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.759 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.71 131.1 14.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 0.0 110.368 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.41 173.28 11.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.698 -0.627 . . . . 0.0 110.034 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 38.4 pt -121.78 159.59 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.624 -0.673 . . . . 0.0 110.324 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.9 t -147.45 153.16 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.527 -0.733 . . . . 0.0 110.181 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.93 172.19 6.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.705 . . . . 0.0 110.069 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.74 149.23 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 110.237 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.8 t -172.02 -167.64 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.522 -0.736 . . . . 0.0 110.757 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.76 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.663 -0.648 . . . . 0.0 111.454 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.35 73.95 0.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.04 -1.037 . . . . 0.0 111.219 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 49.23 29.17 2.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.315 -0.865 . . . . 0.0 111.396 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.07 153.64 21.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.419 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.34 151.49 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.798 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -148.09 127.03 12.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 110.072 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 85.0 mt -81.08 145.26 56.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.969 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -57.96 -166.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.416 1.219 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.82 -43.49 8.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -63.7 -43.89 95.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.55 -0.719 . . . . 0.0 110.362 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.18 -41.79 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 109.526 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -65.46 -31.78 73.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.6 -0.687 . . . . 0.0 109.462 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -40.48 75.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.668 -0.645 . . . . 0.0 109.334 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -72.96 -74.09 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.609 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.36 154.01 14.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.0 109.97 179.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.3 -84.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 109.887 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 71.8 mt 49.48 86.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.066 -1.022 . . . . 0.0 110.964 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.19 -177.21 3.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.527 -0.733 . . . . 0.0 110.538 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -83.12 117.56 22.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.574 -0.704 . . . . 0.0 110.106 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.26 38.22 4.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.34 170.02 9.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.917 . . . . 0.0 110.184 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mt -117.22 72.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.69 149.33 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.52 -0.738 . . . . 0.0 110.336 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.4 156.9 18.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.597 -0.689 . . . . 0.0 110.364 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.34 133.15 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 79.1 p -141.62 145.89 35.56 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.117 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.615 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 44.1 t80 -111.42 140.13 46.26 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -132.75 155.77 48.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.83 20.11 12.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -100.82 -28.04 13.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.795 . . . . 0.0 109.974 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -127.02 -49.25 1.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.706 -0.621 . . . . 0.0 110.246 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.43 35.21 3.39 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.561 ' CG1' ' CD ' ' A' ' 47' ' ' GLN . 35.2 m -136.79 163.1 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.5 -1.0 . . . . 0.0 110.122 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.796 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.6 t -105.03 127.37 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.2 ttmt -111.87 133.55 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.697 -0.627 . . . . 0.0 110.294 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.789 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 5.4 pt -125.54 158.05 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.653 -0.654 . . . . 0.0 110.302 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.602 ' HB2' HG11 ' A' ' 43' ' ' VAL . 4.8 tt0 -153.64 161.36 42.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.716 -0.615 . . . . 0.0 110.32 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.055 0.455 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.77 156.25 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 0.0 109.759 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -145.52 147.05 31.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.531 -0.73 . . . . 0.0 110.598 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -137.81 164.05 29.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.752 -0.593 . . . . 0.0 109.912 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.95 137.93 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.657 -0.652 . . . . 0.0 110.519 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.15 165.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.575 -0.703 . . . . 0.0 109.736 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 tttp -137.07 138.35 40.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.351 -0.843 . . . . 0.0 110.517 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.45 124.96 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.597 -0.689 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 m -168.65 42.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.437 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -139.59 -66.04 0.46 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.605 -0.684 . . . . 0.0 109.457 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.08 46.29 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.752 -0.592 . . . . 0.0 109.995 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' B' ' 29' ' ' GLU . 15.2 m-85 53.42 57.42 6.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 110.803 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 174.71 13.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.463 -0.773 . . . . 0.0 110.81 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.52 145.53 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.753 -0.592 . . . . 0.0 109.693 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 p -110.95 -8.47 14.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 111.368 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.8 mt 59.51 111.6 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.304 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.53 -168.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.039 1.02 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.04 -33.85 26.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 0.0 111.519 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -56.34 -52.43 64.6 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.234 -0.916 . . . . 0.0 110.862 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.22 -47.7 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.393 -0.817 . . . . 0.0 109.593 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -58.63 -28.77 65.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.99 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -45.06 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 109.486 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.64 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.598 -0.688 . . . . 0.0 109.952 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.12 169.92 5.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.402 -0.811 . . . . 0.0 110.817 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.47 -73.43 0.38 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.692 -0.63 . . . . 0.0 110.733 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mm 55.12 93.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 139.16 47.79 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.0 110.365 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' HB2' ' CZ ' ' B' ' 13' ' ' TYR . 5.4 tt0 -67.58 112.15 4.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.543 -0.723 . . . . 0.0 110.154 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.73 35.44 4.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.73 163.98 18.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.579 -0.954 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.3 tp -93.71 107.25 19.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.645 -0.66 . . . . 0.0 110.289 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.9 t -98.72 141.18 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.667 -0.645 . . . . 0.0 109.585 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.75 142.21 46.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.548 -0.72 . . . . 0.0 110.346 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 p -131.37 134.27 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.665 -0.647 . . . . 0.0 109.779 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.1 p -134.25 146.03 49.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.74 . . . . 0.0 111.208 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -104.16 130.56 51.91 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.47 148.1 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 110.556 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.21 38.92 1.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.632 -0.668 . . . . 0.0 110.226 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -144.28 -52.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.92 -30.56 26.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.482 -0.761 . . . . 0.0 110.024 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 39.26 29.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.89 158.27 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.921 . . . . 0.0 109.684 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 61.6 t -98.68 130.48 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 109.504 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -110.08 127.21 54.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.877 -0.514 . . . . 0.0 110.415 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.432 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.4 pt -121.98 146.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.403 -0.811 . . . . 0.0 110.92 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -143.89 -169.58 3.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.871 -0.518 . . . . 0.0 110.186 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.55 165.13 25.93 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.37 -179.84 8.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.357 -0.839 . . . . 0.0 110.337 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -59.3 -167.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.54 -0.725 . . . . 0.0 109.996 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.8 121.3 12.55 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.146 -0.971 . . . . 0.0 111.585 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -83.57 152.08 13.37 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 N-CA-C 108.748 -1.289 . . . . 0.0 108.748 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -135.56 40.15 2.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.345 -0.847 . . . . 0.0 111.12 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.12 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.135 0.493 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.75 156.3 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -145.47 147.13 31.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.484 -0.76 . . . . 0.0 110.59 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -137.95 163.88 30.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.683 -0.636 . . . . 0.0 109.903 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.84 137.89 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.688 -0.632 . . . . 0.0 110.582 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 10.2 p -146.14 165.17 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 0.0 109.725 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -137.03 138.4 40.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.433 -0.792 . . . . 0.0 110.518 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.46 125.17 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 109.54 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -168.75 42.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.475 -0.765 . . . . 0.0 110.43 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -139.61 -65.99 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.24 46.25 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 29' ' ' GLU . 15.2 m-85 53.44 57.57 6.05 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.492 -0.755 . . . . 0.0 110.814 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 174.78 13.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.451 -0.78 . . . . 0.0 110.822 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.64 145.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.843 -0.536 . . . . 0.0 109.666 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -110.78 -8.56 14.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 111.476 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt 59.55 111.69 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.248 -0.907 . . . . 0.0 110.592 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.76 -168.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.089 1.047 . . . . 0.0 111.324 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.78 -33.72 27.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.654 -0.654 . . . . 0.0 111.6 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -56.62 -52.15 65.96 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.14 -0.975 . . . . 0.0 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.44 -47.63 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.384 -0.823 . . . . 0.0 109.43 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -58.74 -28.78 66.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 109.938 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -45.11 80.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.459 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.61 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.13 169.87 5.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.451 -0.781 . . . . 0.0 110.827 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.41 -73.5 0.38 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.7 -0.625 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mm 55.2 93.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.234 -0.916 . . . . 0.0 110.337 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 139.21 47.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 110.339 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 5.5 tt0 -67.59 112.18 4.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.515 -0.74 . . . . 0.0 110.144 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.61 4.9 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.75 163.89 18.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.715 -0.874 . . . . 0.0 110.047 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.5 107.19 19.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.614 -0.679 . . . . 0.0 110.354 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.85 141.25 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.485 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 142.03 46.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.558 -0.714 . . . . 0.0 110.28 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.28 134.31 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 24.0 p -134.22 146.12 49.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -104.12 130.46 51.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.26 148.18 24.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.428 -0.795 . . . . 0.0 110.634 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.27 38.86 1.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.656 -0.652 . . . . 0.0 110.284 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -144.1 -52.78 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 110.07 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.82 -30.68 26.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 0.0 110.048 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.9 39.21 28.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.99 158.14 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.789 -0.83 . . . . 0.0 109.635 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 61.4 t -98.54 130.35 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.314 -0.866 . . . . 0.0 109.555 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -110.02 127.21 54.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.702 -0.624 . . . . 0.0 110.38 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.443 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.4 pt -121.75 146.93 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.423 -0.798 . . . . 0.0 110.917 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -143.91 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 0.0 110.197 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.58 165.13 25.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 110.319 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.37 -179.81 8.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.558 -0.714 . . . . 0.0 110.352 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -59.29 -167.15 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.428 -0.795 . . . . 0.0 110.042 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.88 121.6 12.63 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.32 -0.862 . . . . 0.0 111.593 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.86 152.12 12.91 Favored 'Trans proline' 0 C--N 1.323 -0.795 0 N-CA-C 108.623 -1.337 . . . . 0.0 108.623 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -135.57 40.25 2.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 111.004 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.138 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.182 0.515 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.47 134.91 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 109.97 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.76 153.39 39.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.74 . . . . 0.0 110.582 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.04 162.6 41.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.647 . . . . 0.0 109.746 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 6' ' ' ILE . 15.3 tt -134.93 154.9 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.566 -0.709 . . . . 0.0 110.703 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.36 159.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 109.973 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -156.32 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.72 . . . . 0.0 110.275 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 1.122 ' O ' ' N ' ' B' ' 30' ' ' GLY . 49.0 t -143.59 126.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.87 -169.21 3.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 56.88 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.8 -0.562 . . . . 0.0 111.313 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -152.42 57.73 0.82 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.975 -1.078 . . . . 0.0 110.835 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.944 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 80.3 m-85 50.8 37.38 16.83 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.327 -0.858 . . . . 0.0 111.346 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.45 173.98 6.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.453 -0.78 . . . . 0.0 110.242 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -169.5 141.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.791 . . . . 0.0 110.624 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -108.04 174.47 5.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 109.405 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.9 mm -108.54 133.47 20.6 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.386 -0.821 . . . . 0.0 110.38 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.36 157.32 57.02 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 O-C-N 123.171 1.09 . . . . 0.0 110.195 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.99 57.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 110.612 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -70.86 -53.49 15.01 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.372 -0.83 . . . . 0.0 110.466 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.8 t -59.95 -43.95 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.258 -0.901 . . . . 0.0 109.32 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -59.95 -31.48 69.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.61 -52.57 50.96 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.445 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.53 -68.64 0.67 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.626 -0.671 . . . . 0.0 110.383 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.713 ' CE1' HG22 ' B' ' 44' ' ' VAL . 13.5 t80 -57.96 134.87 56.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.536 -0.728 . . . . 0.0 111.029 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -81.97 123.09 28.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.671 -0.643 . . . . 0.0 109.783 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.9 tt -166.85 85.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.182 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.979 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.4 OUTLIER -95.83 178.28 5.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.294 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -66.62 135.28 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.65 -0.656 . . . . 0.0 110.606 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 1.127 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 61.16 48.66 84.65 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.473 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -106.68 -176.22 3.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -1.019 . . . . 0.0 110.165 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.9 78.84 3.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.792 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.806 HG23 ' CG2' ' B' ' 9' ' ' VAL . 63.7 t -85.6 116.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.35 142.32 32.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.669 -0.644 . . . . 0.0 109.836 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.08 122.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.56 -0.712 . . . . 0.0 109.878 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.3 p -140.55 146.79 38.53 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.311 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.421 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 12.0 t80 -105.03 142.54 34.64 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.36 145.07 27.76 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.135 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.56 32.69 2.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.007 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.63 -59.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.588 -0.695 . . . . 0.0 110.077 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -79.99 -30.02 39.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.666 . . . . 0.0 110.163 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.6 43.06 7.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.5 m -137.82 156.44 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.679 -0.894 . . . . 0.0 110.33 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.737 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 57.6 t -107.34 121.86 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 1.2 ttpt -103.67 136.96 42.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.684 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.76 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 42.9 pt -127.5 149.31 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.934 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -151.79 175.1 12.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.504 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.33 22.76 2.76 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 0.0 110.713 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.8 -175.15 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.28 -0.888 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -138.57 160.31 39.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.606 -0.684 . . . . 0.0 110.098 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -136.6 160.61 65.92 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.666 . . . . 0.0 110.011 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -81.03 67.99 8.46 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.288 1.152 . . . . 0.0 110.059 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -87.42 86.06 7.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.468 -0.77 . . . . 0.0 110.259 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.5 tttt . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.105 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.099 0.476 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.55 134.91 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.543 -0.723 . . . . 0.0 110.022 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.62 153.42 39.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.558 -0.714 . . . . 0.0 110.653 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.14 162.46 41.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.719 -0.613 . . . . 0.0 109.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.413 HG22 HD12 ' B' ' 6' ' ' ILE . 15.4 tt -134.85 154.85 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 110.783 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.33 159.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.686 -0.634 . . . . 0.0 109.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.31 -156.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.516 -0.74 . . . . 0.0 110.275 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 1.127 ' O ' ' N ' ' A' ' 30' ' ' GLY . 49.2 t -143.6 126.34 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.78 -169.18 3.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.611 -0.68 . . . . 0.0 110.404 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 56.87 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.657 -0.652 . . . . 0.0 111.309 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -152.23 57.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.102 -0.999 . . . . 0.0 110.842 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.979 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 81.6 m-85 50.8 37.37 16.8 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 0.0 111.397 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.4 174.13 6.02 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.439 -0.788 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.83 141.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.383 -0.823 . . . . 0.0 110.54 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -108.03 174.33 5.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.644 -0.66 . . . . 0.0 109.388 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.446 HG22 HD13 ' B' ' 17' ' ' ILE . 42.5 mm -108.35 133.47 20.56 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -71.53 157.19 56.74 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 O-C-N 123.304 1.16 . . . . 0.0 110.155 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.72 54.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -71.05 -53.41 14.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.363 -0.836 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 86.7 t -59.94 -43.96 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -60.03 -31.38 69.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.77 -0.581 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.55 -52.56 51.53 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.705 -0.622 . . . . 0.0 109.481 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -68.4 0.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.639 -0.663 . . . . 0.0 110.482 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.694 ' CE1' HG22 ' A' ' 44' ' ' VAL . 13.8 t80 -58.21 135.02 57.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.951 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -81.99 123.03 28.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.644 -0.66 . . . . 0.0 109.815 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 7.0 tt -166.74 85.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.271 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . 0.944 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -0.843 . . . . 0.0 110.311 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.678 ' HA ' HG11 ' A' ' 9' ' ' VAL . 3.5 mt-10 -66.56 135.33 54.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.669 -0.644 . . . . 0.0 110.538 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 1.122 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 61.25 48.67 84.31 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.446 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -106.7 -176.14 2.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -1.009 . . . . 0.0 110.177 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.98 78.86 3.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.589 -0.695 . . . . 0.0 109.852 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.548 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 64.3 t -85.52 116.98 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.643 -0.661 . . . . 0.0 110.145 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.37 142.53 32.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 109.779 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.3 122.12 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.395 -0.815 . . . . 0.0 109.73 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 70.5 p -140.54 146.85 38.64 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -0.823 . . . . 0.0 111.269 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.425 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 11.9 t80 -105.11 142.55 34.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 145.02 27.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.405 -0.809 . . . . 0.0 110.184 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.6 32.6 2.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.706 . . . . 0.0 109.957 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.61 -59.32 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.702 -0.624 . . . . 0.0 110.065 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -80.11 -30.05 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 110.105 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.67 42.97 7.5 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.422 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 34.7 m -137.68 156.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.584 -0.95 . . . . 0.0 110.295 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.76 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 57.5 t -107.38 121.64 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -103.49 136.8 42.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.687 -0.633 . . . . 0.0 110.665 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.737 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 42.5 pt -127.28 149.35 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.767 -0.583 . . . . 0.0 109.99 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -151.66 175.13 12.68 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 0.0 110.495 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.4 22.81 2.74 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.599 -0.688 . . . . 0.0 110.723 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.58 -175.14 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.221 -0.925 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -138.45 160.41 39.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.64 -0.662 . . . . 0.0 110.134 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -136.65 160.54 66.13 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.474 -0.766 . . . . 0.0 109.969 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -81.02 68.24 8.38 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.325 1.171 . . . . 0.0 110.009 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -87.62 86.15 7.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.707 . . . . 0.0 110.226 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 tttt . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 117.818 -1.087 . . . . 0.0 110.108 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.163 0.506 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.75 139.8 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.666 -0.647 . . . . 0.0 109.968 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.14 150.4 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.6 -0.688 . . . . 0.0 110.168 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -156.81 161.88 39.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.624 -0.673 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.4 mt -131.25 136.61 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.585 -0.697 . . . . 0.0 110.216 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.69 170.07 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.748 -0.595 . . . . 0.0 109.785 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.69 152.16 35.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.424 -0.798 . . . . 0.0 110.772 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.977 HG13 ' O ' ' B' ' 28' ' ' LYS . 62.7 t -101.71 136.31 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.74 -0.6 . . . . 0.0 109.591 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.6 p -157.15 -47.01 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.524 -0.735 . . . . 0.0 110.411 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -147.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.652 -0.655 . . . . 0.0 110.182 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.97 60.98 1.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 111.1 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.928 ' CD2' ' O ' ' B' ' 27' ' ' ILE . 27.1 m-85 50.59 32.16 6.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.38 -0.825 . . . . 0.0 111.826 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -88.42 174.64 8.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.299 -0.876 . . . . 0.0 110.101 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.11 135.5 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.022 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.2 m -100.61 150.51 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 110.364 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.434 HD12 ' O ' ' B' ' 13' ' ' TYR . 89.3 mt -101.7 128.95 27.68 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.584 -0.698 . . . . 0.0 109.67 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.1 158.44 25.66 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.121 1.063 . . . . 0.0 110.72 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.14 77.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.639 -0.663 . . . . 0.0 109.874 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.49 -51.91 56.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.643 -0.661 . . . . 0.0 109.571 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.77 -39.26 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.05 -30.07 70.53 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.68 25.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.603 -0.686 . . . . 0.0 109.433 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -79.62 -63.34 1.44 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.684 -0.635 . . . . 0.0 109.846 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HD1' ' CD1' ' B' ' 37' ' ' PHE . 6.4 t80 -53.53 115.24 1.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.268 -0.895 . . . . 0.0 110.695 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -73.77 131.17 41.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.558 -0.714 . . . . 0.0 110.358 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.946 ' O ' ' CD2' ' B' ' 13' ' ' TYR . 6.8 tt -167.56 91.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.64 0.733 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 1.013 ' O ' HG13 ' B' ' 9' ' ' VAL . 8.3 tttt -99.1 -179.65 4.32 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.262 -0.899 . . . . 0.0 110.997 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -75.48 127.08 32.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.973 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.842 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 90.97 26.39 22.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.706 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -103.74 149.55 24.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.538 -0.978 . . . . 0.0 109.776 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.3 mt -101.43 74.59 1.55 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.695 . . . . 0.0 110.708 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.32 151.09 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.426 -0.796 . . . . 0.0 109.569 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -106.61 154.95 20.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.836 . . . . 0.0 111.145 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.21 125.83 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.0 p -130.98 146.95 52.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.865 . . . . 0.0 111.508 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 40.0 t80 -106.49 149.97 26.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -110.07 -167.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.13 -38.71 1.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.7 . . . . 0.0 110.597 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.97 -40.11 12.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 110.598 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -81.66 -37.2 27.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.697 . . . . 0.0 110.537 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.07 72.11 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.862 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 24.7 m -121.21 149.77 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.447 -1.031 . . . . 0.0 109.661 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.891 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 90.3 t -103.62 129.28 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.418 -0.802 . . . . 0.0 109.675 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.909 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 3.8 ttpm? -109.07 130.96 55.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.217 0.532 . . . . 0.0 109.737 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.892 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 10.8 pt -126.53 145.14 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.73 -0.606 . . . . 0.0 110.086 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.96 171.08 16.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 110.303 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -112.03 169.84 8.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.27 57.09 3.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.421 -0.8 . . . . 0.0 110.728 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -101.1 136.22 41.29 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.473 -0.767 . . . . 0.0 110.011 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -122.18 88.1 48.24 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.487 -0.758 . . . . 0.0 111.147 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -63.34 97.41 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.362 1.19 . . . . 0.0 109.807 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.43 92.28 3.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.735 . . . . 0.0 110.379 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.777 179.655 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.05 0.452 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.57 139.95 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.642 -0.661 . . . . 0.0 109.982 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.2 150.57 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.711 -0.618 . . . . 0.0 110.137 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -156.97 161.85 39.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.745 -0.597 . . . . 0.0 109.589 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.26 136.62 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -126.9 169.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.692 -0.63 . . . . 0.0 109.71 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.61 152.04 35.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.518 -0.739 . . . . 0.0 110.787 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 1.013 HG13 ' O ' ' A' ' 28' ' ' LYS . 62.8 t -101.59 136.26 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.665 . . . . 0.0 109.61 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.4 p -157.23 -46.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.746 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.72 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.657 -0.652 . . . . 0.0 110.222 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.9 60.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.093 -1.005 . . . . 0.0 111.213 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.946 ' CD2' ' O ' ' A' ' 27' ' ' ILE . 27.0 m-85 50.61 32.09 6.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.364 -0.835 . . . . 0.0 111.902 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -88.43 174.56 8.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.99 135.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.46 -0.775 . . . . 0.0 109.918 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 m -100.58 150.53 22.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 110.299 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 89.5 mt -101.67 129.0 27.61 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.22 158.52 25.91 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.115 1.061 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.0 77.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -51.65 58.18 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.574 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 83.7 t -62.04 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -66.01 -30.18 70.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.59 26.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.708 -0.62 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.61 -63.37 1.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.741 -0.599 . . . . 0.0 109.887 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.587 ' CE1' HG21 ' A' ' 44' ' ' VAL . 6.3 t80 -53.45 115.21 1.82 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -73.83 131.29 41.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.648 -0.658 . . . . 0.0 110.309 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . 0.928 ' O ' ' CD2' ' A' ' 13' ' ' TYR . 6.8 tt -167.64 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.548 0.69 . . . . 0.0 109.557 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . 0.977 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 tttt -98.99 -179.77 4.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 111.005 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.41 127.12 32.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.638 . . . . 0.0 109.961 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 91.02 26.36 22.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.692 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -103.78 149.44 25.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.972 . . . . 0.0 109.825 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 74.53 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.656 -0.652 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.44 151.19 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.517 -0.739 . . . . 0.0 109.516 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -106.79 154.93 20.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.337 -0.852 . . . . 0.0 111.141 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.17 125.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -130.99 146.97 52.56 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.591 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.569 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 39.8 t80 -106.46 149.95 26.56 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.9 -167.21 1.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.642 -0.661 . . . . 0.0 110.272 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.03 -38.64 1.42 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.633 -0.667 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.05 -40.08 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -0.8 . . . . 0.0 110.604 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -81.77 -37.2 27.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 110.446 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.87 26.29 71.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.909 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 25.5 m -121.32 149.58 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -1.047 . . . . 0.0 109.686 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.892 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 92.3 t -103.62 129.19 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 109.773 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.862 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 3.8 ttpm? -109.09 130.85 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.783 -0.573 . . . . 0.0 109.833 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.891 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 10.8 pt -126.25 145.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.788 -0.57 . . . . 0.0 110.178 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.514 ' HB3' HG11 ' A' ' 43' ' ' VAL . 3.9 pt20 -149.01 171.02 17.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.247 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 tp -111.9 169.81 8.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 109.721 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.33 57.03 3.79 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.43 -0.793 . . . . 0.0 110.704 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -101.1 136.2 41.34 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.523 -0.736 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -122.25 88.15 48.47 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.468 -0.77 . . . . 0.0 111.076 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -63.39 97.56 0.21 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.325 1.171 . . . . 0.0 109.829 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.48 92.29 3.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 110.348 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.826 179.782 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.166 0.508 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.5 t -122.36 150.69 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.55 -0.719 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -156.27 142.94 18.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.491 -0.756 . . . . 0.0 110.736 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.61 166.86 29.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.8 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.0 mt -119.65 126.4 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.478 -0.764 . . . . 0.0 110.226 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.46 167.3 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.56 -0.712 . . . . 0.0 110.072 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -116.29 138.18 51.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.479 -0.763 . . . . 0.0 110.43 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.1 t -78.04 167.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 109.483 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' B' ' 29' ' ' GLU . 11.5 t -170.2 -66.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.33 -0.856 . . . . 0.0 111.164 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -58.08 -166.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.612 -0.68 . . . . 0.0 110.765 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -66.56 76.01 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.674 -0.641 . . . . 0.0 110.801 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 51.84 30.0 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.262 -0.899 . . . . 0.0 111.521 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -89.29 150.61 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.46 -0.775 . . . . 0.0 109.946 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.3 t -121.72 142.56 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 110.693 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.66 132.77 55.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 109.573 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.57 131.25 28.62 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.43 -0.794 . . . . 0.0 109.829 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.04 150.16 74.89 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.044 1.023 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.61 63.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.548 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -67.29 -45.75 75.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.542 -0.724 . . . . 0.0 109.839 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.8 -41.05 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -65.48 -33.6 76.32 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -42.14 96.77 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -80.45 -68.79 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE1' HG22 ' B' ' 44' ' ' VAL . 2.5 t80 -64.17 126.1 26.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.721 -0.612 . . . . 0.0 110.596 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.5 112.06 17.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.581 -0.699 . . . . 0.0 109.294 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.3 tt -154.04 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.73 0.776 . . . . 0.0 109.452 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -101.51 -170.9 1.89 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.429 -0.794 . . . . 0.0 111.438 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' B' ' 10' ' ' SER . 5.2 tt0 -74.21 139.84 44.67 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.279 0.562 . . . . 0.0 110.785 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.68 28.22 65.67 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.5 159.72 15.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -1.028 . . . . 0.0 110.283 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 64.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 110.054 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.01 150.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.743 . . . . 0.0 110.265 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -127.87 136.12 50.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 110.297 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.69 129.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.665 -0.647 . . . . 0.0 109.824 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.4 p -137.88 147.45 44.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.757 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -115.21 144.72 43.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.676 -0.64 . . . . 0.0 109.332 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.35 -174.22 2.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.44 42.01 2.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.561 -0.712 . . . . 0.0 110.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.36 -52.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 110.56 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -115.41 -61.61 1.72 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.745 . . . . 0.0 110.344 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.32 59.18 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.78 149.54 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.569 -0.959 . . . . 0.0 110.145 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.512 HG22 ' CE1' ' B' ' 25' ' ' PHE . 51.1 t -103.28 133.17 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.392 -0.817 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -109.42 136.63 48.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.727 -0.608 . . . . 0.0 110.036 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.471 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 5.3 pt -131.45 150.25 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.401 -0.812 . . . . 0.0 111.21 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -145.35 -167.9 2.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 0.0 109.594 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.45 -88.88 0.23 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.256 -0.903 . . . . 0.0 111.191 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.54 -172.2 1.19 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.089 . . . . 0.0 110.81 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.02 -20.56 4.89 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.628 -0.67 . . . . 0.0 111.31 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 55.51 74.94 0.65 Allowed Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.056 -1.027 . . . . 0.0 111.085 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -81.39 154.89 18.76 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.374 1.197 . . . . 0.0 110.115 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.19 44.42 2.95 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.491 -0.756 . . . . 0.0 110.136 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 118.106 -0.949 . . . . 0.0 109.917 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.026 0.441 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 66.4 t -122.13 150.98 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.654 -0.654 . . . . 0.0 109.652 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -156.65 142.77 18.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.722 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -151.46 166.93 29.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.588 -0.695 . . . . 0.0 109.837 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.1 mt -119.58 126.62 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.513 -0.742 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.64 167.06 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.558 -0.714 . . . . 0.0 110.171 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -116.28 138.13 51.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.527 -0.733 . . . . 0.0 110.468 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -78.1 167.67 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.471 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' SER . . . . . 0.511 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 11.2 t -170.21 -65.96 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -58.01 -166.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -66.52 76.0 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.66 . . . . 0.0 110.871 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 51.93 29.89 6.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.433 -0.792 . . . . 0.0 111.52 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -89.07 150.64 22.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.99 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.91 142.5 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.618 -0.676 . . . . 0.0 110.676 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.61 132.78 55.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.731 -0.606 . . . . 0.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 59.4 mt -96.62 131.19 28.69 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.585 -0.697 . . . . 0.0 109.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.79 150.07 73.5 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.079 1.042 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.67 -30.68 63.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.474 -0.766 . . . . 0.0 110.496 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -67.3 -45.74 75.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.514 -0.741 . . . . 0.0 109.773 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 65.5 t -62.83 -41.17 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.469 -0.769 . . . . 0.0 109.001 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -65.26 -33.72 76.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.696 -0.627 . . . . 0.0 109.365 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -80.47 -68.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.512 ' CE1' HG22 ' A' ' 44' ' ' VAL . 2.5 t80 -64.42 126.21 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.688 -0.633 . . . . 0.0 110.524 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 112.09 17.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 109.327 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 tt -154.16 91.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.76 0.79 . . . . 0.0 109.509 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -101.49 -170.92 1.9 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 111.543 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 10' ' ' SER . 5.2 tt0 -74.07 139.75 44.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.799 -0.563 . . . . 0.0 110.868 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.48 28.54 65.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.61 159.76 15.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -1.0 . . . . 0.0 110.238 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.46 64.78 1.88 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.06 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 10.1 p -75.12 150.74 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.618 -0.676 . . . . 0.0 110.25 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 31.9 tttt -127.82 136.01 50.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.66 130.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.827 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 65.5 p -137.96 147.32 44.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 110.894 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -115.06 144.67 43.27 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.24 -174.13 2.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 110.303 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.47 42.05 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.448 -0.782 . . . . 0.0 110.056 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.4 -52.13 1.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.526 -0.734 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -115.61 -61.79 1.69 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.558 -0.714 . . . . 0.0 110.241 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.35 59.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 32.7 m -140.72 149.46 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.621 -0.929 . . . . 0.0 110.13 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.535 HG22 ' CE1' ' A' ' 25' ' ' PHE . 50.4 t -103.2 132.98 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 110.119 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -109.26 136.52 48.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.658 -0.651 . . . . 0.0 110.135 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.458 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 5.3 pt -131.29 150.11 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.455 -0.778 . . . . 0.0 111.261 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -145.1 -167.8 2.77 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.585 -0.697 . . . . 0.0 109.654 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.4 -88.87 0.23 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.238 -0.914 . . . . 0.0 111.337 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.59 -172.25 1.19 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.953 -1.092 . . . . 0.0 110.854 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.03 -20.51 4.91 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.622 -0.674 . . . . 0.0 111.263 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 55.42 74.97 0.64 Allowed Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 121.083 -1.011 . . . . 0.0 111.026 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -81.4 154.97 18.76 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.283 1.149 . . . . 0.0 110.131 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.3 44.43 2.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.395 -0.815 . . . . 0.0 110.086 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.911 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.146 0.498 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.2 m -123.64 152.7 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.554 -0.716 . . . . 0.0 109.572 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -144.06 153.91 42.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.783 . . . . 0.0 111.046 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -134.06 147.16 50.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.403 HG23 HD22 ' B' ' 32' ' ' LEU . 89.3 mt -111.28 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 110.677 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.17 151.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.65 12.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.526 -0.733 . . . . 0.0 110.72 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.763 HG21 ' O ' ' B' ' 31' ' ' ASP . 76.4 t -75.45 142.29 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.758 -0.589 . . . . 0.0 109.916 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -172.78 3.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 110.0 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 56.58 -86.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.712 -0.617 . . . . 0.0 110.526 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.1 78.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.926 -1.109 . . . . 0.0 109.043 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.79 14.62 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.368 -0.833 . . . . 0.0 109.83 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.06 157.16 26.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.604 -0.685 . . . . 0.0 110.823 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.94 138.47 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.655 -0.653 . . . . 0.0 109.385 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -120.78 152.81 37.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.497 -0.752 . . . . 0.0 110.886 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -97.3 119.59 62.73 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.708 -0.62 . . . . 0.0 109.5 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.21 -174.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.067 1.035 . . . . 0.0 110.622 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.49 25.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.564 -0.71 . . . . 0.0 110.44 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -48.4 42.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 109.982 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.24 -41.63 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.655 -0.653 . . . . 0.0 109.426 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.74 -38.29 81.33 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -36.02 81.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.596 -0.69 . . . . 0.0 109.757 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -76.45 -69.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.67 ' CE2' HG21 ' B' ' 44' ' ' VAL . 0.4 OUTLIER -65.02 149.9 49.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.645 -0.66 . . . . 0.0 109.923 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.88 -80.25 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.752 . . . . 0.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 94.9 mt 50.18 88.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.144 -0.972 . . . . 0.0 110.947 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' O ' HG11 ' B' ' 9' ' ' VAL . 11.7 tptt -109.34 168.09 9.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.589 -0.694 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' HA ' HG13 ' B' ' 9' ' ' VAL . 27.7 mt-10 -69.35 123.7 21.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.587 -0.696 . . . . 0.0 110.024 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.464 ' H ' ' HB ' ' B' ' 9' ' ' VAL . . . 85.47 37.51 9.63 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.877 ' O ' HG21 ' B' ' 9' ' ' VAL . 2.6 m-20 -115.53 133.03 56.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.528 -0.984 . . . . 0.0 110.193 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.577 HD22 HG22 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -69.19 112.25 5.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.598 HG21 HG22 ' B' ' 9' ' ' VAL . 59.9 t -107.62 151.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.593 -0.692 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -125.0 128.09 48.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.21 128.79 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.2 p -136.65 153.0 51.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.257 -0.902 . . . . 0.0 111.872 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 36.6 t80 -124.95 143.79 50.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -117.55 155.96 28.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.438 -0.789 . . . . 0.0 110.894 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -101.37 19.92 16.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.78 -0.575 . . . . 0.0 110.703 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -118.61 -28.48 5.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 110.601 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -105.41 -58.89 1.84 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.402 -0.811 . . . . 0.0 110.296 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.84 33.17 2.68 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.48 162.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.676 -0.896 . . . . 0.0 109.938 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.845 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 37.0 t -112.04 123.85 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.33 -0.856 . . . . 0.0 109.981 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 1.5 ttpm? -105.39 150.37 25.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.837 -0.54 . . . . 0.0 109.813 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.869 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.7 pp -136.98 155.86 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.833 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -154.98 -174.78 5.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.904 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.08 25.12 2.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.492 -0.755 . . . . 0.0 110.68 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.73 148.09 8.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.347 -0.846 . . . . 0.0 110.348 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -170.38 -42.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.517 -0.739 . . . . 0.0 110.215 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.37 64.8 39.92 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.547 -0.721 . . . . 0.0 110.239 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -60.53 124.34 14.89 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 123.253 1.133 . . . . 0.0 110.5 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -141.85 -44.71 0.35 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.446 -0.784 . . . . 0.0 110.15 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.074 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.155 0.502 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.64 152.73 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.51 -0.744 . . . . 0.0 109.552 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -144.1 153.81 42.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.386 -0.821 . . . . 0.0 111.009 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.87 147.14 51.12 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.577 HG22 HD22 ' A' ' 32' ' ' LEU . 89.2 mt -111.24 116.03 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.739 . . . . 0.0 110.679 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.29 151.15 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.63 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.877 HG21 ' O ' ' A' ' 31' ' ' ASP . 69.0 t -75.43 142.18 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.754 -0.591 . . . . 0.0 109.981 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.9 t -159.22 -172.71 3.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.694 . . . . 0.0 109.93 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 56.46 -86.39 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.686 -0.634 . . . . 0.0 110.52 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.19 78.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.045 -1.035 . . . . 0.0 109.17 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.76 14.68 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.344 -0.848 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -117.08 157.15 26.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.582 -0.699 . . . . 0.0 110.786 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -137.9 138.28 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.746 -0.596 . . . . 0.0 109.459 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.5 p -120.62 152.74 37.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 0.0 110.916 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -97.21 119.56 62.93 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.791 -0.568 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.16 -174.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.06 1.031 . . . . 0.0 110.591 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.56 25.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.704 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -48.18 44.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.49 -41.5 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.555 -0.715 . . . . 0.0 109.466 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.64 -38.28 80.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.564 -0.71 . . . . 0.0 109.712 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -36.08 82.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.57 -0.706 . . . . 0.0 109.639 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -76.51 -69.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.781 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.786 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -65.33 150.0 49.02 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 109.887 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.96 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.538 -0.726 . . . . 0.0 109.906 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 94.9 mt 50.14 88.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.262 -0.899 . . . . 0.0 110.97 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -109.4 168.05 9.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.601 -0.687 . . . . 0.0 110.071 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.697 ' HA ' HG11 ' A' ' 9' ' ' VAL . 27.4 mt-10 -69.37 123.75 22.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.738 . . . . 0.0 110.077 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.452 ' H ' ' HB ' ' A' ' 9' ' ' VAL . . . 85.64 37.32 9.62 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.763 ' O ' HG21 ' A' ' 9' ' ' VAL . 2.6 m-20 -115.61 132.9 56.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.588 -0.948 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.403 HD22 HG23 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -69.01 112.41 5.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.522 -0.737 . . . . 0.0 110.022 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.429 HG23 HG21 ' A' ' 9' ' ' VAL . 61.6 t -107.59 151.15 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -124.96 127.8 47.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.324 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -114.99 128.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 71.3 p -136.53 152.94 51.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 111.863 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.62 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 37.1 t80 -124.83 143.62 50.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -117.43 155.84 28.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.482 -0.761 . . . . 0.0 110.868 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -101.46 19.97 16.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.736 -0.603 . . . . 0.0 110.69 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -118.57 -28.7 5.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.358 -0.839 . . . . 0.0 110.616 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -105.36 -58.75 1.85 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.504 -0.747 . . . . 0.0 110.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.77 33.22 2.69 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -141.48 162.69 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.954 . . . . 0.0 109.831 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.869 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 37.8 t -112.11 123.67 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 0.0 109.922 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.5 ttpm? -105.45 150.08 25.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.713 -0.617 . . . . 0.0 109.874 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.845 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.7 pp -136.6 155.96 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.56 -0.713 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -154.92 -174.73 5.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.79 -0.569 . . . . 0.0 110.042 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.97 25.1 2.54 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.436 -0.79 . . . . 0.0 110.713 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.77 148.05 8.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.332 -0.855 . . . . 0.0 110.292 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -170.31 -42.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.51 -0.744 . . . . 0.0 110.164 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.24 64.81 40.99 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.494 -0.754 . . . . 0.0 110.215 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.36 124.3 14.86 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.389 1.205 . . . . 0.0 110.484 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -141.99 -44.57 0.34 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.526 -0.734 . . . . 0.0 110.255 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.054 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.121 0.486 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.96 126.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.596 -0.69 . . . . 0.0 109.848 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.87 147.57 51.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.616 -0.678 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.17 146.38 18.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.708 . . . . 0.0 110.311 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 pt -112.62 150.35 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.63 -0.669 . . . . 0.0 110.218 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.6 m -136.52 150.6 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.625 -0.672 . . . . 0.0 110.267 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -94.06 138.04 32.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.136 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.49 HG11 ' O ' ' B' ' 28' ' ' LYS . 60.6 t -77.04 145.05 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 110.096 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -158.1 -55.4 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.579 -0.701 . . . . 0.0 110.219 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -168.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.666 -0.646 . . . . 0.0 110.033 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -77.93 67.84 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.51 -0.744 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.714 ' HH ' ' HG3' ' B' ' 29' ' ' GLU . 93.7 m-85 53.29 45.33 28.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -0.771 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.03 174.24 6.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.488 -0.758 . . . . 0.0 109.53 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.36 153.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.678 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -150.18 115.31 5.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.829 -0.545 . . . . 0.0 109.536 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.1 mt -71.73 143.01 86.55 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.545 -0.722 . . . . 0.0 110.204 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -61.23 -175.81 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.001 0 O-C-N 123.201 1.106 . . . . 0.0 110.216 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.07 -29.96 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 110.199 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.54 -48.26 49.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.539 -0.726 . . . . 0.0 110.012 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.43 -45.42 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.55 -0.719 . . . . 0.0 109.477 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.66 -32.31 73.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.513 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -63.61 -36.12 82.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 109.535 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -78.86 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.794 -0.566 . . . . 0.0 109.767 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.864 ' CE2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.47 159.58 6.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -80.72 -82.82 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.379 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.415 ' O ' ' HE2' ' B' ' 13' ' ' TYR . 45.3 mt 51.28 87.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.167 -0.958 . . . . 0.0 110.519 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 29.8 mtmt -107.05 -171.45 1.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.525 -0.734 . . . . 0.0 110.515 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.644 ' HA ' HG13 ' B' ' 9' ' ' VAL . 23.9 mt-10 -79.67 137.01 36.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.47 ' N ' ' HB ' ' B' ' 9' ' ' VAL . . . 58.45 44.09 95.51 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.953 . . . . 0.0 110.113 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.77 2.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 110.609 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.26 133.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 109.218 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -125.07 129.25 49.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.452 -0.78 . . . . 0.0 110.975 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t -123.72 129.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -138.17 148.38 44.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.375 -0.828 . . . . 0.0 111.235 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.87 ' CE1' ' CE2' ' B' ' 25' ' ' PHE . 47.9 t80 -113.92 135.65 53.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.32 162.7 12.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.762 . . . . 0.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.37 32.62 4.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.3 p -118.7 -60.69 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 110.102 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -87.03 -50.14 6.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 0.0 110.151 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.61 36.5 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.775 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 35.2 m -133.27 159.68 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -1.01 . . . . 0.0 110.342 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.989 ' HB ' ' CG2' ' B' ' 46' ' ' ILE . 45.6 t -103.23 127.51 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.667 . . . . 0.0 109.403 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.81 ' CD ' HG22 ' B' ' 43' ' ' VAL . 14.5 ttmt -112.13 125.54 54.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.632 . . . . 0.0 110.571 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 1.015 ' CG2' ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -113.04 138.66 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.687 . . . . 0.0 109.489 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.771 ' HG3' HG13 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -151.08 171.86 16.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.708 -0.62 . . . . 0.0 109.971 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.25 -157.95 0.67 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.8 142.18 57.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.47 -0.769 . . . . 0.0 109.601 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.51 -64.22 1.07 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.424 -0.797 . . . . 0.0 110.995 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -135.85 96.88 12.88 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.435 -0.791 . . . . 0.0 111.348 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -68.84 122.9 9.83 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.422 1.222 . . . . 0.0 109.615 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -97.53 54.34 1.18 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.433 -0.792 . . . . 0.0 110.467 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.028 179.724 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.175 0.512 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.76 126.43 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.531 -0.731 . . . . 0.0 109.957 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -129.9 147.63 51.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.23 146.22 18.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.321 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.45 150.2 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.567 -0.708 . . . . 0.0 110.195 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.41 150.56 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.488 -0.757 . . . . 0.0 110.254 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.98 138.02 32.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.683 . . . . 0.0 110.2 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 29' ' ' GLU . 59.7 t -77.0 144.93 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.576 -0.703 . . . . 0.0 110.175 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -157.99 -55.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.591 -0.693 . . . . 0.0 110.278 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -168.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 0.0 110.112 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -78.08 67.92 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.717 . . . . 0.0 110.107 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.497 ' HH ' ' HG3' ' A' ' 29' ' ' GLU . 93.8 m-85 53.29 45.4 28.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 111.184 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.18 174.16 6.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.26 153.16 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.401 -0.812 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.2 t -150.22 115.22 5.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.68 -0.638 . . . . 0.0 109.508 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 80.9 mt -71.74 143.11 86.65 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.504 -0.748 . . . . 0.0 110.224 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.3 -175.91 0.15 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 O-C-N 123.1 1.053 . . . . 0.0 110.055 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.08 -29.74 24.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.582 -0.698 . . . . 0.0 110.242 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.65 -48.16 49.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.535 -0.728 . . . . 0.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.43 -45.48 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 0.0 109.492 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -65.71 -32.23 73.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.635 . . . . 0.0 109.562 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -63.62 -36.09 82.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.679 . . . . 0.0 109.474 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -79.03 -62.62 1.64 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.722 -0.611 . . . . 0.0 109.774 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.73 159.57 6.6 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.735 . . . . 0.0 110.015 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -80.69 -82.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.483 -0.76 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 45.5 mt 51.25 87.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.063 -1.023 . . . . 0.0 110.486 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . 0.49 ' O ' HG11 ' A' ' 9' ' ' VAL . 29.8 mtmt -107.19 -171.35 1.87 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.578 -0.702 . . . . 0.0 110.497 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.714 ' HG3' ' HH ' ' A' ' 13' ' ' TYR . 23.6 mt-10 -79.69 136.98 36.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.478 ' N ' ' HB ' ' A' ' 9' ' ' VAL . . . 58.44 44.15 95.45 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.944 . . . . 0.0 110.142 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.57 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 110.684 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 9' ' ' VAL . 62.1 t -66.95 133.71 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.486 -0.758 . . . . 0.0 109.344 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -125.16 129.27 49.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -0.758 . . . . 0.0 111.04 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.74 129.28 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -138.19 148.42 44.82 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.402 -0.811 . . . . 0.0 111.272 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 25' ' ' PHE . 48.2 t80 -113.92 135.62 53.78 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.34 162.62 13.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.596 -0.69 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.34 32.6 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.627 -0.671 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.7 p -118.6 -60.62 1.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.619 -0.676 . . . . 0.0 110.069 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.15 -50.1 6.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.41 2.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.81 HG22 ' CD ' ' A' ' 45' ' ' LYS . 35.3 m -133.25 159.7 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.536 -0.979 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 1.015 ' HB ' ' CG2' ' A' ' 46' ' ' ILE . 45.9 t -103.26 127.51 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.527 -0.733 . . . . 0.0 109.409 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.775 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 14.8 ttmt -112.08 125.32 53.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.671 -0.643 . . . . 0.0 110.552 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.989 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -112.79 138.6 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.654 -0.654 . . . . 0.0 109.542 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.742 ' HG3' HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -151.04 171.86 16.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.203 0.525 . . . . 0.0 109.916 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.17 -157.9 0.67 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.79 142.13 57.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.37 -0.831 . . . . 0.0 109.633 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.4 -64.33 1.06 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.516 -0.74 . . . . 0.0 111.014 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -135.81 96.8 12.98 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.477 -0.765 . . . . 0.0 111.429 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -68.84 122.82 9.75 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.36 1.189 . . . . 0.0 109.688 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -97.41 54.24 1.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.5 -0.75 . . . . 0.0 110.477 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.019 179.63 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' HB2' ' OD1' ' B' ' 38' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.79 119.83 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -0.75 . . . . 0.0 109.559 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -120.35 126.61 50.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 0.0 110.876 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.58 152.15 45.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.666 -0.646 . . . . 0.0 109.334 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.93 134.01 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.443 -0.786 . . . . 0.0 110.526 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.49 148.91 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 0.0 109.42 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.59 179.99 3.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 110.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.874 HG23 ' HB3' ' B' ' 31' ' ' ASP . 57.6 t -106.75 165.43 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.614 -0.679 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.1 p -102.87 -163.64 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.516 -0.74 . . . . 0.0 110.249 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.7 ' HG2' ' OE2' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -102.02 -25.34 13.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.748 . . . . 0.0 110.337 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.93 29.85 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 0.0 110.442 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.54 ' HE1' ' HA ' ' B' ' 28' ' ' LYS . 64.4 m-85 52.39 25.81 3.72 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.443 -0.786 . . . . 0.0 110.983 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -104.33 151.28 23.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.515 -0.741 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.93 146.07 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.594 -0.691 . . . . 0.0 110.114 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.5 p -110.72 123.94 51.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.689 -0.632 . . . . 0.0 109.756 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.7 mt -66.39 116.34 32.93 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.743 . . . . 0.0 109.711 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.3 169.17 4.11 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.156 1.082 . . . . 0.0 110.477 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.14 68.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.572 -0.705 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.85 -59.83 4.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.431 -0.793 . . . . 0.0 110.312 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.91 -40.78 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.379 -0.826 . . . . 0.0 109.22 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.32 -29.97 68.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.717 -0.614 . . . . 0.0 109.549 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -45.66 56.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.65 -69.13 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.661 -0.649 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.685 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.3 OUTLIER -73.44 151.3 41.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 109.659 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -81.37 -81.28 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.209 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.5 mt 54.49 93.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HA ' ' HE1' ' B' ' 13' ' ' TYR . 0.2 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 0.0 110.453 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.704 ' OE2' ' HG2' ' B' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.82 27.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.711 . . . . 0.0 110.411 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.34 50.9 4.87 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.907 ' HB3' HG22 ' B' ' 9' ' ' VAL . 3.2 t70 -110.06 155.68 21.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.487 -1.008 . . . . 0.0 110.266 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.29 52.34 0.84 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 109.706 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -61.12 170.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 0.0 110.404 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.3 122.03 7.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.69 144.31 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 109.141 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.9 p -138.79 150.53 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.218 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.7 t80 -134.46 147.13 50.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' OD1' ' HB2' ' B' ' 2' ' ' ALA . 2.2 t70 -122.04 178.45 4.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -0.785 . . . . 0.0 110.457 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.01 44.26 2.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.9 p -147.18 -52.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.017 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -40.43 21.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.732 -0.605 . . . . 0.0 109.754 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 32.96 17.51 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.729 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 33.0 m -131.61 156.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.745 ' HB ' ' CG2' ' B' ' 46' ' ' ILE . 56.3 t -104.2 133.81 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.506 -0.746 . . . . 0.0 109.455 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.742 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 0.2 OUTLIER -112.47 129.49 56.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.754 -0.591 . . . . 0.0 110.263 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.761 ' CG2' ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -123.51 139.44 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 109.861 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -158.62 -175.33 5.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 110.139 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mp -107.69 -163.06 0.87 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.19 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.1 tp -61.64 119.73 9.23 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.677 -0.64 . . . . 0.0 110.322 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.42 -168.27 2.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.666 -0.647 . . . . 0.0 109.496 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.0 137.43 46.58 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.397 -0.814 . . . . 0.0 110.13 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -69.79 79.57 0.95 Allowed 'Trans proline' 0 N--CA 1.486 1.033 0 O-C-N 123.248 1.131 . . . . 0.0 110.196 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -61.97 -30.02 70.64 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.743 . . . . 0.0 110.16 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.272 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.434 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.202 0.525 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.85 119.9 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -120.43 126.59 50.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.477 -0.764 . . . . 0.0 110.979 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.51 152.08 45.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.674 -0.641 . . . . 0.0 109.303 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.82 134.04 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.531 -0.731 . . . . 0.0 110.537 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.9 t -137.44 148.96 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.714 -0.616 . . . . 0.0 109.485 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.76 179.9 3.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.431 -0.793 . . . . 0.0 110.326 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.907 HG22 ' HB3' ' A' ' 31' ' ' ASP . 58.0 t -106.77 165.55 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.586 -0.696 . . . . 0.0 110.182 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 78.0 p -102.92 -163.67 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.537 -0.727 . . . . 0.0 110.237 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.704 ' HG2' ' OE2' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -102.05 -25.33 13.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.611 -0.681 . . . . 0.0 110.255 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.92 29.8 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.456 -0.778 . . . . 0.0 110.374 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.567 ' HE1' ' HA ' ' A' ' 28' ' ' LYS . 64.5 m-85 52.35 25.74 3.65 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.463 -0.773 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.23 151.32 23.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.687 . . . . 0.0 109.883 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.99 146.07 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.601 -0.687 . . . . 0.0 110.159 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -110.77 123.95 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.36 116.28 32.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.29 169.03 4.21 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.143 1.075 . . . . 0.0 110.545 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.08 68.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 0.0 110.227 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -59.88 4.72 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.498 -0.751 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 109.229 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.27 -29.97 67.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -45.69 56.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.69 -68.97 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.635 -0.666 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.687 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -73.68 151.34 40.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.613 -0.679 . . . . 0.0 109.572 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -81.31 -81.4 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 111.22 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 15.5 mt 54.66 93.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.044 -1.035 . . . . 0.0 110.049 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . 0.54 ' HA ' ' HE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.612 -0.68 . . . . 0.0 110.436 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.7 ' OE2' ' HG2' ' A' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.79 27.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 110.358 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.45 50.88 4.86 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.874 ' HB3' HG23 ' A' ' 9' ' ' VAL . 3.2 t70 -110.13 155.64 21.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -1.034 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.25 52.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.489 -0.757 . . . . 0.0 109.865 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.9 170.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.605 -0.685 . . . . 0.0 110.481 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.18 122.19 7.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.685 -0.635 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 62.8 t -98.85 144.25 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.488 -0.758 . . . . 0.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -138.75 150.66 46.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.419 -0.8 . . . . 0.0 111.151 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.685 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 35.8 t80 -134.64 147.05 50.09 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 2' ' ' ALA . 2.2 t70 -121.92 178.54 4.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.457 -0.777 . . . . 0.0 110.485 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.1 44.33 2.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.169 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 85.6 p -147.32 -52.12 0.2 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.971 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.44 -40.45 21.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.85 17.71 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.742 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 32.9 m -131.53 156.95 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -1.041 . . . . 0.0 110.337 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.761 ' HB ' ' CG2' ' A' ' 46' ' ' ILE . 53.4 t -104.17 133.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.495 -0.753 . . . . 0.0 109.525 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.729 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -112.42 129.34 56.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 -179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.745 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.25 139.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.575 -0.703 . . . . 0.0 109.921 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -158.73 -175.46 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.171 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mp -107.64 -163.0 0.86 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 17.0 tp -61.73 119.68 9.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.651 -0.656 . . . . 0.0 110.371 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.35 -168.31 2.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.682 -0.636 . . . . 0.0 109.609 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -81.89 137.35 46.97 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.438 -0.789 . . . . 0.0 110.141 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -69.81 79.8 0.94 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.22 1.116 . . . . 0.0 110.157 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -62.23 -30.01 70.79 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.633 -0.667 . . . . 0.0 110.044 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.307 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.2 0.524 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.8 164.87 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.451 -0.781 . . . . 0.0 110.498 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -131.76 146.74 52.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.809 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.33 162.17 39.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.21 136.23 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.639 . . . . 0.0 109.861 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.68 157.49 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 150.4 44.3 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.736 -0.602 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.416 HG21 ' O ' ' B' ' 31' ' ' ASP . 59.8 t -85.85 163.54 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.434 -0.791 . . . . 0.0 109.656 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.86 170.27 10.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.504 -0.748 . . . . 0.0 109.695 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -39.71 77.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -96.85 41.61 1.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.501 -0.749 . . . . 0.0 110.812 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 59.4 m-85 51.35 24.84 2.28 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.387 -0.821 . . . . 0.0 111.476 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -78.84 159.57 27.76 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.423 -0.798 . . . . 0.0 109.231 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.63 155.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.417 -0.802 . . . . 0.0 110.681 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.7 m -141.32 113.55 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -78.25 130.79 70.93 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.723 . . . . 0.0 110.03 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -55.79 -173.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.101 1.053 . . . . 0.0 110.605 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.48 -28.41 16.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.539 -0.726 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -59.24 3.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.53 -0.731 . . . . 0.0 110.915 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 22' ' ' ARG . 27.0 m -63.6 -33.76 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' N ' HG22 ' A' ' 21' ' ' VAL . 18.0 ttm180 -61.97 -37.29 84.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -68.9 -35.26 76.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.576 -0.702 . . . . 0.0 109.232 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -73.33 0.15 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.905 ' HD2' ' CD1' ' B' ' 37' ' ' PHE . 0.7 OUTLIER -60.5 158.63 11.83 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.592 -0.693 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -81.01 -84.12 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.394 -0.816 . . . . 0.0 110.855 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt 53.17 92.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.013 -1.054 . . . . 0.0 110.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -104.13 -170.53 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.695 -0.628 . . . . 0.0 110.818 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.59 126.49 35.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.738 -0.601 . . . . 0.0 110.164 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.1 45.36 15.85 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -112.67 142.93 44.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.988 . . . . 0.0 110.232 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.82 62.86 4.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.608 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -53.32 155.88 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.43 -0.794 . . . . 0.0 110.567 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -110.23 103.06 11.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.69 -0.631 . . . . 0.0 110.66 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.02 110.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.773 . . . . 0.0 108.933 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.2 p -128.14 150.42 49.99 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.562 0.696 . . . . 0.0 111.696 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.912 ' CD1' ' HD2' ' B' ' 25' ' ' PHE . 27.4 t80 -124.63 122.53 37.78 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.8 151.41 24.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 110.361 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.29 20.08 9.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.684 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -46.83 7.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.78 -30.27 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 109.859 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . . . 93.06 47.62 3.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.738 HG11 ' CG ' ' B' ' 47' ' ' GLN . 33.1 m -140.58 159.63 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.538 -0.978 . . . . 0.0 110.368 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.916 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 31.2 t -100.55 133.97 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.42 123.28 49.07 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.132 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.943 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.9 pt -109.17 134.16 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.752 ' HG3' HG11 ' B' ' 43' ' ' VAL . 54.0 tt0 -149.28 165.81 30.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.504 -0.747 . . . . 0.0 110.52 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.37 -41.71 2.7 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.208 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.33 164.12 13.97 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.439 -0.788 . . . . 0.0 110.413 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.63 -171.64 2.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.549 -0.719 . . . . 0.0 109.687 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.28 59.73 8.03 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.804 . . . . 0.0 111.18 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -82.78 121.74 3.32 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.11 1.058 . . . . 0.0 109.922 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.71 -65.88 1.0 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.526 -0.734 . . . . 0.0 110.179 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.412 -179.71 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.106 0.479 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -132.64 164.94 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.54 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -131.82 146.69 52.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.66 -0.65 . . . . 0.0 109.87 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.25 162.01 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.456 -0.778 . . . . 0.0 110.47 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.11 136.21 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.688 -0.632 . . . . 0.0 109.871 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -148.6 157.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.453 -0.78 . . . . 0.0 110.56 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 150.42 44.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 110.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -85.85 163.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 109.657 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.76 170.14 11.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.582 -0.699 . . . . 0.0 109.813 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -39.78 78.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.702 . . . . 0.0 110.502 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -96.84 41.61 1.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.468 -0.77 . . . . 0.0 110.92 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' B' ' 13' ' ' TYR . 58.5 m-85 51.49 24.7 2.34 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.442 -0.786 . . . . 0.0 111.499 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -78.88 159.41 27.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.396 -0.815 . . . . 0.0 109.094 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.59 155.85 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 0.0 110.687 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.5 m -141.3 113.53 8.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.09 130.99 70.74 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.541 -0.724 . . . . 0.0 110.109 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -56.19 -173.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.196 0 O-C-N 123.115 1.061 . . . . 0.0 110.436 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.35 -28.52 16.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.718 . . . . 0.0 110.878 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -59.25 3.03 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.489 -0.757 . . . . 0.0 110.887 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.65 -33.58 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -62.1 -37.11 83.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.203 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -69.08 -35.12 76.16 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -73.29 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.912 ' HD2' ' CD1' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -60.58 158.64 11.99 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -81.02 -84.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.362 -0.836 . . . . 0.0 110.856 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 88.0 mt 53.13 92.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.023 -1.048 . . . . 0.0 110.129 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -104.25 -170.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 110.821 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -88.51 126.54 35.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.825 -0.547 . . . . 0.0 110.185 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 45.26 15.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.416 ' O ' HG21 ' A' ' 9' ' ' VAL . 23.7 t70 -112.62 142.83 44.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.95 . . . . 0.0 110.24 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.85 62.95 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.744 -0.597 . . . . 0.0 109.495 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.5 155.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.479 -0.763 . . . . 0.0 110.583 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -110.33 102.95 11.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 110.591 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.84 110.75 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 49.6 p -128.12 150.62 49.9 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.645 0.736 . . . . 0.0 111.678 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.905 ' CD1' ' HD2' ' A' ' 25' ' ' PHE . 27.4 t80 -124.77 122.55 37.77 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.81 151.39 24.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.462 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.25 19.97 9.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.72 -46.57 7.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.98 -30.23 7.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.701 -0.624 . . . . 0.0 109.785 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . 0.568 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 93.11 47.49 3.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.752 HG11 ' HG3' ' A' ' 47' ' ' GLN . 33.1 m -140.65 159.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.56 -0.965 . . . . 0.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.943 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 32.4 t -100.49 133.81 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.16 123.23 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 111.317 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.916 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.9 pt -109.3 134.19 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.256 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.738 ' CG ' HG11 ' A' ' 43' ' ' VAL . 54.1 tt0 -149.26 165.81 30.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.683 -0.636 . . . . 0.0 110.611 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.45 -41.46 2.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.566 -0.709 . . . . 0.0 110.142 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.39 164.15 13.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.484 -0.76 . . . . 0.0 110.47 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.65 -171.65 2.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.486 -0.759 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.32 59.73 7.98 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.351 -0.843 . . . . 0.0 111.153 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -82.84 121.81 3.31 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.224 1.118 . . . . 0.0 109.884 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -65.9 1.01 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.477 -0.764 . . . . 0.0 110.185 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.434 -179.705 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.18 150.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 110.139 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.95 157.34 44.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.604 -0.685 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.56 143.43 20.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.81 119.78 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.557 -0.714 . . . . 0.0 110.544 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.1 -176.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.474 -0.766 . . . . 0.0 110.139 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.71 163.73 29.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.484 -0.76 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.06 166.08 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.56 -0.712 . . . . 0.0 109.928 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' B' ' 29' ' ' GLU . 15.5 m -107.61 -156.64 0.59 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.468 -0.77 . . . . 0.0 110.514 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -79.09 -52.38 8.28 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.473 -0.767 . . . . 0.0 110.722 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.41 40.07 1.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 110.802 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.747 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 94.2 m-85 50.73 40.14 23.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.345 -0.847 . . . . 0.0 111.227 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.38 153.96 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.19 132.68 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 0.0 110.246 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.49 85.16 2.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.647 . . . . 0.0 109.631 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.0 145.42 89.34 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.62 -0.675 . . . . 0.0 110.273 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -61.9 -159.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.0 0 O-C-N 123.338 1.178 . . . . 0.0 110.367 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.11 -21.09 16.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.0 -55.84 29.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -0.882 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.22 -39.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.594 -0.691 . . . . 0.0 109.683 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -63.82 -32.31 73.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.661 -0.65 . . . . 0.0 109.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -54.1 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.56 -60.82 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.647 -0.658 . . . . 0.0 109.641 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.5 OUTLIER -74.07 128.18 34.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.54 -0.725 . . . . 0.0 110.355 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -78.58 96.97 5.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.517 -0.74 . . . . 0.0 110.104 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.5 mt -132.04 78.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.58 -0.7 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.768 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.3 OUTLIER -87.32 -158.67 0.46 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.653 -0.655 . . . . 0.0 110.606 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' B' ' 10' ' ' SER . 37.1 tt0 -87.41 91.62 8.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.696 -0.628 . . . . 0.0 110.31 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.99 47.24 0.31 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.985 . . . . 0.0 110.352 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mp -75.19 81.42 2.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.989 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -87.21 154.0 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.97 131.79 41.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.616 -0.677 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.91 131.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.532 -0.73 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.55 147.96 48.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.414 -0.804 . . . . 0.0 111.22 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.513 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 29.6 t80 -119.63 141.43 49.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -110.71 154.12 24.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.756 . . . . 0.0 110.733 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.41 29.11 7.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.024 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 p -117.91 -35.21 3.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.713 . . . . 0.0 110.305 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.29 -65.82 1.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.493 -0.754 . . . . 0.0 110.26 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.32 42.6 0.27 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.718 ' HB ' ' CG ' ' B' ' 45' ' ' LYS . 34.6 m -133.9 156.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.971 . . . . 0.0 109.665 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.811 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 29.2 t -116.36 115.4 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.838 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.732 ' CG ' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -99.94 146.82 26.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.735 -0.603 . . . . 0.0 109.997 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.811 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 12.9 pt -128.74 155.81 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.679 -0.638 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.471 ' HB2' HG12 ' B' ' 43' ' ' VAL . 38.9 tt0 -159.95 160.82 33.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.646 -0.659 . . . . 0.0 110.105 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.85 -67.06 0.87 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.591 -0.693 . . . . 0.0 109.994 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 20.9 tp -91.31 97.16 10.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 110.191 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.99 -29.29 7.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.58 -0.7 . . . . 0.0 110.166 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 52.57 64.14 7.79 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.516 -0.74 . . . . 0.0 111.044 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -77.46 -157.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.211 1.111 . . . . 0.0 109.852 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 54.3 m95 56.07 76.87 0.26 Allowed 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.411 -0.806 . . . . 0.0 110.351 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.9 tptt . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.197 179.898 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.19 150.9 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 110.113 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.85 157.41 44.39 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.549 -0.72 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.62 143.48 20.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.244 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.79 119.97 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.559 -0.713 . . . . 0.0 110.477 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.35 -177.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.72 163.71 29.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.497 -0.752 . . . . 0.0 110.507 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.2 t -74.07 166.13 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.599 -0.688 . . . . 0.0 109.904 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 15.4 m -107.69 -156.67 0.59 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.44 -0.787 . . . . 0.0 110.449 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -79.05 -52.46 8.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.47 -0.769 . . . . 0.0 110.663 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.3 39.98 1.11 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.768 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 94.2 m-85 50.86 40.04 23.88 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.321 -0.862 . . . . 0.0 111.218 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.35 154.0 19.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.22 132.78 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.573 -0.704 . . . . 0.0 110.205 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.6 85.17 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 109.609 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.01 145.44 89.36 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.647 -0.658 . . . . 0.0 110.204 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.02 -159.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.986 0 O-C-N 123.347 1.183 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.12 -21.19 16.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.714 -0.616 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.02 -56.01 27.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.339 -0.851 . . . . 0.0 110.366 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -62.06 -39.1 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.576 -0.703 . . . . 0.0 109.7 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -63.89 -32.23 73.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.621 -0.674 . . . . 0.0 109.927 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -54.1 25.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.717 . . . . 0.0 109.645 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.42 -60.95 2.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.614 -0.679 . . . . 0.0 109.654 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.513 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -74.03 128.09 34.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.662 -0.649 . . . . 0.0 110.34 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -78.51 97.05 5.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.559 -0.713 . . . . 0.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . 0.406 HD11 HG23 ' B' ' 27' ' ' ILE . 88.6 mt -132.14 78.51 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.572 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . 0.747 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -87.37 -158.58 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.763 -0.586 . . . . 0.0 110.553 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 10' ' ' SER . 37.1 tt0 -87.51 91.81 8.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.648 -0.657 . . . . 0.0 110.238 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.76 47.38 0.32 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.12 133.9 53.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.971 . . . . 0.0 110.32 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.15 81.53 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.708 -0.62 . . . . 0.0 110.028 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -87.23 153.97 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.563 -0.711 . . . . 0.0 110.392 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.98 131.78 41.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.576 -0.703 . . . . 0.0 110.21 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.95 131.93 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.583 -0.698 . . . . 0.0 109.566 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.69 148.01 48.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 111.237 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 29.8 t80 -119.69 141.41 49.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -110.75 154.04 24.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.29 29.0 7.19 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.626 -0.672 . . . . 0.0 110.094 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 5.4 p -117.79 -35.23 3.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.28 -65.83 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.23 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.28 42.43 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.732 ' HB ' ' CG ' ' A' ' 45' ' ' LYS . 34.6 m -133.78 156.9 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.977 . . . . 0.0 109.704 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.811 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 30.8 t -116.48 115.28 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.291 -0.881 . . . . 0.0 109.986 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.718 ' CG ' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -99.86 146.78 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.811 -0.556 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.811 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 12.7 pt -128.68 155.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.709 -0.62 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -159.88 160.83 34.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.691 -0.63 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.85 -67.07 0.87 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 20.5 tp -91.3 97.11 10.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.602 -0.686 . . . . 0.0 110.216 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -29.34 7.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 110.13 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.405 ' N ' ' HD3' ' B' ' 52' ' ' PRO . 1.8 tt0 52.57 64.23 7.68 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.516 -0.74 . . . . 0.0 111.001 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' B' ' 51' ' ' GLU . 2.3 Cg_endo -77.47 -157.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.123 1.065 . . . . 0.0 109.852 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 54.2 m95 56.1 76.72 0.27 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.38 -0.825 . . . . 0.0 110.39 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 4.8 tptt . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.234 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' N ' ' OE1' ' B' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.063 0.459 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.8 150.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.571 -0.706 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -147.99 116.0 6.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 109.937 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.52 173.96 8.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.47 -0.769 . . . . 0.0 110.641 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.424 HG21 ' HE2' ' B' ' 34' ' ' LYS . 26.8 pt -120.53 130.92 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.685 -0.635 . . . . 0.0 109.894 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.559 HG21 ' O ' ' B' ' 33' ' ' VAL . 33.1 m -131.37 146.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.576 -0.703 . . . . 0.0 110.265 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -103.58 154.21 19.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.39 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 1.032 ' O ' ' HA2' ' B' ' 30' ' ' GLY . 58.2 t -109.91 142.46 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.584 -0.697 . . . . 0.0 109.58 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.9 p -169.83 -170.52 1.04 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 111.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.93 -86.77 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.697 -0.627 . . . . 0.0 110.984 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.76 55.52 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.061 -1.024 . . . . 0.0 110.579 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.456 ' HE1' ' C ' ' B' ' 28' ' ' LYS . 71.9 m-85 49.33 47.43 22.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.457 -0.777 . . . . 0.0 111.048 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -112.25 154.15 26.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 110.13 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.92 135.85 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 110.391 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.4 p -108.2 106.87 17.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.782 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.41 126.96 93.0 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.688 . . . . 0.0 109.584 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.86 -77.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.06 1.032 . . . . 0.0 110.645 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.11 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.48 -0.763 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.77 -46.79 86.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.726 -0.609 . . . . 0.0 110.156 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.73 -43.69 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.698 . . . . 0.0 109.343 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.87 -27.66 68.3 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.612 -0.68 . . . . 0.0 110.164 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.04 -39.19 42.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.985 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -79.46 -70.37 0.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.648 . . . . 0.0 109.969 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.632 ' CD2' ' CG2' ' B' ' 44' ' ' VAL . 0.5 OUTLIER -65.65 133.59 51.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.516 -0.74 . . . . 0.0 110.57 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -81.84 87.92 6.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.59 76.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.593 -0.692 . . . . 0.0 109.481 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' C ' ' HE1' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -58.65 168.86 1.07 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.782 -0.574 . . . . 0.0 110.633 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' CE1' ' B' ' 13' ' ' TYR . 0.5 OUTLIER -74.87 72.66 2.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.73 -0.606 . . . . 0.0 110.139 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 1.03 ' HA2' ' O ' ' B' ' 9' ' ' VAL . . . 137.54 45.17 0.08 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.491 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 2.9 m-20 -105.42 147.54 28.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.613 -0.934 . . . . 0.0 110.323 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.32 76.8 5.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.461 -0.774 . . . . 0.0 110.064 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' HG21 ' B' ' 7' ' ' VAL . 59.0 t -86.65 143.23 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.525 -0.734 . . . . 0.0 110.082 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' B' ' 6' ' ' ILE . 0.6 OUTLIER -111.73 130.59 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.723 . . . . 0.0 110.166 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.95 130.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.625 -0.672 . . . . 0.0 109.498 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 p -129.02 145.01 51.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.54 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 49.8 t80 -121.09 129.73 53.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -107.47 146.9 31.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.426 -0.796 . . . . 0.0 110.774 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 2' ' ' ALA . 28.0 mt-10 -97.94 30.36 3.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.669 -0.644 . . . . 0.0 110.045 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.88 -34.47 3.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.638 -0.664 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -114.66 -42.08 3.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.531 -0.731 . . . . 0.0 110.281 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.52 37.43 4.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.61 152.31 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.73 -0.864 . . . . 0.0 109.645 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.834 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 56.3 t -99.2 127.35 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 2.1 ttpp -108.5 124.37 50.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.831 -0.543 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.818 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 9.1 pt -117.02 148.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.752 . . . . 0.0 110.447 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -161.53 -171.67 3.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.572 -0.705 . . . . 0.0 110.599 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.66 124.14 37.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.061 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 tt -169.76 83.52 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.518 -0.739 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.93 111.6 0.86 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.406 -0.809 . . . . 0.0 110.154 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 62.18 137.83 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.302 0 O-C-N 121.659 -0.651 . . . . 0.0 110.402 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -87.88 78.15 1.56 Allowed 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 122.952 0.975 . . . . 0.0 110.447 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -71.16 90.12 0.87 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.486 -0.759 . . . . 0.0 109.833 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.199 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.476 ' N ' ' OE1' ' A' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.07 0.462 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.79 150.26 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.589 -0.694 . . . . 0.0 110.09 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -148.16 116.01 6.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.677 -0.639 . . . . 0.0 109.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.65 174.06 8.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.714 . . . . 0.0 110.554 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.437 HG23 HD13 ' B' ' 6' ' ' ILE . 27.6 pt -120.57 130.73 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.686 -0.634 . . . . 0.0 109.899 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 33' ' ' VAL . 33.3 m -131.25 146.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.533 -0.729 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -103.5 154.22 19.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 1.03 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 57.7 t -109.95 142.45 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.695 -0.628 . . . . 0.0 109.6 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 84.7 p -169.78 -170.5 1.04 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 0.0 111.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.9 -86.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.721 -0.612 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.7 55.49 1.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.04 -1.038 . . . . 0.0 110.564 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.476 ' HE1' ' C ' ' A' ' 28' ' ' LYS . 71.4 m-85 49.34 47.36 22.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.439 -0.788 . . . . 0.0 111.08 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -112.21 154.22 25.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.161 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.97 135.98 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.624 -0.673 . . . . 0.0 110.314 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 40.5 p -108.31 106.86 17.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.739 -0.601 . . . . 0.0 109.773 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.48 126.91 92.93 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.7 -78.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.091 1.048 . . . . 0.0 110.648 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.74 -37.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.752 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.57 -46.9 85.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.625 -0.672 . . . . 0.0 110.123 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.71 -43.63 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.362 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.94 -27.68 68.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.653 -0.654 . . . . 0.0 110.049 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.05 -39.21 42.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.533 -0.729 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -79.54 -70.32 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.591 -0.693 . . . . 0.0 109.968 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.626 ' CD2' ' CG2' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -65.55 133.52 51.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -0.756 . . . . 0.0 110.563 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -81.88 88.05 6.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.522 -0.736 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.71 76.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 0.0 109.472 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . 0.456 ' C ' ' HE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -58.54 168.74 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.75 -0.594 . . . . 0.0 110.65 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.448 ' N ' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -74.79 72.53 2.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.607 -0.683 . . . . 0.0 110.138 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 1.032 ' HA2' ' O ' ' A' ' 9' ' ' VAL . . . 137.81 44.85 0.08 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.486 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 3.0 m-20 -105.3 147.54 28.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.405 -1.056 . . . . 0.0 110.362 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.35 76.82 5.91 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.519 -0.738 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.559 ' O ' HG21 ' A' ' 7' ' ' VAL . 57.4 t -86.52 143.13 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.512 -0.742 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HE2' HG21 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -111.7 130.57 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.86 130.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 61.2 p -129.1 144.9 51.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.417 -0.802 . . . . 0.0 111.354 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.552 ' CD1' ' CD2' ' A' ' 25' ' ' PHE . 50.1 t80 -121.11 129.86 53.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -107.54 146.88 31.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.656 -0.653 . . . . 0.0 110.823 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 2' ' ' ALA . 28.1 mt-10 -97.99 30.47 3.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.609 -0.682 . . . . 0.0 110.107 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 -34.58 3.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 110.243 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -114.53 -42.17 3.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.501 -0.749 . . . . 0.0 110.319 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.76 37.19 4.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.64 152.08 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.824 -0.809 . . . . 0.0 109.676 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.818 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.0 t -98.95 127.21 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.715 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.2 ttpp -108.26 124.27 50.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.834 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.9 pt -116.92 148.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.535 -0.728 . . . . 0.0 110.464 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -161.18 -171.74 3.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.706 -0.622 . . . . 0.0 110.742 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.67 124.04 36.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.672 . . . . 0.0 110.104 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 tt -169.7 83.45 0.12 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.476 -0.765 . . . . 0.0 110.238 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.89 111.84 0.88 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.461 -0.774 . . . . 0.0 110.106 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 62.07 137.76 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.647 -0.658 . . . . 0.0 110.473 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.0 78.21 1.51 Allowed 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 122.896 0.945 . . . . 0.0 110.537 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -71.08 89.92 0.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.504 -0.747 . . . . 0.0 109.986 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.189 -179.808 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.236 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.77 148.71 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.581 -0.699 . . . . 0.0 109.596 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -140.31 140.2 35.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.898 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.44 161.18 41.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.633 -0.667 . . . . 0.0 109.637 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.23 160.58 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.432 -0.793 . . . . 0.0 110.738 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.45 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.677 -0.64 . . . . 0.0 109.75 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -110.08 151.64 26.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 0.0 110.46 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.08 145.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.647 -0.658 . . . . 0.0 109.649 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 t -172.14 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.535 -0.728 . . . . 0.0 110.741 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.16 -78.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.36 -0.837 . . . . 0.0 111.201 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -162.14 69.18 0.28 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.37 -0.831 . . . . 0.0 110.343 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 52.42 23.94 2.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.271 -0.893 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.9 169.84 8.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.48 -0.762 . . . . 0.0 109.629 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -146.21 135.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.477 -0.764 . . . . 0.0 110.539 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.35 -174.69 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.617 . . . . 0.0 109.525 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.29 138.48 22.86 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -60.3 -164.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.163 1.086 . . . . 0.0 110.271 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.82 -26.41 13.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -65.87 -62.6 1.41 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.498 -0.751 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 22' ' ' ARG . 9.0 p -60.46 -36.18 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 109.609 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' N ' HG12 ' A' ' 21' ' ' VAL . 25.2 ttm180 -64.54 -30.16 71.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.62 -0.675 . . . . 0.0 109.255 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -45.41 82.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -68.76 -71.99 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.671 -0.643 . . . . 0.0 109.27 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -63.12 141.09 58.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.474 -0.766 . . . . 0.0 109.577 179.209 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.39 -83.64 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 110.376 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 25' ' ' PHE . 85.5 mt 51.07 77.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.032 -1.042 . . . . 0.0 110.857 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -105.6 177.25 4.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.449 -0.782 . . . . 0.0 110.205 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.83 77.33 0.88 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.573 -0.704 . . . . 0.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.91 56.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.32 170.38 16.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.94 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.56 103.6 7.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.595 -0.69 . . . . 0.0 110.197 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -95.08 157.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 110.482 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -108.29 131.28 54.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.608 -0.682 . . . . 0.0 110.191 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.4 t -122.43 136.63 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.741 . . . . 0.0 109.317 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 p -141.85 147.48 37.25 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.425 -0.797 . . . . 0.0 111.596 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' B' ' 24' ' ' LYS . 27.1 t80 -106.38 137.16 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.51 175.92 6.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 110.9 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.21 36.64 4.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 110.088 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -127.53 -67.02 0.85 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.621 -0.674 . . . . 0.0 110.023 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.6 -38.58 13.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.21 55.87 0.85 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.48 161.63 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.601 -0.941 . . . . 0.0 110.309 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.629 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 60.3 t -116.08 120.26 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.519 -0.738 . . . . 0.0 109.514 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 17.9 ttmt -109.92 151.53 26.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.752 -0.593 . . . . 0.0 110.799 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.627 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 7.8 pt -134.56 159.58 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.617 -0.677 . . . . 0.0 110.615 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -152.81 164.0 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 110.111 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -149.31 -179.22 6.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.457 -0.777 . . . . 0.0 111.237 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 56.2 160.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.022 0.915 . . . . 0.0 112.464 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.29 -152.3 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.81 145.44 30.16 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.243 -0.911 . . . . 0.0 110.257 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -73.02 94.12 0.81 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 O-C-N 123.247 1.13 . . . . 0.0 110.677 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -156.88 77.72 0.89 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.596 -0.69 . . . . 0.0 110.173 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 tptp . . . . . 0 N--CA 1.502 2.143 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.701 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.202 0.525 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.78 148.65 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.24 140.22 35.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.447 -0.783 . . . . 0.0 110.924 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.43 161.2 41.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.755 -0.591 . . . . 0.0 109.575 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.2 160.59 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.433 -0.792 . . . . 0.0 110.708 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.43 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.642 -0.661 . . . . 0.0 109.663 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -110.06 151.6 27.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.743 . . . . 0.0 110.479 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.08 145.39 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.656 -0.652 . . . . 0.0 109.71 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.9 t -172.13 -37.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.17 -78.11 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.455 -0.778 . . . . 0.0 111.241 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.16 69.02 0.27 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 110.376 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 52.62 23.9 2.86 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.343 -0.848 . . . . 0.0 111.003 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.86 169.78 8.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.644 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -146.21 135.49 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.38 -174.64 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 109.517 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.401 ' CG2' HG11 ' B' ' 21' ' ' VAL . 4.2 mp -138.43 138.5 22.58 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -60.19 -164.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.151 1.079 . . . . 0.0 110.355 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.85 -26.5 13.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.573 -0.704 . . . . 0.0 110.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -65.79 -62.57 1.43 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.41 HG11 ' N ' ' B' ' 22' ' ' ARG . 9.2 p -60.45 -36.25 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.41 ' N ' HG11 ' B' ' 21' ' ' VAL . 25.1 ttm180 -64.5 -30.15 71.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -45.38 81.91 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.408 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 19.7 mmtm -68.77 -71.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.646 -0.659 . . . . 0.0 109.296 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -63.1 141.05 58.91 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -72.38 -83.62 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.402 -0.812 . . . . 0.0 110.428 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 85.6 mt 51.05 77.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.055 -1.028 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -105.58 177.27 4.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.182 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.93 77.41 0.9 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.534 -0.729 . . . . 0.0 110.139 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.84 56.88 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.46 170.4 16.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.577 -0.955 . . . . 0.0 110.103 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.46 103.59 7.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.573 -0.705 . . . . 0.0 110.299 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -95.01 157.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.638 -0.664 . . . . 0.0 110.461 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -108.38 131.23 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.649 -0.657 . . . . 0.0 110.14 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.5 136.56 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.705 . . . . 0.0 109.326 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 8.5 p -141.79 147.52 37.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.396 -0.815 . . . . 0.0 111.479 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -106.39 137.03 45.1 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.39 175.84 6.1 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.279 -0.888 . . . . 0.0 110.993 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.11 36.51 4.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 110.064 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -127.53 -66.88 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.573 -0.704 . . . . 0.0 110.025 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -90.55 -38.61 13.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.578 -0.701 . . . . 0.0 110.072 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.17 55.92 0.85 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.493 HG23 ' HD3' ' A' ' 45' ' ' LYS . 34.1 m -136.54 161.48 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.529 -0.983 . . . . 0.0 110.214 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.627 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.5 t -115.92 120.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.424 -0.798 . . . . 0.0 109.566 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 17.9 ttmt -109.75 151.37 27.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.677 -0.639 . . . . 0.0 110.921 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.629 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 7.8 pt -134.41 159.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.722 -0.611 . . . . 0.0 110.671 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -152.69 164.09 38.41 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 110.123 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mt -149.32 -179.15 6.84 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.391 -0.818 . . . . 0.0 111.31 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 56.1 160.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.98 0.895 . . . . 0.0 112.468 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.35 -152.3 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.8 145.35 29.99 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.177 -0.952 . . . . 0.0 110.314 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -72.86 94.1 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.379 1.199 . . . . 0.0 110.729 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 27.1 m95 -156.93 77.82 0.89 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.489 -0.757 . . . . 0.0 110.082 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 tptp . . . . . 0 N--CA 1.501 2.116 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.779 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.182 0.515 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.96 147.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.593 -0.692 . . . . 0.0 110.152 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -125.79 135.48 52.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.697 -0.627 . . . . 0.0 109.786 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.69 164.5 38.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.0 110.776 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.35 133.16 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.652 -0.655 . . . . 0.0 109.521 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.37 159.32 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -113.09 158.17 20.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.695 -0.628 . . . . 0.0 109.693 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.444 HG22 ' O ' ' B' ' 31' ' ' ASP . 69.9 t -94.18 147.91 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.54 -0.725 . . . . 0.0 110.172 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.7 t -171.05 -168.81 0.68 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.571 -0.705 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.57 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.717 -0.614 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.14 79.5 0.16 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.01 -1.057 . . . . 0.0 111.563 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 53.14 56.99 6.74 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.314 -0.866 . . . . 0.0 111.433 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -130.26 153.33 48.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.82 . . . . 0.0 110.495 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -123.87 101.48 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.703 -0.623 . . . . 0.0 110.074 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -74.87 153.99 38.42 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.543 -0.723 . . . . 0.0 110.077 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -98.91 130.99 26.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.564 -0.71 . . . . 0.0 109.789 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.99 -167.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.042 1.022 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.52 -36.51 17.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 110.221 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.55 -43.17 85.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 110.103 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.32 -38.47 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.714 . . . . 0.0 109.64 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -67.87 -41.47 82.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.168 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -67.55 -45.19 76.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 109.916 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.2 -68.68 0.64 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.704 -0.622 . . . . 0.0 109.999 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -70.87 119.78 15.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.594 -0.691 . . . . 0.0 110.272 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.04 108.68 13.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.706 -0.621 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.65 76.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.472 -0.767 . . . . 0.0 109.981 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -97.23 175.35 6.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.632 -0.668 . . . . 0.0 110.011 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.26 125.62 24.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.52 -0.737 . . . . 0.0 109.997 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 20.4 12.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -111.83 114.8 27.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 95.93 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.624 . . . . 0.0 110.728 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.13 133.13 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.655 -0.653 . . . . 0.0 109.403 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 165.78 11.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.501 -0.749 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.68 136.15 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.658 -0.651 . . . . 0.0 109.873 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.3 p -141.87 146.41 35.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 110.904 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -103.64 140.28 37.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.732 -0.605 . . . . 0.0 109.539 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.33 173.39 6.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.645 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.71 33.97 5.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 110.059 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.5 t -121.65 -63.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 0.0 110.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.37 -35.9 10.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 110.58 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.82 56.97 0.88 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.25 166.92 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.631 -0.923 . . . . 0.0 110.053 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.505 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 47.4 t -119.71 116.6 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.358 -0.839 . . . . 0.0 109.833 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -98.96 139.93 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 110.44 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.502 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.4 pt -131.72 157.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.561 -0.712 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -161.26 168.71 23.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.461 -0.775 . . . . 0.0 110.464 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.61 -152.3 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.539 -0.726 . . . . 0.0 109.568 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tp -56.38 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.409 -0.807 . . . . 0.0 110.802 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.37 136.57 1.35 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.601 -0.687 . . . . 0.0 109.532 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.406 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -124.47 52.59 5.97 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.625 -179.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 51' ' ' GLU . 30.1 Cg_endo -69.24 106.36 1.55 Allowed 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.283 1.149 . . . . 0.0 109.952 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 -63.72 0.68 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.558 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.272 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.225 0.536 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.03 147.17 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.563 -0.71 . . . . 0.0 110.178 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -125.64 135.6 52.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.69 -0.631 . . . . 0.0 109.75 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.76 164.53 38.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.728 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.437 HD13 HG21 ' B' ' 6' ' ' ILE . 87.8 mt -132.49 133.13 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 109.495 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.33 159.31 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.326 -0.859 . . . . 0.0 110.783 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -113.06 158.11 20.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.727 -0.608 . . . . 0.0 109.78 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 73.4 t -94.18 147.83 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 110.185 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -171.04 -168.75 0.68 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.361 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.6 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.674 -0.641 . . . . 0.0 110.831 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.13 79.47 0.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.965 -1.084 . . . . 0.0 111.559 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 53.07 57.15 6.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.301 -0.874 . . . . 0.0 111.459 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -130.47 153.23 49.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.332 -0.855 . . . . 0.0 110.586 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.9 t -123.78 101.4 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.763 -0.586 . . . . 0.0 110.082 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -74.83 153.9 38.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 110.075 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 34.1 mt -98.84 130.93 26.59 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.83 -167.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.161 1.085 . . . . 0.0 110.347 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.51 -36.47 17.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.63 -43.05 85.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.607 -0.683 . . . . 0.0 110.168 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.4 -38.44 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.573 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -67.9 -41.52 82.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.736 -0.603 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -67.5 -45.13 76.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.941 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.36 -68.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 109.971 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -70.87 119.78 15.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.7 -0.625 . . . . 0.0 110.227 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.09 108.75 13.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.627 -0.671 . . . . 0.0 110.327 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.63 76.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -97.25 175.39 6.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.659 -0.651 . . . . 0.0 110.018 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.37 125.74 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 110.017 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 20.42 12.24 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.444 ' O ' HG22 ' A' ' 9' ' ' VAL . 4.9 m-20 -111.77 114.87 28.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.7 95.82 1.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.606 -0.684 . . . . 0.0 110.76 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 64.2 t -94.11 133.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.501 -0.749 . . . . 0.0 109.374 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.37 165.83 11.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.492 -0.755 . . . . 0.0 110.356 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.69 136.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 109.775 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -141.91 146.42 35.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.456 -0.778 . . . . 0.0 110.979 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -103.67 140.36 37.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.481 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.34 173.44 6.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.525 -0.734 . . . . 0.0 110.618 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.7 33.76 5.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.675 -0.641 . . . . 0.0 110.027 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 36.9 t -121.48 -63.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.565 -0.71 . . . . 0.0 110.441 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.3 -35.96 10.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.525 -0.734 . . . . 0.0 110.498 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.85 56.87 0.88 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -133.25 166.75 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.654 -0.909 . . . . 0.0 110.066 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.502 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 47.3 t -119.61 116.64 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.315 -0.865 . . . . 0.0 109.868 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -99.0 139.84 34.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.578 -0.701 . . . . 0.0 110.419 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.505 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.4 pt -131.65 156.86 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 110.384 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -161.0 168.85 23.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.506 -0.746 . . . . 0.0 110.459 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.79 -152.31 0.07 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.639 -0.663 . . . . 0.0 109.555 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tp -56.31 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.369 -0.832 . . . . 0.0 110.816 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.47 136.53 1.31 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.577 -0.702 . . . . 0.0 109.569 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.412 ' N ' ' CD ' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -124.47 52.58 5.96 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.483 -0.76 . . . . 0.0 110.561 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' B' ' 51' ' ' GLU . 29.9 Cg_endo -69.36 106.4 1.58 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 O-C-N 123.235 1.124 . . . . 0.0 109.879 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 -63.59 0.69 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.487 -0.758 . . . . 0.0 110.621 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.258 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.046 0.45 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.38 138.18 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.27 152.11 51.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.562 -0.712 . . . . 0.0 109.9 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.25 152.12 32.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.496 -0.753 . . . . 0.0 110.367 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.8 mt -120.11 125.4 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.634 -0.666 . . . . 0.0 109.567 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.54 155.91 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.498 -0.751 . . . . 0.0 110.59 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.46 145.1 38.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.688 -0.632 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.27 130.74 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.605 -0.684 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -170.85 -157.04 0.13 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.498 -0.751 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 mtt85 55.74 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.727 -0.608 . . . . 0.0 111.075 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -150.83 56.39 0.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.096 -1.002 . . . . 0.0 110.561 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.95 38.25 19.73 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.304 -0.873 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.57 176.94 6.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.25 128.58 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.46 -21.49 21.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.331 -0.856 . . . . 0.0 111.49 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.3 mt 59.87 115.32 0.02 OUTLIER Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.718 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.67 175.18 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 122.858 0.925 . . . . 0.0 110.775 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.59 -27.13 61.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.615 -0.678 . . . . 0.0 110.568 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -54.32 46.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.493 -0.754 . . . . 0.0 110.521 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.53 -45.63 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.38 -0.825 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -60.0 -31.39 69.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -48.42 64.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.629 -0.669 . . . . 0.0 109.502 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' HB3' ' CD2' ' B' ' 37' ' ' PHE . 0.0 OUTLIER -65.12 -65.29 0.69 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.686 -0.633 . . . . 0.0 109.514 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.499 ' CD1' ' CE1' ' B' ' 37' ' ' PHE . 0.6 OUTLIER -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.666 -0.646 . . . . 0.0 110.151 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -73.55 -74.95 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.566 -0.709 . . . . 0.0 109.912 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 27' ' ' ILE . 47.4 mm 52.95 84.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.396 -0.815 . . . . 0.0 110.608 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.35 148.57 37.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.632 -0.668 . . . . 0.0 110.379 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -61.69 109.44 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.586 -0.696 . . . . 0.0 110.134 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 55.22 1.31 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -126.92 158.38 36.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 0.0 110.274 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -92.78 82.95 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.502 HG22 ' CG2' ' B' ' 9' ' ' VAL . 61.2 t -86.81 156.45 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.825 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' B' ' 5' ' ' GLU . 5.1 tttt -134.17 147.14 50.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 110.25 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.81 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 0.0 109.664 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.7 p -134.51 155.84 49.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.987 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE1' ' CD1' ' B' ' 25' ' ' PHE . 26.3 t80 -133.97 121.85 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.708 -0.62 . . . . 0.0 109.536 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -99.97 168.8 9.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 110.174 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.53 32.12 5.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 110.009 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 p -117.61 -48.83 2.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 110.139 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.65 -29.64 12.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 110.163 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.91 39.62 11.54 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.3 155.14 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.888 . . . . 0.0 110.327 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.628 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 40.2 t -103.01 115.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -100.63 130.01 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.844 -0.535 . . . . 0.0 110.165 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.64 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 8.7 pt -124.45 151.44 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.521 -0.737 . . . . 0.0 110.959 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -159.3 -168.98 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.82 -74.57 0.63 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.675 -0.641 . . . . 0.0 110.071 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.6 tp -166.24 140.94 4.45 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.417 -0.802 . . . . 0.0 110.188 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.32 -70.24 0.14 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.462 -0.774 . . . . 0.0 110.45 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -155.19 116.72 2.37 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.448 -0.782 . . . . 0.0 110.346 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.58 88.09 0.28 Allowed 'Trans proline' 0 N--CA 1.486 1.051 0 O-C-N 123.112 1.059 . . . . 0.0 110.478 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -142.53 -46.06 0.32 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.55 -0.719 . . . . 0.0 110.171 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 tttm . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.133 179.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.078 0.466 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.46 138.27 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.573 -0.704 . . . . 0.0 109.998 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -133.3 152.16 51.92 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.649 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.638 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.5 mp0 -151.29 152.15 32.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 mt -120.08 125.43 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.592 -0.692 . . . . 0.0 109.647 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.51 155.84 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.752 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.4 145.2 37.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.653 . . . . 0.0 110.036 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.502 ' CG2' HG22 ' A' ' 33' ' ' VAL . 64.9 t -79.27 130.87 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.569 -0.707 . . . . 0.0 109.991 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -171.09 -157.08 0.12 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.611 -0.68 . . . . 0.0 110.089 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 39.5 mtt85 55.75 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.646 -0.659 . . . . 0.0 111.131 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.82 56.36 0.91 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.067 -1.021 . . . . 0.0 110.518 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.9 38.3 19.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.263 -0.898 . . . . 0.0 110.857 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.6 176.95 6.83 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.52 -0.738 . . . . 0.0 111.179 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.24 128.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.52 -21.44 21.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.492 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 68.5 mt 59.85 115.35 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -57.8 175.19 0.47 Allowed 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 122.893 0.944 . . . . 0.0 110.819 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.07 61.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -54.26 47.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.56 -45.69 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -59.85 -31.56 69.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -48.32 64.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.685 -0.634 . . . . 0.0 109.563 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -65.25 -65.19 0.71 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.629 -0.669 . . . . 0.0 109.484 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.505 ' CD1' ' CE1' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -65.82 164.94 13.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.682 -0.636 . . . . 0.0 110.123 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.59 -74.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.607 -0.683 . . . . 0.0 109.914 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 47.6 mm 52.85 84.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.445 -0.784 . . . . 0.0 110.584 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.39 148.77 37.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.555 -0.716 . . . . 0.0 110.281 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -61.84 109.49 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.594 -0.691 . . . . 0.0 110.098 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 55.15 1.33 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -126.91 158.41 36.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.598 -0.942 . . . . 0.0 110.303 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -92.79 82.92 4.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.8 156.43 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 0.0 109.918 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 5.4 tttt -134.16 147.09 50.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.546 -0.721 . . . . 0.0 110.28 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 47.7 t -127.69 136.11 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.634 -0.666 . . . . 0.0 109.704 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -134.54 155.85 49.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.442 -0.786 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.499 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 26.4 t80 -134.03 121.94 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.705 -0.622 . . . . 0.0 109.468 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -100.07 168.79 9.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.728 -0.607 . . . . 0.0 110.182 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.52 31.97 5.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 74.6 p -117.55 -48.77 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.148 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.67 -29.56 12.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.68 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.82 39.79 11.46 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.31 155.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.744 -0.857 . . . . 0.0 110.343 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.64 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 41.1 t -103.1 115.39 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -100.22 129.8 46.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.761 -0.587 . . . . 0.0 110.342 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.628 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.8 pt -124.1 151.49 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.518 -0.739 . . . . 0.0 110.983 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -159.38 -168.96 2.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.783 -0.573 . . . . 0.0 110.348 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -74.59 0.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 109.958 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 18.6 tp -166.23 140.89 4.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -0.786 . . . . 0.0 110.2 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.28 -70.15 0.15 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.558 -0.714 . . . . 0.0 110.493 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -155.24 116.72 2.37 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.423 -0.798 . . . . 0.0 110.323 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -66.56 88.05 0.27 Allowed 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.129 1.068 . . . . 0.0 110.473 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -142.54 -45.94 0.32 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.603 -0.685 . . . . 0.0 110.261 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 tttm . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.179 179.861 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.053 0.454 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.99 112.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.067 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.38 160.51 14.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.543 -0.723 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.39 148.76 28.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.2 mt -120.32 147.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.638 -0.664 . . . . 0.0 109.777 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 p -168.18 161.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.512 -0.743 . . . . 0.0 110.365 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.86 -170.73 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 110.144 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.77 156.01 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.754 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.8 p -168.95 -176.93 2.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.764 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.94 -157.51 0.15 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.521 -0.737 . . . . 0.0 110.765 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -87.98 65.54 8.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.695 . . . . 0.0 110.271 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.41 33.03 14.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.468 -0.77 . . . . 0.0 111.042 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.86 151.37 25.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.702 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.04 140.03 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 t -144.77 110.59 5.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 109.891 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 88.3 mt -71.26 142.26 86.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.069 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -69.16 179.88 3.09 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.345 1.182 . . . . 0.0 110.465 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.43 43.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.7 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.65 -50.77 72.16 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.11 -36.18 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.267 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.94 -47.67 65.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.312 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -69.33 0.29 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.683 -0.636 . . . . 0.0 109.355 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.3 OUTLIER -66.41 156.25 35.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.579 -0.701 . . . . 0.0 109.719 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.77 -81.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.494 -0.754 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.6 mt 50.63 87.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.191 -0.943 . . . . 0.0 110.895 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -124.77 173.0 8.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.727 . . . . 0.0 109.917 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.86 5.66 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 0.0 110.266 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.27 61.6 1.55 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -133.96 138.08 45.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.522 -0.987 . . . . 0.0 110.152 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.81 90.78 8.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.543 -0.723 . . . . 0.0 110.325 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -97.21 152.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.629 -0.669 . . . . 0.0 109.789 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 151.59 48.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.541 -0.724 . . . . 0.0 110.627 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.0 127.57 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.7 p -127.37 150.11 49.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.497 -0.752 . . . . 0.0 111.367 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.1 t80 -136.23 125.33 24.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.51 -177.68 3.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 0.0 110.532 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -124.24 24.21 8.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.713 -0.617 . . . . 0.0 110.461 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.6 t -119.45 -40.36 2.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 110.072 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.61 -49.6 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 110.128 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.31 43.78 2.49 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.554 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 34.9 m -141.41 156.23 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.576 -0.955 . . . . 0.0 110.032 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' B' ' 46' ' ' ILE . 46.6 t -106.23 125.5 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.956 -0.697 . . . . 0.0 109.925 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.546 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -107.83 128.28 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.665 -0.647 . . . . 0.0 110.259 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG12 ' HB ' ' B' ' 44' ' ' VAL . 22.1 pt -116.76 153.56 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.735 . . . . 0.0 110.356 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -156.26 162.76 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.578 -0.701 . . . . 0.0 110.428 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.52 -66.07 1.11 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 110.166 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 tp -149.3 155.69 40.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.531 -0.731 . . . . 0.0 110.297 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -125.24 139.94 53.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.745 . . . . 0.0 110.052 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -145.13 135.34 11.87 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.548 -0.72 . . . . 0.0 110.275 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -74.23 112.89 3.65 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 O-C-N 123.294 1.155 . . . . 0.0 110.352 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -110.21 51.47 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 110.215 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.2 tttm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.182 179.809 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.047 0.451 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.95 112.78 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.678 . . . . 0.0 110.03 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.4 160.54 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.44 148.68 28.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.545 -0.722 . . . . 0.0 110.43 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 23.3 mt -120.31 147.73 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.643 -0.661 . . . . 0.0 109.757 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.25 161.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.423 -0.798 . . . . 0.0 110.356 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.77 -170.65 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 156.03 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.109 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -169.02 -177.02 2.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.482 -0.761 . . . . 0.0 110.454 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.97 -157.54 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.454 -0.779 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -88.02 65.66 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.226 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.5 32.74 14.69 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.0 111.083 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.7 151.41 25.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.553 -0.717 . . . . 0.0 109.759 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.09 140.03 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -144.67 110.5 5.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.609 -0.682 . . . . 0.0 109.936 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 88.7 mt -71.37 142.33 86.68 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.475 -0.765 . . . . 0.0 110.046 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -69.31 179.95 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.393 1.207 . . . . 0.0 110.419 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.34 43.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.107 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -60.8 -50.6 72.8 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.602 -0.687 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.05 -36.3 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.671 -0.643 . . . . 0.0 109.267 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -64.03 -31.97 73.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.641 -0.662 . . . . 0.0 109.587 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -47.54 65.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.668 . . . . 0.0 109.299 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -69.42 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.292 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -66.37 156.14 35.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.638 -0.664 . . . . 0.0 109.778 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.66 -81.74 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.53 -0.731 . . . . 0.0 110.035 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 61.8 mt 50.59 87.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.138 -0.977 . . . . 0.0 110.87 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -124.73 172.99 8.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.597 -0.689 . . . . 0.0 109.925 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.82 5.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.5 -0.75 . . . . 0.0 110.314 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 61.45 1.56 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -133.84 138.22 45.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 0.0 110.146 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.9 90.83 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 110.343 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.24 152.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.0 109.821 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 151.58 48.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 110.669 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.06 127.53 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 18.5 p -127.46 150.04 49.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.818 . . . . 0.0 111.369 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 34.8 t80 -136.25 125.39 24.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.43 -177.74 3.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 110.57 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.28 24.31 8.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.384 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -119.44 -40.51 2.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.48 -49.67 4.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.647 -0.658 . . . . 0.0 110.154 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.41 43.63 2.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.546 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 34.8 m -141.31 156.13 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.6 -0.941 . . . . 0.0 110.12 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.468 ' HB ' HG12 ' A' ' 46' ' ' ILE . 46.2 t -106.09 125.54 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.554 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -107.86 128.36 54.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.485 HG12 ' HB ' ' A' ' 44' ' ' VAL . 22.2 pt -116.76 153.57 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.583 -0.698 . . . . 0.0 110.321 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -156.34 162.64 40.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.658 -0.651 . . . . 0.0 110.414 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.4 -66.12 1.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.654 -0.654 . . . . 0.0 110.175 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 tp -149.25 155.72 41.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.569 -0.707 . . . . 0.0 110.27 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -125.33 139.94 53.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.565 -0.709 . . . . 0.0 110.019 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -145.09 135.31 11.87 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.513 -0.742 . . . . 0.0 110.31 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -74.22 113.04 3.69 Favored 'Trans proline' 0 N--CA 1.484 0.919 0 O-C-N 123.175 1.092 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -110.31 51.48 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.575 -0.703 . . . . 0.0 110.228 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 7.2 tttm . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.2 179.869 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.101 0.476 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.47 144.38 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.657 -0.652 . . . . 0.0 109.755 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.6 131.08 14.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.508 -0.745 . . . . 0.0 110.306 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.44 173.26 11.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.575 -0.703 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 pt -121.77 159.5 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.642 -0.661 . . . . 0.0 110.286 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 63.2 t -147.42 153.12 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.658 -0.651 . . . . 0.0 110.204 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 172.24 6.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.83 149.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.472 -0.767 . . . . 0.0 110.213 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -171.8 -167.65 0.52 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.542 -0.724 . . . . 0.0 110.799 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.81 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.684 -0.635 . . . . 0.0 111.465 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.36 73.94 0.94 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.949 -1.094 . . . . 0.0 111.181 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 49.2 29.08 2.44 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.37 -0.831 . . . . 0.0 111.427 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.01 153.6 21.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.637 -0.664 . . . . 0.0 110.409 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -126.33 151.58 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.61 -0.681 . . . . 0.0 109.842 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -148.15 127.1 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.645 -0.659 . . . . 0.0 110.147 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.6 mt -81.26 145.38 55.82 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 0.0 109.942 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -58.12 -166.18 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.344 1.181 . . . . 0.0 110.617 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.93 -43.33 8.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.595 -0.691 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -63.71 -44.09 94.63 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.642 -0.661 . . . . 0.0 110.33 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.0 -41.71 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.528 -0.732 . . . . 0.0 109.603 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -65.54 -31.68 72.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.499 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -40.4 75.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.675 -0.641 . . . . 0.0 109.272 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -72.98 -74.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.615 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.3 154.01 14.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.593 -0.692 . . . . 0.0 109.975 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -84.88 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.73 . . . . 0.0 109.853 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.0 mt 49.6 86.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.972 . . . . 0.0 110.902 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.25 -177.22 3.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -0.769 . . . . 0.0 110.596 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -83.15 117.57 22.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 0.0 110.104 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.38 38.01 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.27 170.01 9.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.936 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -117.17 72.24 0.83 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.746 . . . . 0.0 110.136 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -64.65 149.37 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 110.398 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.45 156.95 18.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.67 -0.644 . . . . 0.0 110.329 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.33 133.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.4 p -141.57 145.86 35.6 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.156 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 44.4 t80 -111.47 140.18 46.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -132.81 155.7 48.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 0.0 110.948 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.77 20.02 12.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.239 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -100.94 -27.78 13.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.285 -0.884 . . . . 0.0 109.909 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -127.2 -49.27 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.637 -0.664 . . . . 0.0 110.24 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.42 35.31 3.37 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.602 HG11 ' HB2' ' B' ' 47' ' ' GLN . 35.3 m -136.89 163.12 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.523 -0.987 . . . . 0.0 110.236 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.789 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 59.5 t -105.0 127.61 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.346 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 27.3 ttmt -112.22 133.71 54.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.771 -0.581 . . . . 0.0 110.217 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.796 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 5.3 pt -125.75 158.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.631 -0.668 . . . . 0.0 110.194 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.561 ' CD ' ' CG1' ' B' ' 43' ' ' VAL . 5.0 tt0 -153.72 161.31 42.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.668 -0.645 . . . . 0.0 110.351 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.13 38.13 1.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.578 -0.701 . . . . 0.0 110.056 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 23.2 mt -91.97 124.97 36.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.568 -0.707 . . . . 0.0 110.318 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -143.43 -155.16 0.57 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.639 -0.663 . . . . 0.0 109.817 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -58.64 110.25 2.47 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.475 -0.766 . . . . 0.0 110.183 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.07 131.12 26.02 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.147 1.077 . . . . 0.0 110.588 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -150.45 79.63 1.34 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.622 -0.674 . . . . 0.0 109.86 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.349 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.138 0.494 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.45 144.33 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.759 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.71 131.1 14.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 0.0 110.368 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.41 173.28 11.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.698 -0.627 . . . . 0.0 110.034 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 38.4 pt -121.78 159.59 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.624 -0.673 . . . . 0.0 110.324 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.9 t -147.45 153.16 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.527 -0.733 . . . . 0.0 110.181 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.93 172.19 6.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.705 . . . . 0.0 110.069 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.74 149.23 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 110.237 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.8 t -172.02 -167.64 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.522 -0.736 . . . . 0.0 110.757 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.76 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.663 -0.648 . . . . 0.0 111.454 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.35 73.95 0.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.04 -1.037 . . . . 0.0 111.219 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 49.23 29.17 2.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.315 -0.865 . . . . 0.0 111.396 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.07 153.64 21.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.419 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.34 151.49 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.798 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -148.09 127.03 12.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 110.072 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 85.0 mt -81.08 145.26 56.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.969 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -57.96 -166.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.416 1.219 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.82 -43.49 8.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -63.7 -43.89 95.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.55 -0.719 . . . . 0.0 110.362 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.18 -41.79 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 109.526 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -65.46 -31.78 73.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.6 -0.687 . . . . 0.0 109.462 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -40.48 75.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.668 -0.645 . . . . 0.0 109.334 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -72.96 -74.09 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.609 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.36 154.01 14.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.0 109.97 179.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.3 -84.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 109.887 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 71.8 mt 49.48 86.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.066 -1.022 . . . . 0.0 110.964 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.19 -177.21 3.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.527 -0.733 . . . . 0.0 110.538 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -83.12 117.56 22.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.574 -0.704 . . . . 0.0 110.106 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.26 38.22 4.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.34 170.02 9.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.917 . . . . 0.0 110.184 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mt -117.22 72.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.69 149.33 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.52 -0.738 . . . . 0.0 110.336 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.4 156.9 18.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.597 -0.689 . . . . 0.0 110.364 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.34 133.15 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 79.1 p -141.62 145.89 35.56 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.117 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.615 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 44.1 t80 -111.42 140.13 46.26 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -132.75 155.77 48.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.83 20.11 12.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -100.82 -28.04 13.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.795 . . . . 0.0 109.974 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -127.02 -49.25 1.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.706 -0.621 . . . . 0.0 110.246 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.43 35.21 3.39 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.561 ' CG1' ' CD ' ' A' ' 47' ' ' GLN . 35.2 m -136.79 163.1 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.5 -1.0 . . . . 0.0 110.122 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.796 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.6 t -105.03 127.37 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.2 ttmt -111.87 133.55 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.697 -0.627 . . . . 0.0 110.294 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.789 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 5.4 pt -125.54 158.05 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.653 -0.654 . . . . 0.0 110.302 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.602 ' HB2' HG11 ' A' ' 43' ' ' VAL . 4.8 tt0 -153.64 161.36 42.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.716 -0.615 . . . . 0.0 110.32 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.18 38.18 1.74 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 24.0 mt -91.87 125.03 36.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 110.406 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -143.43 -155.09 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.561 -0.712 . . . . 0.0 109.824 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.75 110.33 2.55 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.506 -0.746 . . . . 0.0 110.198 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.22 130.99 25.41 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.193 1.101 . . . . 0.0 110.557 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -150.34 79.72 1.35 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.653 -0.654 . . . . 0.0 109.83 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.315 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.055 0.455 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.77 156.25 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 0.0 109.759 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -145.52 147.05 31.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.531 -0.73 . . . . 0.0 110.598 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HB2' HG13 ' B' ' 35' ' ' VAL . 1.4 mm-40 -137.81 164.05 29.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.752 -0.593 . . . . 0.0 109.912 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.95 137.93 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.657 -0.652 . . . . 0.0 110.519 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 8' ' ' LYS . 9.9 p -146.15 165.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.575 -0.703 . . . . 0.0 109.736 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.422 ' N ' HG22 ' A' ' 7' ' ' VAL . 16.0 tttp -137.07 138.35 40.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.351 -0.843 . . . . 0.0 110.517 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.45 124.96 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.597 -0.689 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 m -168.65 42.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.437 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -139.59 -66.04 0.46 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.605 -0.684 . . . . 0.0 109.457 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.08 46.29 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.752 -0.592 . . . . 0.0 109.995 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' B' ' 29' ' ' GLU . 15.2 m-85 53.42 57.42 6.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 110.803 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 174.71 13.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.463 -0.773 . . . . 0.0 110.81 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.52 145.53 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.753 -0.592 . . . . 0.0 109.693 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 p -110.95 -8.47 14.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 111.368 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.8 mt 59.51 111.6 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.304 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.53 -168.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.039 1.02 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.04 -33.85 26.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 0.0 111.519 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -56.34 -52.43 64.6 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.234 -0.916 . . . . 0.0 110.862 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.22 -47.7 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.393 -0.817 . . . . 0.0 109.593 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HD2' HG21 ' A' ' 27' ' ' ILE . 9.1 tpp180 -58.63 -28.77 65.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.99 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -45.06 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 109.486 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.64 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.598 -0.688 . . . . 0.0 109.952 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.12 169.92 5.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.402 -0.811 . . . . 0.0 110.817 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.47 -73.43 0.38 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.692 -0.63 . . . . 0.0 110.733 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.547 HG21 ' HD2' ' A' ' 22' ' ' ARG . 47.2 mm 55.12 93.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 139.16 47.79 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.0 110.365 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 13' ' ' TYR . 5.4 tt0 -67.58 112.15 4.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.543 -0.723 . . . . 0.0 110.154 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.73 35.44 4.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.73 163.98 18.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.579 -0.954 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.3 tp -93.71 107.25 19.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.645 -0.66 . . . . 0.0 110.289 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.9 t -98.72 141.18 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.667 -0.645 . . . . 0.0 109.585 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.75 142.21 46.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.548 -0.72 . . . . 0.0 110.346 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 5' ' ' GLU . 12.4 p -131.37 134.27 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.665 -0.647 . . . . 0.0 109.779 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.402 HG22 ' CB ' ' B' ' 4' ' ' GLU . 24.1 p -134.25 146.03 49.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.74 . . . . 0.0 111.208 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -104.16 130.56 51.91 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.47 148.1 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 110.556 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.21 38.92 1.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.632 -0.668 . . . . 0.0 110.226 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -144.28 -52.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB3' HG22 ' A' ' 43' ' ' VAL . 4.7 mt-10 -83.92 -30.56 26.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.482 -0.761 . . . . 0.0 110.024 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 39.26 29.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' B' ' 47' ' ' GLN . 35.8 m -136.89 158.27 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.921 . . . . 0.0 109.684 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 61.6 t -98.68 130.48 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 109.504 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 15.5 ttmt -110.08 127.21 54.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.877 -0.514 . . . . 0.0 110.415 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.449 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.4 pt -121.98 146.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.403 -0.811 . . . . 0.0 110.92 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.545 ' HB3' HG12 ' B' ' 43' ' ' VAL . 17.0 pt20 -143.89 -169.58 3.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.871 -0.518 . . . . 0.0 110.186 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.135 0.493 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.75 156.3 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.402 ' CB ' HG22 ' A' ' 36' ' ' THR . 7.5 tt0 -145.47 147.13 31.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.484 -0.76 . . . . 0.0 110.59 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.4 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 1.4 mm-40 -137.95 163.88 30.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.683 -0.636 . . . . 0.0 109.903 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.84 137.89 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.688 -0.632 . . . . 0.0 110.582 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.417 HG22 ' N ' ' B' ' 8' ' ' LYS . 10.2 p -146.14 165.17 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 0.0 109.725 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.417 ' N ' HG22 ' B' ' 7' ' ' VAL . 16.2 tttp -137.03 138.4 40.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.433 -0.792 . . . . 0.0 110.518 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.46 125.17 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 109.54 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -168.75 42.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.475 -0.765 . . . . 0.0 110.43 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -139.61 -65.99 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.24 46.25 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.07 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 29' ' ' GLU . 15.2 m-85 53.44 57.57 6.05 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.492 -0.755 . . . . 0.0 110.814 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 174.78 13.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.451 -0.78 . . . . 0.0 110.822 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.64 145.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.843 -0.536 . . . . 0.0 109.666 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -110.78 -8.56 14.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 111.476 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt 59.55 111.69 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.248 -0.907 . . . . 0.0 110.592 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.76 -168.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.089 1.047 . . . . 0.0 111.324 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.78 -33.72 27.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.654 -0.654 . . . . 0.0 111.6 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -56.62 -52.15 65.96 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.14 -0.975 . . . . 0.0 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.44 -47.63 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.384 -0.823 . . . . 0.0 109.43 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.556 ' HD2' HG21 ' B' ' 27' ' ' ILE . 9.1 tpp180 -58.74 -28.78 66.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 109.938 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -45.11 80.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.459 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.61 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.13 169.87 5.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.451 -0.781 . . . . 0.0 110.827 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.41 -73.5 0.38 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.7 -0.625 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.556 HG21 ' HD2' ' B' ' 22' ' ' ARG . 46.9 mm 55.2 93.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.234 -0.916 . . . . 0.0 110.337 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 139.21 47.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 110.339 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 5.5 tt0 -67.59 112.18 4.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.515 -0.74 . . . . 0.0 110.144 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.61 4.9 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.75 163.89 18.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.715 -0.874 . . . . 0.0 110.047 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.5 107.19 19.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.614 -0.679 . . . . 0.0 110.354 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.85 141.25 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.485 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 142.03 46.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.558 -0.714 . . . . 0.0 110.28 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 5' ' ' GLU . 12.1 p -131.28 134.31 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 24.0 p -134.22 146.12 49.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -104.12 130.46 51.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.26 148.18 24.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.428 -0.795 . . . . 0.0 110.634 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.27 38.86 1.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.656 -0.652 . . . . 0.0 110.284 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -144.1 -52.78 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 110.07 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.525 ' HB3' HG22 ' B' ' 43' ' ' VAL . 4.7 mt-10 -83.82 -30.68 26.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 0.0 110.048 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.9 39.21 28.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 47' ' ' GLN . 35.6 m -136.99 158.14 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.789 -0.83 . . . . 0.0 109.635 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 61.4 t -98.54 130.35 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.314 -0.866 . . . . 0.0 109.555 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.406 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 16.8 ttmt -110.02 127.21 54.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.702 -0.624 . . . . 0.0 110.38 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.46 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.4 pt -121.75 146.93 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.423 -0.798 . . . . 0.0 110.917 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.546 ' HB3' HG12 ' A' ' 43' ' ' VAL . 17.0 pt20 -143.91 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 0.0 110.197 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 110.319 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.182 0.515 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.47 134.91 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 109.97 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.721 ' HA ' HG22 ' B' ' 36' ' ' THR . 0.2 OUTLIER -122.76 153.39 39.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.74 . . . . 0.0 110.582 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.04 162.6 41.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.647 . . . . 0.0 109.746 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 tt -134.93 154.9 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.566 -0.709 . . . . 0.0 110.703 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.36 159.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 109.973 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -156.32 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.72 . . . . 0.0 110.275 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.122 ' O ' ' N ' ' B' ' 30' ' ' GLY . 49.0 t -143.59 126.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.87 -169.21 3.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 56.88 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.8 -0.562 . . . . 0.0 111.313 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -152.42 57.73 0.82 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.975 -1.078 . . . . 0.0 110.835 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.008 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 80.3 m-85 50.8 37.38 16.83 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.327 -0.858 . . . . 0.0 111.346 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.45 173.98 6.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.453 -0.78 . . . . 0.0 110.242 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -169.5 141.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.791 . . . . 0.0 110.624 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -108.04 174.47 5.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 109.405 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.9 mm -108.54 133.47 20.6 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.386 -0.821 . . . . 0.0 110.38 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.578 ' HG2' HG23 ' A' ' 21' ' ' VAL . 33.0 Cg_endo -71.36 157.32 57.02 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 O-C-N 123.171 1.09 . . . . 0.0 110.195 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.99 57.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 110.612 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -70.86 -53.49 15.01 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.372 -0.83 . . . . 0.0 110.466 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.578 HG23 ' HG2' ' A' ' 18' ' ' PRO . 98.8 t -59.95 -43.95 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.258 -0.901 . . . . 0.0 109.32 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -59.95 -31.48 69.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.61 -52.57 50.96 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.445 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.53 -68.64 0.67 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.626 -0.671 . . . . 0.0 110.383 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.058 ' CE1' HG23 ' B' ' 44' ' ' VAL . 13.5 t80 -57.96 134.87 56.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.536 -0.728 . . . . 0.0 111.029 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -81.97 123.09 28.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.671 -0.643 . . . . 0.0 109.783 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 27' ' ' ILE . 6.9 tt -166.85 85.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.182 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 1.008 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.4 OUTLIER -95.83 178.28 5.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.294 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.632 ' HA ' HG12 ' B' ' 9' ' ' VAL . 3.5 mt-10 -66.62 135.28 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.65 -0.656 . . . . 0.0 110.606 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 1.127 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 61.16 48.66 84.65 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -106.68 -176.22 3.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -1.019 . . . . 0.0 110.165 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 32' ' ' LEU . 2.0 mm? -95.9 78.84 3.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.792 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.572 HG21 ' CG2' ' B' ' 9' ' ' VAL . 63.7 t -85.6 116.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.35 142.32 32.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.669 -0.644 . . . . 0.0 109.836 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.08 122.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.56 -0.712 . . . . 0.0 109.878 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.707 HG22 ' HA ' ' B' ' 4' ' ' GLU . 68.3 p -140.55 146.79 38.53 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.311 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.421 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 12.0 t80 -105.03 142.54 34.64 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.36 145.07 27.76 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.135 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.56 32.69 2.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.007 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.63 -59.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.588 -0.695 . . . . 0.0 110.077 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -79.99 -30.02 39.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.666 . . . . 0.0 110.163 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.6 43.06 7.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.5 m -137.82 156.44 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.679 -0.894 . . . . 0.0 110.33 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.043 HG23 ' CE1' ' B' ' 25' ' ' PHE . 57.6 t -107.34 121.86 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' HG21 ' B' ' 43' ' ' VAL . 1.2 ttpt -103.67 136.96 42.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.684 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.776 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 42.9 pt -127.5 149.31 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.934 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.74 ' HB3' HG12 ' B' ' 43' ' ' VAL . 10.2 pt20 -151.79 175.1 12.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.504 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 0.0 110.713 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.099 0.476 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.55 134.91 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.543 -0.723 . . . . 0.0 110.022 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' A' ' 36' ' ' THR . 0.2 OUTLIER -122.62 153.42 39.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.558 -0.714 . . . . 0.0 110.653 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.14 162.46 41.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.719 -0.613 . . . . 0.0 109.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -134.85 154.85 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 110.783 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.33 159.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.686 -0.634 . . . . 0.0 109.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.31 -156.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.516 -0.74 . . . . 0.0 110.275 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 1.127 ' O ' ' N ' ' A' ' 30' ' ' GLY . 49.2 t -143.6 126.34 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.78 -169.18 3.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.611 -0.68 . . . . 0.0 110.404 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 56.87 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.657 -0.652 . . . . 0.0 111.309 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -152.23 57.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.102 -0.999 . . . . 0.0 110.842 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 1.008 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 81.6 m-85 50.8 37.37 16.8 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 0.0 111.397 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.4 174.13 6.02 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.439 -0.788 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.83 141.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.383 -0.823 . . . . 0.0 110.54 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -108.03 174.33 5.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.644 -0.66 . . . . 0.0 109.388 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 42.5 mm -108.35 133.47 20.56 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.587 ' HG2' HG23 ' B' ' 21' ' ' VAL . 32.8 Cg_endo -71.53 157.19 56.74 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 O-C-N 123.304 1.16 . . . . 0.0 110.155 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.72 54.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -71.05 -53.41 14.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.363 -0.836 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.587 HG23 ' HG2' ' B' ' 18' ' ' PRO . 86.7 t -59.94 -43.96 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -60.03 -31.38 69.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.77 -0.581 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.55 -52.56 51.53 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.705 -0.622 . . . . 0.0 109.481 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -68.4 0.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.639 -0.663 . . . . 0.0 110.482 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 1.043 ' CE1' HG23 ' A' ' 44' ' ' VAL . 13.8 t80 -58.21 135.02 57.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.951 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -81.99 123.03 28.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.644 -0.66 . . . . 0.0 109.815 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.631 ' O ' HG23 ' B' ' 27' ' ' ILE . 7.0 tt -166.74 85.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.271 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 1.008 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -0.843 . . . . 0.0 110.311 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.644 ' HA ' HG12 ' A' ' 9' ' ' VAL . 3.5 mt-10 -66.56 135.33 54.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.669 -0.644 . . . . 0.0 110.538 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLY . . . . . 1.122 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 61.25 48.67 84.31 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.463 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -106.7 -176.14 2.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -1.009 . . . . 0.0 110.177 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' B' ' 32' ' ' LEU . 2.0 mm? -95.98 78.86 3.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.589 -0.695 . . . . 0.0 109.852 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.565 HG21 ' CG2' ' A' ' 9' ' ' VAL . 64.3 t -85.52 116.98 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.643 -0.661 . . . . 0.0 110.145 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.37 142.53 32.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 109.779 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.3 122.12 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.395 -0.815 . . . . 0.0 109.73 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 4' ' ' GLU . 70.5 p -140.54 146.85 38.64 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -0.823 . . . . 0.0 111.269 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.428 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 11.9 t80 -105.11 142.55 34.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 145.02 27.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.405 -0.809 . . . . 0.0 110.184 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.6 32.6 2.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.706 . . . . 0.0 109.957 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.61 -59.32 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.702 -0.624 . . . . 0.0 110.065 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -80.11 -30.05 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 110.105 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.67 42.97 7.5 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.7 m -137.68 156.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.584 -0.95 . . . . 0.0 110.295 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 1.058 HG23 ' CE1' ' A' ' 25' ' ' PHE . 57.5 t -107.38 121.64 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 43' ' ' VAL . 1.3 ttpt -103.49 136.8 42.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.687 -0.633 . . . . 0.0 110.665 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.754 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 42.5 pt -127.28 149.35 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.767 -0.583 . . . . 0.0 109.99 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.728 ' HB3' HG12 ' A' ' 43' ' ' VAL . 10.2 pt20 -151.66 175.13 12.68 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 0.0 110.495 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.599 -0.688 . . . . 0.0 110.723 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.163 0.506 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.75 139.8 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.666 -0.647 . . . . 0.0 109.968 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.14 150.4 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.6 -0.688 . . . . 0.0 110.168 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -156.81 161.88 39.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.624 -0.673 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.4 mt -131.25 136.61 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.585 -0.697 . . . . 0.0 110.216 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.69 170.07 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.748 -0.595 . . . . 0.0 109.785 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.69 152.16 35.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.424 -0.798 . . . . 0.0 110.772 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.86 ' O ' ' N ' ' B' ' 30' ' ' GLY . 62.7 t -101.71 136.31 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.74 -0.6 . . . . 0.0 109.591 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.6 p -157.15 -47.01 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.524 -0.735 . . . . 0.0 110.411 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -147.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.652 -0.655 . . . . 0.0 110.182 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.97 60.98 1.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 111.1 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.928 ' CD2' ' O ' ' B' ' 27' ' ' ILE . 27.1 m-85 50.59 32.16 6.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.38 -0.825 . . . . 0.0 111.826 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -88.42 174.64 8.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.299 -0.876 . . . . 0.0 110.101 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.11 135.5 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.022 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.2 m -100.61 150.51 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 110.364 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.3 mt -101.7 128.95 27.68 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.584 -0.698 . . . . 0.0 109.67 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.1 158.44 25.66 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.121 1.063 . . . . 0.0 110.72 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.14 77.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.639 -0.663 . . . . 0.0 109.874 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.49 -51.91 56.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.643 -0.661 . . . . 0.0 109.571 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.77 -39.26 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.05 -30.07 70.53 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.68 25.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.603 -0.686 . . . . 0.0 109.433 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -79.62 -63.34 1.44 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.684 -0.635 . . . . 0.0 109.846 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.817 ' CE1' HG23 ' B' ' 44' ' ' VAL . 6.4 t80 -53.53 115.24 1.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.268 -0.895 . . . . 0.0 110.695 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.449 ' O ' HD22 ' A' ' 48' ' ' LEU . 12.4 mt-30 -73.77 131.17 41.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.558 -0.714 . . . . 0.0 110.358 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.946 ' O ' ' CD2' ' B' ' 13' ' ' TYR . 6.8 tt -167.56 91.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.64 0.733 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.752 ' HA ' ' CE2' ' B' ' 13' ' ' TYR . 8.3 tttt -99.1 -179.65 4.32 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.262 -0.899 . . . . 0.0 110.997 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.579 ' HA ' HG12 ' B' ' 9' ' ' VAL . 23.5 mt-10 -75.48 127.08 32.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.973 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.842 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 90.97 26.39 22.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.767 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -103.74 149.55 24.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.538 -0.978 . . . . 0.0 109.776 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.3 mt -101.43 74.59 1.55 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.695 . . . . 0.0 110.708 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.32 151.09 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.426 -0.796 . . . . 0.0 109.569 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -106.61 154.95 20.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.836 . . . . 0.0 111.145 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.695 ' HA ' HG22 ' A' ' 46' ' ' ILE . 8.4 p -145.21 125.83 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.0 p -130.98 146.95 52.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.865 . . . . 0.0 111.508 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 40.0 t80 -106.49 149.97 26.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -110.07 -167.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.13 -38.71 1.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.7 . . . . 0.0 110.597 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.97 -40.11 12.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 110.598 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' A' ' 43' ' ' VAL . 13.8 mp0 -81.66 -37.2 27.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.697 . . . . 0.0 110.537 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.07 72.11 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.889 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 24.7 m -121.21 149.77 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.447 -1.031 . . . . 0.0 109.661 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.901 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 90.3 t -103.62 129.28 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.418 -0.802 . . . . 0.0 109.675 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.938 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 3.8 ttpm? -109.07 130.96 55.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.217 0.532 . . . . 0.0 109.737 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.903 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 10.8 pt -126.53 145.14 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.73 -0.606 . . . . 0.0 110.086 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.847 ' HB3' HG12 ' B' ' 43' ' ' VAL . 4.0 pt20 -148.96 171.08 16.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 110.303 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 26' ' ' GLN . 1.7 tp . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.05 0.452 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.57 139.95 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.642 -0.661 . . . . 0.0 109.982 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.2 150.57 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.711 -0.618 . . . . 0.0 110.137 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -156.97 161.85 39.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.745 -0.597 . . . . 0.0 109.589 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.26 136.62 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -126.9 169.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.692 -0.63 . . . . 0.0 109.71 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.61 152.04 35.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.518 -0.739 . . . . 0.0 110.787 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.842 ' O ' ' N ' ' A' ' 30' ' ' GLY . 62.8 t -101.59 136.26 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.665 . . . . 0.0 109.61 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.4 p -157.23 -46.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.746 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.41 ' HB3' ' HG2' ' B' ' 14' ' ' GLN . 0.3 OUTLIER -69.72 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.657 -0.652 . . . . 0.0 110.222 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.9 60.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.093 -1.005 . . . . 0.0 111.213 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.946 ' CD2' ' O ' ' A' ' 27' ' ' ILE . 27.0 m-85 50.61 32.09 6.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.364 -0.835 . . . . 0.0 111.902 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.41 ' HG2' ' HB3' ' B' ' 11' ' ' ARG . 17.1 pt20 -88.43 174.56 8.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.99 135.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.46 -0.775 . . . . 0.0 109.918 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 m -100.58 150.53 22.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 110.299 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 89.5 mt -101.67 129.0 27.61 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.22 158.52 25.91 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.115 1.061 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.0 77.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -51.65 58.18 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.574 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 83.7 t -62.04 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -66.01 -30.18 70.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.59 26.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.708 -0.62 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.61 -63.37 1.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.741 -0.599 . . . . 0.0 109.887 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.802 ' CE1' HG23 ' A' ' 44' ' ' VAL . 6.3 t80 -53.45 115.21 1.82 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.441 ' O ' HD22 ' B' ' 48' ' ' LEU . 12.3 mt-30 -73.83 131.29 41.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.648 -0.658 . . . . 0.0 110.309 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.928 ' O ' ' CD2' ' A' ' 13' ' ' TYR . 6.8 tt -167.64 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.548 0.69 . . . . 0.0 109.557 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.744 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 7.6 tttt -98.99 -179.77 4.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 111.005 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.582 ' HA ' HG12 ' A' ' 9' ' ' VAL . 23.3 mt-10 -75.41 127.12 32.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.638 . . . . 0.0 109.961 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 91.02 26.36 22.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.767 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -103.78 149.44 25.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.972 . . . . 0.0 109.825 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 74.53 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.656 -0.652 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.44 151.19 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.517 -0.739 . . . . 0.0 109.516 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -106.79 154.93 20.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.337 -0.852 . . . . 0.0 111.141 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.691 ' HA ' HG22 ' B' ' 46' ' ' ILE . 8.2 p -145.17 125.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -130.99 146.97 52.56 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.591 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.575 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 39.8 t80 -106.46 149.95 26.56 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.9 -167.21 1.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.642 -0.661 . . . . 0.0 110.272 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.03 -38.64 1.42 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.633 -0.667 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.05 -40.08 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -0.8 . . . . 0.0 110.604 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' B' ' 43' ' ' VAL . 13.6 mp0 -81.77 -37.2 27.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 110.446 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.87 26.29 71.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.938 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 25.5 m -121.32 149.58 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -1.047 . . . . 0.0 109.686 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.903 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 92.3 t -103.62 129.19 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 109.773 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.889 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 3.8 ttpm? -109.09 130.85 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.783 -0.573 . . . . 0.0 109.833 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.901 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 10.8 pt -126.25 145.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.788 -0.57 . . . . 0.0 110.178 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.844 ' HB3' HG12 ' A' ' 43' ' ' VAL . 3.9 pt20 -149.01 171.02 17.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.247 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.441 HD22 ' O ' ' B' ' 26' ' ' GLN . 1.8 tp . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 109.721 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.166 0.508 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.5 t -122.36 150.69 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.55 -0.719 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.569 ' CB ' HG22 ' B' ' 36' ' ' THR . 1.2 pt-20 -156.27 142.94 18.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.491 -0.756 . . . . 0.0 110.736 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.61 166.86 29.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.8 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.0 mt -119.65 126.4 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.478 -0.764 . . . . 0.0 110.226 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.451 HG22 ' N ' ' A' ' 8' ' ' LYS . 12.3 p -127.46 167.3 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.56 -0.712 . . . . 0.0 110.072 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 7' ' ' VAL . 6.9 ttmt -116.29 138.18 51.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.479 -0.763 . . . . 0.0 110.43 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 10' ' ' SER . 59.1 t -78.04 167.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 109.483 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' B' ' 29' ' ' GLU . 11.5 t -170.2 -66.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.33 -0.856 . . . . 0.0 111.164 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . 3.6 mtt180 -58.08 -166.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.612 -0.68 . . . . 0.0 110.765 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -66.56 76.01 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.674 -0.641 . . . . 0.0 110.801 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 51.84 30.0 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.262 -0.899 . . . . 0.0 111.521 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 11' ' ' ARG . 28.3 mt-30 -89.29 150.61 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.46 -0.775 . . . . 0.0 109.946 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.3 t -121.72 142.56 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 110.693 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.66 132.77 55.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 109.573 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.57 131.25 28.62 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.43 -0.794 . . . . 0.0 109.829 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.04 150.16 74.89 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.044 1.023 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.61 63.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.548 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -67.29 -45.75 75.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.542 -0.724 . . . . 0.0 109.839 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.8 -41.05 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -65.48 -33.6 76.32 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -42.14 96.77 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -80.45 -68.79 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.87 ' CE1' HG23 ' B' ' 44' ' ' VAL . 2.5 t80 -64.17 126.1 26.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.721 -0.612 . . . . 0.0 110.596 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.5 112.06 17.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.581 -0.699 . . . . 0.0 109.294 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 27' ' ' ILE . 4.3 tt -154.04 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.73 0.776 . . . . 0.0 109.452 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HA ' ' CE1' ' B' ' 13' ' ' TYR . 25.8 mttm -101.51 -170.9 1.89 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.429 -0.794 . . . . 0.0 111.438 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' B' ' 10' ' ' SER . 5.2 tt0 -74.21 139.84 44.67 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.279 0.562 . . . . 0.0 110.785 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.68 28.22 65.67 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.5 159.72 15.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -1.028 . . . . 0.0 110.283 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 64.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 110.054 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.409 HG13 HG13 ' B' ' 7' ' ' VAL . 9.9 p -75.01 150.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.743 . . . . 0.0 110.265 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' B' ' 5' ' ' GLU . 32.4 tttt -127.87 136.12 50.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 110.297 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 46' ' ' ILE . 57.8 t -107.69 129.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.665 -0.647 . . . . 0.0 109.824 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.562 HG22 ' CB ' ' B' ' 4' ' ' GLU . 65.4 p -137.88 147.45 44.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.757 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -115.21 144.72 43.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.676 -0.64 . . . . 0.0 109.332 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.35 -174.22 2.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.44 42.01 2.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.561 -0.712 . . . . 0.0 110.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.36 -52.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 110.56 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -115.41 -61.61 1.72 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.745 . . . . 0.0 110.344 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.32 59.18 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' B' ' 47' ' ' GLN . 32.9 m -140.78 149.54 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.569 -0.959 . . . . 0.0 110.145 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.863 HG23 ' CE1' ' B' ' 25' ' ' PHE . 51.1 t -103.28 133.17 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.392 -0.817 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 2.8 ttpt -109.42 136.63 48.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.727 -0.608 . . . . 0.0 110.036 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.555 HG22 ' HA ' ' A' ' 35' ' ' VAL . 5.3 pt -131.45 150.25 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.401 -0.812 . . . . 0.0 111.21 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.428 ' HB3' HG12 ' B' ' 43' ' ' VAL . 28.1 pt20 -145.35 -167.9 2.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 0.0 109.594 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.61 HD11 HD12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.256 -0.903 . . . . 0.0 111.191 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.026 0.441 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 66.4 t -122.13 150.98 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.654 -0.654 . . . . 0.0 109.652 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.562 ' CB ' HG22 ' A' ' 36' ' ' THR . 1.2 pt-20 -156.65 142.77 18.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.722 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 2.5 mp0 -151.46 166.93 29.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.588 -0.695 . . . . 0.0 109.837 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.1 mt -119.58 126.62 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.513 -0.742 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.45 HG22 ' N ' ' B' ' 8' ' ' LYS . 13.9 p -127.64 167.06 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.558 -0.714 . . . . 0.0 110.171 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.45 ' N ' HG22 ' B' ' 7' ' ' VAL . 6.9 ttmt -116.28 138.13 51.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.527 -0.733 . . . . 0.0 110.468 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.465 HG12 ' N ' ' B' ' 10' ' ' SER . 58.7 t -78.1 167.67 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.471 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.511 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 11.2 t -170.21 -65.96 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' B' ' 14' ' ' GLN . 3.6 mtt180 -58.01 -166.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -66.52 76.0 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.66 . . . . 0.0 110.871 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 28' ' ' LYS . 92.0 m-85 51.93 29.89 6.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.433 -0.792 . . . . 0.0 111.52 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' B' ' 11' ' ' ARG . 28.3 mt-30 -89.07 150.64 22.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.99 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.91 142.5 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.618 -0.676 . . . . 0.0 110.676 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.61 132.78 55.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.731 -0.606 . . . . 0.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 59.4 mt -96.62 131.19 28.69 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.585 -0.697 . . . . 0.0 109.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.79 150.07 73.5 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.079 1.042 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.67 -30.68 63.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.474 -0.766 . . . . 0.0 110.496 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -67.3 -45.74 75.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.514 -0.741 . . . . 0.0 109.773 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 65.5 t -62.83 -41.17 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.469 -0.769 . . . . 0.0 109.001 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -65.26 -33.72 76.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.696 -0.627 . . . . 0.0 109.365 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -80.47 -68.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.863 ' CE1' HG23 ' A' ' 44' ' ' VAL . 2.5 t80 -64.42 126.21 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.688 -0.633 . . . . 0.0 110.524 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 112.09 17.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 109.327 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.638 ' O ' HG23 ' B' ' 27' ' ' ILE . 5.2 tt -154.16 91.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.76 0.79 . . . . 0.0 109.509 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -101.49 -170.92 1.9 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 111.543 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 10' ' ' SER . 5.2 tt0 -74.07 139.75 44.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.799 -0.563 . . . . 0.0 110.868 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.48 28.54 65.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.61 159.76 15.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -1.0 . . . . 0.0 110.238 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.46 64.78 1.88 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.06 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.43 HG13 HG13 ' A' ' 7' ' ' VAL . 10.1 p -75.12 150.74 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.618 -0.676 . . . . 0.0 110.25 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 31.9 tttt -127.82 136.01 50.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' B' ' 46' ' ' ILE . 58.3 t -107.66 130.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.827 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.569 HG22 ' CB ' ' A' ' 4' ' ' GLU . 65.5 p -137.96 147.32 44.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 110.894 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -115.06 144.67 43.27 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.24 -174.13 2.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 110.303 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.47 42.05 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.448 -0.782 . . . . 0.0 110.056 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.4 -52.13 1.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.526 -0.734 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -115.61 -61.79 1.69 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.558 -0.714 . . . . 0.0 110.241 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.35 59.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.428 HG12 ' HB3' ' A' ' 47' ' ' GLN . 32.7 m -140.72 149.46 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.621 -0.929 . . . . 0.0 110.13 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.87 HG23 ' CE1' ' A' ' 25' ' ' PHE . 50.4 t -103.2 132.98 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 110.119 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.8 ttpt -109.26 136.52 48.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.658 -0.651 . . . . 0.0 110.135 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' B' ' 35' ' ' VAL . 5.3 pt -131.29 150.11 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.455 -0.778 . . . . 0.0 111.261 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.416 ' HB3' HG12 ' A' ' 43' ' ' VAL . 28.0 pt20 -145.1 -167.8 2.77 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.585 -0.697 . . . . 0.0 109.654 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.553 HD11 HD12 ' B' ' 27' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.238 -0.914 . . . . 0.0 111.337 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.146 0.498 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.2 m -123.64 152.7 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.554 -0.716 . . . . 0.0 109.572 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.495 ' CB ' HG22 ' B' ' 36' ' ' THR . 8.0 pt-20 -144.06 153.91 42.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.783 . . . . 0.0 111.046 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -134.06 147.16 50.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.696 HG23 HD21 ' B' ' 32' ' ' LEU . 89.3 mt -111.28 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 110.677 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.17 151.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.65 12.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.526 -0.733 . . . . 0.0 110.72 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.86 HG23 ' O ' ' B' ' 31' ' ' ASP . 76.4 t -75.45 142.29 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.758 -0.589 . . . . 0.0 109.916 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -172.78 3.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 110.0 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 56.58 -86.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.712 -0.617 . . . . 0.0 110.526 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.1 78.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.926 -1.109 . . . . 0.0 109.043 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.79 14.62 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.368 -0.833 . . . . 0.0 109.83 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.06 157.16 26.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.604 -0.685 . . . . 0.0 110.823 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.94 138.47 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.655 -0.653 . . . . 0.0 109.385 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -120.78 152.81 37.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.497 -0.752 . . . . 0.0 110.886 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -97.3 119.59 62.73 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.708 -0.62 . . . . 0.0 109.5 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.21 -174.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.067 1.035 . . . . 0.0 110.622 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.49 25.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.564 -0.71 . . . . 0.0 110.44 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -48.4 42.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 109.982 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.24 -41.63 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.655 -0.653 . . . . 0.0 109.426 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.74 -38.29 81.33 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -36.02 81.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.596 -0.69 . . . . 0.0 109.757 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -76.45 -69.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.934 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.4 OUTLIER -65.02 149.9 49.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.645 -0.66 . . . . 0.0 109.923 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.88 -80.25 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.752 . . . . 0.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' A' ' 25' ' ' PHE . 94.9 mt 50.18 88.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.144 -0.972 . . . . 0.0 110.947 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.637 ' O ' HG11 ' B' ' 9' ' ' VAL . 11.7 tptt -109.34 168.09 9.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.589 -0.694 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -69.35 123.7 21.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.587 -0.696 . . . . 0.0 110.024 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.497 ' H ' ' HB ' ' B' ' 9' ' ' VAL . . . 85.47 37.51 9.63 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.884 ' O ' HG23 ' B' ' 9' ' ' VAL . 2.6 m-20 -115.53 133.03 56.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.528 -0.984 . . . . 0.0 110.193 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HG23 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -69.19 112.25 5.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 48' ' ' LEU . 59.9 t -107.62 151.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.593 -0.692 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -125.0 128.09 48.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.21 128.79 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.483 HG22 ' CB ' ' B' ' 4' ' ' GLU . 69.2 p -136.65 153.0 51.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.257 -0.902 . . . . 0.0 111.872 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 36.6 t80 -124.95 143.79 50.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -117.55 155.96 28.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.438 -0.789 . . . . 0.0 110.894 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -101.37 19.92 16.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.78 -0.575 . . . . 0.0 110.703 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -118.61 -28.48 5.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 110.601 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -105.41 -58.89 1.84 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.402 -0.811 . . . . 0.0 110.296 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.84 33.17 2.68 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' B' ' 47' ' ' GLN . 33.9 m -141.48 162.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.676 -0.896 . . . . 0.0 109.938 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.917 HG23 ' CE2' ' B' ' 25' ' ' PHE . 37.0 t -112.04 123.85 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.33 -0.856 . . . . 0.0 109.981 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 1.5 ttpm? -105.39 150.37 25.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.837 -0.54 . . . . 0.0 109.813 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.885 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.7 pp -136.98 155.86 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.833 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.641 ' HB3' HG12 ' B' ' 43' ' ' VAL . 1.8 pt20 -154.98 -174.78 5.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.904 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.41 HD11 HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.492 -0.755 . . . . 0.0 110.68 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.155 0.502 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.64 152.73 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.51 -0.744 . . . . 0.0 109.552 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.483 ' CB ' HG22 ' A' ' 36' ' ' THR . 8.0 pt-20 -144.1 153.81 42.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.386 -0.821 . . . . 0.0 111.009 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.87 147.14 51.12 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.658 HG23 HD21 ' A' ' 32' ' ' LEU . 89.2 mt -111.24 116.03 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.739 . . . . 0.0 110.679 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.29 151.15 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.63 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 31' ' ' ASP . 69.0 t -75.43 142.18 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.754 -0.591 . . . . 0.0 109.981 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.9 t -159.22 -172.71 3.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.694 . . . . 0.0 109.93 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 56.46 -86.39 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.686 -0.634 . . . . 0.0 110.52 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.19 78.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.045 -1.035 . . . . 0.0 109.17 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.76 14.68 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.344 -0.848 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -117.08 157.15 26.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.582 -0.699 . . . . 0.0 110.786 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -137.9 138.28 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.746 -0.596 . . . . 0.0 109.459 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.5 p -120.62 152.74 37.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 0.0 110.916 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -97.21 119.56 62.93 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.791 -0.568 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.16 -174.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.06 1.031 . . . . 0.0 110.591 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.56 25.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.704 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -48.18 44.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.49 -41.5 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.555 -0.715 . . . . 0.0 109.466 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.64 -38.28 80.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.564 -0.71 . . . . 0.0 109.712 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -36.08 82.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.57 -0.706 . . . . 0.0 109.639 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -76.51 -69.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.781 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.917 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -65.33 150.0 49.02 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 109.887 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.96 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.538 -0.726 . . . . 0.0 109.906 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' B' ' 25' ' ' PHE . 94.9 mt 50.14 88.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.262 -0.899 . . . . 0.0 110.97 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.638 ' O ' HG11 ' A' ' 9' ' ' VAL . 11.8 tptt -109.4 168.05 9.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.601 -0.687 . . . . 0.0 110.071 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -69.37 123.75 22.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.738 . . . . 0.0 110.077 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLY . . . . . 0.498 ' H ' ' HB ' ' A' ' 9' ' ' VAL . . . 85.64 37.32 9.62 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.6 m-20 -115.61 132.9 56.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.588 -0.948 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -69.01 112.41 5.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.522 -0.737 . . . . 0.0 110.022 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.59 151.15 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -124.96 127.8 47.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.324 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -114.99 128.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.495 HG22 ' CB ' ' A' ' 4' ' ' GLU . 71.3 p -136.53 152.94 51.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 111.863 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.62 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 37.1 t80 -124.83 143.62 50.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -117.43 155.84 28.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.482 -0.761 . . . . 0.0 110.868 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -101.46 19.97 16.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.736 -0.603 . . . . 0.0 110.69 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -118.57 -28.7 5.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.358 -0.839 . . . . 0.0 110.616 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -105.36 -58.75 1.85 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.504 -0.747 . . . . 0.0 110.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.77 33.22 2.69 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.0 m -141.48 162.69 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.954 . . . . 0.0 109.831 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.934 HG23 ' CE2' ' A' ' 25' ' ' PHE . 37.8 t -112.11 123.67 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 0.0 109.922 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.5 ttpm? -105.45 150.08 25.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.713 -0.617 . . . . 0.0 109.874 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.861 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.7 pp -136.6 155.96 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.56 -0.713 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.631 ' HB3' HG12 ' A' ' 43' ' ' VAL . 1.8 pt20 -154.92 -174.73 5.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.79 -0.569 . . . . 0.0 110.042 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.436 -0.79 . . . . 0.0 110.713 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.121 0.486 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.96 126.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.596 -0.69 . . . . 0.0 109.848 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.87 147.57 51.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.616 -0.678 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.17 146.38 18.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.708 . . . . 0.0 110.311 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 pt -112.62 150.35 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.63 -0.669 . . . . 0.0 110.218 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.6 m -136.52 150.6 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.625 -0.672 . . . . 0.0 110.267 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -94.06 138.04 32.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.136 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.537 HG11 ' O ' ' B' ' 28' ' ' LYS . 60.6 t -77.04 145.05 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 110.096 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -158.1 -55.4 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.579 -0.701 . . . . 0.0 110.219 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -168.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.666 -0.646 . . . . 0.0 110.033 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -77.93 67.84 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.51 -0.744 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.475 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 93.7 m-85 53.29 45.33 28.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -0.771 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.03 174.24 6.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.488 -0.758 . . . . 0.0 109.53 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.36 153.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.678 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.568 ' O ' HG23 ' A' ' 16' ' ' THR . 7.1 t -150.18 115.31 5.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.829 -0.545 . . . . 0.0 109.536 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.1 mt -71.73 143.01 86.55 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.545 -0.722 . . . . 0.0 110.204 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -61.23 -175.81 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.001 0 O-C-N 123.201 1.106 . . . . 0.0 110.216 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.07 -29.96 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 110.199 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.54 -48.26 49.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.539 -0.726 . . . . 0.0 110.012 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.43 -45.42 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.55 -0.719 . . . . 0.0 109.477 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.66 -32.31 73.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.513 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -63.61 -36.12 82.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 109.535 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -78.86 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.794 -0.566 . . . . 0.0 109.767 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.864 ' CE2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.47 159.58 6.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -80.72 -82.82 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.379 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.414 ' O ' ' HE2' ' B' ' 13' ' ' TYR . 45.3 mt 51.28 87.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.167 -0.958 . . . . 0.0 110.519 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.539 ' O ' HG11 ' B' ' 9' ' ' VAL . 29.8 mtmt -107.05 -171.45 1.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.525 -0.734 . . . . 0.0 110.515 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -79.67 137.01 36.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.478 ' N ' ' HB ' ' B' ' 9' ' ' VAL . . . 58.45 44.09 95.51 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.953 . . . . 0.0 110.113 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.77 2.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 110.609 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.749 HG13 HD11 ' A' ' 46' ' ' ILE . 64.9 t -67.26 133.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 109.218 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -125.07 129.25 49.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.452 -0.78 . . . . 0.0 110.975 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 46' ' ' ILE . 61.7 t -123.72 129.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -138.17 148.38 44.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.375 -0.828 . . . . 0.0 111.235 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.87 ' CE1' ' CE2' ' B' ' 25' ' ' PHE . 47.9 t80 -113.92 135.65 53.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.32 162.7 12.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.762 . . . . 0.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.37 32.62 4.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.3 p -118.7 -60.69 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 110.102 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -87.03 -50.14 6.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 0.0 110.151 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.61 36.5 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.805 HG21 ' HD3' ' B' ' 45' ' ' LYS . 35.2 m -133.27 159.68 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -1.01 . . . . 0.0 110.342 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.004 ' HB ' ' CG2' ' B' ' 46' ' ' ILE . 45.6 t -103.23 127.51 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.667 . . . . 0.0 109.403 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.83 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 14.5 ttmt -112.13 125.54 54.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.632 . . . . 0.0 110.571 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.029 ' CG2' ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -113.04 138.66 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.687 . . . . 0.0 109.489 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.838 ' N ' HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -151.08 171.86 16.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.708 -0.62 . . . . 0.0 109.971 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.175 0.512 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.76 126.43 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.531 -0.731 . . . . 0.0 109.957 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -129.9 147.63 51.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.23 146.22 18.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.321 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.45 150.2 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.567 -0.708 . . . . 0.0 110.195 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.41 150.56 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.488 -0.757 . . . . 0.0 110.254 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.98 138.02 32.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.683 . . . . 0.0 110.2 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 28' ' ' LYS . 59.7 t -77.0 144.93 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.576 -0.703 . . . . 0.0 110.175 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -157.99 -55.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.591 -0.693 . . . . 0.0 110.278 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -168.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 0.0 110.112 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -78.08 67.92 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.717 . . . . 0.0 110.107 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.503 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 93.8 m-85 53.29 45.4 28.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 111.184 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.18 174.16 6.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.26 153.16 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.401 -0.812 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.574 ' O ' HG23 ' B' ' 16' ' ' THR . 7.2 t -150.22 115.22 5.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.68 -0.638 . . . . 0.0 109.508 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 80.9 mt -71.74 143.11 86.65 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.504 -0.748 . . . . 0.0 110.224 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.3 -175.91 0.15 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 O-C-N 123.1 1.053 . . . . 0.0 110.055 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.08 -29.74 24.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.582 -0.698 . . . . 0.0 110.242 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.65 -48.16 49.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.535 -0.728 . . . . 0.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.43 -45.48 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 0.0 109.492 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -65.71 -32.23 73.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.635 . . . . 0.0 109.562 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -63.62 -36.09 82.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.679 . . . . 0.0 109.474 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -79.03 -62.62 1.64 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.722 -0.611 . . . . 0.0 109.774 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.73 159.57 6.6 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.735 . . . . 0.0 110.015 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -80.69 -82.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.483 -0.76 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' B' ' 25' ' ' PHE . 45.5 mt 51.25 87.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.063 -1.023 . . . . 0.0 110.486 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.537 ' O ' HG11 ' A' ' 9' ' ' VAL . 29.8 mtmt -107.19 -171.35 1.87 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.578 -0.702 . . . . 0.0 110.497 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -79.69 136.98 36.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLY . . . . . 0.485 ' N ' ' HB ' ' A' ' 9' ' ' VAL . . . 58.44 44.15 95.45 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.944 . . . . 0.0 110.142 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.57 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 110.684 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.744 HG13 HD11 ' B' ' 46' ' ' ILE . 62.1 t -66.95 133.71 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.486 -0.758 . . . . 0.0 109.344 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -125.16 129.27 49.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -0.758 . . . . 0.0 111.04 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.674 HG22 HG12 ' B' ' 46' ' ' ILE . 62.0 t -123.74 129.28 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -138.19 148.42 44.82 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.402 -0.811 . . . . 0.0 111.272 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 25' ' ' PHE . 48.2 t80 -113.92 135.62 53.78 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.34 162.62 13.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.596 -0.69 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.34 32.6 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.627 -0.671 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.7 p -118.6 -60.62 1.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.619 -0.676 . . . . 0.0 110.069 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.15 -50.1 6.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.41 2.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.83 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 35.3 m -133.25 159.7 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.536 -0.979 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 1.029 ' HB ' ' CG2' ' A' ' 46' ' ' ILE . 45.9 t -103.26 127.51 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.527 -0.733 . . . . 0.0 109.409 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.808 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 14.8 ttmt -112.08 125.32 53.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.671 -0.643 . . . . 0.0 110.552 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 1.004 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -112.79 138.6 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.654 -0.654 . . . . 0.0 109.542 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.832 ' N ' HD13 ' B' ' 46' ' ' ILE . 0.2 OUTLIER -151.04 171.86 16.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.203 0.525 . . . . 0.0 109.916 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.79 119.83 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -0.75 . . . . 0.0 109.559 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -120.35 126.61 50.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 0.0 110.876 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.58 152.15 45.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.666 -0.646 . . . . 0.0 109.334 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.93 134.01 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.443 -0.786 . . . . 0.0 110.526 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.49 148.91 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 0.0 109.42 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.59 179.99 3.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 110.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.852 HG21 ' HB3' ' B' ' 31' ' ' ASP . 57.6 t -106.75 165.43 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.614 -0.679 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.444 ' N ' HG12 ' A' ' 9' ' ' VAL . 77.1 p -102.87 -163.64 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.516 -0.74 . . . . 0.0 110.249 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.718 ' HG2' ' OE2' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -102.02 -25.34 13.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.748 . . . . 0.0 110.337 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.93 29.85 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 0.0 110.442 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.559 ' HE1' ' HA ' ' B' ' 28' ' ' LYS . 64.4 m-85 52.39 25.81 3.72 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.443 -0.786 . . . . 0.0 110.983 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -104.33 151.28 23.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.515 -0.741 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.93 146.07 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.594 -0.691 . . . . 0.0 110.114 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.5 p -110.72 123.94 51.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.689 -0.632 . . . . 0.0 109.756 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.7 mt -66.39 116.34 32.93 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.743 . . . . 0.0 109.711 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.3 169.17 4.11 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.156 1.082 . . . . 0.0 110.477 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.14 68.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.572 -0.705 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.85 -59.83 4.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.431 -0.793 . . . . 0.0 110.312 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.91 -40.78 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.379 -0.826 . . . . 0.0 109.22 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.32 -29.97 68.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.717 -0.614 . . . . 0.0 109.549 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -45.66 56.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.65 -69.13 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.661 -0.649 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.685 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.3 OUTLIER -73.44 151.3 41.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 109.659 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -81.37 -81.28 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.209 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 25' ' ' PHE . 15.5 mt 54.49 93.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HA ' ' HE1' ' B' ' 13' ' ' TYR . 0.2 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 0.0 110.453 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.717 ' OE2' ' HG2' ' B' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.82 27.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.711 . . . . 0.0 110.411 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.34 50.9 4.87 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.847 ' HB3' HG21 ' B' ' 9' ' ' VAL . 3.2 t70 -110.06 155.68 21.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.487 -1.008 . . . . 0.0 110.266 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.29 52.34 0.84 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 109.706 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 46' ' ' ILE . 35.9 m -61.12 170.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 0.0 110.404 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.3 122.03 7.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.69 144.31 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 109.141 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.9 p -138.79 150.53 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.218 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.7 t80 -134.46 147.13 50.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -122.04 178.45 4.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -0.785 . . . . 0.0 110.457 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.01 44.26 2.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.9 p -147.18 -52.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.017 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -40.43 21.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.732 -0.605 . . . . 0.0 109.754 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 32.96 17.51 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.765 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 33.0 m -131.61 156.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.05 ' HB ' HG22 ' B' ' 46' ' ' ILE . 56.3 t -104.2 133.81 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.506 -0.746 . . . . 0.0 109.455 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.766 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 0.2 OUTLIER -112.47 129.49 56.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.754 -0.591 . . . . 0.0 110.263 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.039 HG22 ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -123.51 139.44 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 109.861 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.862 ' N ' HD13 ' A' ' 46' ' ' ILE . 3.4 pm0 -158.62 -175.33 5.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 110.139 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' CD1' HG12 ' A' ' 33' ' ' VAL . 1.4 mp . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.19 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.202 0.525 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.85 119.9 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -120.43 126.59 50.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.477 -0.764 . . . . 0.0 110.979 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.51 152.08 45.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.674 -0.641 . . . . 0.0 109.303 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.82 134.04 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.531 -0.731 . . . . 0.0 110.537 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.9 t -137.44 148.96 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.714 -0.616 . . . . 0.0 109.485 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.76 179.9 3.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.431 -0.793 . . . . 0.0 110.326 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 31' ' ' ASP . 58.0 t -106.77 165.55 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.586 -0.696 . . . . 0.0 110.182 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.429 ' N ' HG12 ' B' ' 9' ' ' VAL . 78.0 p -102.92 -163.67 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.537 -0.727 . . . . 0.0 110.237 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.717 ' HG2' ' OE2' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -102.05 -25.33 13.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.611 -0.681 . . . . 0.0 110.255 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.92 29.8 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.456 -0.778 . . . . 0.0 110.374 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.583 ' HE1' ' HA ' ' A' ' 28' ' ' LYS . 64.5 m-85 52.35 25.74 3.65 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.463 -0.773 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.23 151.32 23.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.687 . . . . 0.0 109.883 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.99 146.07 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.601 -0.687 . . . . 0.0 110.159 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -110.77 123.95 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.36 116.28 32.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.29 169.03 4.21 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.143 1.075 . . . . 0.0 110.545 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.08 68.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 0.0 110.227 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -59.88 4.72 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.498 -0.751 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 109.229 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.27 -29.97 67.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -45.69 56.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.69 -68.97 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.635 -0.666 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.687 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -73.68 151.34 40.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.613 -0.679 . . . . 0.0 109.572 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -81.31 -81.4 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 111.22 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' B' ' 25' ' ' PHE . 15.5 mt 54.66 93.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.044 -1.035 . . . . 0.0 110.049 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.564 ' O ' HG11 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.612 -0.68 . . . . 0.0 110.436 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.718 ' OE2' ' HG2' ' A' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.79 27.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 110.358 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.45 50.88 4.86 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.852 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.2 t70 -110.13 155.64 21.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -1.034 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.25 52.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.489 -0.757 . . . . 0.0 109.865 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.604 ' HB ' HD11 ' B' ' 46' ' ' ILE . 35.7 m -60.9 170.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.605 -0.685 . . . . 0.0 110.481 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.18 122.19 7.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.685 -0.635 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 62.8 t -98.85 144.25 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.488 -0.758 . . . . 0.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -138.75 150.66 46.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.419 -0.8 . . . . 0.0 111.151 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.685 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 35.8 t80 -134.64 147.05 50.09 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -121.92 178.54 4.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.457 -0.777 . . . . 0.0 110.485 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.1 44.33 2.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.169 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 85.6 p -147.32 -52.12 0.2 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.971 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.44 -40.45 21.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.85 17.71 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.766 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 32.9 m -131.53 156.95 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -1.041 . . . . 0.0 110.337 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 1.039 ' HB ' HG22 ' A' ' 46' ' ' ILE . 53.4 t -104.17 133.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.495 -0.753 . . . . 0.0 109.525 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.765 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -112.42 129.34 56.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 -179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 1.05 HG22 ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.25 139.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.575 -0.703 . . . . 0.0 109.921 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.86 ' N ' HD13 ' B' ' 46' ' ' ILE . 3.4 pm0 -158.73 -175.46 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.171 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.41 ' CD1' HG12 ' B' ' 33' ' ' VAL . 1.4 mp . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.2 0.524 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.8 164.87 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.451 -0.781 . . . . 0.0 110.498 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.597 ' HA ' HG22 ' B' ' 36' ' ' THR . 1.9 tm-20 -131.76 146.74 52.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.809 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.33 162.17 39.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.455 ' C ' HG13 ' A' ' 7' ' ' VAL . 2.4 pp -141.21 136.23 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.639 . . . . 0.0 109.861 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.455 HG13 ' C ' ' A' ' 6' ' ' ILE . 35.9 m -148.68 157.49 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 150.4 44.3 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.736 -0.602 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 31' ' ' ASP . 59.8 t -85.85 163.54 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.434 -0.791 . . . . 0.0 109.656 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -88.86 170.27 10.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.504 -0.748 . . . . 0.0 109.695 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -39.71 77.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -96.85 41.61 1.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.501 -0.749 . . . . 0.0 110.812 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 59.4 m-85 51.35 24.84 2.28 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.387 -0.821 . . . . 0.0 111.476 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.84 159.57 27.76 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.423 -0.798 . . . . 0.0 109.231 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.63 155.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.417 -0.802 . . . . 0.0 110.681 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.7 m -141.32 113.55 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -78.25 130.79 70.93 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.723 . . . . 0.0 110.03 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' A' ' 21' ' ' VAL . 23.0 Cg_exo -55.79 -173.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.101 1.053 . . . . 0.0 110.605 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.48 -28.41 16.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.539 -0.726 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -59.24 3.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.53 -0.731 . . . . 0.0 110.915 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 18' ' ' PRO . 27.0 m -63.6 -33.76 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -61.97 -37.29 84.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -68.9 -35.26 76.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.576 -0.702 . . . . 0.0 109.232 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -73.33 0.15 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.903 ' HD2' ' CD1' ' B' ' 37' ' ' PHE . 0.7 OUTLIER -60.5 158.63 11.83 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.592 -0.693 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -81.01 -84.12 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.394 -0.816 . . . . 0.0 110.855 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt 53.17 92.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.013 -1.054 . . . . 0.0 110.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -104.13 -170.53 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.695 -0.628 . . . . 0.0 110.818 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.59 126.49 35.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.738 -0.601 . . . . 0.0 110.164 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.1 45.36 15.85 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' O ' HG23 ' B' ' 9' ' ' VAL . 23.8 t70 -112.67 142.93 44.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.988 . . . . 0.0 110.232 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.82 62.86 4.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.608 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.414 HG12 HD11 ' A' ' 48' ' ' LEU . 27.5 m -53.32 155.88 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.43 -0.794 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -110.23 103.06 11.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.69 -0.631 . . . . 0.0 110.66 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.02 110.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.773 . . . . 0.0 108.933 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.589 HG22 ' HA ' ' B' ' 4' ' ' GLU . 47.2 p -128.14 150.42 49.99 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.562 0.696 . . . . 0.0 111.696 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.911 ' CD1' ' HD2' ' B' ' 25' ' ' PHE . 27.4 t80 -124.63 122.53 37.78 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.8 151.41 24.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 110.361 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.29 20.08 9.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.684 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -46.83 7.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.78 -30.27 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 109.859 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . . . 93.06 47.62 3.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' CG ' ' B' ' 47' ' ' GLN . 33.1 m -140.58 159.63 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.538 -0.978 . . . . 0.0 110.368 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.94 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 31.2 t -100.55 133.97 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.42 123.28 49.07 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.132 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.962 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.9 pt -109.17 134.16 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.803 ' CG ' HG12 ' B' ' 43' ' ' VAL . 54.0 tt0 -149.28 165.81 30.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.504 -0.747 . . . . 0.0 110.52 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.208 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.106 0.479 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -132.64 164.94 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.54 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.589 ' HA ' HG22 ' A' ' 36' ' ' THR . 1.9 tm-20 -131.82 146.69 52.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.66 -0.65 . . . . 0.0 109.87 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.25 162.01 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.456 -0.778 . . . . 0.0 110.47 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.456 ' C ' HG13 ' B' ' 7' ' ' VAL . 2.4 pp -141.11 136.21 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.688 -0.632 . . . . 0.0 109.871 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.456 HG13 ' C ' ' B' ' 6' ' ' ILE . 35.5 m -148.6 157.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.453 -0.78 . . . . 0.0 110.56 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 150.42 44.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 110.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 31' ' ' ASP . 59.8 t -85.85 163.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 109.657 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.414 ' N ' HG12 ' B' ' 9' ' ' VAL . 0.6 OUTLIER -88.76 170.14 11.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.582 -0.699 . . . . 0.0 109.813 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -39.78 78.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.702 . . . . 0.0 110.502 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -96.84 41.61 1.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.468 -0.77 . . . . 0.0 110.92 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' B' ' 13' ' ' TYR . 58.5 m-85 51.49 24.7 2.34 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.442 -0.786 . . . . 0.0 111.499 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.88 159.41 27.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.396 -0.815 . . . . 0.0 109.094 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.59 155.85 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 0.0 110.687 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.5 m -141.3 113.53 8.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.09 130.99 70.74 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.541 -0.724 . . . . 0.0 110.109 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.402 ' HD2' HG21 ' B' ' 21' ' ' VAL . 22.8 Cg_exo -56.19 -173.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.196 0 O-C-N 123.115 1.061 . . . . 0.0 110.436 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.35 -28.52 16.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.718 . . . . 0.0 110.878 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -59.25 3.03 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.489 -0.757 . . . . 0.0 110.887 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.402 HG21 ' HD2' ' B' ' 18' ' ' PRO . 26.9 m -63.65 -33.58 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -62.1 -37.11 83.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.203 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -69.08 -35.12 76.16 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -73.29 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.911 ' HD2' ' CD1' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -60.58 158.64 11.99 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -81.02 -84.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.362 -0.836 . . . . 0.0 110.856 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 88.0 mt 53.13 92.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.023 -1.048 . . . . 0.0 110.129 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -104.25 -170.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 110.821 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -88.51 126.54 35.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.825 -0.547 . . . . 0.0 110.185 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 45.26 15.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 9' ' ' VAL . 23.7 t70 -112.62 142.83 44.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.95 . . . . 0.0 110.24 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.85 62.95 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.744 -0.597 . . . . 0.0 109.495 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.431 HG12 HD11 ' B' ' 48' ' ' LEU . 28.0 m -53.5 155.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.479 -0.763 . . . . 0.0 110.583 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -110.33 102.95 11.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 110.591 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.84 110.75 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 4' ' ' GLU . 49.6 p -128.12 150.62 49.9 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.645 0.736 . . . . 0.0 111.678 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.903 ' CD1' ' HD2' ' A' ' 25' ' ' PHE . 27.4 t80 -124.77 122.55 37.77 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.81 151.39 24.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.462 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.25 19.97 9.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.72 -46.57 7.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.98 -30.23 7.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.701 -0.624 . . . . 0.0 109.785 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLY . . . . . 0.568 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 93.11 47.49 3.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.803 HG12 ' CG ' ' A' ' 47' ' ' GLN . 33.1 m -140.65 159.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.56 -0.965 . . . . 0.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.962 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 32.4 t -100.49 133.81 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.16 123.23 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 111.317 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.94 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.9 pt -109.3 134.19 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.256 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.787 ' CG ' HG12 ' A' ' 43' ' ' VAL . 54.1 tt0 -149.26 165.81 30.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.683 -0.636 . . . . 0.0 110.611 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.431 HD11 HG12 ' B' ' 33' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.566 -0.709 . . . . 0.0 110.142 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.18 150.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 110.139 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.95 157.34 44.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.604 -0.685 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.56 143.43 20.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.81 119.78 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.557 -0.714 . . . . 0.0 110.544 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.1 -176.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.474 -0.766 . . . . 0.0 110.139 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.71 163.73 29.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.484 -0.76 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG11 ' O ' ' B' ' 28' ' ' LYS . 59.6 t -74.06 166.08 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.56 -0.712 . . . . 0.0 109.928 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' B' ' 29' ' ' GLU . 15.5 m -107.61 -156.64 0.59 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.468 -0.77 . . . . 0.0 110.514 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HA ' ' OE2' ' B' ' 29' ' ' GLU . 8.2 ttp180 -79.09 -52.38 8.28 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.473 -0.767 . . . . 0.0 110.722 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.41 40.07 1.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 110.802 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.755 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 94.2 m-85 50.73 40.14 23.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.345 -0.847 . . . . 0.0 111.227 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.38 153.96 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.19 132.68 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 0.0 110.246 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.49 85.16 2.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.647 . . . . 0.0 109.631 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 23.0 mt -61.0 145.42 89.34 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.62 -0.675 . . . . 0.0 110.273 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 16.4 Cg_exo -61.9 -159.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.0 0 O-C-N 123.338 1.178 . . . . 0.0 110.367 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.11 -21.09 16.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.0 -55.84 29.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -0.882 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.22 -39.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.594 -0.691 . . . . 0.0 109.683 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -63.82 -32.31 73.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.661 -0.65 . . . . 0.0 109.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -54.1 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.56 -60.82 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.647 -0.658 . . . . 0.0 109.641 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.5 OUTLIER -74.07 128.18 34.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.54 -0.725 . . . . 0.0 110.355 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -78.58 96.97 5.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.517 -0.74 . . . . 0.0 110.104 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.5 mt -132.04 78.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.58 -0.7 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.782 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.3 OUTLIER -87.32 -158.67 0.46 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.653 -0.655 . . . . 0.0 110.606 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' B' ' 10' ' ' SER . 37.1 tt0 -87.41 91.62 8.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.696 -0.628 . . . . 0.0 110.31 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.99 47.24 0.31 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB2' HG21 ' B' ' 9' ' ' VAL . 2.2 m-20 -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.985 . . . . 0.0 110.352 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mp -75.19 81.42 2.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.989 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -87.21 154.0 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.97 131.79 41.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.616 -0.677 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.91 131.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.532 -0.73 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.55 147.96 48.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.414 -0.804 . . . . 0.0 111.22 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.513 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 29.6 t80 -119.63 141.43 49.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -110.71 154.12 24.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.756 . . . . 0.0 110.733 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.41 29.11 7.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.024 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 p -117.91 -35.21 3.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.713 . . . . 0.0 110.305 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.29 -65.82 1.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.493 -0.754 . . . . 0.0 110.26 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.32 42.6 0.27 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.73 ' HB ' ' CG ' ' B' ' 45' ' ' LYS . 34.6 m -133.9 156.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.971 . . . . 0.0 109.665 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.829 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 29.2 t -116.36 115.4 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.838 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.746 ' CG ' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -99.94 146.82 26.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.735 -0.603 . . . . 0.0 109.997 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.83 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 12.9 pt -128.74 155.81 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.679 -0.638 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.411 ' OE1' ' CG1' ' B' ' 43' ' ' VAL . 38.9 tt0 -159.95 160.82 33.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.646 -0.659 . . . . 0.0 110.105 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 O-C-N 121.591 -0.693 . . . . 0.0 109.994 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.19 150.9 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 110.113 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.85 157.41 44.39 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.549 -0.72 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.62 143.48 20.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.244 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.79 119.97 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.559 -0.713 . . . . 0.0 110.477 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.35 -177.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.72 163.71 29.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.497 -0.752 . . . . 0.0 110.507 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 28' ' ' LYS . 59.2 t -74.07 166.13 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.599 -0.688 . . . . 0.0 109.904 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 15.4 m -107.69 -156.67 0.59 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.44 -0.787 . . . . 0.0 110.449 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.409 ' HA ' ' OE2' ' A' ' 29' ' ' GLU . 8.3 ttp180 -79.05 -52.46 8.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.47 -0.769 . . . . 0.0 110.663 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.3 39.98 1.11 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.782 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 94.2 m-85 50.86 40.04 23.88 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.321 -0.862 . . . . 0.0 111.218 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.35 154.0 19.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.22 132.78 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.573 -0.704 . . . . 0.0 110.205 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.6 85.17 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 109.609 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.01 145.44 89.36 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.647 -0.658 . . . . 0.0 110.204 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.02 -159.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.986 0 O-C-N 123.347 1.183 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.12 -21.19 16.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.714 -0.616 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.02 -56.01 27.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.339 -0.851 . . . . 0.0 110.366 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -62.06 -39.1 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.576 -0.703 . . . . 0.0 109.7 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -63.89 -32.23 73.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.621 -0.674 . . . . 0.0 109.927 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -54.1 25.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.717 . . . . 0.0 109.645 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.42 -60.95 2.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.614 -0.679 . . . . 0.0 109.654 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.562 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -74.03 128.09 34.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.662 -0.649 . . . . 0.0 110.34 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -78.51 97.05 5.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.559 -0.713 . . . . 0.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 88.6 mt -132.14 78.51 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.572 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.755 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -87.37 -158.58 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.763 -0.586 . . . . 0.0 110.553 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' SER . 37.1 tt0 -87.51 91.81 8.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.648 -0.657 . . . . 0.0 110.238 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.76 47.38 0.32 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.412 ' HB2' HG21 ' A' ' 9' ' ' VAL . 2.2 m-20 -111.12 133.9 53.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.971 . . . . 0.0 110.32 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.15 81.53 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.708 -0.62 . . . . 0.0 110.028 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -87.23 153.97 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.563 -0.711 . . . . 0.0 110.392 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.98 131.78 41.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.576 -0.703 . . . . 0.0 110.21 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.95 131.93 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.583 -0.698 . . . . 0.0 109.566 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.69 148.01 48.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 111.237 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 29.8 t80 -119.69 141.41 49.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -110.75 154.04 24.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.29 29.0 7.19 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.626 -0.672 . . . . 0.0 110.094 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 5.4 p -117.79 -35.23 3.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.28 -65.83 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.23 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.28 42.43 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.746 ' HB ' ' CG ' ' A' ' 45' ' ' LYS . 34.6 m -133.78 156.9 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.977 . . . . 0.0 109.704 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.83 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 30.8 t -116.48 115.28 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.291 -0.881 . . . . 0.0 109.986 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.73 ' CG ' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -99.86 146.78 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.811 -0.556 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.829 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 12.7 pt -128.68 155.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.709 -0.62 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -159.88 160.83 34.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.691 -0.63 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.469 ' N ' ' OE1' ' B' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.063 0.459 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.8 150.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.571 -0.706 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -147.99 116.0 6.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 109.937 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.52 173.96 8.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.47 -0.769 . . . . 0.0 110.641 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.419 HG22 ' HE2' ' B' ' 34' ' ' LYS . 26.8 pt -120.53 130.92 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.685 -0.635 . . . . 0.0 109.894 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' ' 33' ' ' VAL . 33.1 m -131.37 146.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.576 -0.703 . . . . 0.0 110.265 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -103.58 154.21 19.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.39 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.025 ' O ' ' HA2' ' B' ' 30' ' ' GLY . 58.2 t -109.91 142.46 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.584 -0.697 . . . . 0.0 109.58 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.9 p -169.83 -170.52 1.04 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 111.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.93 -86.77 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.697 -0.627 . . . . 0.0 110.984 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.76 55.52 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.061 -1.024 . . . . 0.0 110.579 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HE1' ' C ' ' B' ' 28' ' ' LYS . 71.9 m-85 49.33 47.43 22.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.457 -0.777 . . . . 0.0 111.048 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -112.25 154.15 26.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 110.13 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.92 135.85 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 110.391 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.4 p -108.2 106.87 17.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.782 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.41 126.96 93.0 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.688 . . . . 0.0 109.584 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.86 -77.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.06 1.032 . . . . 0.0 110.645 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.11 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.48 -0.763 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.77 -46.79 86.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.726 -0.609 . . . . 0.0 110.156 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.73 -43.69 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.698 . . . . 0.0 109.343 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.87 -27.66 68.3 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.612 -0.68 . . . . 0.0 110.164 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.04 -39.19 42.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.985 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -79.46 -70.37 0.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.648 . . . . 0.0 109.969 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.972 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.5 OUTLIER -65.65 133.59 51.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.516 -0.74 . . . . 0.0 110.57 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -81.84 87.92 6.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.59 76.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.593 -0.692 . . . . 0.0 109.481 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' C ' ' HE1' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -58.65 168.86 1.07 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.782 -0.574 . . . . 0.0 110.633 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' CE1' ' B' ' 13' ' ' TYR . 0.5 OUTLIER -74.87 72.66 2.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.73 -0.606 . . . . 0.0 110.139 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 1.027 ' HA2' ' O ' ' B' ' 9' ' ' VAL . . . 137.54 45.17 0.08 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.512 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 2.9 m-20 -105.42 147.54 28.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.613 -0.934 . . . . 0.0 110.323 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.32 76.8 5.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.461 -0.774 . . . . 0.0 110.064 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.445 ' O ' HG22 ' B' ' 7' ' ' VAL . 59.0 t -86.65 143.23 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.525 -0.734 . . . . 0.0 110.082 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -111.73 130.59 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.723 . . . . 0.0 110.166 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HA ' HG22 ' A' ' 46' ' ' ILE . 60.4 t -101.95 130.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.625 -0.672 . . . . 0.0 109.498 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 p -129.02 145.01 51.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.54 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 49.8 t80 -121.09 129.73 53.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -107.47 146.9 31.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.426 -0.796 . . . . 0.0 110.774 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 2' ' ' ALA . 28.0 mt-10 -97.94 30.36 3.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.669 -0.644 . . . . 0.0 110.045 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.88 -34.47 3.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.638 -0.664 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -114.66 -42.08 3.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.531 -0.731 . . . . 0.0 110.281 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.52 37.43 4.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.825 HG12 ' HB3' ' B' ' 47' ' ' GLN . 32.7 m -134.61 152.31 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.73 -0.864 . . . . 0.0 109.645 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.961 HG23 ' CE2' ' B' ' 25' ' ' PHE . 56.3 t -99.2 127.35 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 2.1 ttpp -108.5 124.37 50.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.831 -0.543 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.833 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 9.1 pt -117.02 148.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.752 . . . . 0.0 110.447 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.821 ' HB3' HG12 ' B' ' 43' ' ' VAL . 18.3 pt20 -161.53 -171.67 3.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.572 -0.705 . . . . 0.0 110.599 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.061 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ALA . . . . . 0.476 ' N ' ' OE1' ' A' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.07 0.462 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.79 150.26 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.589 -0.694 . . . . 0.0 110.09 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -148.16 116.01 6.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.677 -0.639 . . . . 0.0 109.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.65 174.06 8.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.714 . . . . 0.0 110.554 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.414 HG22 ' HE2' ' A' ' 34' ' ' LYS . 27.6 pt -120.57 130.73 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.686 -0.634 . . . . 0.0 109.899 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 33' ' ' VAL . 33.3 m -131.25 146.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.533 -0.729 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -103.5 154.22 19.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 1.027 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 57.7 t -109.95 142.45 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.695 -0.628 . . . . 0.0 109.6 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 84.7 p -169.78 -170.5 1.04 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 0.0 111.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.9 -86.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.721 -0.612 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.7 55.49 1.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.04 -1.038 . . . . 0.0 110.564 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.476 ' HE1' ' C ' ' A' ' 28' ' ' LYS . 71.4 m-85 49.34 47.36 22.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.439 -0.788 . . . . 0.0 111.08 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -112.21 154.22 25.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.161 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.97 135.98 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.624 -0.673 . . . . 0.0 110.314 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 40.5 p -108.31 106.86 17.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.739 -0.601 . . . . 0.0 109.773 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.48 126.91 92.93 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.7 -78.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.091 1.048 . . . . 0.0 110.648 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.74 -37.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.752 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.57 -46.9 85.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.625 -0.672 . . . . 0.0 110.123 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.71 -43.63 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.362 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.94 -27.68 68.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.653 -0.654 . . . . 0.0 110.049 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.05 -39.21 42.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.533 -0.729 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -79.54 -70.32 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.591 -0.693 . . . . 0.0 109.968 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.961 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -65.55 133.52 51.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -0.756 . . . . 0.0 110.563 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -81.88 88.05 6.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.522 -0.736 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.71 76.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 0.0 109.472 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.454 ' C ' ' HE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -58.54 168.74 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.75 -0.594 . . . . 0.0 110.65 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.448 ' N ' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -74.79 72.53 2.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.607 -0.683 . . . . 0.0 110.138 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLY . . . . . 1.025 ' HA2' ' O ' ' A' ' 9' ' ' VAL . . . 137.81 44.85 0.08 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.505 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 3.0 m-20 -105.3 147.54 28.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.405 -1.056 . . . . 0.0 110.362 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.35 76.82 5.91 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.519 -0.738 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 7' ' ' VAL . 57.4 t -86.52 143.13 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.512 -0.742 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.419 ' HE2' HG22 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -111.7 130.57 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' B' ' 46' ' ' ILE . 60.1 t -101.86 130.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 61.2 p -129.1 144.9 51.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.417 -0.802 . . . . 0.0 111.354 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.552 ' CD1' ' CD2' ' A' ' 25' ' ' PHE . 50.1 t80 -121.11 129.86 53.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -107.54 146.88 31.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.656 -0.653 . . . . 0.0 110.823 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 2' ' ' ALA . 28.1 mt-10 -97.99 30.47 3.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.609 -0.682 . . . . 0.0 110.107 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 -34.58 3.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 110.243 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -114.53 -42.17 3.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.501 -0.749 . . . . 0.0 110.319 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.76 37.19 4.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.821 HG12 ' HB3' ' A' ' 47' ' ' GLN . 32.6 m -134.64 152.08 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.824 -0.809 . . . . 0.0 109.676 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.972 HG23 ' CE2' ' A' ' 25' ' ' PHE . 60.0 t -98.95 127.21 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.715 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.2 ttpp -108.26 124.27 50.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.85 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.9 pt -116.92 148.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.535 -0.728 . . . . 0.0 110.464 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.825 ' HB3' HG12 ' A' ' 43' ' ' VAL . 18.4 pt20 -161.18 -171.74 3.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.706 -0.622 . . . . 0.0 110.742 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.672 . . . . 0.0 110.104 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.236 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.77 148.71 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.581 -0.699 . . . . 0.0 109.596 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -140.31 140.2 35.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.898 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.44 161.18 41.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.633 -0.667 . . . . 0.0 109.637 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.23 160.58 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.432 -0.793 . . . . 0.0 110.738 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.45 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.677 -0.64 . . . . 0.0 109.75 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -110.08 151.64 26.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 0.0 110.46 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.08 145.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.647 -0.658 . . . . 0.0 109.649 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 t -172.14 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.535 -0.728 . . . . 0.0 110.741 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.16 -78.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.36 -0.837 . . . . 0.0 111.201 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -162.14 69.18 0.28 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.37 -0.831 . . . . 0.0 110.343 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 52.42 23.94 2.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.271 -0.893 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' C ' HG23 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -109.9 169.84 8.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.48 -0.762 . . . . 0.0 109.629 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 14' ' ' GLN . 58.0 t -146.21 135.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.477 -0.764 . . . . 0.0 110.539 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.35 -174.69 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.617 . . . . 0.0 109.525 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.437 ' CG2' HG13 ' A' ' 21' ' ' VAL . 4.2 mp -138.29 138.48 22.86 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 21.6 Cg_exo -60.3 -164.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.163 1.086 . . . . 0.0 110.271 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.82 -26.41 13.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -65.87 -62.6 1.41 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.498 -0.751 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.437 HG13 ' CG2' ' A' ' 17' ' ' ILE . 9.0 p -60.46 -36.18 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 109.609 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -64.54 -30.16 71.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.62 -0.675 . . . . 0.0 109.255 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -45.41 82.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' B' ' 37' ' ' PHE . 19.7 mmtm -68.76 -71.99 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.671 -0.643 . . . . 0.0 109.27 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' B' ' 44' ' ' VAL . 0.2 OUTLIER -63.12 141.09 58.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.474 -0.766 . . . . 0.0 109.577 179.209 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.39 -83.64 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 110.376 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.5 mt 51.07 77.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.032 -1.042 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.407 ' HA ' ' CE1' ' B' ' 13' ' ' TYR . 1.1 ttpt -105.6 177.25 4.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.449 -0.782 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.83 77.33 0.88 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.573 -0.704 . . . . 0.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.91 56.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.32 170.38 16.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.94 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.56 103.6 7.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.595 -0.69 . . . . 0.0 110.197 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 48' ' ' LEU . 9.4 p -95.08 157.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 110.482 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -108.29 131.28 54.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.608 -0.682 . . . . 0.0 110.191 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 46' ' ' ILE . 57.4 t -122.43 136.63 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.741 . . . . 0.0 109.317 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 p -141.85 147.48 37.25 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.425 -0.797 . . . . 0.0 111.596 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' B' ' 24' ' ' LYS . 27.1 t80 -106.38 137.16 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.51 175.92 6.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 110.9 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.21 36.64 4.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 110.088 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -127.53 -67.02 0.85 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.621 -0.674 . . . . 0.0 110.023 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.6 -38.58 13.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.21 55.87 0.85 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.687 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.1 m -136.48 161.63 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.601 -0.941 . . . . 0.0 110.309 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.644 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 60.3 t -116.08 120.26 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.519 -0.738 . . . . 0.0 109.514 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 17.9 ttmt -109.92 151.53 26.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.752 -0.593 . . . . 0.0 110.799 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.639 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 7.8 pt -134.56 159.58 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.617 -0.677 . . . . 0.0 110.615 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.711 ' HB3' HG12 ' B' ' 43' ' ' VAL . 8.4 pt20 -152.81 164.0 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 110.111 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.451 HD11 ' HB ' ' A' ' 33' ' ' VAL . 1.1 mt . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.457 -0.777 . . . . 0.0 111.237 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.202 0.525 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.78 148.65 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.24 140.22 35.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.447 -0.783 . . . . 0.0 110.924 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.43 161.2 41.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.755 -0.591 . . . . 0.0 109.575 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.2 160.59 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.433 -0.792 . . . . 0.0 110.708 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.43 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.642 -0.661 . . . . 0.0 109.663 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -110.06 151.6 27.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.743 . . . . 0.0 110.479 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.08 145.39 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.656 -0.652 . . . . 0.0 109.71 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.9 t -172.13 -37.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.17 -78.11 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.455 -0.778 . . . . 0.0 111.241 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.16 69.02 0.27 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 110.376 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.407 ' CE1' ' HA ' ' A' ' 28' ' ' LYS . 23.7 m-85 52.62 23.9 2.86 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.343 -0.848 . . . . 0.0 111.003 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.416 ' C ' HG23 ' B' ' 15' ' ' VAL . 1.0 OUTLIER -109.86 169.78 8.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.644 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.416 HG23 ' C ' ' B' ' 14' ' ' GLN . 57.4 t -146.21 135.49 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.38 -174.64 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 109.517 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.439 ' CG2' HG13 ' B' ' 21' ' ' VAL . 4.2 mp -138.43 138.5 22.58 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -60.19 -164.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.151 1.079 . . . . 0.0 110.355 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.85 -26.5 13.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.573 -0.704 . . . . 0.0 110.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -65.79 -62.57 1.43 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.439 HG13 ' CG2' ' B' ' 17' ' ' ILE . 9.2 p -60.45 -36.25 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -64.5 -30.15 71.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -45.38 81.91 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 19.7 mmtm -68.77 -71.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.646 -0.659 . . . . 0.0 109.296 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.501 ' CE1' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -63.1 141.05 58.91 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -72.38 -83.62 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.402 -0.812 . . . . 0.0 110.428 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 85.6 mt 51.05 77.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.055 -1.028 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -105.58 177.27 4.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.182 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.93 77.41 0.9 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.534 -0.729 . . . . 0.0 110.139 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.84 56.88 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.46 170.4 16.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.577 -0.955 . . . . 0.0 110.103 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.46 103.59 7.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.573 -0.705 . . . . 0.0 110.299 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' B' ' 48' ' ' LEU . 9.4 p -95.01 157.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.638 -0.664 . . . . 0.0 110.461 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -108.38 131.23 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.649 -0.657 . . . . 0.0 110.14 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.613 HG22 HG22 ' B' ' 46' ' ' ILE . 60.3 t -122.5 136.56 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.705 . . . . 0.0 109.326 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 8.5 p -141.79 147.52 37.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.396 -0.815 . . . . 0.0 111.479 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.41 ' CE2' ' HB3' ' A' ' 24' ' ' LYS . 26.9 t80 -106.39 137.03 45.1 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.39 175.84 6.1 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.279 -0.888 . . . . 0.0 110.993 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.11 36.51 4.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 110.064 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -127.53 -66.88 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.573 -0.704 . . . . 0.0 110.025 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -90.55 -38.61 13.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.578 -0.701 . . . . 0.0 110.072 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.17 55.92 0.85 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.711 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.1 m -136.54 161.48 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.529 -0.983 . . . . 0.0 110.214 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.639 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.5 t -115.92 120.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.424 -0.798 . . . . 0.0 109.566 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 17.9 ttmt -109.75 151.37 27.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.677 -0.639 . . . . 0.0 110.921 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.644 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 7.8 pt -134.41 159.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.722 -0.611 . . . . 0.0 110.671 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.687 ' HB3' HG12 ' A' ' 43' ' ' VAL . 8.5 pt20 -152.69 164.09 38.41 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 110.123 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' B' ' 33' ' ' VAL . 1.2 mt . . . . . 0 N--CA 1.498 1.962 0 O-C-N 121.391 -0.818 . . . . 0.0 111.31 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.182 0.515 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.96 147.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.593 -0.692 . . . . 0.0 110.152 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' B' ' 36' ' ' THR . 10.3 mt-10 -125.79 135.48 52.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.697 -0.627 . . . . 0.0 109.786 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.69 164.5 38.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.0 110.776 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.35 133.16 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.652 -0.655 . . . . 0.0 109.521 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.37 159.32 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -113.09 158.17 20.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.695 -0.628 . . . . 0.0 109.693 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.58 HG23 ' O ' ' B' ' 31' ' ' ASP . 69.9 t -94.18 147.91 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.54 -0.725 . . . . 0.0 110.172 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.7 t -171.05 -168.81 0.68 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.571 -0.705 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.57 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.717 -0.614 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.14 79.5 0.16 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.01 -1.057 . . . . 0.0 111.563 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 53.14 56.99 6.74 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.314 -0.866 . . . . 0.0 111.433 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -130.26 153.33 48.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.82 . . . . 0.0 110.495 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -123.87 101.48 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.703 -0.623 . . . . 0.0 110.074 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 16' ' ' THR . 6.7 t -74.87 153.99 38.42 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.543 -0.723 . . . . 0.0 110.077 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -98.91 130.99 26.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.564 -0.71 . . . . 0.0 109.789 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.99 -167.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.042 1.022 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.52 -36.51 17.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 110.221 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.55 -43.17 85.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 110.103 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.32 -38.47 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.714 . . . . 0.0 109.64 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -67.87 -41.47 82.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.168 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -67.55 -45.19 76.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 109.916 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.2 -68.68 0.64 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.704 -0.622 . . . . 0.0 109.999 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.6 OUTLIER -70.87 119.78 15.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.594 -0.691 . . . . 0.0 110.272 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.04 108.68 13.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.706 -0.621 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.65 76.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.472 -0.767 . . . . 0.0 109.981 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -97.23 175.35 6.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.632 -0.668 . . . . 0.0 110.011 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.26 125.62 24.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.52 -0.737 . . . . 0.0 109.997 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 20.4 12.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.591 ' O ' HG23 ' B' ' 9' ' ' VAL . 4.9 m-20 -111.83 114.8 27.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 95.93 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.624 . . . . 0.0 110.728 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.13 133.13 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.655 -0.653 . . . . 0.0 109.403 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 165.78 11.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.501 -0.749 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.68 136.15 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.658 -0.651 . . . . 0.0 109.873 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.645 HG22 ' HA ' ' B' ' 4' ' ' GLU . 71.3 p -141.87 146.41 35.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 110.904 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -103.64 140.28 37.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.732 -0.605 . . . . 0.0 109.539 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.33 173.39 6.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.645 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.71 33.97 5.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 110.059 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.5 t -121.65 -63.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 0.0 110.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.37 -35.9 10.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 110.58 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.82 56.97 0.88 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.823 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.2 m -133.25 166.92 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.631 -0.923 . . . . 0.0 110.053 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.537 HG23 ' CE2' ' B' ' 25' ' ' PHE . 47.4 t -119.71 116.6 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.358 -0.839 . . . . 0.0 109.833 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 4.1 ttpt -98.96 139.93 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 110.44 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.516 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.4 pt -131.72 157.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.561 -0.712 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.826 ' HB3' HG12 ' B' ' 43' ' ' VAL . 17.3 pt20 -161.26 168.71 23.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.461 -0.775 . . . . 0.0 110.464 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.539 -0.726 . . . . 0.0 109.568 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.225 0.536 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.03 147.17 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.563 -0.71 . . . . 0.0 110.178 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.645 ' HA ' HG22 ' A' ' 36' ' ' THR . 10.3 mt-10 -125.64 135.6 52.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.69 -0.631 . . . . 0.0 109.75 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.76 164.53 38.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.728 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 87.8 mt -132.49 133.13 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 109.495 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.33 159.31 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.326 -0.859 . . . . 0.0 110.783 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -113.06 158.11 20.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.727 -0.608 . . . . 0.0 109.78 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 31' ' ' ASP . 73.4 t -94.18 147.83 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 110.185 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -171.04 -168.75 0.68 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.361 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.6 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.674 -0.641 . . . . 0.0 110.831 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.13 79.47 0.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.965 -1.084 . . . . 0.0 111.559 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 53.07 57.15 6.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.301 -0.874 . . . . 0.0 111.459 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -130.47 153.23 49.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.332 -0.855 . . . . 0.0 110.586 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.9 t -123.78 101.4 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.763 -0.586 . . . . 0.0 110.082 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -74.83 153.9 38.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 110.075 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 34.1 mt -98.84 130.93 26.59 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.83 -167.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.161 1.085 . . . . 0.0 110.347 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.51 -36.47 17.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.63 -43.05 85.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.607 -0.683 . . . . 0.0 110.168 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.4 -38.44 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.573 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -67.9 -41.52 82.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.736 -0.603 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -67.5 -45.13 76.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.941 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.36 -68.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 109.971 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.537 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -70.87 119.78 15.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.7 -0.625 . . . . 0.0 110.227 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.09 108.75 13.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.627 -0.671 . . . . 0.0 110.327 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.63 76.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -97.25 175.39 6.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.659 -0.651 . . . . 0.0 110.018 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.37 125.74 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 110.017 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 20.42 12.24 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.58 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.9 m-20 -111.77 114.87 28.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.7 95.82 1.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.606 -0.684 . . . . 0.0 110.76 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 64.2 t -94.11 133.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.501 -0.749 . . . . 0.0 109.374 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.37 165.83 11.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.492 -0.755 . . . . 0.0 110.356 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.69 136.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 109.775 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 4' ' ' GLU . 69.8 p -141.91 146.42 35.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.456 -0.778 . . . . 0.0 110.979 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -103.67 140.36 37.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.481 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.34 173.44 6.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.525 -0.734 . . . . 0.0 110.618 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.7 33.76 5.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.675 -0.641 . . . . 0.0 110.027 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 36.9 t -121.48 -63.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.565 -0.71 . . . . 0.0 110.441 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.3 -35.96 10.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.525 -0.734 . . . . 0.0 110.498 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.85 56.87 0.88 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.826 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.0 m -133.25 166.75 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.654 -0.909 . . . . 0.0 110.066 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.531 HG23 ' CE2' ' A' ' 25' ' ' PHE . 47.3 t -119.61 116.64 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.315 -0.865 . . . . 0.0 109.868 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.424 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 4.2 ttpt -99.0 139.84 34.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.578 -0.701 . . . . 0.0 110.419 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.518 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.4 pt -131.65 156.86 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 110.384 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.823 ' HB3' HG12 ' A' ' 43' ' ' VAL . 17.3 pt20 -161.0 168.85 23.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.506 -0.746 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.639 -0.663 . . . . 0.0 109.555 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.046 0.45 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.38 138.18 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.27 152.11 51.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.562 -0.712 . . . . 0.0 109.9 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.25 152.12 32.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.496 -0.753 . . . . 0.0 110.367 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.8 mt -120.11 125.4 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.634 -0.666 . . . . 0.0 109.567 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.54 155.91 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.498 -0.751 . . . . 0.0 110.59 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.46 145.1 38.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.688 -0.632 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.27 130.74 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.605 -0.684 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -170.85 -157.04 0.13 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.498 -0.751 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 mtt85 55.74 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.727 -0.608 . . . . 0.0 111.075 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -150.83 56.39 0.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.096 -1.002 . . . . 0.0 110.561 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.95 38.25 19.73 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.304 -0.873 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.57 176.94 6.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.25 128.58 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.46 -21.49 21.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.331 -0.856 . . . . 0.0 111.49 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.3 mt 59.87 115.32 0.02 OUTLIER Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.718 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.67 175.18 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 122.858 0.925 . . . . 0.0 110.775 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.59 -27.13 61.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.615 -0.678 . . . . 0.0 110.568 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -54.32 46.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.493 -0.754 . . . . 0.0 110.521 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.53 -45.63 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.38 -0.825 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -60.0 -31.39 69.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -48.42 64.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.629 -0.669 . . . . 0.0 109.502 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' B' ' 37' ' ' PHE . 0.0 OUTLIER -65.12 -65.29 0.69 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.686 -0.633 . . . . 0.0 109.514 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.665 ' CE1' HG23 ' B' ' 44' ' ' VAL . 0.6 OUTLIER -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.666 -0.646 . . . . 0.0 110.151 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -73.55 -74.95 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.566 -0.709 . . . . 0.0 109.912 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.4 mm 52.95 84.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.396 -0.815 . . . . 0.0 110.608 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.35 148.57 37.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.632 -0.668 . . . . 0.0 110.379 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -61.69 109.44 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.586 -0.696 . . . . 0.0 110.134 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 55.22 1.31 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' OD2' HD21 ' A' ' 48' ' ' LEU . 3.2 t0 -126.92 158.38 36.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 0.0 110.274 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -92.78 82.95 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.81 156.45 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.825 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' B' ' 5' ' ' GLU . 5.1 tttt -134.17 147.14 50.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 110.25 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 46' ' ' ILE . 48.3 t -127.81 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 0.0 109.664 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.7 p -134.51 155.84 49.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.987 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE1' ' CD1' ' B' ' 25' ' ' PHE . 26.3 t80 -133.97 121.85 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.708 -0.62 . . . . 0.0 109.536 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -99.97 168.8 9.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 110.174 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.53 32.12 5.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 110.009 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 p -117.61 -48.83 2.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 110.139 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.65 -29.64 12.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 110.163 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.91 39.62 11.54 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' B' ' 47' ' ' GLN . 34.0 m -128.3 155.14 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.888 . . . . 0.0 110.327 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.646 HG23 ' CE1' ' B' ' 25' ' ' PHE . 40.2 t -103.01 115.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -100.63 130.01 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.844 -0.535 . . . . 0.0 110.165 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.656 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 8.7 pt -124.45 151.44 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.521 -0.737 . . . . 0.0 110.959 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.561 ' HG3' HG12 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -159.3 -168.98 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.34 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.455 HD21 ' OD2' ' A' ' 31' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.675 -0.641 . . . . 0.0 110.071 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.078 0.466 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.46 138.27 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.573 -0.704 . . . . 0.0 109.998 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -133.3 152.16 51.92 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.649 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.5 mp0 -151.29 152.15 32.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 mt -120.08 125.43 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.592 -0.692 . . . . 0.0 109.647 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.51 155.84 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.752 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.4 145.2 37.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.653 . . . . 0.0 110.036 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 64.9 t -79.27 130.87 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.569 -0.707 . . . . 0.0 109.991 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -171.09 -157.08 0.12 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.611 -0.68 . . . . 0.0 110.089 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 39.5 mtt85 55.75 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.646 -0.659 . . . . 0.0 111.131 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.82 56.36 0.91 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.067 -1.021 . . . . 0.0 110.518 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.9 38.3 19.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.263 -0.898 . . . . 0.0 110.857 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.6 176.95 6.83 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.52 -0.738 . . . . 0.0 111.179 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.24 128.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.52 -21.44 21.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.492 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 68.5 mt 59.85 115.35 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -57.8 175.19 0.47 Allowed 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 122.893 0.944 . . . . 0.0 110.819 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.07 61.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -54.26 47.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.56 -45.69 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -59.85 -31.56 69.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -48.32 64.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.685 -0.634 . . . . 0.0 109.563 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -65.25 -65.19 0.71 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.629 -0.669 . . . . 0.0 109.484 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.646 ' CE1' HG23 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -65.82 164.94 13.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.682 -0.636 . . . . 0.0 110.123 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.59 -74.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.607 -0.683 . . . . 0.0 109.914 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 47.6 mm 52.85 84.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.445 -0.784 . . . . 0.0 110.584 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.39 148.77 37.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.555 -0.716 . . . . 0.0 110.281 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -61.84 109.49 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.594 -0.691 . . . . 0.0 110.098 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 55.15 1.33 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.444 ' OD2' HD21 ' B' ' 48' ' ' LEU . 3.2 t0 -126.91 158.41 36.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.598 -0.942 . . . . 0.0 110.303 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -92.79 82.92 4.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.8 156.43 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 0.0 109.918 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 5.4 tttt -134.16 147.09 50.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.546 -0.721 . . . . 0.0 110.28 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.514 HG22 HG22 ' B' ' 46' ' ' ILE . 47.7 t -127.69 136.11 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.634 -0.666 . . . . 0.0 109.704 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -134.54 155.85 49.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.442 -0.786 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.499 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 26.4 t80 -134.03 121.94 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.705 -0.622 . . . . 0.0 109.468 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -100.07 168.79 9.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.728 -0.607 . . . . 0.0 110.182 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.52 31.97 5.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 74.6 p -117.55 -48.77 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.148 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.67 -29.56 12.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.68 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.82 39.79 11.46 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.561 HG12 ' HG3' ' A' ' 47' ' ' GLN . 34.7 m -128.31 155.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.744 -0.857 . . . . 0.0 110.343 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.665 HG23 ' CE1' ' A' ' 25' ' ' PHE . 41.1 t -103.1 115.39 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -100.22 129.8 46.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.761 -0.587 . . . . 0.0 110.342 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.645 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.8 pt -124.1 151.49 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.518 -0.739 . . . . 0.0 110.983 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.596 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -159.38 -168.96 2.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.783 -0.573 . . . . 0.0 110.348 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.444 HD21 ' OD2' ' B' ' 31' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 109.958 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.053 0.454 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.99 112.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.067 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.38 160.51 14.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.543 -0.723 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.39 148.76 28.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.2 mt -120.32 147.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.638 -0.664 . . . . 0.0 109.777 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 HG13 ' B' ' 33' ' ' VAL . 9.7 p -168.18 161.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.512 -0.743 . . . . 0.0 110.365 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.86 -170.73 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 110.144 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.77 156.01 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.754 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.8 p -168.95 -176.93 2.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.764 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.94 -157.51 0.15 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.521 -0.737 . . . . 0.0 110.765 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -87.98 65.54 8.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.695 . . . . 0.0 110.271 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.41 33.03 14.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.468 -0.77 . . . . 0.0 111.042 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.86 151.37 25.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.702 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.04 140.03 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.592 ' O ' HG23 ' A' ' 16' ' ' THR . 6.6 t -144.77 110.59 5.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 109.891 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.416 HG23 ' HD2' ' A' ' 18' ' ' PRO . 88.3 mt -71.26 142.26 86.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.069 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD2' HG23 ' A' ' 17' ' ' ILE . 30.5 Cg_endo -69.16 179.88 3.09 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.345 1.182 . . . . 0.0 110.465 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.43 43.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.7 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.65 -50.77 72.16 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.11 -36.18 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.267 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.94 -47.67 65.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.312 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -69.33 0.29 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.683 -0.636 . . . . 0.0 109.355 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.67 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.3 OUTLIER -66.41 156.25 35.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.579 -0.701 . . . . 0.0 109.719 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.77 -81.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.494 -0.754 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 25' ' ' PHE . 61.6 mt 50.63 87.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.191 -0.943 . . . . 0.0 110.895 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -124.77 173.0 8.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.727 . . . . 0.0 109.917 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.86 5.66 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 0.0 110.266 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.27 61.6 1.55 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.458 ' HB3' HD21 ' A' ' 48' ' ' LEU . 1.8 m-20 -133.96 138.08 45.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.522 -0.987 . . . . 0.0 110.152 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.81 90.78 8.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.543 -0.723 . . . . 0.0 110.325 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.443 HG13 HG13 ' B' ' 7' ' ' VAL . 7.7 p -97.21 152.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.629 -0.669 . . . . 0.0 109.789 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 151.59 48.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.541 -0.724 . . . . 0.0 110.627 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.0 127.57 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.7 p -127.37 150.11 49.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.497 -0.752 . . . . 0.0 111.367 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.1 t80 -136.23 125.33 24.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.51 -177.68 3.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 0.0 110.532 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -124.24 24.21 8.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.713 -0.617 . . . . 0.0 110.461 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.6 t -119.45 -40.36 2.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 110.072 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.61 -49.6 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 110.128 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.31 43.78 2.49 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' B' ' 47' ' ' GLN . 34.9 m -141.41 156.23 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.576 -0.955 . . . . 0.0 110.032 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.684 HG23 ' CE2' ' B' ' 25' ' ' PHE . 46.6 t -106.23 125.5 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.956 -0.697 . . . . 0.0 109.925 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.579 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -107.83 128.28 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.665 -0.647 . . . . 0.0 110.259 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.498 HG12 ' HB ' ' B' ' 44' ' ' VAL . 22.1 pt -116.76 153.56 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.735 . . . . 0.0 110.356 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.64 ' HB2' HG12 ' B' ' 43' ' ' VAL . 1.6 tm0? -156.26 162.76 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.578 -0.701 . . . . 0.0 110.428 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 31' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 110.166 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.047 0.451 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.95 112.78 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.678 . . . . 0.0 110.03 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.4 160.54 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.44 148.68 28.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.545 -0.722 . . . . 0.0 110.43 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 23.3 mt -120.31 147.73 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.643 -0.661 . . . . 0.0 109.757 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 33' ' ' VAL . 9.6 p -168.25 161.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.423 -0.798 . . . . 0.0 110.356 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.77 -170.65 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 156.03 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.109 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -169.02 -177.02 2.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.482 -0.761 . . . . 0.0 110.454 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.97 -157.54 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.454 -0.779 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -88.02 65.66 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.226 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.5 32.74 14.69 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.0 111.083 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.7 151.41 25.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.553 -0.717 . . . . 0.0 109.759 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.09 140.03 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.584 ' O ' HG23 ' B' ' 16' ' ' THR . 6.8 t -144.67 110.5 5.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.609 -0.682 . . . . 0.0 109.936 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.408 HG23 ' HD2' ' B' ' 18' ' ' PRO . 88.7 mt -71.37 142.33 86.68 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.475 -0.765 . . . . 0.0 110.046 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.408 ' HD2' HG23 ' B' ' 17' ' ' ILE . 30.5 Cg_endo -69.31 179.95 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.393 1.207 . . . . 0.0 110.419 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.34 43.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.107 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -60.8 -50.6 72.8 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.602 -0.687 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.05 -36.3 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.671 -0.643 . . . . 0.0 109.267 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -64.03 -31.97 73.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.641 -0.662 . . . . 0.0 109.587 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -47.54 65.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.668 . . . . 0.0 109.299 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -69.42 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.292 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.684 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -66.37 156.14 35.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.638 -0.664 . . . . 0.0 109.778 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.66 -81.74 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.53 -0.731 . . . . 0.0 110.035 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' B' ' 25' ' ' PHE . 61.8 mt 50.59 87.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.138 -0.977 . . . . 0.0 110.87 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -124.73 172.99 8.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.597 -0.689 . . . . 0.0 109.925 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.82 5.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.5 -0.75 . . . . 0.0 110.314 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 61.45 1.56 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.473 ' HB3' HD21 ' B' ' 48' ' ' LEU . 1.8 m-20 -133.84 138.22 45.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 0.0 110.146 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.9 90.83 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 110.343 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 7' ' ' VAL . 7.8 p -97.24 152.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.0 109.821 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 151.58 48.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 110.669 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.06 127.53 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 18.5 p -127.46 150.04 49.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.818 . . . . 0.0 111.369 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 34.8 t80 -136.25 125.39 24.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.43 -177.74 3.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 110.57 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.28 24.31 8.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.384 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -119.44 -40.51 2.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.48 -49.67 4.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.647 -0.658 . . . . 0.0 110.154 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.41 43.63 2.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.64 HG12 ' HB2' ' A' ' 47' ' ' GLN . 34.8 m -141.31 156.13 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.6 -0.941 . . . . 0.0 110.12 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.67 HG23 ' CE2' ' A' ' 25' ' ' PHE . 46.2 t -106.09 125.54 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.579 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -107.86 128.36 54.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.514 HG12 ' HB ' ' A' ' 44' ' ' VAL . 22.2 pt -116.76 153.57 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.583 -0.698 . . . . 0.0 110.321 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.631 ' HB2' HG12 ' A' ' 43' ' ' VAL . 1.6 tm0? -156.34 162.64 40.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.658 -0.651 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' B' ' 31' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.654 -0.654 . . . . 0.0 110.175 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.101 0.476 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.47 144.38 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.657 -0.652 . . . . 0.0 109.755 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.6 131.08 14.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.508 -0.745 . . . . 0.0 110.306 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.44 173.26 11.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.575 -0.703 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.424 ' C ' HG23 ' A' ' 7' ' ' VAL . 38.9 pt -121.77 159.5 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.642 -0.661 . . . . 0.0 110.286 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.424 HG23 ' C ' ' A' ' 6' ' ' ILE . 63.2 t -147.42 153.12 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.658 -0.651 . . . . 0.0 110.204 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 172.24 6.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.83 149.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.472 -0.767 . . . . 0.0 110.213 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -171.8 -167.65 0.52 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.542 -0.724 . . . . 0.0 110.799 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.81 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.684 -0.635 . . . . 0.0 111.465 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.36 73.94 0.94 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.949 -1.094 . . . . 0.0 111.181 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 49.2 29.08 2.44 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.37 -0.831 . . . . 0.0 111.427 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.01 153.6 21.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.637 -0.664 . . . . 0.0 110.409 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -126.33 151.58 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.61 -0.681 . . . . 0.0 109.842 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -148.15 127.1 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.645 -0.659 . . . . 0.0 110.147 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 84.6 mt -81.26 145.38 55.82 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 0.0 109.942 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 28.6 Cg_exo -58.12 -166.18 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.344 1.181 . . . . 0.0 110.617 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.93 -43.33 8.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.595 -0.691 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -63.71 -44.09 94.63 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.642 -0.661 . . . . 0.0 110.33 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.0 -41.71 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.528 -0.732 . . . . 0.0 109.603 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -65.54 -31.68 72.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.499 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -40.4 75.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.675 -0.641 . . . . 0.0 109.272 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -72.98 -74.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.615 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.3 154.01 14.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.593 -0.692 . . . . 0.0 109.975 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -84.88 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.73 . . . . 0.0 109.853 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.473 HD12 ' HB3' ' A' ' 25' ' ' PHE . 71.0 mt 49.6 86.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.972 . . . . 0.0 110.902 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.25 -177.22 3.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -0.769 . . . . 0.0 110.596 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -83.15 117.57 22.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 0.0 110.104 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.38 38.01 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.27 170.01 9.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.936 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -117.17 72.24 0.83 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.746 . . . . 0.0 110.136 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -64.65 149.37 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 110.398 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.45 156.95 18.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.67 -0.644 . . . . 0.0 110.329 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG23 ' CG1' ' A' ' 44' ' ' VAL . 7.9 p -151.33 133.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.4 p -141.57 145.86 35.6 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.156 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 44.4 t80 -111.47 140.18 46.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -132.81 155.7 48.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 0.0 110.948 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.77 20.02 12.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.239 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -100.94 -27.78 13.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.285 -0.884 . . . . 0.0 109.909 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -127.2 -49.27 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.637 -0.664 . . . . 0.0 110.24 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.42 35.31 3.37 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' B' ' 47' ' ' GLN . 35.3 m -136.89 163.12 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.523 -0.987 . . . . 0.0 110.236 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.803 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 59.5 t -105.0 127.61 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.346 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 27.3 ttmt -112.22 133.71 54.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.771 -0.581 . . . . 0.0 110.217 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.81 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 5.3 pt -125.75 158.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.631 -0.668 . . . . 0.0 110.194 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.665 ' HB2' HG12 ' B' ' 43' ' ' VAL . 5.0 tt0 -153.72 161.31 42.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.668 -0.645 . . . . 0.0 110.351 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.578 -0.701 . . . . 0.0 110.056 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.138 0.494 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.45 144.33 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.759 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.71 131.1 14.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 0.0 110.368 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.41 173.28 11.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.698 -0.627 . . . . 0.0 110.034 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.433 ' C ' HG23 ' B' ' 7' ' ' VAL . 38.4 pt -121.78 159.59 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.624 -0.673 . . . . 0.0 110.324 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.433 HG23 ' C ' ' B' ' 6' ' ' ILE . 62.9 t -147.45 153.16 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.527 -0.733 . . . . 0.0 110.181 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.93 172.19 6.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.705 . . . . 0.0 110.069 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.74 149.23 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 110.237 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.8 t -172.02 -167.64 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.522 -0.736 . . . . 0.0 110.757 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.76 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.663 -0.648 . . . . 0.0 111.454 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.35 73.95 0.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.04 -1.037 . . . . 0.0 111.219 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 49.23 29.17 2.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.315 -0.865 . . . . 0.0 111.396 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.07 153.64 21.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.419 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.34 151.49 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.798 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -148.09 127.03 12.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 110.072 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 85.0 mt -81.08 145.26 56.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.969 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -57.96 -166.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.416 1.219 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.82 -43.49 8.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -63.7 -43.89 95.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.55 -0.719 . . . . 0.0 110.362 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.18 -41.79 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 109.526 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -65.46 -31.78 73.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.6 -0.687 . . . . 0.0 109.462 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -40.48 75.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.668 -0.645 . . . . 0.0 109.334 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -72.96 -74.09 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.609 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.36 154.01 14.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.0 109.97 179.474 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.3 -84.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 109.887 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ILE . . . . . 0.473 HD12 ' HB3' ' B' ' 25' ' ' PHE . 71.8 mt 49.48 86.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.066 -1.022 . . . . 0.0 110.964 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.19 -177.21 3.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.527 -0.733 . . . . 0.0 110.538 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -83.12 117.56 22.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.574 -0.704 . . . . 0.0 110.106 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.26 38.22 4.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.34 170.02 9.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.917 . . . . 0.0 110.184 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mt -117.22 72.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.69 149.33 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.52 -0.738 . . . . 0.0 110.336 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.4 156.9 18.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.597 -0.689 . . . . 0.0 110.364 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.424 HG23 ' CG1' ' B' ' 44' ' ' VAL . 7.8 p -151.34 133.15 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 79.1 p -141.62 145.89 35.56 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.117 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.615 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 44.1 t80 -111.42 140.13 46.26 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -132.75 155.77 48.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.83 20.11 12.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -100.82 -28.04 13.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.795 . . . . 0.0 109.974 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -127.02 -49.25 1.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.706 -0.621 . . . . 0.0 110.246 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.43 35.21 3.39 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 47' ' ' GLN . 35.2 m -136.79 163.1 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.5 -1.0 . . . . 0.0 110.122 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.81 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.6 t -105.03 127.37 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.2 ttmt -111.87 133.55 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.697 -0.627 . . . . 0.0 110.294 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.803 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 5.4 pt -125.54 158.05 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.653 -0.654 . . . . 0.0 110.302 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.641 ' HB2' HG12 ' A' ' 43' ' ' VAL . 4.8 tt0 -153.64 161.36 42.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.716 -0.615 . . . . 0.0 110.32 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.055 0.455 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.77 156.25 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 0.0 109.759 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -145.52 147.05 31.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.531 -0.73 . . . . 0.0 110.598 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HB2' HG13 ' B' ' 35' ' ' VAL . 1.4 mm-40 -137.81 164.05 29.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.752 -0.593 . . . . 0.0 109.912 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.95 137.93 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.657 -0.652 . . . . 0.0 110.519 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 8' ' ' LYS . 9.9 p -146.15 165.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.575 -0.703 . . . . 0.0 109.736 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' N ' HG22 ' A' ' 7' ' ' VAL . 16.0 tttp -137.07 138.35 40.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.351 -0.843 . . . . 0.0 110.517 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.45 124.96 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.597 -0.689 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 m -168.65 42.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.437 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -139.59 -66.04 0.46 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.605 -0.684 . . . . 0.0 109.457 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.08 46.29 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.752 -0.592 . . . . 0.0 109.995 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' B' ' 29' ' ' GLU . 15.2 m-85 53.42 57.42 6.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 110.803 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 174.71 13.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.463 -0.773 . . . . 0.0 110.81 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.52 145.53 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.753 -0.592 . . . . 0.0 109.693 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 p -110.95 -8.47 14.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 111.368 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.8 mt 59.51 111.6 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.304 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.53 -168.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.039 1.02 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.04 -33.85 26.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 0.0 111.519 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -56.34 -52.43 64.6 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.234 -0.916 . . . . 0.0 110.862 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.22 -47.7 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.393 -0.817 . . . . 0.0 109.593 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HD2' HG21 ' A' ' 27' ' ' ILE . 9.1 tpp180 -58.63 -28.77 65.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.99 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -45.06 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 109.486 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.64 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.598 -0.688 . . . . 0.0 109.952 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.12 169.92 5.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.402 -0.811 . . . . 0.0 110.817 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.47 -73.43 0.38 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.692 -0.63 . . . . 0.0 110.733 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.547 HG21 ' HD2' ' A' ' 22' ' ' ARG . 47.2 mm 55.12 93.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 139.16 47.79 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.0 110.365 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 13' ' ' TYR . 5.4 tt0 -67.58 112.15 4.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.543 -0.723 . . . . 0.0 110.154 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.73 35.44 4.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.73 163.98 18.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.579 -0.954 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.3 tp -93.71 107.25 19.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.645 -0.66 . . . . 0.0 110.289 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.9 t -98.72 141.18 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.667 -0.645 . . . . 0.0 109.585 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.75 142.21 46.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.548 -0.72 . . . . 0.0 110.346 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 5' ' ' GLU . 12.4 p -131.37 134.27 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.665 -0.647 . . . . 0.0 109.779 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.402 HG22 ' CB ' ' B' ' 4' ' ' GLU . 24.1 p -134.25 146.03 49.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.74 . . . . 0.0 111.208 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -104.16 130.56 51.91 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.47 148.1 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 110.556 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.21 38.92 1.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.632 -0.668 . . . . 0.0 110.226 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -144.28 -52.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB3' HG22 ' A' ' 43' ' ' VAL . 4.7 mt-10 -83.92 -30.56 26.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.482 -0.761 . . . . 0.0 110.024 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 39.26 29.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' B' ' 47' ' ' GLN . 35.8 m -136.89 158.27 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.921 . . . . 0.0 109.684 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 61.6 t -98.68 130.48 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 109.504 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 15.5 ttmt -110.08 127.21 54.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.877 -0.514 . . . . 0.0 110.415 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.449 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.4 pt -121.98 146.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.403 -0.811 . . . . 0.0 110.92 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.545 ' HB3' HG12 ' B' ' 43' ' ' VAL . 17.0 pt20 -143.89 -169.58 3.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.871 -0.518 . . . . 0.0 110.186 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.55 165.13 25.93 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.37 -179.84 8.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.357 -0.839 . . . . 0.0 110.337 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -59.3 -167.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.54 -0.725 . . . . 0.0 109.996 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.8 121.3 12.55 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.146 -0.971 . . . . 0.0 111.585 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -83.57 152.08 13.37 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 N-CA-C 108.748 -1.289 . . . . 0.0 108.748 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -135.56 40.15 2.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.345 -0.847 . . . . 0.0 111.12 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.12 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.135 0.493 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.75 156.3 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.402 ' CB ' HG22 ' A' ' 36' ' ' THR . 7.5 tt0 -145.47 147.13 31.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.484 -0.76 . . . . 0.0 110.59 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.4 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 1.4 mm-40 -137.95 163.88 30.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.683 -0.636 . . . . 0.0 109.903 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.84 137.89 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.688 -0.632 . . . . 0.0 110.582 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.417 HG22 ' N ' ' B' ' 8' ' ' LYS . 10.2 p -146.14 165.17 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 0.0 109.725 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.417 ' N ' HG22 ' B' ' 7' ' ' VAL . 16.2 tttp -137.03 138.4 40.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.433 -0.792 . . . . 0.0 110.518 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.46 125.17 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 109.54 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -168.75 42.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.475 -0.765 . . . . 0.0 110.43 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -139.61 -65.99 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.24 46.25 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.07 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 29' ' ' GLU . 15.2 m-85 53.44 57.57 6.05 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.492 -0.755 . . . . 0.0 110.814 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 174.78 13.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.451 -0.78 . . . . 0.0 110.822 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.64 145.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.843 -0.536 . . . . 0.0 109.666 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -110.78 -8.56 14.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 111.476 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt 59.55 111.69 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.248 -0.907 . . . . 0.0 110.592 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.76 -168.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.089 1.047 . . . . 0.0 111.324 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.78 -33.72 27.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.654 -0.654 . . . . 0.0 111.6 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -56.62 -52.15 65.96 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.14 -0.975 . . . . 0.0 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.44 -47.63 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.384 -0.823 . . . . 0.0 109.43 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.556 ' HD2' HG21 ' B' ' 27' ' ' ILE . 9.1 tpp180 -58.74 -28.78 66.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 109.938 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -45.11 80.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.459 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.61 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.13 169.87 5.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.451 -0.781 . . . . 0.0 110.827 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.41 -73.5 0.38 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.7 -0.625 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.556 HG21 ' HD2' ' B' ' 22' ' ' ARG . 46.9 mm 55.2 93.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.234 -0.916 . . . . 0.0 110.337 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 139.21 47.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 110.339 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 5.5 tt0 -67.59 112.18 4.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.515 -0.74 . . . . 0.0 110.144 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.61 4.9 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.75 163.89 18.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.715 -0.874 . . . . 0.0 110.047 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.5 107.19 19.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.614 -0.679 . . . . 0.0 110.354 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.85 141.25 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.485 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 142.03 46.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.558 -0.714 . . . . 0.0 110.28 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 5' ' ' GLU . 12.1 p -131.28 134.31 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 24.0 p -134.22 146.12 49.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -104.12 130.46 51.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.26 148.18 24.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.428 -0.795 . . . . 0.0 110.634 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.27 38.86 1.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.656 -0.652 . . . . 0.0 110.284 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -144.1 -52.78 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 110.07 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.525 ' HB3' HG22 ' B' ' 43' ' ' VAL . 4.7 mt-10 -83.82 -30.68 26.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 0.0 110.048 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.9 39.21 28.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 47' ' ' GLN . 35.6 m -136.99 158.14 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.789 -0.83 . . . . 0.0 109.635 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 61.4 t -98.54 130.35 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.314 -0.866 . . . . 0.0 109.555 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.406 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 16.8 ttmt -110.02 127.21 54.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.702 -0.624 . . . . 0.0 110.38 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.46 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.4 pt -121.75 146.93 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.423 -0.798 . . . . 0.0 110.917 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.546 ' HB3' HG12 ' A' ' 43' ' ' VAL . 17.0 pt20 -143.91 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 0.0 110.197 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.58 165.13 25.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 110.319 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.37 -179.81 8.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.558 -0.714 . . . . 0.0 110.352 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -59.29 -167.15 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.428 -0.795 . . . . 0.0 110.042 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.88 121.6 12.63 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.32 -0.862 . . . . 0.0 111.593 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.86 152.12 12.91 Favored 'Trans proline' 0 C--N 1.323 -0.795 0 N-CA-C 108.623 -1.337 . . . . 0.0 108.623 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -135.57 40.25 2.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 111.004 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.138 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.182 0.515 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.47 134.91 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 109.97 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.721 ' HA ' HG22 ' B' ' 36' ' ' THR . 0.2 OUTLIER -122.76 153.39 39.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.74 . . . . 0.0 110.582 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.04 162.6 41.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.647 . . . . 0.0 109.746 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 tt -134.93 154.9 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.566 -0.709 . . . . 0.0 110.703 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.36 159.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 109.973 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -156.32 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.72 . . . . 0.0 110.275 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.122 ' O ' ' N ' ' B' ' 30' ' ' GLY . 49.0 t -143.59 126.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.87 -169.21 3.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 56.88 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.8 -0.562 . . . . 0.0 111.313 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -152.42 57.73 0.82 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.975 -1.078 . . . . 0.0 110.835 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.008 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 80.3 m-85 50.8 37.38 16.83 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.327 -0.858 . . . . 0.0 111.346 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.45 173.98 6.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.453 -0.78 . . . . 0.0 110.242 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -169.5 141.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.791 . . . . 0.0 110.624 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -108.04 174.47 5.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 109.405 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.9 mm -108.54 133.47 20.6 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.386 -0.821 . . . . 0.0 110.38 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.578 ' HG2' HG23 ' A' ' 21' ' ' VAL . 33.0 Cg_endo -71.36 157.32 57.02 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 O-C-N 123.171 1.09 . . . . 0.0 110.195 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.99 57.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 110.612 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -70.86 -53.49 15.01 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.372 -0.83 . . . . 0.0 110.466 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.578 HG23 ' HG2' ' A' ' 18' ' ' PRO . 98.8 t -59.95 -43.95 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.258 -0.901 . . . . 0.0 109.32 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -59.95 -31.48 69.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.61 -52.57 50.96 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.445 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.53 -68.64 0.67 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.626 -0.671 . . . . 0.0 110.383 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.058 ' CE1' HG23 ' B' ' 44' ' ' VAL . 13.5 t80 -57.96 134.87 56.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.536 -0.728 . . . . 0.0 111.029 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -81.97 123.09 28.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.671 -0.643 . . . . 0.0 109.783 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 27' ' ' ILE . 6.9 tt -166.85 85.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.182 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 1.008 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.4 OUTLIER -95.83 178.28 5.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.294 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.632 ' HA ' HG12 ' B' ' 9' ' ' VAL . 3.5 mt-10 -66.62 135.28 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.65 -0.656 . . . . 0.0 110.606 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 1.127 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 61.16 48.66 84.65 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -106.68 -176.22 3.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -1.019 . . . . 0.0 110.165 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 32' ' ' LEU . 2.0 mm? -95.9 78.84 3.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.792 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.572 HG21 ' CG2' ' B' ' 9' ' ' VAL . 63.7 t -85.6 116.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.35 142.32 32.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.669 -0.644 . . . . 0.0 109.836 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.08 122.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.56 -0.712 . . . . 0.0 109.878 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.707 HG22 ' HA ' ' B' ' 4' ' ' GLU . 68.3 p -140.55 146.79 38.53 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.311 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.421 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 12.0 t80 -105.03 142.54 34.64 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.36 145.07 27.76 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.135 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.56 32.69 2.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.007 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.63 -59.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.588 -0.695 . . . . 0.0 110.077 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -79.99 -30.02 39.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.666 . . . . 0.0 110.163 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.6 43.06 7.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.5 m -137.82 156.44 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.679 -0.894 . . . . 0.0 110.33 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.043 HG23 ' CE1' ' B' ' 25' ' ' PHE . 57.6 t -107.34 121.86 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' HG21 ' B' ' 43' ' ' VAL . 1.2 ttpt -103.67 136.96 42.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.684 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.776 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 42.9 pt -127.5 149.31 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.934 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.74 ' HB3' HG12 ' B' ' 43' ' ' VAL . 10.2 pt20 -151.79 175.1 12.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.504 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.33 22.76 2.76 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 0.0 110.713 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.8 -175.15 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.28 -0.888 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -138.57 160.31 39.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.606 -0.684 . . . . 0.0 110.098 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -136.6 160.61 65.92 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.666 . . . . 0.0 110.011 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -81.03 67.99 8.46 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.288 1.152 . . . . 0.0 110.059 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -87.42 86.06 7.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.468 -0.77 . . . . 0.0 110.259 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.5 tttt . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.105 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.099 0.476 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.55 134.91 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.543 -0.723 . . . . 0.0 110.022 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' A' ' 36' ' ' THR . 0.2 OUTLIER -122.62 153.42 39.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.558 -0.714 . . . . 0.0 110.653 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.14 162.46 41.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.719 -0.613 . . . . 0.0 109.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -134.85 154.85 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 110.783 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.33 159.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.686 -0.634 . . . . 0.0 109.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.31 -156.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.516 -0.74 . . . . 0.0 110.275 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 1.127 ' O ' ' N ' ' A' ' 30' ' ' GLY . 49.2 t -143.6 126.34 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.78 -169.18 3.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.611 -0.68 . . . . 0.0 110.404 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 56.87 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.657 -0.652 . . . . 0.0 111.309 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -152.23 57.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.102 -0.999 . . . . 0.0 110.842 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 1.008 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 81.6 m-85 50.8 37.37 16.8 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 0.0 111.397 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.4 174.13 6.02 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.439 -0.788 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.83 141.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.383 -0.823 . . . . 0.0 110.54 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -108.03 174.33 5.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.644 -0.66 . . . . 0.0 109.388 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 42.5 mm -108.35 133.47 20.56 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.587 ' HG2' HG23 ' B' ' 21' ' ' VAL . 32.8 Cg_endo -71.53 157.19 56.74 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 O-C-N 123.304 1.16 . . . . 0.0 110.155 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.72 54.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -71.05 -53.41 14.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.363 -0.836 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.587 HG23 ' HG2' ' B' ' 18' ' ' PRO . 86.7 t -59.94 -43.96 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -60.03 -31.38 69.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.77 -0.581 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.55 -52.56 51.53 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.705 -0.622 . . . . 0.0 109.481 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -68.4 0.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.639 -0.663 . . . . 0.0 110.482 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 1.043 ' CE1' HG23 ' A' ' 44' ' ' VAL . 13.8 t80 -58.21 135.02 57.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.951 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -81.99 123.03 28.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.644 -0.66 . . . . 0.0 109.815 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.631 ' O ' HG23 ' B' ' 27' ' ' ILE . 7.0 tt -166.74 85.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.271 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 1.008 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -0.843 . . . . 0.0 110.311 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.644 ' HA ' HG12 ' A' ' 9' ' ' VAL . 3.5 mt-10 -66.56 135.33 54.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.669 -0.644 . . . . 0.0 110.538 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 1.122 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 61.25 48.67 84.31 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.463 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -106.7 -176.14 2.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -1.009 . . . . 0.0 110.177 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' B' ' 32' ' ' LEU . 2.0 mm? -95.98 78.86 3.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.589 -0.695 . . . . 0.0 109.852 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.565 HG21 ' CG2' ' A' ' 9' ' ' VAL . 64.3 t -85.52 116.98 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.643 -0.661 . . . . 0.0 110.145 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.37 142.53 32.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 109.779 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.3 122.12 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.395 -0.815 . . . . 0.0 109.73 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 4' ' ' GLU . 70.5 p -140.54 146.85 38.64 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -0.823 . . . . 0.0 111.269 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.428 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 11.9 t80 -105.11 142.55 34.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 145.02 27.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.405 -0.809 . . . . 0.0 110.184 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.6 32.6 2.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.706 . . . . 0.0 109.957 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.61 -59.32 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.702 -0.624 . . . . 0.0 110.065 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -80.11 -30.05 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 110.105 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.67 42.97 7.5 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.7 m -137.68 156.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.584 -0.95 . . . . 0.0 110.295 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 1.058 HG23 ' CE1' ' A' ' 25' ' ' PHE . 57.5 t -107.38 121.64 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 43' ' ' VAL . 1.3 ttpt -103.49 136.8 42.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.687 -0.633 . . . . 0.0 110.665 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.754 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 42.5 pt -127.28 149.35 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.767 -0.583 . . . . 0.0 109.99 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.728 ' HB3' HG12 ' A' ' 43' ' ' VAL . 10.2 pt20 -151.66 175.13 12.68 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 0.0 110.495 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.4 22.81 2.74 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.599 -0.688 . . . . 0.0 110.723 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.58 -175.14 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.221 -0.925 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -138.45 160.41 39.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.64 -0.662 . . . . 0.0 110.134 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -136.65 160.54 66.13 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.474 -0.766 . . . . 0.0 109.969 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -81.02 68.24 8.38 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.325 1.171 . . . . 0.0 110.009 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -87.62 86.15 7.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.707 . . . . 0.0 110.226 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 tttt . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 117.818 -1.087 . . . . 0.0 110.108 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.163 0.506 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.75 139.8 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.666 -0.647 . . . . 0.0 109.968 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.14 150.4 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.6 -0.688 . . . . 0.0 110.168 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -156.81 161.88 39.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.624 -0.673 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.4 mt -131.25 136.61 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.585 -0.697 . . . . 0.0 110.216 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.69 170.07 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.748 -0.595 . . . . 0.0 109.785 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.69 152.16 35.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.424 -0.798 . . . . 0.0 110.772 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.86 ' O ' ' N ' ' B' ' 30' ' ' GLY . 62.7 t -101.71 136.31 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.74 -0.6 . . . . 0.0 109.591 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.6 p -157.15 -47.01 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.524 -0.735 . . . . 0.0 110.411 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -147.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.652 -0.655 . . . . 0.0 110.182 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.97 60.98 1.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 111.1 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.928 ' CD2' ' O ' ' B' ' 27' ' ' ILE . 27.1 m-85 50.59 32.16 6.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.38 -0.825 . . . . 0.0 111.826 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -88.42 174.64 8.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.299 -0.876 . . . . 0.0 110.101 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.11 135.5 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.022 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.2 m -100.61 150.51 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 110.364 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.3 mt -101.7 128.95 27.68 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.584 -0.698 . . . . 0.0 109.67 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.1 158.44 25.66 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.121 1.063 . . . . 0.0 110.72 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.14 77.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.639 -0.663 . . . . 0.0 109.874 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.49 -51.91 56.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.643 -0.661 . . . . 0.0 109.571 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.77 -39.26 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.05 -30.07 70.53 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.68 25.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.603 -0.686 . . . . 0.0 109.433 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -79.62 -63.34 1.44 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.684 -0.635 . . . . 0.0 109.846 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.817 ' CE1' HG23 ' B' ' 44' ' ' VAL . 6.4 t80 -53.53 115.24 1.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.268 -0.895 . . . . 0.0 110.695 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.449 ' O ' HD22 ' A' ' 48' ' ' LEU . 12.4 mt-30 -73.77 131.17 41.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.558 -0.714 . . . . 0.0 110.358 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.946 ' O ' ' CD2' ' B' ' 13' ' ' TYR . 6.8 tt -167.56 91.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.64 0.733 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.752 ' HA ' ' CE2' ' B' ' 13' ' ' TYR . 8.3 tttt -99.1 -179.65 4.32 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.262 -0.899 . . . . 0.0 110.997 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.579 ' HA ' HG12 ' B' ' 9' ' ' VAL . 23.5 mt-10 -75.48 127.08 32.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.973 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.842 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 90.97 26.39 22.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.767 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -103.74 149.55 24.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.538 -0.978 . . . . 0.0 109.776 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.3 mt -101.43 74.59 1.55 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.695 . . . . 0.0 110.708 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.32 151.09 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.426 -0.796 . . . . 0.0 109.569 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -106.61 154.95 20.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.836 . . . . 0.0 111.145 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.695 ' HA ' HG22 ' A' ' 46' ' ' ILE . 8.4 p -145.21 125.83 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.0 p -130.98 146.95 52.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.865 . . . . 0.0 111.508 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 40.0 t80 -106.49 149.97 26.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -110.07 -167.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.13 -38.71 1.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.7 . . . . 0.0 110.597 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.97 -40.11 12.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 110.598 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' A' ' 43' ' ' VAL . 13.8 mp0 -81.66 -37.2 27.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.697 . . . . 0.0 110.537 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.07 72.11 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.889 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 24.7 m -121.21 149.77 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.447 -1.031 . . . . 0.0 109.661 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.901 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 90.3 t -103.62 129.28 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.418 -0.802 . . . . 0.0 109.675 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.938 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 3.8 ttpm? -109.07 130.96 55.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.217 0.532 . . . . 0.0 109.737 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.903 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 10.8 pt -126.53 145.14 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.73 -0.606 . . . . 0.0 110.086 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.847 ' HB3' HG12 ' B' ' 43' ' ' VAL . 4.0 pt20 -148.96 171.08 16.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 110.303 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 26' ' ' GLN . 1.7 tp -112.03 169.84 8.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.27 57.09 3.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.421 -0.8 . . . . 0.0 110.728 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -101.1 136.22 41.29 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.473 -0.767 . . . . 0.0 110.011 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -122.18 88.1 48.24 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.487 -0.758 . . . . 0.0 111.147 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -63.34 97.41 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.362 1.19 . . . . 0.0 109.807 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.43 92.28 3.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.735 . . . . 0.0 110.379 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.777 179.655 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.05 0.452 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.57 139.95 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.642 -0.661 . . . . 0.0 109.982 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.2 150.57 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.711 -0.618 . . . . 0.0 110.137 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -156.97 161.85 39.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.745 -0.597 . . . . 0.0 109.589 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.26 136.62 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -126.9 169.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.692 -0.63 . . . . 0.0 109.71 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.61 152.04 35.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.518 -0.739 . . . . 0.0 110.787 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.842 ' O ' ' N ' ' A' ' 30' ' ' GLY . 62.8 t -101.59 136.26 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.665 . . . . 0.0 109.61 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.4 p -157.23 -46.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.746 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.41 ' HB3' ' HG2' ' B' ' 14' ' ' GLN . 0.3 OUTLIER -69.72 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.657 -0.652 . . . . 0.0 110.222 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.9 60.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.093 -1.005 . . . . 0.0 111.213 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.946 ' CD2' ' O ' ' A' ' 27' ' ' ILE . 27.0 m-85 50.61 32.09 6.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.364 -0.835 . . . . 0.0 111.902 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.41 ' HG2' ' HB3' ' B' ' 11' ' ' ARG . 17.1 pt20 -88.43 174.56 8.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.99 135.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.46 -0.775 . . . . 0.0 109.918 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 m -100.58 150.53 22.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 110.299 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 89.5 mt -101.67 129.0 27.61 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.22 158.52 25.91 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.115 1.061 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.0 77.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -51.65 58.18 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.574 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 83.7 t -62.04 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -66.01 -30.18 70.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.59 26.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.708 -0.62 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.61 -63.37 1.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.741 -0.599 . . . . 0.0 109.887 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.802 ' CE1' HG23 ' A' ' 44' ' ' VAL . 6.3 t80 -53.45 115.21 1.82 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.441 ' O ' HD22 ' B' ' 48' ' ' LEU . 12.3 mt-30 -73.83 131.29 41.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.648 -0.658 . . . . 0.0 110.309 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.928 ' O ' ' CD2' ' A' ' 13' ' ' TYR . 6.8 tt -167.64 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.548 0.69 . . . . 0.0 109.557 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.744 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 7.6 tttt -98.99 -179.77 4.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 111.005 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.582 ' HA ' HG12 ' A' ' 9' ' ' VAL . 23.3 mt-10 -75.41 127.12 32.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.638 . . . . 0.0 109.961 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 91.02 26.36 22.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.767 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -103.78 149.44 25.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.972 . . . . 0.0 109.825 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 74.53 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.656 -0.652 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.44 151.19 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.517 -0.739 . . . . 0.0 109.516 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -106.79 154.93 20.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.337 -0.852 . . . . 0.0 111.141 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.691 ' HA ' HG22 ' B' ' 46' ' ' ILE . 8.2 p -145.17 125.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -130.99 146.97 52.56 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.591 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.575 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 39.8 t80 -106.46 149.95 26.56 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.9 -167.21 1.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.642 -0.661 . . . . 0.0 110.272 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.03 -38.64 1.42 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.633 -0.667 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.05 -40.08 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -0.8 . . . . 0.0 110.604 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' B' ' 43' ' ' VAL . 13.6 mp0 -81.77 -37.2 27.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 110.446 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.87 26.29 71.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.938 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 25.5 m -121.32 149.58 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -1.047 . . . . 0.0 109.686 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.903 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 92.3 t -103.62 129.19 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 109.773 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.889 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 3.8 ttpm? -109.09 130.85 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.783 -0.573 . . . . 0.0 109.833 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.901 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 10.8 pt -126.25 145.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.788 -0.57 . . . . 0.0 110.178 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.844 ' HB3' HG12 ' A' ' 43' ' ' VAL . 3.9 pt20 -149.01 171.02 17.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.247 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.441 HD22 ' O ' ' B' ' 26' ' ' GLN . 1.8 tp -111.9 169.81 8.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 109.721 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.33 57.03 3.79 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.43 -0.793 . . . . 0.0 110.704 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -101.1 136.2 41.34 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.523 -0.736 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -122.25 88.15 48.47 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.468 -0.77 . . . . 0.0 111.076 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -63.39 97.56 0.21 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.325 1.171 . . . . 0.0 109.829 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.48 92.29 3.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 110.348 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.826 179.782 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.166 0.508 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.5 t -122.36 150.69 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.55 -0.719 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.569 ' CB ' HG22 ' B' ' 36' ' ' THR . 1.2 pt-20 -156.27 142.94 18.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.491 -0.756 . . . . 0.0 110.736 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.61 166.86 29.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.8 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.0 mt -119.65 126.4 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.478 -0.764 . . . . 0.0 110.226 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.451 HG22 ' N ' ' A' ' 8' ' ' LYS . 12.3 p -127.46 167.3 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.56 -0.712 . . . . 0.0 110.072 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 7' ' ' VAL . 6.9 ttmt -116.29 138.18 51.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.479 -0.763 . . . . 0.0 110.43 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 10' ' ' SER . 59.1 t -78.04 167.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 109.483 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' B' ' 29' ' ' GLU . 11.5 t -170.2 -66.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.33 -0.856 . . . . 0.0 111.164 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . 3.6 mtt180 -58.08 -166.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.612 -0.68 . . . . 0.0 110.765 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -66.56 76.01 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.674 -0.641 . . . . 0.0 110.801 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 51.84 30.0 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.262 -0.899 . . . . 0.0 111.521 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 11' ' ' ARG . 28.3 mt-30 -89.29 150.61 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.46 -0.775 . . . . 0.0 109.946 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.3 t -121.72 142.56 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 110.693 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.66 132.77 55.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 109.573 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.57 131.25 28.62 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.43 -0.794 . . . . 0.0 109.829 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.04 150.16 74.89 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.044 1.023 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.61 63.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.548 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -67.29 -45.75 75.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.542 -0.724 . . . . 0.0 109.839 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.8 -41.05 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -65.48 -33.6 76.32 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -42.14 96.77 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -80.45 -68.79 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.87 ' CE1' HG23 ' B' ' 44' ' ' VAL . 2.5 t80 -64.17 126.1 26.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.721 -0.612 . . . . 0.0 110.596 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.5 112.06 17.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.581 -0.699 . . . . 0.0 109.294 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 27' ' ' ILE . 4.3 tt -154.04 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.73 0.776 . . . . 0.0 109.452 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HA ' ' CE1' ' B' ' 13' ' ' TYR . 25.8 mttm -101.51 -170.9 1.89 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.429 -0.794 . . . . 0.0 111.438 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' B' ' 10' ' ' SER . 5.2 tt0 -74.21 139.84 44.67 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.279 0.562 . . . . 0.0 110.785 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.68 28.22 65.67 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.5 159.72 15.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -1.028 . . . . 0.0 110.283 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 64.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 110.054 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.409 HG13 HG13 ' B' ' 7' ' ' VAL . 9.9 p -75.01 150.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.743 . . . . 0.0 110.265 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' B' ' 5' ' ' GLU . 32.4 tttt -127.87 136.12 50.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 110.297 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 46' ' ' ILE . 57.8 t -107.69 129.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.665 -0.647 . . . . 0.0 109.824 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.562 HG22 ' CB ' ' B' ' 4' ' ' GLU . 65.4 p -137.88 147.45 44.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.757 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -115.21 144.72 43.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.676 -0.64 . . . . 0.0 109.332 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.35 -174.22 2.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.44 42.01 2.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.561 -0.712 . . . . 0.0 110.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.36 -52.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 110.56 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -115.41 -61.61 1.72 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.745 . . . . 0.0 110.344 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.32 59.18 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' B' ' 47' ' ' GLN . 32.9 m -140.78 149.54 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.569 -0.959 . . . . 0.0 110.145 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.863 HG23 ' CE1' ' B' ' 25' ' ' PHE . 51.1 t -103.28 133.17 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.392 -0.817 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 2.8 ttpt -109.42 136.63 48.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.727 -0.608 . . . . 0.0 110.036 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.555 HG22 ' HA ' ' A' ' 35' ' ' VAL . 5.3 pt -131.45 150.25 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.401 -0.812 . . . . 0.0 111.21 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.428 ' HB3' HG12 ' B' ' 43' ' ' VAL . 28.1 pt20 -145.35 -167.9 2.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 0.0 109.594 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.61 HD11 HD12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -138.45 -88.88 0.23 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.256 -0.903 . . . . 0.0 111.191 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.54 -172.2 1.19 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.089 . . . . 0.0 110.81 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.02 -20.56 4.89 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.628 -0.67 . . . . 0.0 111.31 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 55.51 74.94 0.65 Allowed Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.056 -1.027 . . . . 0.0 111.085 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -81.39 154.89 18.76 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.374 1.197 . . . . 0.0 110.115 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.19 44.42 2.95 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.491 -0.756 . . . . 0.0 110.136 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 118.106 -0.949 . . . . 0.0 109.917 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.026 0.441 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 66.4 t -122.13 150.98 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.654 -0.654 . . . . 0.0 109.652 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.562 ' CB ' HG22 ' A' ' 36' ' ' THR . 1.2 pt-20 -156.65 142.77 18.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.722 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 2.5 mp0 -151.46 166.93 29.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.588 -0.695 . . . . 0.0 109.837 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.1 mt -119.58 126.62 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.513 -0.742 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.45 HG22 ' N ' ' B' ' 8' ' ' LYS . 13.9 p -127.64 167.06 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.558 -0.714 . . . . 0.0 110.171 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.45 ' N ' HG22 ' B' ' 7' ' ' VAL . 6.9 ttmt -116.28 138.13 51.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.527 -0.733 . . . . 0.0 110.468 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.465 HG12 ' N ' ' B' ' 10' ' ' SER . 58.7 t -78.1 167.67 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.471 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.511 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 11.2 t -170.21 -65.96 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' B' ' 14' ' ' GLN . 3.6 mtt180 -58.01 -166.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -66.52 76.0 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.66 . . . . 0.0 110.871 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 28' ' ' LYS . 92.0 m-85 51.93 29.89 6.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.433 -0.792 . . . . 0.0 111.52 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' B' ' 11' ' ' ARG . 28.3 mt-30 -89.07 150.64 22.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.99 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.91 142.5 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.618 -0.676 . . . . 0.0 110.676 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.61 132.78 55.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.731 -0.606 . . . . 0.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 59.4 mt -96.62 131.19 28.69 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.585 -0.697 . . . . 0.0 109.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.79 150.07 73.5 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.079 1.042 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.67 -30.68 63.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.474 -0.766 . . . . 0.0 110.496 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -67.3 -45.74 75.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.514 -0.741 . . . . 0.0 109.773 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 65.5 t -62.83 -41.17 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.469 -0.769 . . . . 0.0 109.001 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -65.26 -33.72 76.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.696 -0.627 . . . . 0.0 109.365 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -80.47 -68.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.863 ' CE1' HG23 ' A' ' 44' ' ' VAL . 2.5 t80 -64.42 126.21 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.688 -0.633 . . . . 0.0 110.524 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 112.09 17.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 109.327 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.638 ' O ' HG23 ' B' ' 27' ' ' ILE . 5.2 tt -154.16 91.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.76 0.79 . . . . 0.0 109.509 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -101.49 -170.92 1.9 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 111.543 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 10' ' ' SER . 5.2 tt0 -74.07 139.75 44.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.799 -0.563 . . . . 0.0 110.868 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.48 28.54 65.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.61 159.76 15.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -1.0 . . . . 0.0 110.238 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.46 64.78 1.88 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.06 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.43 HG13 HG13 ' A' ' 7' ' ' VAL . 10.1 p -75.12 150.74 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.618 -0.676 . . . . 0.0 110.25 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 31.9 tttt -127.82 136.01 50.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' B' ' 46' ' ' ILE . 58.3 t -107.66 130.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.827 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.569 HG22 ' CB ' ' A' ' 4' ' ' GLU . 65.5 p -137.96 147.32 44.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 110.894 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -115.06 144.67 43.27 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.24 -174.13 2.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 110.303 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.47 42.05 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.448 -0.782 . . . . 0.0 110.056 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.4 -52.13 1.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.526 -0.734 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -115.61 -61.79 1.69 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.558 -0.714 . . . . 0.0 110.241 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.35 59.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.428 HG12 ' HB3' ' A' ' 47' ' ' GLN . 32.7 m -140.72 149.46 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.621 -0.929 . . . . 0.0 110.13 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.87 HG23 ' CE1' ' A' ' 25' ' ' PHE . 50.4 t -103.2 132.98 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 110.119 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.8 ttpt -109.26 136.52 48.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.658 -0.651 . . . . 0.0 110.135 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' B' ' 35' ' ' VAL . 5.3 pt -131.29 150.11 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.455 -0.778 . . . . 0.0 111.261 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.416 ' HB3' HG12 ' A' ' 43' ' ' VAL . 28.0 pt20 -145.1 -167.8 2.77 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.585 -0.697 . . . . 0.0 109.654 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.553 HD11 HD12 ' B' ' 27' ' ' ILE . 0.3 OUTLIER -138.4 -88.87 0.23 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.238 -0.914 . . . . 0.0 111.337 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.59 -172.25 1.19 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.953 -1.092 . . . . 0.0 110.854 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.03 -20.51 4.91 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.622 -0.674 . . . . 0.0 111.263 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 55.42 74.97 0.64 Allowed Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 121.083 -1.011 . . . . 0.0 111.026 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -81.4 154.97 18.76 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.283 1.149 . . . . 0.0 110.131 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.3 44.43 2.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.395 -0.815 . . . . 0.0 110.086 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.911 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.146 0.498 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.2 m -123.64 152.7 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.554 -0.716 . . . . 0.0 109.572 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.495 ' CB ' HG22 ' B' ' 36' ' ' THR . 8.0 pt-20 -144.06 153.91 42.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.783 . . . . 0.0 111.046 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -134.06 147.16 50.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.696 HG23 HD21 ' B' ' 32' ' ' LEU . 89.3 mt -111.28 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 110.677 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.17 151.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.65 12.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.526 -0.733 . . . . 0.0 110.72 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.86 HG23 ' O ' ' B' ' 31' ' ' ASP . 76.4 t -75.45 142.29 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.758 -0.589 . . . . 0.0 109.916 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -172.78 3.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 110.0 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 56.58 -86.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.712 -0.617 . . . . 0.0 110.526 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.1 78.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.926 -1.109 . . . . 0.0 109.043 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.79 14.62 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.368 -0.833 . . . . 0.0 109.83 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.06 157.16 26.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.604 -0.685 . . . . 0.0 110.823 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.94 138.47 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.655 -0.653 . . . . 0.0 109.385 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -120.78 152.81 37.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.497 -0.752 . . . . 0.0 110.886 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -97.3 119.59 62.73 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.708 -0.62 . . . . 0.0 109.5 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.21 -174.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.067 1.035 . . . . 0.0 110.622 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.49 25.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.564 -0.71 . . . . 0.0 110.44 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -48.4 42.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 109.982 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.24 -41.63 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.655 -0.653 . . . . 0.0 109.426 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.74 -38.29 81.33 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -36.02 81.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.596 -0.69 . . . . 0.0 109.757 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -76.45 -69.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.934 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.4 OUTLIER -65.02 149.9 49.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.645 -0.66 . . . . 0.0 109.923 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.88 -80.25 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.752 . . . . 0.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' A' ' 25' ' ' PHE . 94.9 mt 50.18 88.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.144 -0.972 . . . . 0.0 110.947 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.637 ' O ' HG11 ' B' ' 9' ' ' VAL . 11.7 tptt -109.34 168.09 9.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.589 -0.694 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -69.35 123.7 21.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.587 -0.696 . . . . 0.0 110.024 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.497 ' H ' ' HB ' ' B' ' 9' ' ' VAL . . . 85.47 37.51 9.63 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.884 ' O ' HG23 ' B' ' 9' ' ' VAL . 2.6 m-20 -115.53 133.03 56.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.528 -0.984 . . . . 0.0 110.193 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HG23 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -69.19 112.25 5.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 48' ' ' LEU . 59.9 t -107.62 151.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.593 -0.692 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -125.0 128.09 48.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.21 128.79 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.483 HG22 ' CB ' ' B' ' 4' ' ' GLU . 69.2 p -136.65 153.0 51.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.257 -0.902 . . . . 0.0 111.872 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 36.6 t80 -124.95 143.79 50.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -117.55 155.96 28.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.438 -0.789 . . . . 0.0 110.894 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -101.37 19.92 16.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.78 -0.575 . . . . 0.0 110.703 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -118.61 -28.48 5.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 110.601 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -105.41 -58.89 1.84 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.402 -0.811 . . . . 0.0 110.296 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.84 33.17 2.68 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' B' ' 47' ' ' GLN . 33.9 m -141.48 162.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.676 -0.896 . . . . 0.0 109.938 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.917 HG23 ' CE2' ' B' ' 25' ' ' PHE . 37.0 t -112.04 123.85 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.33 -0.856 . . . . 0.0 109.981 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 1.5 ttpm? -105.39 150.37 25.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.837 -0.54 . . . . 0.0 109.813 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.885 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.7 pp -136.98 155.86 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.833 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.641 ' HB3' HG12 ' B' ' 43' ' ' VAL . 1.8 pt20 -154.98 -174.78 5.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.904 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -139.08 25.12 2.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.492 -0.755 . . . . 0.0 110.68 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -164.73 148.09 8.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.347 -0.846 . . . . 0.0 110.348 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -170.38 -42.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.517 -0.739 . . . . 0.0 110.215 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.37 64.8 39.92 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.547 -0.721 . . . . 0.0 110.239 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -60.53 124.34 14.89 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 123.253 1.133 . . . . 0.0 110.5 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -141.85 -44.71 0.35 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.446 -0.784 . . . . 0.0 110.15 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.074 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.155 0.502 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.64 152.73 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.51 -0.744 . . . . 0.0 109.552 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.483 ' CB ' HG22 ' A' ' 36' ' ' THR . 8.0 pt-20 -144.1 153.81 42.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.386 -0.821 . . . . 0.0 111.009 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.87 147.14 51.12 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.658 HG23 HD21 ' A' ' 32' ' ' LEU . 89.2 mt -111.24 116.03 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.739 . . . . 0.0 110.679 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.29 151.15 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.63 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 31' ' ' ASP . 69.0 t -75.43 142.18 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.754 -0.591 . . . . 0.0 109.981 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.9 t -159.22 -172.71 3.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.694 . . . . 0.0 109.93 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 56.46 -86.39 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.686 -0.634 . . . . 0.0 110.52 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.19 78.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.045 -1.035 . . . . 0.0 109.17 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.76 14.68 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.344 -0.848 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -117.08 157.15 26.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.582 -0.699 . . . . 0.0 110.786 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -137.9 138.28 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.746 -0.596 . . . . 0.0 109.459 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.5 p -120.62 152.74 37.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 0.0 110.916 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -97.21 119.56 62.93 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.791 -0.568 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.16 -174.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.06 1.031 . . . . 0.0 110.591 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.56 25.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.704 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -48.18 44.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.49 -41.5 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.555 -0.715 . . . . 0.0 109.466 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.64 -38.28 80.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.564 -0.71 . . . . 0.0 109.712 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -36.08 82.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.57 -0.706 . . . . 0.0 109.639 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -76.51 -69.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.781 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.917 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -65.33 150.0 49.02 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 109.887 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.96 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.538 -0.726 . . . . 0.0 109.906 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' B' ' 25' ' ' PHE . 94.9 mt 50.14 88.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.262 -0.899 . . . . 0.0 110.97 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.638 ' O ' HG11 ' A' ' 9' ' ' VAL . 11.8 tptt -109.4 168.05 9.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.601 -0.687 . . . . 0.0 110.071 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -69.37 123.75 22.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.738 . . . . 0.0 110.077 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.498 ' H ' ' HB ' ' A' ' 9' ' ' VAL . . . 85.64 37.32 9.62 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.6 m-20 -115.61 132.9 56.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.588 -0.948 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -69.01 112.41 5.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.522 -0.737 . . . . 0.0 110.022 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.59 151.15 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -124.96 127.8 47.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.324 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -114.99 128.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.495 HG22 ' CB ' ' A' ' 4' ' ' GLU . 71.3 p -136.53 152.94 51.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 111.863 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.62 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 37.1 t80 -124.83 143.62 50.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -117.43 155.84 28.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.482 -0.761 . . . . 0.0 110.868 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -101.46 19.97 16.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.736 -0.603 . . . . 0.0 110.69 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -118.57 -28.7 5.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.358 -0.839 . . . . 0.0 110.616 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -105.36 -58.75 1.85 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.504 -0.747 . . . . 0.0 110.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.77 33.22 2.69 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.0 m -141.48 162.69 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.954 . . . . 0.0 109.831 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.934 HG23 ' CE2' ' A' ' 25' ' ' PHE . 37.8 t -112.11 123.67 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 0.0 109.922 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.5 ttpm? -105.45 150.08 25.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.713 -0.617 . . . . 0.0 109.874 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.861 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.7 pp -136.6 155.96 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.56 -0.713 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.631 ' HB3' HG12 ' A' ' 43' ' ' VAL . 1.8 pt20 -154.92 -174.73 5.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.79 -0.569 . . . . 0.0 110.042 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.439 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.2 OUTLIER -138.97 25.1 2.54 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.436 -0.79 . . . . 0.0 110.713 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.439 HD12 ' O ' ' B' ' 48' ' ' LEU . 0.2 OUTLIER -164.77 148.05 8.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.332 -0.855 . . . . 0.0 110.292 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -170.31 -42.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.51 -0.744 . . . . 0.0 110.164 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.24 64.81 40.99 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.494 -0.754 . . . . 0.0 110.215 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.36 124.3 14.86 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.389 1.205 . . . . 0.0 110.484 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -141.99 -44.57 0.34 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.526 -0.734 . . . . 0.0 110.255 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.054 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.121 0.486 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.96 126.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.596 -0.69 . . . . 0.0 109.848 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.87 147.57 51.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.616 -0.678 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.17 146.38 18.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.708 . . . . 0.0 110.311 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 pt -112.62 150.35 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.63 -0.669 . . . . 0.0 110.218 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.6 m -136.52 150.6 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.625 -0.672 . . . . 0.0 110.267 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -94.06 138.04 32.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.136 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.537 HG11 ' O ' ' B' ' 28' ' ' LYS . 60.6 t -77.04 145.05 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 110.096 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -158.1 -55.4 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.579 -0.701 . . . . 0.0 110.219 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -168.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.666 -0.646 . . . . 0.0 110.033 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -77.93 67.84 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.51 -0.744 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.475 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 93.7 m-85 53.29 45.33 28.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -0.771 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.03 174.24 6.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.488 -0.758 . . . . 0.0 109.53 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.36 153.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.678 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.568 ' O ' HG23 ' A' ' 16' ' ' THR . 7.1 t -150.18 115.31 5.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.829 -0.545 . . . . 0.0 109.536 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.1 mt -71.73 143.01 86.55 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.545 -0.722 . . . . 0.0 110.204 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -61.23 -175.81 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.001 0 O-C-N 123.201 1.106 . . . . 0.0 110.216 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.07 -29.96 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 110.199 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.54 -48.26 49.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.539 -0.726 . . . . 0.0 110.012 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.43 -45.42 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.55 -0.719 . . . . 0.0 109.477 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.66 -32.31 73.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.513 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -63.61 -36.12 82.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 109.535 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -78.86 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.794 -0.566 . . . . 0.0 109.767 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.864 ' CE2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.47 159.58 6.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -80.72 -82.82 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.379 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.414 ' O ' ' HE2' ' B' ' 13' ' ' TYR . 45.3 mt 51.28 87.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.167 -0.958 . . . . 0.0 110.519 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' O ' HG11 ' B' ' 9' ' ' VAL . 29.8 mtmt -107.05 -171.45 1.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.525 -0.734 . . . . 0.0 110.515 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -79.67 137.01 36.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.478 ' N ' ' HB ' ' B' ' 9' ' ' VAL . . . 58.45 44.09 95.51 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.953 . . . . 0.0 110.113 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.77 2.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 110.609 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.749 HG13 HD11 ' A' ' 46' ' ' ILE . 64.9 t -67.26 133.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 109.218 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -125.07 129.25 49.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.452 -0.78 . . . . 0.0 110.975 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 46' ' ' ILE . 61.7 t -123.72 129.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -138.17 148.38 44.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.375 -0.828 . . . . 0.0 111.235 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.87 ' CE1' ' CE2' ' B' ' 25' ' ' PHE . 47.9 t80 -113.92 135.65 53.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.32 162.7 12.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.762 . . . . 0.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.37 32.62 4.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.3 p -118.7 -60.69 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 110.102 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -87.03 -50.14 6.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 0.0 110.151 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.61 36.5 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.805 HG21 ' HD3' ' B' ' 45' ' ' LYS . 35.2 m -133.27 159.68 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -1.01 . . . . 0.0 110.342 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.004 ' HB ' ' CG2' ' B' ' 46' ' ' ILE . 45.6 t -103.23 127.51 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.667 . . . . 0.0 109.403 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.83 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 14.5 ttmt -112.13 125.54 54.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.632 . . . . 0.0 110.571 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.029 ' CG2' ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -113.04 138.66 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.687 . . . . 0.0 109.489 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.838 ' N ' HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -151.08 171.86 16.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.708 -0.62 . . . . 0.0 109.971 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.25 -157.95 0.67 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 50' ' ' LYS . 1.1 tt -61.8 142.18 57.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.47 -0.769 . . . . 0.0 109.601 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.516 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -101.51 -64.22 1.07 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.424 -0.797 . . . . 0.0 110.995 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -135.85 96.88 12.88 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.435 -0.791 . . . . 0.0 111.348 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HG3' HD22 ' A' ' 49' ' ' LEU . 9.1 Cg_exo -68.84 122.9 9.83 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.422 1.222 . . . . 0.0 109.615 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -97.53 54.34 1.18 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.433 -0.792 . . . . 0.0 110.467 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.028 179.724 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.175 0.512 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.76 126.43 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.531 -0.731 . . . . 0.0 109.957 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -129.9 147.63 51.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.23 146.22 18.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.321 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.45 150.2 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.567 -0.708 . . . . 0.0 110.195 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.41 150.56 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.488 -0.757 . . . . 0.0 110.254 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.98 138.02 32.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.683 . . . . 0.0 110.2 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 28' ' ' LYS . 59.7 t -77.0 144.93 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.576 -0.703 . . . . 0.0 110.175 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -157.99 -55.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.591 -0.693 . . . . 0.0 110.278 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -168.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 0.0 110.112 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -78.08 67.92 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.717 . . . . 0.0 110.107 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.503 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 93.8 m-85 53.29 45.4 28.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 111.184 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.18 174.16 6.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.26 153.16 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.401 -0.812 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.574 ' O ' HG23 ' B' ' 16' ' ' THR . 7.2 t -150.22 115.22 5.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.68 -0.638 . . . . 0.0 109.508 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 80.9 mt -71.74 143.11 86.65 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.504 -0.748 . . . . 0.0 110.224 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.3 -175.91 0.15 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 O-C-N 123.1 1.053 . . . . 0.0 110.055 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.08 -29.74 24.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.582 -0.698 . . . . 0.0 110.242 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.65 -48.16 49.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.535 -0.728 . . . . 0.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.43 -45.48 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 0.0 109.492 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -65.71 -32.23 73.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.635 . . . . 0.0 109.562 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -63.62 -36.09 82.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.679 . . . . 0.0 109.474 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -79.03 -62.62 1.64 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.722 -0.611 . . . . 0.0 109.774 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.73 159.57 6.6 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.735 . . . . 0.0 110.015 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -80.69 -82.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.483 -0.76 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' B' ' 25' ' ' PHE . 45.5 mt 51.25 87.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.063 -1.023 . . . . 0.0 110.486 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.537 ' O ' HG11 ' A' ' 9' ' ' VAL . 29.8 mtmt -107.19 -171.35 1.87 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.578 -0.702 . . . . 0.0 110.497 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -79.69 136.98 36.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.485 ' N ' ' HB ' ' A' ' 9' ' ' VAL . . . 58.44 44.15 95.45 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.944 . . . . 0.0 110.142 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.57 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 110.684 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.744 HG13 HD11 ' B' ' 46' ' ' ILE . 62.1 t -66.95 133.71 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.486 -0.758 . . . . 0.0 109.344 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -125.16 129.27 49.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -0.758 . . . . 0.0 111.04 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.674 HG22 HG12 ' B' ' 46' ' ' ILE . 62.0 t -123.74 129.28 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -138.19 148.42 44.82 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.402 -0.811 . . . . 0.0 111.272 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 25' ' ' PHE . 48.2 t80 -113.92 135.62 53.78 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.34 162.62 13.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.596 -0.69 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.34 32.6 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.627 -0.671 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.7 p -118.6 -60.62 1.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.619 -0.676 . . . . 0.0 110.069 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.15 -50.1 6.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.41 2.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.83 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 35.3 m -133.25 159.7 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.536 -0.979 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 1.029 ' HB ' ' CG2' ' A' ' 46' ' ' ILE . 45.9 t -103.26 127.51 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.527 -0.733 . . . . 0.0 109.409 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.808 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 14.8 ttmt -112.08 125.32 53.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.671 -0.643 . . . . 0.0 110.552 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 1.004 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -112.79 138.6 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.654 -0.654 . . . . 0.0 109.542 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.832 ' N ' HD13 ' B' ' 46' ' ' ILE . 0.2 OUTLIER -151.04 171.86 16.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.203 0.525 . . . . 0.0 109.916 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.17 -157.9 0.67 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.529 HD23 ' N ' ' B' ' 50' ' ' LYS . 1.0 OUTLIER -61.79 142.13 57.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.37 -0.831 . . . . 0.0 109.633 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 50' ' ' LYS . . . . . 0.529 ' N ' HD23 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -101.4 -64.33 1.06 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.516 -0.74 . . . . 0.0 111.014 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -135.81 96.8 12.98 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.477 -0.765 . . . . 0.0 111.429 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.445 ' HG3' HD22 ' B' ' 49' ' ' LEU . 9.9 Cg_exo -68.84 122.82 9.75 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.36 1.189 . . . . 0.0 109.688 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -97.41 54.24 1.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.5 -0.75 . . . . 0.0 110.477 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.019 179.63 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.79 119.83 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -0.75 . . . . 0.0 109.559 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -120.35 126.61 50.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 0.0 110.876 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.58 152.15 45.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.666 -0.646 . . . . 0.0 109.334 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.93 134.01 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.443 -0.786 . . . . 0.0 110.526 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.49 148.91 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 0.0 109.42 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.59 179.99 3.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 110.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.852 HG21 ' HB3' ' B' ' 31' ' ' ASP . 57.6 t -106.75 165.43 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.614 -0.679 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.444 ' N ' HG12 ' A' ' 9' ' ' VAL . 77.1 p -102.87 -163.64 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.516 -0.74 . . . . 0.0 110.249 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.718 ' HG2' ' OE2' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -102.02 -25.34 13.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.748 . . . . 0.0 110.337 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.93 29.85 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 0.0 110.442 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.559 ' HE1' ' HA ' ' B' ' 28' ' ' LYS . 64.4 m-85 52.39 25.81 3.72 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.443 -0.786 . . . . 0.0 110.983 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -104.33 151.28 23.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.515 -0.741 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.93 146.07 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.594 -0.691 . . . . 0.0 110.114 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.5 p -110.72 123.94 51.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.689 -0.632 . . . . 0.0 109.756 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.7 mt -66.39 116.34 32.93 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.743 . . . . 0.0 109.711 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.3 169.17 4.11 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.156 1.082 . . . . 0.0 110.477 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.14 68.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.572 -0.705 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.85 -59.83 4.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.431 -0.793 . . . . 0.0 110.312 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.91 -40.78 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.379 -0.826 . . . . 0.0 109.22 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.32 -29.97 68.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.717 -0.614 . . . . 0.0 109.549 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -45.66 56.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.65 -69.13 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.661 -0.649 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.685 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.3 OUTLIER -73.44 151.3 41.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 109.659 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -81.37 -81.28 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.209 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 25' ' ' PHE . 15.5 mt 54.49 93.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HA ' ' HE1' ' B' ' 13' ' ' TYR . 0.2 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 0.0 110.453 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.717 ' OE2' ' HG2' ' B' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.82 27.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.711 . . . . 0.0 110.411 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.34 50.9 4.87 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.847 ' HB3' HG21 ' B' ' 9' ' ' VAL . 3.2 t70 -110.06 155.68 21.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.487 -1.008 . . . . 0.0 110.266 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.29 52.34 0.84 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 109.706 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 46' ' ' ILE . 35.9 m -61.12 170.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 0.0 110.404 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.3 122.03 7.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.69 144.31 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 109.141 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.9 p -138.79 150.53 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.218 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.7 t80 -134.46 147.13 50.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -122.04 178.45 4.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -0.785 . . . . 0.0 110.457 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.01 44.26 2.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.9 p -147.18 -52.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.017 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -40.43 21.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.732 -0.605 . . . . 0.0 109.754 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 32.96 17.51 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.765 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 33.0 m -131.61 156.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.05 ' HB ' HG22 ' B' ' 46' ' ' ILE . 56.3 t -104.2 133.81 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.506 -0.746 . . . . 0.0 109.455 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.766 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 0.2 OUTLIER -112.47 129.49 56.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.754 -0.591 . . . . 0.0 110.263 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.039 HG22 ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -123.51 139.44 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 109.861 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.862 ' N ' HD13 ' A' ' 46' ' ' ILE . 3.4 pm0 -158.62 -175.33 5.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 110.139 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' CD1' HG12 ' A' ' 33' ' ' VAL . 1.4 mp -107.69 -163.06 0.87 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.19 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.1 tp -61.64 119.73 9.23 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.677 -0.64 . . . . 0.0 110.322 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.42 -168.27 2.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.666 -0.647 . . . . 0.0 109.496 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.0 137.43 46.58 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.397 -0.814 . . . . 0.0 110.13 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -69.79 79.57 0.95 Allowed 'Trans proline' 0 N--CA 1.486 1.033 0 O-C-N 123.248 1.131 . . . . 0.0 110.196 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -61.97 -30.02 70.64 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.743 . . . . 0.0 110.16 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.272 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.202 0.525 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.85 119.9 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -120.43 126.59 50.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.477 -0.764 . . . . 0.0 110.979 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.51 152.08 45.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.674 -0.641 . . . . 0.0 109.303 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.82 134.04 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.531 -0.731 . . . . 0.0 110.537 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.9 t -137.44 148.96 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.714 -0.616 . . . . 0.0 109.485 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.76 179.9 3.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.431 -0.793 . . . . 0.0 110.326 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 31' ' ' ASP . 58.0 t -106.77 165.55 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.586 -0.696 . . . . 0.0 110.182 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.429 ' N ' HG12 ' B' ' 9' ' ' VAL . 78.0 p -102.92 -163.67 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.537 -0.727 . . . . 0.0 110.237 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.717 ' HG2' ' OE2' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -102.05 -25.33 13.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.611 -0.681 . . . . 0.0 110.255 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.92 29.8 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.456 -0.778 . . . . 0.0 110.374 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.583 ' HE1' ' HA ' ' A' ' 28' ' ' LYS . 64.5 m-85 52.35 25.74 3.65 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.463 -0.773 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.23 151.32 23.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.687 . . . . 0.0 109.883 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.99 146.07 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.601 -0.687 . . . . 0.0 110.159 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -110.77 123.95 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.36 116.28 32.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.29 169.03 4.21 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.143 1.075 . . . . 0.0 110.545 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.08 68.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 0.0 110.227 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -59.88 4.72 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.498 -0.751 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 109.229 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.27 -29.97 67.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -45.69 56.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.69 -68.97 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.635 -0.666 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.687 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -73.68 151.34 40.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.613 -0.679 . . . . 0.0 109.572 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -81.31 -81.4 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 111.22 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' B' ' 25' ' ' PHE . 15.5 mt 54.66 93.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.044 -1.035 . . . . 0.0 110.049 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.564 ' O ' HG11 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.612 -0.68 . . . . 0.0 110.436 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.718 ' OE2' ' HG2' ' A' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.79 27.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 110.358 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.45 50.88 4.86 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.852 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.2 t70 -110.13 155.64 21.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -1.034 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.25 52.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.489 -0.757 . . . . 0.0 109.865 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.604 ' HB ' HD11 ' B' ' 46' ' ' ILE . 35.7 m -60.9 170.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.605 -0.685 . . . . 0.0 110.481 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.18 122.19 7.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.685 -0.635 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 62.8 t -98.85 144.25 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.488 -0.758 . . . . 0.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -138.75 150.66 46.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.419 -0.8 . . . . 0.0 111.151 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.685 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 35.8 t80 -134.64 147.05 50.09 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -121.92 178.54 4.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.457 -0.777 . . . . 0.0 110.485 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.1 44.33 2.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.169 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 85.6 p -147.32 -52.12 0.2 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.971 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.44 -40.45 21.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.85 17.71 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.766 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 32.9 m -131.53 156.95 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -1.041 . . . . 0.0 110.337 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 1.039 ' HB ' HG22 ' A' ' 46' ' ' ILE . 53.4 t -104.17 133.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.495 -0.753 . . . . 0.0 109.525 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.765 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -112.42 129.34 56.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 -179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 1.05 HG22 ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.25 139.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.575 -0.703 . . . . 0.0 109.921 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.86 ' N ' HD13 ' B' ' 46' ' ' ILE . 3.4 pm0 -158.73 -175.46 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.171 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.41 ' CD1' HG12 ' B' ' 33' ' ' VAL . 1.4 mp -107.64 -163.0 0.86 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 17.0 tp -61.73 119.68 9.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.651 -0.656 . . . . 0.0 110.371 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.35 -168.31 2.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.682 -0.636 . . . . 0.0 109.609 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -81.89 137.35 46.97 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.438 -0.789 . . . . 0.0 110.141 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -69.81 79.8 0.94 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.22 1.116 . . . . 0.0 110.157 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -62.23 -30.01 70.79 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.633 -0.667 . . . . 0.0 110.044 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.307 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.2 0.524 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.8 164.87 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.451 -0.781 . . . . 0.0 110.498 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.597 ' HA ' HG22 ' B' ' 36' ' ' THR . 1.9 tm-20 -131.76 146.74 52.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.809 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.33 162.17 39.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.455 ' C ' HG13 ' A' ' 7' ' ' VAL . 2.4 pp -141.21 136.23 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.639 . . . . 0.0 109.861 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.455 HG13 ' C ' ' A' ' 6' ' ' ILE . 35.9 m -148.68 157.49 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 150.4 44.3 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.736 -0.602 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 31' ' ' ASP . 59.8 t -85.85 163.54 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.434 -0.791 . . . . 0.0 109.656 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -88.86 170.27 10.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.504 -0.748 . . . . 0.0 109.695 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -39.71 77.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -96.85 41.61 1.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.501 -0.749 . . . . 0.0 110.812 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 59.4 m-85 51.35 24.84 2.28 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.387 -0.821 . . . . 0.0 111.476 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.84 159.57 27.76 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.423 -0.798 . . . . 0.0 109.231 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.63 155.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.417 -0.802 . . . . 0.0 110.681 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.7 m -141.32 113.55 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -78.25 130.79 70.93 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.723 . . . . 0.0 110.03 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' A' ' 21' ' ' VAL . 23.0 Cg_exo -55.79 -173.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.101 1.053 . . . . 0.0 110.605 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.48 -28.41 16.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.539 -0.726 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -59.24 3.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.53 -0.731 . . . . 0.0 110.915 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 18' ' ' PRO . 27.0 m -63.6 -33.76 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -61.97 -37.29 84.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -68.9 -35.26 76.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.576 -0.702 . . . . 0.0 109.232 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -73.33 0.15 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.903 ' HD2' ' CD1' ' B' ' 37' ' ' PHE . 0.7 OUTLIER -60.5 158.63 11.83 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.592 -0.693 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -81.01 -84.12 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.394 -0.816 . . . . 0.0 110.855 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt 53.17 92.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.013 -1.054 . . . . 0.0 110.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -104.13 -170.53 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.695 -0.628 . . . . 0.0 110.818 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.59 126.49 35.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.738 -0.601 . . . . 0.0 110.164 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.1 45.36 15.85 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' O ' HG23 ' B' ' 9' ' ' VAL . 23.8 t70 -112.67 142.93 44.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.988 . . . . 0.0 110.232 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.82 62.86 4.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.608 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.414 HG12 HD11 ' A' ' 48' ' ' LEU . 27.5 m -53.32 155.88 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.43 -0.794 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -110.23 103.06 11.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.69 -0.631 . . . . 0.0 110.66 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.02 110.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.773 . . . . 0.0 108.933 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.589 HG22 ' HA ' ' B' ' 4' ' ' GLU . 47.2 p -128.14 150.42 49.99 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.562 0.696 . . . . 0.0 111.696 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.911 ' CD1' ' HD2' ' B' ' 25' ' ' PHE . 27.4 t80 -124.63 122.53 37.78 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.8 151.41 24.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 110.361 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.29 20.08 9.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.684 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -46.83 7.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.78 -30.27 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 109.859 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . . . 93.06 47.62 3.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' CG ' ' B' ' 47' ' ' GLN . 33.1 m -140.58 159.63 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.538 -0.978 . . . . 0.0 110.368 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.94 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 31.2 t -100.55 133.97 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.42 123.28 49.07 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.132 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.962 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.9 pt -109.17 134.16 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.803 ' CG ' HG12 ' B' ' 43' ' ' VAL . 54.0 tt0 -149.28 165.81 30.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.504 -0.747 . . . . 0.0 110.52 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -119.37 -41.71 2.7 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.208 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.33 164.12 13.97 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.439 -0.788 . . . . 0.0 110.413 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.63 -171.64 2.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.549 -0.719 . . . . 0.0 109.687 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.28 59.73 8.03 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.804 . . . . 0.0 111.18 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -82.78 121.74 3.32 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.11 1.058 . . . . 0.0 109.922 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.71 -65.88 1.0 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.526 -0.734 . . . . 0.0 110.179 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.412 -179.71 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.106 0.479 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -132.64 164.94 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.54 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.589 ' HA ' HG22 ' A' ' 36' ' ' THR . 1.9 tm-20 -131.82 146.69 52.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.66 -0.65 . . . . 0.0 109.87 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.25 162.01 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.456 -0.778 . . . . 0.0 110.47 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.456 ' C ' HG13 ' B' ' 7' ' ' VAL . 2.4 pp -141.11 136.21 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.688 -0.632 . . . . 0.0 109.871 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.456 HG13 ' C ' ' B' ' 6' ' ' ILE . 35.5 m -148.6 157.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.453 -0.78 . . . . 0.0 110.56 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 150.42 44.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 110.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 31' ' ' ASP . 59.8 t -85.85 163.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 109.657 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.414 ' N ' HG12 ' B' ' 9' ' ' VAL . 0.6 OUTLIER -88.76 170.14 11.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.582 -0.699 . . . . 0.0 109.813 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -39.78 78.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.702 . . . . 0.0 110.502 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -96.84 41.61 1.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.468 -0.77 . . . . 0.0 110.92 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' B' ' 13' ' ' TYR . 58.5 m-85 51.49 24.7 2.34 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.442 -0.786 . . . . 0.0 111.499 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.88 159.41 27.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.396 -0.815 . . . . 0.0 109.094 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.59 155.85 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 0.0 110.687 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.5 m -141.3 113.53 8.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.09 130.99 70.74 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.541 -0.724 . . . . 0.0 110.109 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.402 ' HD2' HG21 ' B' ' 21' ' ' VAL . 22.8 Cg_exo -56.19 -173.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.196 0 O-C-N 123.115 1.061 . . . . 0.0 110.436 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.35 -28.52 16.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.718 . . . . 0.0 110.878 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -59.25 3.03 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.489 -0.757 . . . . 0.0 110.887 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.402 HG21 ' HD2' ' B' ' 18' ' ' PRO . 26.9 m -63.65 -33.58 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -62.1 -37.11 83.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.203 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -69.08 -35.12 76.16 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -73.29 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.911 ' HD2' ' CD1' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -60.58 158.64 11.99 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -81.02 -84.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.362 -0.836 . . . . 0.0 110.856 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 88.0 mt 53.13 92.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.023 -1.048 . . . . 0.0 110.129 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -104.25 -170.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 110.821 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -88.51 126.54 35.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.825 -0.547 . . . . 0.0 110.185 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 45.26 15.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 9' ' ' VAL . 23.7 t70 -112.62 142.83 44.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.95 . . . . 0.0 110.24 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.85 62.95 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.744 -0.597 . . . . 0.0 109.495 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.431 HG12 HD11 ' B' ' 48' ' ' LEU . 28.0 m -53.5 155.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.479 -0.763 . . . . 0.0 110.583 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -110.33 102.95 11.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 110.591 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.84 110.75 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 4' ' ' GLU . 49.6 p -128.12 150.62 49.9 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.645 0.736 . . . . 0.0 111.678 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.903 ' CD1' ' HD2' ' A' ' 25' ' ' PHE . 27.4 t80 -124.77 122.55 37.77 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.81 151.39 24.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.462 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.25 19.97 9.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.72 -46.57 7.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.98 -30.23 7.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.701 -0.624 . . . . 0.0 109.785 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.568 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 93.11 47.49 3.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.803 HG12 ' CG ' ' A' ' 47' ' ' GLN . 33.1 m -140.65 159.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.56 -0.965 . . . . 0.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.962 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 32.4 t -100.49 133.81 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.16 123.23 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 111.317 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.94 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.9 pt -109.3 134.19 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.256 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.787 ' CG ' HG12 ' A' ' 43' ' ' VAL . 54.1 tt0 -149.26 165.81 30.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.683 -0.636 . . . . 0.0 110.611 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.431 HD11 HG12 ' B' ' 33' ' ' VAL . 0.7 OUTLIER -119.45 -41.46 2.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.566 -0.709 . . . . 0.0 110.142 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.39 164.15 13.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.484 -0.76 . . . . 0.0 110.47 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.65 -171.65 2.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.486 -0.759 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.32 59.73 7.98 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.351 -0.843 . . . . 0.0 111.153 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -82.84 121.81 3.31 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.224 1.118 . . . . 0.0 109.884 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -65.9 1.01 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.477 -0.764 . . . . 0.0 110.185 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.434 -179.705 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.18 150.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 110.139 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.95 157.34 44.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.604 -0.685 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.56 143.43 20.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.81 119.78 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.557 -0.714 . . . . 0.0 110.544 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.1 -176.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.474 -0.766 . . . . 0.0 110.139 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.71 163.73 29.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.484 -0.76 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG11 ' O ' ' B' ' 28' ' ' LYS . 59.6 t -74.06 166.08 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.56 -0.712 . . . . 0.0 109.928 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' B' ' 29' ' ' GLU . 15.5 m -107.61 -156.64 0.59 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.468 -0.77 . . . . 0.0 110.514 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HA ' ' OE2' ' B' ' 29' ' ' GLU . 8.2 ttp180 -79.09 -52.38 8.28 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.473 -0.767 . . . . 0.0 110.722 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.41 40.07 1.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 110.802 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.755 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 94.2 m-85 50.73 40.14 23.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.345 -0.847 . . . . 0.0 111.227 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.38 153.96 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.19 132.68 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 0.0 110.246 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.49 85.16 2.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.647 . . . . 0.0 109.631 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 23.0 mt -61.0 145.42 89.34 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.62 -0.675 . . . . 0.0 110.273 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 16.4 Cg_exo -61.9 -159.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.0 0 O-C-N 123.338 1.178 . . . . 0.0 110.367 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.11 -21.09 16.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.0 -55.84 29.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -0.882 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.22 -39.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.594 -0.691 . . . . 0.0 109.683 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -63.82 -32.31 73.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.661 -0.65 . . . . 0.0 109.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -54.1 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.56 -60.82 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.647 -0.658 . . . . 0.0 109.641 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.5 OUTLIER -74.07 128.18 34.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.54 -0.725 . . . . 0.0 110.355 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -78.58 96.97 5.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.517 -0.74 . . . . 0.0 110.104 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.5 mt -132.04 78.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.58 -0.7 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.782 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.3 OUTLIER -87.32 -158.67 0.46 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.653 -0.655 . . . . 0.0 110.606 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' B' ' 10' ' ' SER . 37.1 tt0 -87.41 91.62 8.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.696 -0.628 . . . . 0.0 110.31 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.99 47.24 0.31 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB2' HG21 ' B' ' 9' ' ' VAL . 2.2 m-20 -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.985 . . . . 0.0 110.352 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mp -75.19 81.42 2.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.989 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -87.21 154.0 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.97 131.79 41.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.616 -0.677 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.91 131.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.532 -0.73 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.55 147.96 48.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.414 -0.804 . . . . 0.0 111.22 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.513 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 29.6 t80 -119.63 141.43 49.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -110.71 154.12 24.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.756 . . . . 0.0 110.733 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.41 29.11 7.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.024 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 p -117.91 -35.21 3.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.713 . . . . 0.0 110.305 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.29 -65.82 1.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.493 -0.754 . . . . 0.0 110.26 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.32 42.6 0.27 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.73 ' HB ' ' CG ' ' B' ' 45' ' ' LYS . 34.6 m -133.9 156.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.971 . . . . 0.0 109.665 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.829 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 29.2 t -116.36 115.4 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.838 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.746 ' CG ' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -99.94 146.82 26.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.735 -0.603 . . . . 0.0 109.997 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.83 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 12.9 pt -128.74 155.81 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.679 -0.638 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.411 ' OE1' ' CG1' ' B' ' 43' ' ' VAL . 38.9 tt0 -159.95 160.82 33.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.646 -0.659 . . . . 0.0 110.105 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.85 -67.06 0.87 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.591 -0.693 . . . . 0.0 109.994 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 20.9 tp -91.31 97.16 10.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 110.191 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.99 -29.29 7.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.58 -0.7 . . . . 0.0 110.166 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 52.57 64.14 7.79 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.516 -0.74 . . . . 0.0 111.044 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -77.46 -157.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.211 1.111 . . . . 0.0 109.852 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 54.3 m95 56.07 76.87 0.26 Allowed 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.411 -0.806 . . . . 0.0 110.351 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.9 tptt . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.197 179.898 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.19 150.9 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 110.113 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.85 157.41 44.39 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.549 -0.72 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.62 143.48 20.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.244 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.79 119.97 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.559 -0.713 . . . . 0.0 110.477 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.35 -177.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.72 163.71 29.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.497 -0.752 . . . . 0.0 110.507 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 28' ' ' LYS . 59.2 t -74.07 166.13 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.599 -0.688 . . . . 0.0 109.904 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 15.4 m -107.69 -156.67 0.59 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.44 -0.787 . . . . 0.0 110.449 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.409 ' HA ' ' OE2' ' A' ' 29' ' ' GLU . 8.3 ttp180 -79.05 -52.46 8.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.47 -0.769 . . . . 0.0 110.663 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.3 39.98 1.11 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.782 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 94.2 m-85 50.86 40.04 23.88 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.321 -0.862 . . . . 0.0 111.218 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.35 154.0 19.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.22 132.78 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.573 -0.704 . . . . 0.0 110.205 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.6 85.17 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 109.609 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.01 145.44 89.36 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.647 -0.658 . . . . 0.0 110.204 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.02 -159.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.986 0 O-C-N 123.347 1.183 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.12 -21.19 16.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.714 -0.616 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.02 -56.01 27.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.339 -0.851 . . . . 0.0 110.366 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -62.06 -39.1 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.576 -0.703 . . . . 0.0 109.7 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -63.89 -32.23 73.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.621 -0.674 . . . . 0.0 109.927 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -54.1 25.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.717 . . . . 0.0 109.645 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.42 -60.95 2.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.614 -0.679 . . . . 0.0 109.654 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.562 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -74.03 128.09 34.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.662 -0.649 . . . . 0.0 110.34 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -78.51 97.05 5.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.559 -0.713 . . . . 0.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 88.6 mt -132.14 78.51 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.572 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.755 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -87.37 -158.58 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.763 -0.586 . . . . 0.0 110.553 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' SER . 37.1 tt0 -87.51 91.81 8.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.648 -0.657 . . . . 0.0 110.238 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.76 47.38 0.32 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.412 ' HB2' HG21 ' A' ' 9' ' ' VAL . 2.2 m-20 -111.12 133.9 53.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.971 . . . . 0.0 110.32 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.15 81.53 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.708 -0.62 . . . . 0.0 110.028 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -87.23 153.97 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.563 -0.711 . . . . 0.0 110.392 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.98 131.78 41.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.576 -0.703 . . . . 0.0 110.21 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.95 131.93 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.583 -0.698 . . . . 0.0 109.566 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.69 148.01 48.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 111.237 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 29.8 t80 -119.69 141.41 49.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -110.75 154.04 24.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.29 29.0 7.19 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.626 -0.672 . . . . 0.0 110.094 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 5.4 p -117.79 -35.23 3.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.28 -65.83 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.23 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.28 42.43 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.746 ' HB ' ' CG ' ' A' ' 45' ' ' LYS . 34.6 m -133.78 156.9 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.977 . . . . 0.0 109.704 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.83 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 30.8 t -116.48 115.28 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.291 -0.881 . . . . 0.0 109.986 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.73 ' CG ' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -99.86 146.78 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.811 -0.556 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.829 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 12.7 pt -128.68 155.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.709 -0.62 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -159.88 160.83 34.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.691 -0.63 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.85 -67.07 0.87 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 20.5 tp -91.3 97.11 10.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.602 -0.686 . . . . 0.0 110.216 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -29.34 7.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 110.13 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.401 ' N ' ' HD3' ' B' ' 52' ' ' PRO . 1.8 tt0 52.57 64.23 7.68 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.516 -0.74 . . . . 0.0 111.001 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' B' ' 51' ' ' GLU . 2.3 Cg_endo -77.47 -157.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.123 1.065 . . . . 0.0 109.852 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 54.2 m95 56.1 76.72 0.27 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.38 -0.825 . . . . 0.0 110.39 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 4.8 tptt . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.234 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' N ' ' OE1' ' B' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.063 0.459 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.8 150.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.571 -0.706 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -147.99 116.0 6.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 109.937 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.52 173.96 8.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.47 -0.769 . . . . 0.0 110.641 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.419 HG22 ' HE2' ' B' ' 34' ' ' LYS . 26.8 pt -120.53 130.92 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.685 -0.635 . . . . 0.0 109.894 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' ' 33' ' ' VAL . 33.1 m -131.37 146.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.576 -0.703 . . . . 0.0 110.265 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -103.58 154.21 19.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.39 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.025 ' O ' ' HA2' ' B' ' 30' ' ' GLY . 58.2 t -109.91 142.46 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.584 -0.697 . . . . 0.0 109.58 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.9 p -169.83 -170.52 1.04 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 111.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.93 -86.77 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.697 -0.627 . . . . 0.0 110.984 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.76 55.52 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.061 -1.024 . . . . 0.0 110.579 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HE1' ' C ' ' B' ' 28' ' ' LYS . 71.9 m-85 49.33 47.43 22.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.457 -0.777 . . . . 0.0 111.048 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -112.25 154.15 26.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 110.13 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.92 135.85 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 110.391 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.4 p -108.2 106.87 17.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.782 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.41 126.96 93.0 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.688 . . . . 0.0 109.584 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.86 -77.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.06 1.032 . . . . 0.0 110.645 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.11 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.48 -0.763 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.77 -46.79 86.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.726 -0.609 . . . . 0.0 110.156 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.73 -43.69 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.698 . . . . 0.0 109.343 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.87 -27.66 68.3 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.612 -0.68 . . . . 0.0 110.164 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.04 -39.19 42.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.985 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -79.46 -70.37 0.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.648 . . . . 0.0 109.969 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.972 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.5 OUTLIER -65.65 133.59 51.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.516 -0.74 . . . . 0.0 110.57 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -81.84 87.92 6.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.59 76.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.593 -0.692 . . . . 0.0 109.481 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' C ' ' HE1' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -58.65 168.86 1.07 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.782 -0.574 . . . . 0.0 110.633 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' CE1' ' B' ' 13' ' ' TYR . 0.5 OUTLIER -74.87 72.66 2.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.73 -0.606 . . . . 0.0 110.139 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 1.027 ' HA2' ' O ' ' B' ' 9' ' ' VAL . . . 137.54 45.17 0.08 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.512 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 2.9 m-20 -105.42 147.54 28.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.613 -0.934 . . . . 0.0 110.323 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.32 76.8 5.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.461 -0.774 . . . . 0.0 110.064 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.445 ' O ' HG22 ' B' ' 7' ' ' VAL . 59.0 t -86.65 143.23 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.525 -0.734 . . . . 0.0 110.082 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -111.73 130.59 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.723 . . . . 0.0 110.166 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HA ' HG22 ' A' ' 46' ' ' ILE . 60.4 t -101.95 130.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.625 -0.672 . . . . 0.0 109.498 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 p -129.02 145.01 51.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.54 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 49.8 t80 -121.09 129.73 53.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -107.47 146.9 31.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.426 -0.796 . . . . 0.0 110.774 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 2' ' ' ALA . 28.0 mt-10 -97.94 30.36 3.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.669 -0.644 . . . . 0.0 110.045 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.88 -34.47 3.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.638 -0.664 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -114.66 -42.08 3.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.531 -0.731 . . . . 0.0 110.281 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.52 37.43 4.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.825 HG12 ' HB3' ' B' ' 47' ' ' GLN . 32.7 m -134.61 152.31 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.73 -0.864 . . . . 0.0 109.645 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.961 HG23 ' CE2' ' B' ' 25' ' ' PHE . 56.3 t -99.2 127.35 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 2.1 ttpp -108.5 124.37 50.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.831 -0.543 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.833 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 9.1 pt -117.02 148.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.752 . . . . 0.0 110.447 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.821 ' HB3' HG12 ' B' ' 43' ' ' VAL . 18.3 pt20 -161.53 -171.67 3.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.572 -0.705 . . . . 0.0 110.599 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.66 124.14 37.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.061 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.59 ' O ' HD23 ' A' ' 49' ' ' LEU . 4.2 tt -169.76 83.52 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.518 -0.739 . . . . 0.0 110.219 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.93 111.6 0.86 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.406 -0.809 . . . . 0.0 110.154 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.9 mt-10 62.18 137.83 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.302 0 O-C-N 121.659 -0.651 . . . . 0.0 110.402 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -87.88 78.15 1.56 Allowed 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 122.952 0.975 . . . . 0.0 110.447 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 51' ' ' GLU . 58.7 m95 -71.16 90.12 0.87 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.486 -0.759 . . . . 0.0 109.833 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.199 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.476 ' N ' ' OE1' ' A' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.07 0.462 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.79 150.26 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.589 -0.694 . . . . 0.0 110.09 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -148.16 116.01 6.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.677 -0.639 . . . . 0.0 109.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.65 174.06 8.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.714 . . . . 0.0 110.554 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.414 HG22 ' HE2' ' A' ' 34' ' ' LYS . 27.6 pt -120.57 130.73 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.686 -0.634 . . . . 0.0 109.899 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 33' ' ' VAL . 33.3 m -131.25 146.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.533 -0.729 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -103.5 154.22 19.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 1.027 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 57.7 t -109.95 142.45 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.695 -0.628 . . . . 0.0 109.6 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 84.7 p -169.78 -170.5 1.04 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 0.0 111.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.9 -86.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.721 -0.612 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.7 55.49 1.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.04 -1.038 . . . . 0.0 110.564 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.476 ' HE1' ' C ' ' A' ' 28' ' ' LYS . 71.4 m-85 49.34 47.36 22.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.439 -0.788 . . . . 0.0 111.08 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -112.21 154.22 25.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.161 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.97 135.98 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.624 -0.673 . . . . 0.0 110.314 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 40.5 p -108.31 106.86 17.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.739 -0.601 . . . . 0.0 109.773 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.48 126.91 92.93 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.7 -78.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.091 1.048 . . . . 0.0 110.648 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.74 -37.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.752 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.57 -46.9 85.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.625 -0.672 . . . . 0.0 110.123 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.71 -43.63 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.362 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.94 -27.68 68.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.653 -0.654 . . . . 0.0 110.049 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.05 -39.21 42.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.533 -0.729 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -79.54 -70.32 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.591 -0.693 . . . . 0.0 109.968 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.961 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -65.55 133.52 51.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -0.756 . . . . 0.0 110.563 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -81.88 88.05 6.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.522 -0.736 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.71 76.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 0.0 109.472 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.454 ' C ' ' HE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -58.54 168.74 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.75 -0.594 . . . . 0.0 110.65 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.448 ' N ' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -74.79 72.53 2.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.607 -0.683 . . . . 0.0 110.138 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 1.025 ' HA2' ' O ' ' A' ' 9' ' ' VAL . . . 137.81 44.85 0.08 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.505 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 3.0 m-20 -105.3 147.54 28.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.405 -1.056 . . . . 0.0 110.362 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.35 76.82 5.91 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.519 -0.738 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 7' ' ' VAL . 57.4 t -86.52 143.13 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.512 -0.742 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.419 ' HE2' HG22 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -111.7 130.57 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' B' ' 46' ' ' ILE . 60.1 t -101.86 130.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 61.2 p -129.1 144.9 51.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.417 -0.802 . . . . 0.0 111.354 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.552 ' CD1' ' CD2' ' A' ' 25' ' ' PHE . 50.1 t80 -121.11 129.86 53.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -107.54 146.88 31.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.656 -0.653 . . . . 0.0 110.823 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 2' ' ' ALA . 28.1 mt-10 -97.99 30.47 3.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.609 -0.682 . . . . 0.0 110.107 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 -34.58 3.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 110.243 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -114.53 -42.17 3.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.501 -0.749 . . . . 0.0 110.319 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.76 37.19 4.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.821 HG12 ' HB3' ' A' ' 47' ' ' GLN . 32.6 m -134.64 152.08 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.824 -0.809 . . . . 0.0 109.676 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.972 HG23 ' CE2' ' A' ' 25' ' ' PHE . 60.0 t -98.95 127.21 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.715 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.2 ttpp -108.26 124.27 50.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.85 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.9 pt -116.92 148.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.535 -0.728 . . . . 0.0 110.464 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.825 ' HB3' HG12 ' A' ' 43' ' ' VAL . 18.4 pt20 -161.18 -171.74 3.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.706 -0.622 . . . . 0.0 110.742 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.67 124.04 36.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.672 . . . . 0.0 110.104 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.586 ' O ' HD23 ' B' ' 49' ' ' LEU . 4.5 tt -169.7 83.45 0.12 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.476 -0.765 . . . . 0.0 110.238 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.89 111.84 0.88 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.461 -0.774 . . . . 0.0 110.106 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.412 ' HB3' ' CD1' ' B' ' 53' ' ' TRP . 1.9 mt-10 62.07 137.76 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.647 -0.658 . . . . 0.0 110.473 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.0 78.21 1.51 Allowed 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 122.896 0.945 . . . . 0.0 110.537 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' TRP . . . . . 0.412 ' CD1' ' HB3' ' B' ' 51' ' ' GLU . 59.4 m95 -71.08 89.92 0.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.504 -0.747 . . . . 0.0 109.986 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.189 -179.808 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.236 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.77 148.71 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.581 -0.699 . . . . 0.0 109.596 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -140.31 140.2 35.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.898 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.44 161.18 41.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.633 -0.667 . . . . 0.0 109.637 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.23 160.58 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.432 -0.793 . . . . 0.0 110.738 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.45 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.677 -0.64 . . . . 0.0 109.75 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -110.08 151.64 26.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 0.0 110.46 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.08 145.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.647 -0.658 . . . . 0.0 109.649 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 t -172.14 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.535 -0.728 . . . . 0.0 110.741 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.16 -78.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.36 -0.837 . . . . 0.0 111.201 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -162.14 69.18 0.28 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.37 -0.831 . . . . 0.0 110.343 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 52.42 23.94 2.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.271 -0.893 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' C ' HG23 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -109.9 169.84 8.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.48 -0.762 . . . . 0.0 109.629 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 14' ' ' GLN . 58.0 t -146.21 135.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.477 -0.764 . . . . 0.0 110.539 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.35 -174.69 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.617 . . . . 0.0 109.525 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.437 ' CG2' HG13 ' A' ' 21' ' ' VAL . 4.2 mp -138.29 138.48 22.86 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 21.6 Cg_exo -60.3 -164.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.163 1.086 . . . . 0.0 110.271 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.82 -26.41 13.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -65.87 -62.6 1.41 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.498 -0.751 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.437 HG13 ' CG2' ' A' ' 17' ' ' ILE . 9.0 p -60.46 -36.18 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 109.609 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -64.54 -30.16 71.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.62 -0.675 . . . . 0.0 109.255 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -45.41 82.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' B' ' 37' ' ' PHE . 19.7 mmtm -68.76 -71.99 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.671 -0.643 . . . . 0.0 109.27 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' B' ' 44' ' ' VAL . 0.2 OUTLIER -63.12 141.09 58.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.474 -0.766 . . . . 0.0 109.577 179.209 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.39 -83.64 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 110.376 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.5 mt 51.07 77.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.032 -1.042 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.407 ' HA ' ' CE1' ' B' ' 13' ' ' TYR . 1.1 ttpt -105.6 177.25 4.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.449 -0.782 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.83 77.33 0.88 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.573 -0.704 . . . . 0.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.91 56.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.32 170.38 16.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.94 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.56 103.6 7.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.595 -0.69 . . . . 0.0 110.197 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 48' ' ' LEU . 9.4 p -95.08 157.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 110.482 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -108.29 131.28 54.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.608 -0.682 . . . . 0.0 110.191 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 46' ' ' ILE . 57.4 t -122.43 136.63 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.741 . . . . 0.0 109.317 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 p -141.85 147.48 37.25 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.425 -0.797 . . . . 0.0 111.596 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' B' ' 24' ' ' LYS . 27.1 t80 -106.38 137.16 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.51 175.92 6.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 110.9 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.21 36.64 4.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 110.088 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -127.53 -67.02 0.85 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.621 -0.674 . . . . 0.0 110.023 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.6 -38.58 13.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.21 55.87 0.85 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.687 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.1 m -136.48 161.63 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.601 -0.941 . . . . 0.0 110.309 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.644 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 60.3 t -116.08 120.26 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.519 -0.738 . . . . 0.0 109.514 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 17.9 ttmt -109.92 151.53 26.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.752 -0.593 . . . . 0.0 110.799 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.639 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 7.8 pt -134.56 159.58 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.617 -0.677 . . . . 0.0 110.615 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.711 ' HB3' HG12 ' B' ' 43' ' ' VAL . 8.4 pt20 -152.81 164.0 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 110.111 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.451 HD11 ' HB ' ' A' ' 33' ' ' VAL . 1.1 mt -149.31 -179.22 6.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.457 -0.777 . . . . 0.0 111.237 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 56.2 160.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.022 0.915 . . . . 0.0 112.464 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.29 -152.3 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.81 145.44 30.16 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.243 -0.911 . . . . 0.0 110.257 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -73.02 94.12 0.81 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 O-C-N 123.247 1.13 . . . . 0.0 110.677 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -156.88 77.72 0.89 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.596 -0.69 . . . . 0.0 110.173 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 tptp . . . . . 0 N--CA 1.502 2.143 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.701 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.202 0.525 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.78 148.65 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.24 140.22 35.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.447 -0.783 . . . . 0.0 110.924 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.43 161.2 41.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.755 -0.591 . . . . 0.0 109.575 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.2 160.59 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.433 -0.792 . . . . 0.0 110.708 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.43 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.642 -0.661 . . . . 0.0 109.663 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -110.06 151.6 27.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.743 . . . . 0.0 110.479 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.08 145.39 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.656 -0.652 . . . . 0.0 109.71 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.9 t -172.13 -37.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.17 -78.11 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.455 -0.778 . . . . 0.0 111.241 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.16 69.02 0.27 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 110.376 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.407 ' CE1' ' HA ' ' A' ' 28' ' ' LYS . 23.7 m-85 52.62 23.9 2.86 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.343 -0.848 . . . . 0.0 111.003 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.416 ' C ' HG23 ' B' ' 15' ' ' VAL . 1.0 OUTLIER -109.86 169.78 8.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.644 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.416 HG23 ' C ' ' B' ' 14' ' ' GLN . 57.4 t -146.21 135.49 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.38 -174.64 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 109.517 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.439 ' CG2' HG13 ' B' ' 21' ' ' VAL . 4.2 mp -138.43 138.5 22.58 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -60.19 -164.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.151 1.079 . . . . 0.0 110.355 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.85 -26.5 13.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.573 -0.704 . . . . 0.0 110.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -65.79 -62.57 1.43 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.439 HG13 ' CG2' ' B' ' 17' ' ' ILE . 9.2 p -60.45 -36.25 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -64.5 -30.15 71.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -45.38 81.91 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 19.7 mmtm -68.77 -71.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.646 -0.659 . . . . 0.0 109.296 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.501 ' CE1' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -63.1 141.05 58.91 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -72.38 -83.62 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.402 -0.812 . . . . 0.0 110.428 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 85.6 mt 51.05 77.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.055 -1.028 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -105.58 177.27 4.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.182 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.93 77.41 0.9 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.534 -0.729 . . . . 0.0 110.139 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.84 56.88 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.46 170.4 16.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.577 -0.955 . . . . 0.0 110.103 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.46 103.59 7.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.573 -0.705 . . . . 0.0 110.299 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' B' ' 48' ' ' LEU . 9.4 p -95.01 157.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.638 -0.664 . . . . 0.0 110.461 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -108.38 131.23 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.649 -0.657 . . . . 0.0 110.14 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.613 HG22 HG22 ' B' ' 46' ' ' ILE . 60.3 t -122.5 136.56 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.705 . . . . 0.0 109.326 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 8.5 p -141.79 147.52 37.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.396 -0.815 . . . . 0.0 111.479 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.41 ' CE2' ' HB3' ' A' ' 24' ' ' LYS . 26.9 t80 -106.39 137.03 45.1 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.39 175.84 6.1 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.279 -0.888 . . . . 0.0 110.993 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.11 36.51 4.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 110.064 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -127.53 -66.88 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.573 -0.704 . . . . 0.0 110.025 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -90.55 -38.61 13.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.578 -0.701 . . . . 0.0 110.072 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.17 55.92 0.85 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.711 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.1 m -136.54 161.48 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.529 -0.983 . . . . 0.0 110.214 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.639 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.5 t -115.92 120.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.424 -0.798 . . . . 0.0 109.566 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 17.9 ttmt -109.75 151.37 27.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.677 -0.639 . . . . 0.0 110.921 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.644 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 7.8 pt -134.41 159.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.722 -0.611 . . . . 0.0 110.671 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.687 ' HB3' HG12 ' A' ' 43' ' ' VAL . 8.5 pt20 -152.69 164.09 38.41 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 110.123 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' B' ' 33' ' ' VAL . 1.2 mt -149.32 -179.15 6.84 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.391 -0.818 . . . . 0.0 111.31 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 56.1 160.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.98 0.895 . . . . 0.0 112.468 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.35 -152.3 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.8 145.35 29.99 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.177 -0.952 . . . . 0.0 110.314 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -72.86 94.1 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.379 1.199 . . . . 0.0 110.729 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 27.1 m95 -156.93 77.82 0.89 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.489 -0.757 . . . . 0.0 110.082 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 tptp . . . . . 0 N--CA 1.501 2.116 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.779 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.182 0.515 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.96 147.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.593 -0.692 . . . . 0.0 110.152 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' B' ' 36' ' ' THR . 10.3 mt-10 -125.79 135.48 52.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.697 -0.627 . . . . 0.0 109.786 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.69 164.5 38.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.0 110.776 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.35 133.16 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.652 -0.655 . . . . 0.0 109.521 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.37 159.32 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -113.09 158.17 20.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.695 -0.628 . . . . 0.0 109.693 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.58 HG23 ' O ' ' B' ' 31' ' ' ASP . 69.9 t -94.18 147.91 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.54 -0.725 . . . . 0.0 110.172 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.7 t -171.05 -168.81 0.68 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.571 -0.705 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.57 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.717 -0.614 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.14 79.5 0.16 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.01 -1.057 . . . . 0.0 111.563 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 53.14 56.99 6.74 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.314 -0.866 . . . . 0.0 111.433 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -130.26 153.33 48.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.82 . . . . 0.0 110.495 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -123.87 101.48 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.703 -0.623 . . . . 0.0 110.074 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 16' ' ' THR . 6.7 t -74.87 153.99 38.42 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.543 -0.723 . . . . 0.0 110.077 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -98.91 130.99 26.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.564 -0.71 . . . . 0.0 109.789 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.99 -167.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.042 1.022 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.52 -36.51 17.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 110.221 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.55 -43.17 85.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 110.103 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.32 -38.47 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.714 . . . . 0.0 109.64 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -67.87 -41.47 82.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.168 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -67.55 -45.19 76.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 109.916 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.2 -68.68 0.64 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.704 -0.622 . . . . 0.0 109.999 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.6 OUTLIER -70.87 119.78 15.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.594 -0.691 . . . . 0.0 110.272 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.04 108.68 13.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.706 -0.621 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.65 76.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.472 -0.767 . . . . 0.0 109.981 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -97.23 175.35 6.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.632 -0.668 . . . . 0.0 110.011 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.26 125.62 24.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.52 -0.737 . . . . 0.0 109.997 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 20.4 12.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.591 ' O ' HG23 ' B' ' 9' ' ' VAL . 4.9 m-20 -111.83 114.8 27.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 95.93 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.624 . . . . 0.0 110.728 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.13 133.13 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.655 -0.653 . . . . 0.0 109.403 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 165.78 11.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.501 -0.749 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.68 136.15 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.658 -0.651 . . . . 0.0 109.873 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.645 HG22 ' HA ' ' B' ' 4' ' ' GLU . 71.3 p -141.87 146.41 35.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 110.904 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -103.64 140.28 37.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.732 -0.605 . . . . 0.0 109.539 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.33 173.39 6.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.645 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.71 33.97 5.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 110.059 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.5 t -121.65 -63.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 0.0 110.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.37 -35.9 10.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 110.58 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.82 56.97 0.88 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.823 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.2 m -133.25 166.92 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.631 -0.923 . . . . 0.0 110.053 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.537 HG23 ' CE2' ' B' ' 25' ' ' PHE . 47.4 t -119.71 116.6 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.358 -0.839 . . . . 0.0 109.833 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 4.1 ttpt -98.96 139.93 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 110.44 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.516 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.4 pt -131.72 157.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.561 -0.712 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.826 ' HB3' HG12 ' B' ' 43' ' ' VAL . 17.3 pt20 -161.26 168.71 23.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.461 -0.775 . . . . 0.0 110.464 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.61 -152.3 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.539 -0.726 . . . . 0.0 109.568 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tp -56.38 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.409 -0.807 . . . . 0.0 110.802 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.37 136.57 1.35 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.601 -0.687 . . . . 0.0 109.532 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.406 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -124.47 52.59 5.97 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.625 -179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 51' ' ' GLU . 30.1 Cg_endo -69.24 106.36 1.55 Allowed 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.283 1.149 . . . . 0.0 109.952 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 -63.72 0.68 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.558 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.272 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.225 0.536 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.03 147.17 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.563 -0.71 . . . . 0.0 110.178 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.645 ' HA ' HG22 ' A' ' 36' ' ' THR . 10.3 mt-10 -125.64 135.6 52.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.69 -0.631 . . . . 0.0 109.75 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.76 164.53 38.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.728 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 87.8 mt -132.49 133.13 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 109.495 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.33 159.31 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.326 -0.859 . . . . 0.0 110.783 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -113.06 158.11 20.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.727 -0.608 . . . . 0.0 109.78 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 31' ' ' ASP . 73.4 t -94.18 147.83 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 110.185 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -171.04 -168.75 0.68 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.361 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.6 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.674 -0.641 . . . . 0.0 110.831 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.13 79.47 0.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.965 -1.084 . . . . 0.0 111.559 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 53.07 57.15 6.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.301 -0.874 . . . . 0.0 111.459 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -130.47 153.23 49.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.332 -0.855 . . . . 0.0 110.586 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.9 t -123.78 101.4 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.763 -0.586 . . . . 0.0 110.082 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -74.83 153.9 38.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 110.075 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 34.1 mt -98.84 130.93 26.59 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.83 -167.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.161 1.085 . . . . 0.0 110.347 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.51 -36.47 17.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.63 -43.05 85.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.607 -0.683 . . . . 0.0 110.168 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.4 -38.44 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.573 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -67.9 -41.52 82.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.736 -0.603 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -67.5 -45.13 76.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.941 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.36 -68.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 109.971 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.537 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -70.87 119.78 15.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.7 -0.625 . . . . 0.0 110.227 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.09 108.75 13.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.627 -0.671 . . . . 0.0 110.327 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.63 76.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -97.25 175.39 6.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.659 -0.651 . . . . 0.0 110.018 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.37 125.74 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 110.017 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 20.42 12.24 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.58 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.9 m-20 -111.77 114.87 28.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.7 95.82 1.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.606 -0.684 . . . . 0.0 110.76 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 64.2 t -94.11 133.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.501 -0.749 . . . . 0.0 109.374 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.37 165.83 11.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.492 -0.755 . . . . 0.0 110.356 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.69 136.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 109.775 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 4' ' ' GLU . 69.8 p -141.91 146.42 35.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.456 -0.778 . . . . 0.0 110.979 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -103.67 140.36 37.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.481 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.34 173.44 6.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.525 -0.734 . . . . 0.0 110.618 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.7 33.76 5.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.675 -0.641 . . . . 0.0 110.027 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 36.9 t -121.48 -63.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.565 -0.71 . . . . 0.0 110.441 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.3 -35.96 10.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.525 -0.734 . . . . 0.0 110.498 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.85 56.87 0.88 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.826 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.0 m -133.25 166.75 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.654 -0.909 . . . . 0.0 110.066 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.531 HG23 ' CE2' ' A' ' 25' ' ' PHE . 47.3 t -119.61 116.64 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.315 -0.865 . . . . 0.0 109.868 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.424 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 4.2 ttpt -99.0 139.84 34.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.578 -0.701 . . . . 0.0 110.419 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.518 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.4 pt -131.65 156.86 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 110.384 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.823 ' HB3' HG12 ' A' ' 43' ' ' VAL . 17.3 pt20 -161.0 168.85 23.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.506 -0.746 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.79 -152.31 0.07 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.639 -0.663 . . . . 0.0 109.555 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tp -56.31 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.369 -0.832 . . . . 0.0 110.816 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.47 136.53 1.31 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.577 -0.702 . . . . 0.0 109.569 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.412 ' N ' ' CD ' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -124.47 52.58 5.96 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.483 -0.76 . . . . 0.0 110.561 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' B' ' 51' ' ' GLU . 29.9 Cg_endo -69.36 106.4 1.58 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 O-C-N 123.235 1.124 . . . . 0.0 109.879 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 -63.59 0.69 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.487 -0.758 . . . . 0.0 110.621 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.258 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.046 0.45 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.38 138.18 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.27 152.11 51.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.562 -0.712 . . . . 0.0 109.9 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.25 152.12 32.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.496 -0.753 . . . . 0.0 110.367 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.8 mt -120.11 125.4 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.634 -0.666 . . . . 0.0 109.567 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.54 155.91 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.498 -0.751 . . . . 0.0 110.59 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.46 145.1 38.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.688 -0.632 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.27 130.74 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.605 -0.684 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -170.85 -157.04 0.13 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.498 -0.751 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 mtt85 55.74 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.727 -0.608 . . . . 0.0 111.075 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -150.83 56.39 0.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.096 -1.002 . . . . 0.0 110.561 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.95 38.25 19.73 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.304 -0.873 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.57 176.94 6.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.25 128.58 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.46 -21.49 21.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.331 -0.856 . . . . 0.0 111.49 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.3 mt 59.87 115.32 0.02 OUTLIER Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.718 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.67 175.18 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 122.858 0.925 . . . . 0.0 110.775 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.59 -27.13 61.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.615 -0.678 . . . . 0.0 110.568 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -54.32 46.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.493 -0.754 . . . . 0.0 110.521 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.53 -45.63 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.38 -0.825 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -60.0 -31.39 69.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -48.42 64.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.629 -0.669 . . . . 0.0 109.502 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' B' ' 37' ' ' PHE . 0.0 OUTLIER -65.12 -65.29 0.69 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.686 -0.633 . . . . 0.0 109.514 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.665 ' CE1' HG23 ' B' ' 44' ' ' VAL . 0.6 OUTLIER -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.666 -0.646 . . . . 0.0 110.151 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -73.55 -74.95 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.566 -0.709 . . . . 0.0 109.912 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.4 mm 52.95 84.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.396 -0.815 . . . . 0.0 110.608 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.35 148.57 37.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.632 -0.668 . . . . 0.0 110.379 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -61.69 109.44 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.586 -0.696 . . . . 0.0 110.134 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 55.22 1.31 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' OD2' HD21 ' A' ' 48' ' ' LEU . 3.2 t0 -126.92 158.38 36.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 0.0 110.274 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -92.78 82.95 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.81 156.45 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.825 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' B' ' 5' ' ' GLU . 5.1 tttt -134.17 147.14 50.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 110.25 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 46' ' ' ILE . 48.3 t -127.81 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 0.0 109.664 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.7 p -134.51 155.84 49.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.987 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE1' ' CD1' ' B' ' 25' ' ' PHE . 26.3 t80 -133.97 121.85 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.708 -0.62 . . . . 0.0 109.536 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -99.97 168.8 9.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 110.174 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.53 32.12 5.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 110.009 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 p -117.61 -48.83 2.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 110.139 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.65 -29.64 12.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 110.163 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.91 39.62 11.54 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' B' ' 47' ' ' GLN . 34.0 m -128.3 155.14 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.888 . . . . 0.0 110.327 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.646 HG23 ' CE1' ' B' ' 25' ' ' PHE . 40.2 t -103.01 115.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -100.63 130.01 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.844 -0.535 . . . . 0.0 110.165 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.656 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 8.7 pt -124.45 151.44 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.521 -0.737 . . . . 0.0 110.959 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.561 ' HG3' HG12 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -159.3 -168.98 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.34 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.455 HD21 ' OD2' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -112.82 -74.57 0.63 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.675 -0.641 . . . . 0.0 110.071 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 49' ' ' LEU . 18.6 tp -166.24 140.94 4.45 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.417 -0.802 . . . . 0.0 110.188 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.32 -70.24 0.14 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.462 -0.774 . . . . 0.0 110.45 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -155.19 116.72 2.37 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.448 -0.782 . . . . 0.0 110.346 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.58 88.09 0.28 Allowed 'Trans proline' 0 N--CA 1.486 1.051 0 O-C-N 123.112 1.059 . . . . 0.0 110.478 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -142.53 -46.06 0.32 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.55 -0.719 . . . . 0.0 110.171 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 tttm . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.133 179.905 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.078 0.466 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.46 138.27 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.573 -0.704 . . . . 0.0 109.998 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -133.3 152.16 51.92 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.649 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.5 mp0 -151.29 152.15 32.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 mt -120.08 125.43 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.592 -0.692 . . . . 0.0 109.647 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.51 155.84 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.752 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.4 145.2 37.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.653 . . . . 0.0 110.036 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 64.9 t -79.27 130.87 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.569 -0.707 . . . . 0.0 109.991 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -171.09 -157.08 0.12 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.611 -0.68 . . . . 0.0 110.089 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 39.5 mtt85 55.75 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.646 -0.659 . . . . 0.0 111.131 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.82 56.36 0.91 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.067 -1.021 . . . . 0.0 110.518 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.9 38.3 19.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.263 -0.898 . . . . 0.0 110.857 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.6 176.95 6.83 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.52 -0.738 . . . . 0.0 111.179 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.24 128.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.52 -21.44 21.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.492 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 68.5 mt 59.85 115.35 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -57.8 175.19 0.47 Allowed 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 122.893 0.944 . . . . 0.0 110.819 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.07 61.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -54.26 47.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.56 -45.69 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -59.85 -31.56 69.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -48.32 64.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.685 -0.634 . . . . 0.0 109.563 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -65.25 -65.19 0.71 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.629 -0.669 . . . . 0.0 109.484 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.646 ' CE1' HG23 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -65.82 164.94 13.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.682 -0.636 . . . . 0.0 110.123 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.59 -74.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.607 -0.683 . . . . 0.0 109.914 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 47.6 mm 52.85 84.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.445 -0.784 . . . . 0.0 110.584 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.39 148.77 37.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.555 -0.716 . . . . 0.0 110.281 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -61.84 109.49 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.594 -0.691 . . . . 0.0 110.098 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 55.15 1.33 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.444 ' OD2' HD21 ' B' ' 48' ' ' LEU . 3.2 t0 -126.91 158.41 36.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.598 -0.942 . . . . 0.0 110.303 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -92.79 82.92 4.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.8 156.43 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 0.0 109.918 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 5.4 tttt -134.16 147.09 50.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.546 -0.721 . . . . 0.0 110.28 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.514 HG22 HG22 ' B' ' 46' ' ' ILE . 47.7 t -127.69 136.11 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.634 -0.666 . . . . 0.0 109.704 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -134.54 155.85 49.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.442 -0.786 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.499 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 26.4 t80 -134.03 121.94 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.705 -0.622 . . . . 0.0 109.468 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -100.07 168.79 9.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.728 -0.607 . . . . 0.0 110.182 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.52 31.97 5.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 74.6 p -117.55 -48.77 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.148 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.67 -29.56 12.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.68 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.82 39.79 11.46 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.561 HG12 ' HG3' ' A' ' 47' ' ' GLN . 34.7 m -128.31 155.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.744 -0.857 . . . . 0.0 110.343 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.665 HG23 ' CE1' ' A' ' 25' ' ' PHE . 41.1 t -103.1 115.39 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -100.22 129.8 46.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.761 -0.587 . . . . 0.0 110.342 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.645 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.8 pt -124.1 151.49 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.518 -0.739 . . . . 0.0 110.983 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.596 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -159.38 -168.96 2.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.783 -0.573 . . . . 0.0 110.348 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.444 HD21 ' OD2' ' B' ' 31' ' ' ASP . 0.3 OUTLIER -112.9 -74.59 0.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 109.958 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' B' ' 49' ' ' LEU . 18.6 tp -166.23 140.89 4.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -0.786 . . . . 0.0 110.2 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.28 -70.15 0.15 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.558 -0.714 . . . . 0.0 110.493 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -155.24 116.72 2.37 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.423 -0.798 . . . . 0.0 110.323 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -66.56 88.05 0.27 Allowed 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.129 1.068 . . . . 0.0 110.473 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -142.54 -45.94 0.32 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.603 -0.685 . . . . 0.0 110.261 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 tttm . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.179 179.861 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.053 0.454 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.99 112.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.067 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.38 160.51 14.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.543 -0.723 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.39 148.76 28.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.2 mt -120.32 147.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.638 -0.664 . . . . 0.0 109.777 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 HG13 ' B' ' 33' ' ' VAL . 9.7 p -168.18 161.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.512 -0.743 . . . . 0.0 110.365 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.86 -170.73 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 110.144 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.77 156.01 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.754 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.8 p -168.95 -176.93 2.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.764 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.94 -157.51 0.15 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.521 -0.737 . . . . 0.0 110.765 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -87.98 65.54 8.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.695 . . . . 0.0 110.271 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.41 33.03 14.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.468 -0.77 . . . . 0.0 111.042 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.86 151.37 25.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.702 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.04 140.03 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.592 ' O ' HG23 ' A' ' 16' ' ' THR . 6.6 t -144.77 110.59 5.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 109.891 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.416 HG23 ' HD2' ' A' ' 18' ' ' PRO . 88.3 mt -71.26 142.26 86.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.069 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD2' HG23 ' A' ' 17' ' ' ILE . 30.5 Cg_endo -69.16 179.88 3.09 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.345 1.182 . . . . 0.0 110.465 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.43 43.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.7 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.65 -50.77 72.16 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.11 -36.18 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.267 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.94 -47.67 65.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.312 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -69.33 0.29 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.683 -0.636 . . . . 0.0 109.355 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.67 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.3 OUTLIER -66.41 156.25 35.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.579 -0.701 . . . . 0.0 109.719 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.77 -81.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.494 -0.754 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 25' ' ' PHE . 61.6 mt 50.63 87.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.191 -0.943 . . . . 0.0 110.895 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -124.77 173.0 8.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.727 . . . . 0.0 109.917 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.86 5.66 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 0.0 110.266 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.27 61.6 1.55 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.458 ' HB3' HD21 ' A' ' 48' ' ' LEU . 1.8 m-20 -133.96 138.08 45.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.522 -0.987 . . . . 0.0 110.152 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.81 90.78 8.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.543 -0.723 . . . . 0.0 110.325 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.443 HG13 HG13 ' B' ' 7' ' ' VAL . 7.7 p -97.21 152.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.629 -0.669 . . . . 0.0 109.789 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 151.59 48.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.541 -0.724 . . . . 0.0 110.627 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.0 127.57 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.7 p -127.37 150.11 49.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.497 -0.752 . . . . 0.0 111.367 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.1 t80 -136.23 125.33 24.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.51 -177.68 3.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 0.0 110.532 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -124.24 24.21 8.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.713 -0.617 . . . . 0.0 110.461 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.6 t -119.45 -40.36 2.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 110.072 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.61 -49.6 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 110.128 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.31 43.78 2.49 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' B' ' 47' ' ' GLN . 34.9 m -141.41 156.23 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.576 -0.955 . . . . 0.0 110.032 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.684 HG23 ' CE2' ' B' ' 25' ' ' PHE . 46.6 t -106.23 125.5 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.956 -0.697 . . . . 0.0 109.925 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.579 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -107.83 128.28 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.665 -0.647 . . . . 0.0 110.259 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.498 HG12 ' HB ' ' B' ' 44' ' ' VAL . 22.1 pt -116.76 153.56 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.735 . . . . 0.0 110.356 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.64 ' HB2' HG12 ' B' ' 43' ' ' VAL . 1.6 tm0? -156.26 162.76 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.578 -0.701 . . . . 0.0 110.428 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -118.52 -66.07 1.11 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 110.166 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 tp -149.3 155.69 40.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.531 -0.731 . . . . 0.0 110.297 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -125.24 139.94 53.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.745 . . . . 0.0 110.052 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -145.13 135.34 11.87 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.548 -0.72 . . . . 0.0 110.275 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -74.23 112.89 3.65 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 O-C-N 123.294 1.155 . . . . 0.0 110.352 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -110.21 51.47 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 110.215 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.2 tttm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.182 179.809 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.047 0.451 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.95 112.78 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.678 . . . . 0.0 110.03 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.4 160.54 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.44 148.68 28.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.545 -0.722 . . . . 0.0 110.43 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 23.3 mt -120.31 147.73 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.643 -0.661 . . . . 0.0 109.757 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 33' ' ' VAL . 9.6 p -168.25 161.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.423 -0.798 . . . . 0.0 110.356 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.77 -170.65 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 156.03 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.109 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -169.02 -177.02 2.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.482 -0.761 . . . . 0.0 110.454 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.97 -157.54 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.454 -0.779 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -88.02 65.66 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.226 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.5 32.74 14.69 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.0 111.083 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.7 151.41 25.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.553 -0.717 . . . . 0.0 109.759 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.09 140.03 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.584 ' O ' HG23 ' B' ' 16' ' ' THR . 6.8 t -144.67 110.5 5.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.609 -0.682 . . . . 0.0 109.936 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.408 HG23 ' HD2' ' B' ' 18' ' ' PRO . 88.7 mt -71.37 142.33 86.68 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.475 -0.765 . . . . 0.0 110.046 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.408 ' HD2' HG23 ' B' ' 17' ' ' ILE . 30.5 Cg_endo -69.31 179.95 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.393 1.207 . . . . 0.0 110.419 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.34 43.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.107 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -60.8 -50.6 72.8 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.602 -0.687 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.05 -36.3 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.671 -0.643 . . . . 0.0 109.267 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -64.03 -31.97 73.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.641 -0.662 . . . . 0.0 109.587 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -47.54 65.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.668 . . . . 0.0 109.299 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -69.42 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.292 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.684 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -66.37 156.14 35.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.638 -0.664 . . . . 0.0 109.778 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.66 -81.74 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.53 -0.731 . . . . 0.0 110.035 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' B' ' 25' ' ' PHE . 61.8 mt 50.59 87.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.138 -0.977 . . . . 0.0 110.87 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -124.73 172.99 8.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.597 -0.689 . . . . 0.0 109.925 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.82 5.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.5 -0.75 . . . . 0.0 110.314 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 61.45 1.56 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.473 ' HB3' HD21 ' B' ' 48' ' ' LEU . 1.8 m-20 -133.84 138.22 45.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 0.0 110.146 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.9 90.83 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 110.343 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 7' ' ' VAL . 7.8 p -97.24 152.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.0 109.821 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 151.58 48.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 110.669 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.06 127.53 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 18.5 p -127.46 150.04 49.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.818 . . . . 0.0 111.369 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 34.8 t80 -136.25 125.39 24.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.43 -177.74 3.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 110.57 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.28 24.31 8.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.384 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -119.44 -40.51 2.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.48 -49.67 4.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.647 -0.658 . . . . 0.0 110.154 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.41 43.63 2.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.64 HG12 ' HB2' ' A' ' 47' ' ' GLN . 34.8 m -141.31 156.13 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.6 -0.941 . . . . 0.0 110.12 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.67 HG23 ' CE2' ' A' ' 25' ' ' PHE . 46.2 t -106.09 125.54 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.579 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -107.86 128.36 54.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.514 HG12 ' HB ' ' A' ' 44' ' ' VAL . 22.2 pt -116.76 153.57 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.583 -0.698 . . . . 0.0 110.321 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.631 ' HB2' HG12 ' A' ' 43' ' ' VAL . 1.6 tm0? -156.34 162.64 40.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.658 -0.651 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' B' ' 31' ' ' ASP . 0.5 OUTLIER -118.4 -66.12 1.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.654 -0.654 . . . . 0.0 110.175 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 tp -149.25 155.72 41.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.569 -0.707 . . . . 0.0 110.27 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -125.33 139.94 53.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.565 -0.709 . . . . 0.0 110.019 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -145.09 135.31 11.87 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.513 -0.742 . . . . 0.0 110.31 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -74.22 113.04 3.69 Favored 'Trans proline' 0 N--CA 1.484 0.919 0 O-C-N 123.175 1.092 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -110.31 51.48 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.575 -0.703 . . . . 0.0 110.228 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 7.2 tttm . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.2 179.869 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.101 0.476 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.47 144.38 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.657 -0.652 . . . . 0.0 109.755 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.6 131.08 14.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.508 -0.745 . . . . 0.0 110.306 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.44 173.26 11.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.575 -0.703 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.424 ' C ' HG23 ' A' ' 7' ' ' VAL . 38.9 pt -121.77 159.5 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.642 -0.661 . . . . 0.0 110.286 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.424 HG23 ' C ' ' A' ' 6' ' ' ILE . 63.2 t -147.42 153.12 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.658 -0.651 . . . . 0.0 110.204 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 172.24 6.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.83 149.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.472 -0.767 . . . . 0.0 110.213 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -171.8 -167.65 0.52 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.542 -0.724 . . . . 0.0 110.799 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.81 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.684 -0.635 . . . . 0.0 111.465 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.36 73.94 0.94 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.949 -1.094 . . . . 0.0 111.181 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 49.2 29.08 2.44 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.37 -0.831 . . . . 0.0 111.427 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.01 153.6 21.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.637 -0.664 . . . . 0.0 110.409 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -126.33 151.58 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.61 -0.681 . . . . 0.0 109.842 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -148.15 127.1 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.645 -0.659 . . . . 0.0 110.147 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 84.6 mt -81.26 145.38 55.82 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 0.0 109.942 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 28.6 Cg_exo -58.12 -166.18 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.344 1.181 . . . . 0.0 110.617 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.93 -43.33 8.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.595 -0.691 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -63.71 -44.09 94.63 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.642 -0.661 . . . . 0.0 110.33 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.0 -41.71 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.528 -0.732 . . . . 0.0 109.603 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -65.54 -31.68 72.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.499 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -40.4 75.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.675 -0.641 . . . . 0.0 109.272 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -72.98 -74.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.615 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.3 154.01 14.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.593 -0.692 . . . . 0.0 109.975 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -84.88 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.73 . . . . 0.0 109.853 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.473 HD12 ' HB3' ' A' ' 25' ' ' PHE . 71.0 mt 49.6 86.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.972 . . . . 0.0 110.902 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.25 -177.22 3.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -0.769 . . . . 0.0 110.596 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -83.15 117.57 22.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 0.0 110.104 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.38 38.01 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.27 170.01 9.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.936 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -117.17 72.24 0.83 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.746 . . . . 0.0 110.136 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -64.65 149.37 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 110.398 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.45 156.95 18.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.67 -0.644 . . . . 0.0 110.329 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG23 ' CG1' ' A' ' 44' ' ' VAL . 7.9 p -151.33 133.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.4 p -141.57 145.86 35.6 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.156 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 44.4 t80 -111.47 140.18 46.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -132.81 155.7 48.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 0.0 110.948 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.77 20.02 12.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.239 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -100.94 -27.78 13.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.285 -0.884 . . . . 0.0 109.909 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -127.2 -49.27 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.637 -0.664 . . . . 0.0 110.24 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.42 35.31 3.37 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' B' ' 47' ' ' GLN . 35.3 m -136.89 163.12 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.523 -0.987 . . . . 0.0 110.236 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.803 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 59.5 t -105.0 127.61 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.346 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 27.3 ttmt -112.22 133.71 54.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.771 -0.581 . . . . 0.0 110.217 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.81 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 5.3 pt -125.75 158.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.631 -0.668 . . . . 0.0 110.194 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.665 ' HB2' HG12 ' B' ' 43' ' ' VAL . 5.0 tt0 -153.72 161.31 42.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.668 -0.645 . . . . 0.0 110.351 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.13 38.13 1.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.578 -0.701 . . . . 0.0 110.056 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 23.2 mt -91.97 124.97 36.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.568 -0.707 . . . . 0.0 110.318 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -143.43 -155.16 0.57 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.639 -0.663 . . . . 0.0 109.817 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -58.64 110.25 2.47 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.475 -0.766 . . . . 0.0 110.183 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.07 131.12 26.02 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.147 1.077 . . . . 0.0 110.588 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -150.45 79.63 1.34 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.622 -0.674 . . . . 0.0 109.86 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.349 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.138 0.494 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.45 144.33 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.759 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.71 131.1 14.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 0.0 110.368 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.41 173.28 11.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.698 -0.627 . . . . 0.0 110.034 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.433 ' C ' HG23 ' B' ' 7' ' ' VAL . 38.4 pt -121.78 159.59 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.624 -0.673 . . . . 0.0 110.324 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.433 HG23 ' C ' ' B' ' 6' ' ' ILE . 62.9 t -147.45 153.16 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.527 -0.733 . . . . 0.0 110.181 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.93 172.19 6.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.705 . . . . 0.0 110.069 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.74 149.23 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 110.237 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.8 t -172.02 -167.64 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.522 -0.736 . . . . 0.0 110.757 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.76 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.663 -0.648 . . . . 0.0 111.454 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.35 73.95 0.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.04 -1.037 . . . . 0.0 111.219 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 49.23 29.17 2.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.315 -0.865 . . . . 0.0 111.396 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.07 153.64 21.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.419 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.34 151.49 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.798 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -148.09 127.03 12.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 110.072 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 85.0 mt -81.08 145.26 56.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.969 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -57.96 -166.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.416 1.219 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.82 -43.49 8.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -63.7 -43.89 95.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.55 -0.719 . . . . 0.0 110.362 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.18 -41.79 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 109.526 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -65.46 -31.78 73.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.6 -0.687 . . . . 0.0 109.462 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -40.48 75.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.668 -0.645 . . . . 0.0 109.334 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -72.96 -74.09 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.609 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.36 154.01 14.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.0 109.97 179.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.3 -84.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 109.887 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ILE . . . . . 0.473 HD12 ' HB3' ' B' ' 25' ' ' PHE . 71.8 mt 49.48 86.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.066 -1.022 . . . . 0.0 110.964 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.19 -177.21 3.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.527 -0.733 . . . . 0.0 110.538 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -83.12 117.56 22.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.574 -0.704 . . . . 0.0 110.106 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.26 38.22 4.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.34 170.02 9.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.917 . . . . 0.0 110.184 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mt -117.22 72.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.69 149.33 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.52 -0.738 . . . . 0.0 110.336 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.4 156.9 18.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.597 -0.689 . . . . 0.0 110.364 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.424 HG23 ' CG1' ' B' ' 44' ' ' VAL . 7.8 p -151.34 133.15 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 79.1 p -141.62 145.89 35.56 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.117 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.615 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 44.1 t80 -111.42 140.13 46.26 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -132.75 155.77 48.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.83 20.11 12.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -100.82 -28.04 13.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.795 . . . . 0.0 109.974 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -127.02 -49.25 1.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.706 -0.621 . . . . 0.0 110.246 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.43 35.21 3.39 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 47' ' ' GLN . 35.2 m -136.79 163.1 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.5 -1.0 . . . . 0.0 110.122 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.81 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.6 t -105.03 127.37 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.2 ttmt -111.87 133.55 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.697 -0.627 . . . . 0.0 110.294 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.803 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 5.4 pt -125.54 158.05 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.653 -0.654 . . . . 0.0 110.302 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.641 ' HB2' HG12 ' A' ' 43' ' ' VAL . 4.8 tt0 -153.64 161.36 42.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.716 -0.615 . . . . 0.0 110.32 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.18 38.18 1.74 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 24.0 mt -91.87 125.03 36.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 110.406 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -143.43 -155.09 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.561 -0.712 . . . . 0.0 109.824 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.75 110.33 2.55 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.506 -0.746 . . . . 0.0 110.198 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.22 130.99 25.41 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.193 1.101 . . . . 0.0 110.557 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -150.34 79.72 1.35 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.653 -0.654 . . . . 0.0 109.83 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.315 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.055 0.455 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.77 156.25 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 0.0 109.759 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -145.52 147.05 31.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.531 -0.73 . . . . 0.0 110.598 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HB2' HG13 ' B' ' 35' ' ' VAL . 1.4 mm-40 -137.81 164.05 29.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.752 -0.593 . . . . 0.0 109.912 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.95 137.93 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.657 -0.652 . . . . 0.0 110.519 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 8' ' ' LYS . 9.9 p -146.15 165.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.575 -0.703 . . . . 0.0 109.736 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.422 ' N ' HG22 ' A' ' 7' ' ' VAL . 16.0 tttp -137.07 138.35 40.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.351 -0.843 . . . . 0.0 110.517 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.45 124.96 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.597 -0.689 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 m -168.65 42.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.437 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -139.59 -66.04 0.46 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.605 -0.684 . . . . 0.0 109.457 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.08 46.29 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.752 -0.592 . . . . 0.0 109.995 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' B' ' 29' ' ' GLU . 15.2 m-85 53.42 57.42 6.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 110.803 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 174.71 13.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.463 -0.773 . . . . 0.0 110.81 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.52 145.53 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.753 -0.592 . . . . 0.0 109.693 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 p -110.95 -8.47 14.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 111.368 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.8 mt 59.51 111.6 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.304 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.53 -168.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.039 1.02 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.04 -33.85 26.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 0.0 111.519 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -56.34 -52.43 64.6 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.234 -0.916 . . . . 0.0 110.862 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.22 -47.7 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.393 -0.817 . . . . 0.0 109.593 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HD2' HG21 ' A' ' 27' ' ' ILE . 9.1 tpp180 -58.63 -28.77 65.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.99 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -45.06 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 109.486 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.64 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.598 -0.688 . . . . 0.0 109.952 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.12 169.92 5.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.402 -0.811 . . . . 0.0 110.817 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.47 -73.43 0.38 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.692 -0.63 . . . . 0.0 110.733 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.547 HG21 ' HD2' ' A' ' 22' ' ' ARG . 47.2 mm 55.12 93.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 139.16 47.79 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.0 110.365 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 13' ' ' TYR . 5.4 tt0 -67.58 112.15 4.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.543 -0.723 . . . . 0.0 110.154 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.73 35.44 4.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.73 163.98 18.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.579 -0.954 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.3 tp -93.71 107.25 19.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.645 -0.66 . . . . 0.0 110.289 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.9 t -98.72 141.18 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.667 -0.645 . . . . 0.0 109.585 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.75 142.21 46.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.548 -0.72 . . . . 0.0 110.346 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 5' ' ' GLU . 12.4 p -131.37 134.27 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.665 -0.647 . . . . 0.0 109.779 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.402 HG22 ' CB ' ' B' ' 4' ' ' GLU . 24.1 p -134.25 146.03 49.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.74 . . . . 0.0 111.208 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -104.16 130.56 51.91 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.47 148.1 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 110.556 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.21 38.92 1.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.632 -0.668 . . . . 0.0 110.226 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -144.28 -52.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB3' HG22 ' A' ' 43' ' ' VAL . 4.7 mt-10 -83.92 -30.56 26.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.482 -0.761 . . . . 0.0 110.024 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 39.26 29.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' B' ' 47' ' ' GLN . 35.8 m -136.89 158.27 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.921 . . . . 0.0 109.684 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 61.6 t -98.68 130.48 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 109.504 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 15.5 ttmt -110.08 127.21 54.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.877 -0.514 . . . . 0.0 110.415 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.449 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.4 pt -121.98 146.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.403 -0.811 . . . . 0.0 110.92 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.545 ' HB3' HG12 ' B' ' 43' ' ' VAL . 17.0 pt20 -143.89 -169.58 3.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.871 -0.518 . . . . 0.0 110.186 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.135 0.493 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.75 156.3 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.402 ' CB ' HG22 ' A' ' 36' ' ' THR . 7.5 tt0 -145.47 147.13 31.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.484 -0.76 . . . . 0.0 110.59 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.4 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 1.4 mm-40 -137.95 163.88 30.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.683 -0.636 . . . . 0.0 109.903 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.84 137.89 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.688 -0.632 . . . . 0.0 110.582 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.417 HG22 ' N ' ' B' ' 8' ' ' LYS . 10.2 p -146.14 165.17 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 0.0 109.725 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.417 ' N ' HG22 ' B' ' 7' ' ' VAL . 16.2 tttp -137.03 138.4 40.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.433 -0.792 . . . . 0.0 110.518 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.46 125.17 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 109.54 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -168.75 42.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.475 -0.765 . . . . 0.0 110.43 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -139.61 -65.99 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.24 46.25 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 29' ' ' GLU . 15.2 m-85 53.44 57.57 6.05 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.492 -0.755 . . . . 0.0 110.814 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 174.78 13.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.451 -0.78 . . . . 0.0 110.822 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.64 145.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.843 -0.536 . . . . 0.0 109.666 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -110.78 -8.56 14.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 111.476 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt 59.55 111.69 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.248 -0.907 . . . . 0.0 110.592 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.76 -168.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.089 1.047 . . . . 0.0 111.324 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.78 -33.72 27.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.654 -0.654 . . . . 0.0 111.6 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -56.62 -52.15 65.96 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.14 -0.975 . . . . 0.0 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.44 -47.63 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.384 -0.823 . . . . 0.0 109.43 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.556 ' HD2' HG21 ' B' ' 27' ' ' ILE . 9.1 tpp180 -58.74 -28.78 66.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 109.938 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -45.11 80.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.459 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.61 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.13 169.87 5.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.451 -0.781 . . . . 0.0 110.827 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.41 -73.5 0.38 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.7 -0.625 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.556 HG21 ' HD2' ' B' ' 22' ' ' ARG . 46.9 mm 55.2 93.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.234 -0.916 . . . . 0.0 110.337 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 139.21 47.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 110.339 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 5.5 tt0 -67.59 112.18 4.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.515 -0.74 . . . . 0.0 110.144 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.61 4.9 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.75 163.89 18.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.715 -0.874 . . . . 0.0 110.047 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.5 107.19 19.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.614 -0.679 . . . . 0.0 110.354 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.85 141.25 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.485 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 142.03 46.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.558 -0.714 . . . . 0.0 110.28 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 5' ' ' GLU . 12.1 p -131.28 134.31 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 24.0 p -134.22 146.12 49.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -104.12 130.46 51.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.26 148.18 24.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.428 -0.795 . . . . 0.0 110.634 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.27 38.86 1.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.656 -0.652 . . . . 0.0 110.284 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -144.1 -52.78 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 110.07 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.525 ' HB3' HG22 ' B' ' 43' ' ' VAL . 4.7 mt-10 -83.82 -30.68 26.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 0.0 110.048 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.9 39.21 28.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 47' ' ' GLN . 35.6 m -136.99 158.14 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.789 -0.83 . . . . 0.0 109.635 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 61.4 t -98.54 130.35 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.314 -0.866 . . . . 0.0 109.555 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.406 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 16.8 ttmt -110.02 127.21 54.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.702 -0.624 . . . . 0.0 110.38 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.46 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.4 pt -121.75 146.93 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.423 -0.798 . . . . 0.0 110.917 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.546 ' HB3' HG12 ' A' ' 43' ' ' VAL . 17.0 pt20 -143.91 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 0.0 110.197 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 110.319 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.182 0.515 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.47 134.91 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 109.97 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.721 ' HA ' HG22 ' B' ' 36' ' ' THR . 0.2 OUTLIER -122.76 153.39 39.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.74 . . . . 0.0 110.582 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.04 162.6 41.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.647 . . . . 0.0 109.746 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 tt -134.93 154.9 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.566 -0.709 . . . . 0.0 110.703 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.36 159.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 109.973 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -156.32 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.72 . . . . 0.0 110.275 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.122 ' O ' ' N ' ' B' ' 30' ' ' GLY . 49.0 t -143.59 126.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.87 -169.21 3.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 56.88 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.8 -0.562 . . . . 0.0 111.313 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -152.42 57.73 0.82 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.975 -1.078 . . . . 0.0 110.835 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.008 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 80.3 m-85 50.8 37.38 16.83 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.327 -0.858 . . . . 0.0 111.346 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.45 173.98 6.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.453 -0.78 . . . . 0.0 110.242 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -169.5 141.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.791 . . . . 0.0 110.624 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -108.04 174.47 5.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 109.405 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.9 mm -108.54 133.47 20.6 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.386 -0.821 . . . . 0.0 110.38 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.578 ' HG2' HG23 ' A' ' 21' ' ' VAL . 33.0 Cg_endo -71.36 157.32 57.02 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 O-C-N 123.171 1.09 . . . . 0.0 110.195 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.99 57.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 110.612 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -70.86 -53.49 15.01 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.372 -0.83 . . . . 0.0 110.466 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.578 HG23 ' HG2' ' A' ' 18' ' ' PRO . 98.8 t -59.95 -43.95 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.258 -0.901 . . . . 0.0 109.32 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -59.95 -31.48 69.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.61 -52.57 50.96 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.445 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.53 -68.64 0.67 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.626 -0.671 . . . . 0.0 110.383 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.058 ' CE1' HG23 ' B' ' 44' ' ' VAL . 13.5 t80 -57.96 134.87 56.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.536 -0.728 . . . . 0.0 111.029 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -81.97 123.09 28.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.671 -0.643 . . . . 0.0 109.783 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 27' ' ' ILE . 6.9 tt -166.85 85.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.182 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 1.008 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.4 OUTLIER -95.83 178.28 5.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.294 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.632 ' HA ' HG12 ' B' ' 9' ' ' VAL . 3.5 mt-10 -66.62 135.28 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.65 -0.656 . . . . 0.0 110.606 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 1.127 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 61.16 48.66 84.65 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -106.68 -176.22 3.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -1.019 . . . . 0.0 110.165 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.434 ' HA ' HD13 ' A' ' 32' ' ' LEU . 2.0 mm? -95.9 78.84 3.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.792 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.572 HG21 ' CG2' ' B' ' 9' ' ' VAL . 63.7 t -85.6 116.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.35 142.32 32.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.669 -0.644 . . . . 0.0 109.836 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.08 122.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.56 -0.712 . . . . 0.0 109.878 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.707 HG22 ' HA ' ' B' ' 4' ' ' GLU . 68.3 p -140.55 146.79 38.53 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.311 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.421 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 12.0 t80 -105.03 142.54 34.64 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.36 145.07 27.76 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.135 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.56 32.69 2.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.007 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.63 -59.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.588 -0.695 . . . . 0.0 110.077 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -79.99 -30.02 39.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.666 . . . . 0.0 110.163 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.6 43.06 7.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.5 m -137.82 156.44 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.679 -0.894 . . . . 0.0 110.33 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.043 HG23 ' CE1' ' B' ' 25' ' ' PHE . 57.6 t -107.34 121.86 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' HG21 ' B' ' 43' ' ' VAL . 1.2 ttpt -103.67 136.96 42.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.684 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.776 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 42.9 pt -127.5 149.31 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.934 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.74 ' HB3' HG12 ' B' ' 43' ' ' VAL . 10.2 pt20 -151.79 175.1 12.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.504 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 0.0 110.713 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.099 0.476 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.55 134.91 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.543 -0.723 . . . . 0.0 110.022 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' A' ' 36' ' ' THR . 0.2 OUTLIER -122.62 153.42 39.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.558 -0.714 . . . . 0.0 110.653 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.14 162.46 41.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.719 -0.613 . . . . 0.0 109.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -134.85 154.85 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 110.783 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.33 159.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.686 -0.634 . . . . 0.0 109.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.31 -156.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.516 -0.74 . . . . 0.0 110.275 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 1.127 ' O ' ' N ' ' A' ' 30' ' ' GLY . 49.2 t -143.6 126.34 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.78 -169.18 3.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.611 -0.68 . . . . 0.0 110.404 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 56.87 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.657 -0.652 . . . . 0.0 111.309 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -152.23 57.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.102 -0.999 . . . . 0.0 110.842 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 1.008 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 81.6 m-85 50.8 37.37 16.8 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 0.0 111.397 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.4 174.13 6.02 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.439 -0.788 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.83 141.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.383 -0.823 . . . . 0.0 110.54 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -108.03 174.33 5.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.644 -0.66 . . . . 0.0 109.388 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 42.5 mm -108.35 133.47 20.56 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.587 ' HG2' HG23 ' B' ' 21' ' ' VAL . 32.8 Cg_endo -71.53 157.19 56.74 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 O-C-N 123.304 1.16 . . . . 0.0 110.155 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.72 54.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -71.05 -53.41 14.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.363 -0.836 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.587 HG23 ' HG2' ' B' ' 18' ' ' PRO . 86.7 t -59.94 -43.96 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -60.03 -31.38 69.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.77 -0.581 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.55 -52.56 51.53 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.705 -0.622 . . . . 0.0 109.481 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -68.4 0.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.639 -0.663 . . . . 0.0 110.482 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 1.043 ' CE1' HG23 ' A' ' 44' ' ' VAL . 13.8 t80 -58.21 135.02 57.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.951 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -81.99 123.03 28.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.644 -0.66 . . . . 0.0 109.815 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.631 HG23 ' O ' ' B' ' 27' ' ' ILE . 7.0 tt -166.74 85.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.271 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 1.008 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -0.843 . . . . 0.0 110.311 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.644 ' HA ' HG12 ' A' ' 9' ' ' VAL . 3.5 mt-10 -66.56 135.33 54.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.669 -0.644 . . . . 0.0 110.538 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . 1.122 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 61.25 48.67 84.31 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.463 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -106.7 -176.14 2.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -1.009 . . . . 0.0 110.177 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' B' ' 32' ' ' LEU . 2.0 mm? -95.98 78.86 3.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.589 -0.695 . . . . 0.0 109.852 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.565 HG21 ' CG2' ' A' ' 9' ' ' VAL . 64.3 t -85.52 116.98 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.643 -0.661 . . . . 0.0 110.145 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.37 142.53 32.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 109.779 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.3 122.12 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.395 -0.815 . . . . 0.0 109.73 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 4' ' ' GLU . 70.5 p -140.54 146.85 38.64 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -0.823 . . . . 0.0 111.269 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.428 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 11.9 t80 -105.11 142.55 34.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 145.02 27.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.405 -0.809 . . . . 0.0 110.184 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.6 32.6 2.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.706 . . . . 0.0 109.957 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.61 -59.32 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.702 -0.624 . . . . 0.0 110.065 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -80.11 -30.05 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 110.105 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.67 42.97 7.5 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.7 m -137.68 156.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.584 -0.95 . . . . 0.0 110.295 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 1.058 HG23 ' CE1' ' A' ' 25' ' ' PHE . 57.5 t -107.38 121.64 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 43' ' ' VAL . 1.3 ttpt -103.49 136.8 42.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.687 -0.633 . . . . 0.0 110.665 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.754 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 42.5 pt -127.28 149.35 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.767 -0.583 . . . . 0.0 109.99 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.728 ' HB3' HG12 ' A' ' 43' ' ' VAL . 10.2 pt20 -151.66 175.13 12.68 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 0.0 110.495 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.599 -0.688 . . . . 0.0 110.723 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.163 0.506 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.75 139.8 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.666 -0.647 . . . . 0.0 109.968 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.14 150.4 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.6 -0.688 . . . . 0.0 110.168 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -156.81 161.88 39.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.624 -0.673 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.4 mt -131.25 136.61 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.585 -0.697 . . . . 0.0 110.216 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.69 170.07 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.748 -0.595 . . . . 0.0 109.785 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.69 152.16 35.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.424 -0.798 . . . . 0.0 110.772 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.86 ' O ' ' N ' ' B' ' 30' ' ' GLY . 62.7 t -101.71 136.31 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.74 -0.6 . . . . 0.0 109.591 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.6 p -157.15 -47.01 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.524 -0.735 . . . . 0.0 110.411 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -147.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.652 -0.655 . . . . 0.0 110.182 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.97 60.98 1.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 111.1 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.928 ' CD2' ' O ' ' B' ' 27' ' ' ILE . 27.1 m-85 50.59 32.16 6.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.38 -0.825 . . . . 0.0 111.826 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -88.42 174.64 8.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.299 -0.876 . . . . 0.0 110.101 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.11 135.5 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.022 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.2 m -100.61 150.51 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 110.364 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.3 mt -101.7 128.95 27.68 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.584 -0.698 . . . . 0.0 109.67 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.1 158.44 25.66 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.121 1.063 . . . . 0.0 110.72 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.14 77.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.639 -0.663 . . . . 0.0 109.874 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.49 -51.91 56.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.643 -0.661 . . . . 0.0 109.571 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.77 -39.26 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.05 -30.07 70.53 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.68 25.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.603 -0.686 . . . . 0.0 109.433 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -79.62 -63.34 1.44 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.684 -0.635 . . . . 0.0 109.846 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.817 ' CE1' HG23 ' B' ' 44' ' ' VAL . 6.4 t80 -53.53 115.24 1.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.268 -0.895 . . . . 0.0 110.695 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.449 ' O ' HD22 ' A' ' 48' ' ' LEU . 12.4 mt-30 -73.77 131.17 41.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.558 -0.714 . . . . 0.0 110.358 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.946 ' O ' ' CD2' ' B' ' 13' ' ' TYR . 6.8 tt -167.56 91.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.64 0.733 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.752 ' HA ' ' CE2' ' B' ' 13' ' ' TYR . 8.3 tttt -99.1 -179.65 4.32 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.262 -0.899 . . . . 0.0 110.997 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.579 ' HA ' HG12 ' B' ' 9' ' ' VAL . 23.5 mt-10 -75.48 127.08 32.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.973 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.842 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 90.97 26.39 22.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.767 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -103.74 149.55 24.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.538 -0.978 . . . . 0.0 109.776 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.3 mt -101.43 74.59 1.55 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.695 . . . . 0.0 110.708 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.32 151.09 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.426 -0.796 . . . . 0.0 109.569 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -106.61 154.95 20.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.836 . . . . 0.0 111.145 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.695 ' HA ' HG22 ' A' ' 46' ' ' ILE . 8.4 p -145.21 125.83 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.0 p -130.98 146.95 52.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.865 . . . . 0.0 111.508 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 40.0 t80 -106.49 149.97 26.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -110.07 -167.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.13 -38.71 1.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.7 . . . . 0.0 110.597 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.97 -40.11 12.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 110.598 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' A' ' 43' ' ' VAL . 13.8 mp0 -81.66 -37.2 27.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.697 . . . . 0.0 110.537 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.07 72.11 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.889 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 24.7 m -121.21 149.77 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.447 -1.031 . . . . 0.0 109.661 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.901 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 90.3 t -103.62 129.28 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.418 -0.802 . . . . 0.0 109.675 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.938 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 3.8 ttpm? -109.07 130.96 55.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.217 0.532 . . . . 0.0 109.737 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.903 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 10.8 pt -126.53 145.14 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.73 -0.606 . . . . 0.0 110.086 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.847 ' HB3' HG12 ' B' ' 43' ' ' VAL . 4.0 pt20 -148.96 171.08 16.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 110.303 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 26' ' ' GLN . 1.7 tp . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.05 0.452 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.57 139.95 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.642 -0.661 . . . . 0.0 109.982 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.2 150.57 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.711 -0.618 . . . . 0.0 110.137 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -156.97 161.85 39.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.745 -0.597 . . . . 0.0 109.589 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.26 136.62 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -126.9 169.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.692 -0.63 . . . . 0.0 109.71 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.61 152.04 35.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.518 -0.739 . . . . 0.0 110.787 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.842 ' O ' ' N ' ' A' ' 30' ' ' GLY . 62.8 t -101.59 136.26 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.665 . . . . 0.0 109.61 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.4 p -157.23 -46.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.746 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.41 ' HB3' ' HG2' ' B' ' 14' ' ' GLN . 0.3 OUTLIER -69.72 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.657 -0.652 . . . . 0.0 110.222 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.9 60.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.093 -1.005 . . . . 0.0 111.213 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.946 ' CD2' ' O ' ' A' ' 27' ' ' ILE . 27.0 m-85 50.61 32.09 6.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.364 -0.835 . . . . 0.0 111.902 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.41 ' HG2' ' HB3' ' B' ' 11' ' ' ARG . 17.1 pt20 -88.43 174.56 8.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.99 135.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.46 -0.775 . . . . 0.0 109.918 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 m -100.58 150.53 22.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 110.299 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 89.5 mt -101.67 129.0 27.61 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.22 158.52 25.91 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.115 1.061 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.0 77.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -51.65 58.18 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.574 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 83.7 t -62.04 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -66.01 -30.18 70.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.59 26.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.708 -0.62 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.61 -63.37 1.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.741 -0.599 . . . . 0.0 109.887 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.802 ' CE1' HG23 ' A' ' 44' ' ' VAL . 6.3 t80 -53.45 115.21 1.82 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.441 ' O ' HD22 ' B' ' 48' ' ' LEU . 12.3 mt-30 -73.83 131.29 41.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.648 -0.658 . . . . 0.0 110.309 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.928 ' O ' ' CD2' ' A' ' 13' ' ' TYR . 6.8 tt -167.64 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.548 0.69 . . . . 0.0 109.557 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.744 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 7.6 tttt -98.99 -179.77 4.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 111.005 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.582 ' HA ' HG12 ' A' ' 9' ' ' VAL . 23.3 mt-10 -75.41 127.12 32.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.638 . . . . 0.0 109.961 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 91.02 26.36 22.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.767 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -103.78 149.44 25.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.972 . . . . 0.0 109.825 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 74.53 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.656 -0.652 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.44 151.19 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.517 -0.739 . . . . 0.0 109.516 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -106.79 154.93 20.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.337 -0.852 . . . . 0.0 111.141 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.691 ' HA ' HG22 ' B' ' 46' ' ' ILE . 8.2 p -145.17 125.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -130.99 146.97 52.56 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.591 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.575 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 39.8 t80 -106.46 149.95 26.56 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.9 -167.21 1.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.642 -0.661 . . . . 0.0 110.272 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.03 -38.64 1.42 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.633 -0.667 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.05 -40.08 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -0.8 . . . . 0.0 110.604 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' B' ' 43' ' ' VAL . 13.6 mp0 -81.77 -37.2 27.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 110.446 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.87 26.29 71.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.938 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 25.5 m -121.32 149.58 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -1.047 . . . . 0.0 109.686 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.903 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 92.3 t -103.62 129.19 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 109.773 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.889 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 3.8 ttpm? -109.09 130.85 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.783 -0.573 . . . . 0.0 109.833 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.901 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 10.8 pt -126.25 145.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.788 -0.57 . . . . 0.0 110.178 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.844 ' HB3' HG12 ' A' ' 43' ' ' VAL . 3.9 pt20 -149.01 171.02 17.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.247 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.441 HD22 ' O ' ' B' ' 26' ' ' GLN . 1.8 tp . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 109.721 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.166 0.508 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.5 t -122.36 150.69 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.55 -0.719 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.569 ' CB ' HG22 ' B' ' 36' ' ' THR . 1.2 pt-20 -156.27 142.94 18.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.491 -0.756 . . . . 0.0 110.736 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.61 166.86 29.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.8 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.0 mt -119.65 126.4 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.478 -0.764 . . . . 0.0 110.226 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.451 HG22 ' N ' ' A' ' 8' ' ' LYS . 12.3 p -127.46 167.3 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.56 -0.712 . . . . 0.0 110.072 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 7' ' ' VAL . 6.9 ttmt -116.29 138.18 51.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.479 -0.763 . . . . 0.0 110.43 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 10' ' ' SER . 59.1 t -78.04 167.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 109.483 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' B' ' 29' ' ' GLU . 11.5 t -170.2 -66.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.33 -0.856 . . . . 0.0 111.164 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . 3.6 mtt180 -58.08 -166.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.612 -0.68 . . . . 0.0 110.765 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -66.56 76.01 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.674 -0.641 . . . . 0.0 110.801 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 51.84 30.0 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.262 -0.899 . . . . 0.0 111.521 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 11' ' ' ARG . 31.2 mt-30 -89.29 150.61 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.46 -0.775 . . . . 0.0 109.946 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.3 t -121.72 142.56 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 110.693 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.66 132.77 55.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 109.573 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.57 131.25 28.62 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.43 -0.794 . . . . 0.0 109.829 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.04 150.16 74.89 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.044 1.023 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.61 63.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.548 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -67.29 -45.75 75.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.542 -0.724 . . . . 0.0 109.839 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.8 -41.05 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -65.48 -33.6 76.32 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -42.14 96.77 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -80.45 -68.79 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.87 ' CE1' HG23 ' B' ' 44' ' ' VAL . 2.5 t80 -64.17 126.1 26.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.721 -0.612 . . . . 0.0 110.596 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.5 112.06 17.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.581 -0.699 . . . . 0.0 109.294 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 27' ' ' ILE . 4.3 tt -154.04 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.73 0.776 . . . . 0.0 109.452 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HA ' ' CE1' ' B' ' 13' ' ' TYR . 25.8 mttm -101.51 -170.9 1.89 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.429 -0.794 . . . . 0.0 111.438 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' B' ' 10' ' ' SER . 5.2 tt0 -74.21 139.84 44.67 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.279 0.562 . . . . 0.0 110.785 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.68 28.22 65.67 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.5 159.72 15.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -1.028 . . . . 0.0 110.283 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 64.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 110.054 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.409 HG13 HG13 ' B' ' 7' ' ' VAL . 9.9 p -75.01 150.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.743 . . . . 0.0 110.265 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' B' ' 5' ' ' GLU . 32.4 tttt -127.87 136.12 50.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 110.297 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 46' ' ' ILE . 57.8 t -107.69 129.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.665 -0.647 . . . . 0.0 109.824 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.562 HG22 ' CB ' ' B' ' 4' ' ' GLU . 65.4 p -137.88 147.45 44.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.757 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -115.21 144.72 43.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.676 -0.64 . . . . 0.0 109.332 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.35 -174.22 2.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.44 42.01 2.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.561 -0.712 . . . . 0.0 110.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.36 -52.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 110.56 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -115.41 -61.61 1.72 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.745 . . . . 0.0 110.344 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.32 59.18 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' B' ' 47' ' ' GLN . 32.9 m -140.78 149.54 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.569 -0.959 . . . . 0.0 110.145 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.863 HG23 ' CE1' ' B' ' 25' ' ' PHE . 51.1 t -103.28 133.17 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.392 -0.817 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 2.8 ttpt -109.42 136.63 48.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.727 -0.608 . . . . 0.0 110.036 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.555 HG22 ' HA ' ' A' ' 35' ' ' VAL . 5.3 pt -131.45 150.25 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.401 -0.812 . . . . 0.0 111.21 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.428 ' HB3' HG12 ' B' ' 43' ' ' VAL . 28.1 pt20 -145.35 -167.9 2.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 0.0 109.594 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.61 HD11 HD12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.256 -0.903 . . . . 0.0 111.191 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.026 0.441 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 66.4 t -122.13 150.98 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.654 -0.654 . . . . 0.0 109.652 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.562 ' CB ' HG22 ' A' ' 36' ' ' THR . 1.2 pt-20 -156.65 142.77 18.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.722 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 2.5 mp0 -151.46 166.93 29.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.588 -0.695 . . . . 0.0 109.837 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.1 mt -119.58 126.62 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.513 -0.742 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.45 HG22 ' N ' ' B' ' 8' ' ' LYS . 13.9 p -127.64 167.06 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.558 -0.714 . . . . 0.0 110.171 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.45 ' N ' HG22 ' B' ' 7' ' ' VAL . 6.9 ttmt -116.28 138.13 51.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.527 -0.733 . . . . 0.0 110.468 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.465 HG12 ' N ' ' B' ' 10' ' ' SER . 58.7 t -78.1 167.67 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.471 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.511 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 11.2 t -170.21 -65.96 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' B' ' 14' ' ' GLN . 3.6 mtt180 -58.01 -166.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -66.52 76.0 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.66 . . . . 0.0 110.871 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 28' ' ' LYS . 92.0 m-85 51.93 29.89 6.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.433 -0.792 . . . . 0.0 111.52 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' B' ' 11' ' ' ARG . 31.1 mt-30 -89.07 150.64 22.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.99 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.91 142.5 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.618 -0.676 . . . . 0.0 110.676 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.61 132.78 55.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.731 -0.606 . . . . 0.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 59.4 mt -96.62 131.19 28.69 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.585 -0.697 . . . . 0.0 109.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.79 150.07 73.5 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.079 1.042 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.67 -30.68 63.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.474 -0.766 . . . . 0.0 110.496 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -67.3 -45.74 75.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.514 -0.741 . . . . 0.0 109.773 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 65.5 t -62.83 -41.17 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.469 -0.769 . . . . 0.0 109.001 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -65.26 -33.72 76.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.696 -0.627 . . . . 0.0 109.365 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -80.47 -68.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.863 ' CE1' HG23 ' A' ' 44' ' ' VAL . 2.5 t80 -64.42 126.21 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.688 -0.633 . . . . 0.0 110.524 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 112.09 17.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 109.327 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.638 HG23 ' O ' ' B' ' 27' ' ' ILE . 5.2 tt -154.16 91.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.76 0.79 . . . . 0.0 109.509 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -101.49 -170.92 1.9 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 111.543 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 10' ' ' SER . 5.2 tt0 -74.07 139.75 44.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.799 -0.563 . . . . 0.0 110.868 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.48 28.54 65.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.61 159.76 15.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -1.0 . . . . 0.0 110.238 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.46 64.78 1.88 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.06 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.43 HG13 HG13 ' A' ' 7' ' ' VAL . 10.1 p -75.12 150.74 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.618 -0.676 . . . . 0.0 110.25 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 31.9 tttt -127.82 136.01 50.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' B' ' 46' ' ' ILE . 58.3 t -107.66 130.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.827 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.569 HG22 ' CB ' ' A' ' 4' ' ' GLU . 65.5 p -137.96 147.32 44.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 110.894 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -115.06 144.67 43.27 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.24 -174.13 2.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 110.303 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.47 42.05 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.448 -0.782 . . . . 0.0 110.056 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.4 -52.13 1.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.526 -0.734 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -115.61 -61.79 1.69 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.558 -0.714 . . . . 0.0 110.241 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.35 59.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.428 HG12 ' HB3' ' A' ' 47' ' ' GLN . 32.7 m -140.72 149.46 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.621 -0.929 . . . . 0.0 110.13 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.87 HG23 ' CE1' ' A' ' 25' ' ' PHE . 50.4 t -103.2 132.98 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 110.119 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.8 ttpt -109.26 136.52 48.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.658 -0.651 . . . . 0.0 110.135 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' B' ' 35' ' ' VAL . 5.3 pt -131.29 150.11 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.455 -0.778 . . . . 0.0 111.261 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.416 ' HB3' HG12 ' A' ' 43' ' ' VAL . 28.0 pt20 -145.1 -167.8 2.77 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.585 -0.697 . . . . 0.0 109.654 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.553 HD11 HD12 ' B' ' 27' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.238 -0.914 . . . . 0.0 111.337 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.146 0.498 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.2 m -123.64 152.7 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.554 -0.716 . . . . 0.0 109.572 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.495 ' CB ' HG22 ' B' ' 36' ' ' THR . 8.0 pt-20 -144.06 153.91 42.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.783 . . . . 0.0 111.046 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -134.06 147.16 50.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.696 HG23 HD21 ' B' ' 32' ' ' LEU . 89.3 mt -111.28 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 110.677 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.17 151.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.65 12.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.526 -0.733 . . . . 0.0 110.72 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.86 HG23 ' O ' ' B' ' 31' ' ' ASP . 76.4 t -75.45 142.29 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.758 -0.589 . . . . 0.0 109.916 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -172.78 3.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 110.0 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 56.58 -86.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.712 -0.617 . . . . 0.0 110.526 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.1 78.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.926 -1.109 . . . . 0.0 109.043 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.79 14.62 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.368 -0.833 . . . . 0.0 109.83 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.06 157.16 26.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.604 -0.685 . . . . 0.0 110.823 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.94 138.47 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.655 -0.653 . . . . 0.0 109.385 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -120.78 152.81 37.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.497 -0.752 . . . . 0.0 110.886 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -97.3 119.59 62.73 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.708 -0.62 . . . . 0.0 109.5 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.21 -174.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.067 1.035 . . . . 0.0 110.622 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.49 25.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.564 -0.71 . . . . 0.0 110.44 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -48.4 42.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 109.982 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.24 -41.63 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.655 -0.653 . . . . 0.0 109.426 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.74 -38.29 81.33 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -36.02 81.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.596 -0.69 . . . . 0.0 109.757 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -76.45 -69.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.934 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.4 OUTLIER -65.02 149.9 49.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.645 -0.66 . . . . 0.0 109.923 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.88 -80.25 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.752 . . . . 0.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' A' ' 25' ' ' PHE . 94.9 mt 50.18 88.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.144 -0.972 . . . . 0.0 110.947 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.637 ' O ' HG11 ' B' ' 9' ' ' VAL . 11.7 tptt -109.34 168.09 9.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.589 -0.694 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -69.35 123.7 21.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.587 -0.696 . . . . 0.0 110.024 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.497 ' H ' ' HB ' ' B' ' 9' ' ' VAL . . . 85.47 37.51 9.63 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.884 ' O ' HG23 ' B' ' 9' ' ' VAL . 2.6 m-20 -115.53 133.03 56.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.528 -0.984 . . . . 0.0 110.193 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HG23 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -69.19 112.25 5.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 48' ' ' LEU . 59.9 t -107.62 151.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.593 -0.692 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -125.0 128.09 48.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.21 128.79 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.483 HG22 ' CB ' ' B' ' 4' ' ' GLU . 69.2 p -136.65 153.0 51.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.257 -0.902 . . . . 0.0 111.872 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 36.6 t80 -124.95 143.79 50.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -117.55 155.96 28.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.438 -0.789 . . . . 0.0 110.894 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -101.37 19.92 16.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.78 -0.575 . . . . 0.0 110.703 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -118.61 -28.48 5.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 110.601 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -105.41 -58.89 1.84 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.402 -0.811 . . . . 0.0 110.296 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.84 33.17 2.68 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' B' ' 47' ' ' GLN . 33.9 m -141.48 162.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.676 -0.896 . . . . 0.0 109.938 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.917 HG23 ' CE2' ' B' ' 25' ' ' PHE . 37.0 t -112.04 123.85 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.33 -0.856 . . . . 0.0 109.981 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 1.5 ttpm? -105.39 150.37 25.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.837 -0.54 . . . . 0.0 109.813 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.885 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.7 pp -136.98 155.86 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.833 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.641 ' HB3' HG12 ' B' ' 43' ' ' VAL . 1.8 pt20 -154.98 -174.78 5.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.904 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.41 HD11 HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.492 -0.755 . . . . 0.0 110.68 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.155 0.502 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.64 152.73 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.51 -0.744 . . . . 0.0 109.552 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.483 ' CB ' HG22 ' A' ' 36' ' ' THR . 8.0 pt-20 -144.1 153.81 42.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.386 -0.821 . . . . 0.0 111.009 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.87 147.14 51.12 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.658 HG23 HD21 ' A' ' 32' ' ' LEU . 89.2 mt -111.24 116.03 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.739 . . . . 0.0 110.679 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.29 151.15 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.63 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 31' ' ' ASP . 69.0 t -75.43 142.18 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.754 -0.591 . . . . 0.0 109.981 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.9 t -159.22 -172.71 3.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.694 . . . . 0.0 109.93 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 56.46 -86.39 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.686 -0.634 . . . . 0.0 110.52 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.19 78.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.045 -1.035 . . . . 0.0 109.17 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.76 14.68 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.344 -0.848 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -117.08 157.15 26.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.582 -0.699 . . . . 0.0 110.786 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -137.9 138.28 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.746 -0.596 . . . . 0.0 109.459 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.5 p -120.62 152.74 37.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 0.0 110.916 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -97.21 119.56 62.93 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.791 -0.568 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.16 -174.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.06 1.031 . . . . 0.0 110.591 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.56 25.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.704 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -48.18 44.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.49 -41.5 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.555 -0.715 . . . . 0.0 109.466 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.64 -38.28 80.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.564 -0.71 . . . . 0.0 109.712 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -36.08 82.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.57 -0.706 . . . . 0.0 109.639 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -76.51 -69.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.781 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.917 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -65.33 150.0 49.02 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 109.887 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.96 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.538 -0.726 . . . . 0.0 109.906 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' B' ' 25' ' ' PHE . 94.9 mt 50.14 88.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.262 -0.899 . . . . 0.0 110.97 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.638 ' O ' HG11 ' A' ' 9' ' ' VAL . 11.8 tptt -109.4 168.05 9.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.601 -0.687 . . . . 0.0 110.071 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -69.37 123.75 22.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.738 . . . . 0.0 110.077 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . 0.498 ' H ' ' HB ' ' A' ' 9' ' ' VAL . . . 85.64 37.32 9.62 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.6 m-20 -115.61 132.9 56.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.588 -0.948 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -69.01 112.41 5.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.522 -0.737 . . . . 0.0 110.022 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.59 151.15 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -124.96 127.8 47.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.324 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -114.99 128.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.495 HG22 ' CB ' ' A' ' 4' ' ' GLU . 71.3 p -136.53 152.94 51.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 111.863 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.62 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 37.1 t80 -124.83 143.62 50.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -117.43 155.84 28.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.482 -0.761 . . . . 0.0 110.868 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -101.46 19.97 16.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.736 -0.603 . . . . 0.0 110.69 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -118.57 -28.7 5.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.358 -0.839 . . . . 0.0 110.616 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -105.36 -58.75 1.85 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.504 -0.747 . . . . 0.0 110.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.77 33.22 2.69 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.0 m -141.48 162.69 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.954 . . . . 0.0 109.831 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.934 HG23 ' CE2' ' A' ' 25' ' ' PHE . 37.8 t -112.11 123.67 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 0.0 109.922 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.5 ttpm? -105.45 150.08 25.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.713 -0.617 . . . . 0.0 109.874 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.861 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.7 pp -136.6 155.96 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.56 -0.713 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.631 ' HB3' HG12 ' A' ' 43' ' ' VAL . 1.8 pt20 -154.92 -174.73 5.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.79 -0.569 . . . . 0.0 110.042 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.436 -0.79 . . . . 0.0 110.713 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.121 0.486 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.96 126.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.596 -0.69 . . . . 0.0 109.848 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.87 147.57 51.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.616 -0.678 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.17 146.38 18.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.708 . . . . 0.0 110.311 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 pt -112.62 150.35 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.63 -0.669 . . . . 0.0 110.218 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.6 m -136.52 150.6 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.625 -0.672 . . . . 0.0 110.267 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -94.06 138.04 32.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.136 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.537 HG11 ' O ' ' B' ' 28' ' ' LYS . 60.6 t -77.04 145.05 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 110.096 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -158.1 -55.4 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.579 -0.701 . . . . 0.0 110.219 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -168.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.666 -0.646 . . . . 0.0 110.033 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -77.93 67.84 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.51 -0.744 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.475 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 93.7 m-85 53.29 45.33 28.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -0.771 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.03 174.24 6.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.488 -0.758 . . . . 0.0 109.53 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.36 153.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.678 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 16' ' ' THR . 7.1 t -150.18 115.31 5.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.829 -0.545 . . . . 0.0 109.536 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.1 mt -71.73 143.01 86.55 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.545 -0.722 . . . . 0.0 110.204 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -61.23 -175.81 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.001 0 O-C-N 123.201 1.106 . . . . 0.0 110.216 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.07 -29.96 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 110.199 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.54 -48.26 49.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.539 -0.726 . . . . 0.0 110.012 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.43 -45.42 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.55 -0.719 . . . . 0.0 109.477 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.66 -32.31 73.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.513 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -63.61 -36.12 82.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 109.535 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -78.86 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.794 -0.566 . . . . 0.0 109.767 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.864 ' CE2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.47 159.58 6.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -80.72 -82.82 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.379 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.414 ' O ' ' HE2' ' B' ' 13' ' ' TYR . 45.3 mt 51.28 87.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.167 -0.958 . . . . 0.0 110.519 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.539 ' O ' HG11 ' B' ' 9' ' ' VAL . 29.8 mtmt -107.05 -171.45 1.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.525 -0.734 . . . . 0.0 110.515 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -79.67 137.01 36.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.478 ' N ' ' HB ' ' B' ' 9' ' ' VAL . . . 58.45 44.09 95.51 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.953 . . . . 0.0 110.113 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.77 2.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 110.609 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.749 HG13 HD11 ' A' ' 46' ' ' ILE . 64.9 t -67.26 133.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 109.218 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -125.07 129.25 49.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.452 -0.78 . . . . 0.0 110.975 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 46' ' ' ILE . 61.7 t -123.72 129.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -138.17 148.38 44.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.375 -0.828 . . . . 0.0 111.235 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.87 ' CE1' ' CE2' ' B' ' 25' ' ' PHE . 47.9 t80 -113.92 135.65 53.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.32 162.7 12.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.762 . . . . 0.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.37 32.62 4.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.3 p -118.7 -60.69 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 110.102 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -87.03 -50.14 6.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 0.0 110.151 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.61 36.5 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.805 HG21 ' HD3' ' B' ' 45' ' ' LYS . 35.2 m -133.27 159.68 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -1.01 . . . . 0.0 110.342 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.004 ' HB ' ' CG2' ' B' ' 46' ' ' ILE . 45.6 t -103.23 127.51 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.667 . . . . 0.0 109.403 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.83 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 14.5 ttmt -112.13 125.54 54.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.632 . . . . 0.0 110.571 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.029 ' CG2' ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -113.04 138.66 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.687 . . . . 0.0 109.489 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.838 ' N ' HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -151.08 171.86 16.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.708 -0.62 . . . . 0.0 109.971 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.175 0.512 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.76 126.43 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.531 -0.731 . . . . 0.0 109.957 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -129.9 147.63 51.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.23 146.22 18.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.321 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.45 150.2 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.567 -0.708 . . . . 0.0 110.195 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.41 150.56 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.488 -0.757 . . . . 0.0 110.254 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.98 138.02 32.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.683 . . . . 0.0 110.2 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 28' ' ' LYS . 59.7 t -77.0 144.93 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.576 -0.703 . . . . 0.0 110.175 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -157.99 -55.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.591 -0.693 . . . . 0.0 110.278 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -168.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 0.0 110.112 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -78.08 67.92 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.717 . . . . 0.0 110.107 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.503 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 93.8 m-85 53.29 45.4 28.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 111.184 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.18 174.16 6.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.26 153.16 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.401 -0.812 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.574 HG23 ' O ' ' B' ' 16' ' ' THR . 7.2 t -150.22 115.22 5.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.68 -0.638 . . . . 0.0 109.508 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 80.9 mt -71.74 143.11 86.65 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.504 -0.748 . . . . 0.0 110.224 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.3 -175.91 0.15 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 O-C-N 123.1 1.053 . . . . 0.0 110.055 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.08 -29.74 24.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.582 -0.698 . . . . 0.0 110.242 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.65 -48.16 49.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.535 -0.728 . . . . 0.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.43 -45.48 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 0.0 109.492 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -65.71 -32.23 73.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.635 . . . . 0.0 109.562 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -63.62 -36.09 82.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.679 . . . . 0.0 109.474 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -79.03 -62.62 1.64 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.722 -0.611 . . . . 0.0 109.774 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.73 159.57 6.6 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.735 . . . . 0.0 110.015 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -80.69 -82.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.483 -0.76 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' B' ' 25' ' ' PHE . 45.5 mt 51.25 87.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.063 -1.023 . . . . 0.0 110.486 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.537 ' O ' HG11 ' A' ' 9' ' ' VAL . 29.8 mtmt -107.19 -171.35 1.87 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.578 -0.702 . . . . 0.0 110.497 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -79.69 136.98 36.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . 0.485 ' N ' ' HB ' ' A' ' 9' ' ' VAL . . . 58.44 44.15 95.45 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.944 . . . . 0.0 110.142 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.57 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 110.684 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.744 HG13 HD11 ' B' ' 46' ' ' ILE . 62.1 t -66.95 133.71 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.486 -0.758 . . . . 0.0 109.344 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -125.16 129.27 49.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -0.758 . . . . 0.0 111.04 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.674 HG22 HG12 ' B' ' 46' ' ' ILE . 62.0 t -123.74 129.28 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -138.19 148.42 44.82 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.402 -0.811 . . . . 0.0 111.272 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 25' ' ' PHE . 48.2 t80 -113.92 135.62 53.78 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.34 162.62 13.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.596 -0.69 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.34 32.6 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.627 -0.671 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.7 p -118.6 -60.62 1.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.619 -0.676 . . . . 0.0 110.069 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.15 -50.1 6.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.41 2.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.83 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 35.3 m -133.25 159.7 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.536 -0.979 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 1.029 ' HB ' ' CG2' ' A' ' 46' ' ' ILE . 45.9 t -103.26 127.51 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.527 -0.733 . . . . 0.0 109.409 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.808 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 14.8 ttmt -112.08 125.32 53.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.671 -0.643 . . . . 0.0 110.552 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 1.004 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -112.79 138.6 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.654 -0.654 . . . . 0.0 109.542 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.832 ' N ' HD13 ' B' ' 46' ' ' ILE . 0.2 OUTLIER -151.04 171.86 16.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.203 0.525 . . . . 0.0 109.916 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.79 119.83 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -0.75 . . . . 0.0 109.559 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -120.35 126.61 50.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 0.0 110.876 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.58 152.15 45.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.666 -0.646 . . . . 0.0 109.334 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.93 134.01 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.443 -0.786 . . . . 0.0 110.526 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.49 148.91 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 0.0 109.42 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.59 179.99 3.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 110.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.852 HG21 ' HB3' ' B' ' 31' ' ' ASP . 57.6 t -106.75 165.43 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.614 -0.679 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.444 ' N ' HG12 ' A' ' 9' ' ' VAL . 77.1 p -102.87 -163.64 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.516 -0.74 . . . . 0.0 110.249 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.718 ' HG2' ' OE2' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -102.02 -25.34 13.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.748 . . . . 0.0 110.337 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.93 29.85 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 0.0 110.442 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.559 ' HE1' ' HA ' ' B' ' 28' ' ' LYS . 64.4 m-85 52.39 25.81 3.72 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.443 -0.786 . . . . 0.0 110.983 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -104.33 151.28 23.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.515 -0.741 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.93 146.07 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.594 -0.691 . . . . 0.0 110.114 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.5 p -110.72 123.94 51.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.689 -0.632 . . . . 0.0 109.756 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.7 mt -66.39 116.34 32.93 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.743 . . . . 0.0 109.711 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.3 169.17 4.11 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.156 1.082 . . . . 0.0 110.477 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.14 68.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.572 -0.705 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.85 -59.83 4.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.431 -0.793 . . . . 0.0 110.312 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.91 -40.78 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.379 -0.826 . . . . 0.0 109.22 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.32 -29.97 68.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.717 -0.614 . . . . 0.0 109.549 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -45.66 56.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.65 -69.13 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.661 -0.649 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.685 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.3 OUTLIER -73.44 151.3 41.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 109.659 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -81.37 -81.28 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.209 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 25' ' ' PHE . 15.5 mt 54.49 93.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HA ' ' HE1' ' B' ' 13' ' ' TYR . 0.2 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 0.0 110.453 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.717 ' OE2' ' HG2' ' B' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.82 27.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.711 . . . . 0.0 110.411 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.34 50.9 4.87 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.847 ' HB3' HG21 ' B' ' 9' ' ' VAL . 3.2 t70 -110.06 155.68 21.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.487 -1.008 . . . . 0.0 110.266 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.29 52.34 0.84 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 109.706 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 46' ' ' ILE . 35.9 m -61.12 170.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 0.0 110.404 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.3 122.03 7.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.69 144.31 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 109.141 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.9 p -138.79 150.53 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.218 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.7 t80 -134.46 147.13 50.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -122.04 178.45 4.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -0.785 . . . . 0.0 110.457 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.01 44.26 2.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.9 p -147.18 -52.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.017 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -40.43 21.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.732 -0.605 . . . . 0.0 109.754 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 32.96 17.51 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.765 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 33.0 m -131.61 156.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.05 ' HB ' HG22 ' B' ' 46' ' ' ILE . 56.3 t -104.2 133.81 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.506 -0.746 . . . . 0.0 109.455 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.766 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 0.2 OUTLIER -112.47 129.49 56.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.754 -0.591 . . . . 0.0 110.263 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.039 HG22 ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -123.51 139.44 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 109.861 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.862 ' N ' HD13 ' A' ' 46' ' ' ILE . 3.4 pm0 -158.62 -175.33 5.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 110.139 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' CD1' HG12 ' A' ' 33' ' ' VAL . 1.4 mp . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.19 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.202 0.525 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.85 119.9 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -120.43 126.59 50.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.477 -0.764 . . . . 0.0 110.979 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.51 152.08 45.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.674 -0.641 . . . . 0.0 109.303 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.82 134.04 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.531 -0.731 . . . . 0.0 110.537 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.9 t -137.44 148.96 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.714 -0.616 . . . . 0.0 109.485 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.76 179.9 3.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.431 -0.793 . . . . 0.0 110.326 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 31' ' ' ASP . 58.0 t -106.77 165.55 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.586 -0.696 . . . . 0.0 110.182 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.429 ' N ' HG12 ' B' ' 9' ' ' VAL . 78.0 p -102.92 -163.67 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.537 -0.727 . . . . 0.0 110.237 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.717 ' HG2' ' OE2' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -102.05 -25.33 13.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.611 -0.681 . . . . 0.0 110.255 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.92 29.8 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.456 -0.778 . . . . 0.0 110.374 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.583 ' HE1' ' HA ' ' A' ' 28' ' ' LYS . 64.5 m-85 52.35 25.74 3.65 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.463 -0.773 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.23 151.32 23.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.687 . . . . 0.0 109.883 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.99 146.07 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.601 -0.687 . . . . 0.0 110.159 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -110.77 123.95 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.36 116.28 32.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.29 169.03 4.21 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.143 1.075 . . . . 0.0 110.545 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.08 68.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 0.0 110.227 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -59.88 4.72 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.498 -0.751 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 109.229 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.27 -29.97 67.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -45.69 56.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.69 -68.97 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.635 -0.666 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.687 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -73.68 151.34 40.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.613 -0.679 . . . . 0.0 109.572 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -81.31 -81.4 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 111.22 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' B' ' 25' ' ' PHE . 15.5 mt 54.66 93.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.044 -1.035 . . . . 0.0 110.049 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.564 ' O ' HG11 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.612 -0.68 . . . . 0.0 110.436 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.718 ' OE2' ' HG2' ' A' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.79 27.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 110.358 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.45 50.88 4.86 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.852 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.2 t70 -110.13 155.64 21.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -1.034 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.25 52.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.489 -0.757 . . . . 0.0 109.865 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.604 ' HB ' HD11 ' B' ' 46' ' ' ILE . 35.7 m -60.9 170.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.605 -0.685 . . . . 0.0 110.481 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.18 122.19 7.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.685 -0.635 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 62.8 t -98.85 144.25 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.488 -0.758 . . . . 0.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -138.75 150.66 46.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.419 -0.8 . . . . 0.0 111.151 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.685 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 35.8 t80 -134.64 147.05 50.09 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -121.92 178.54 4.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.457 -0.777 . . . . 0.0 110.485 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.1 44.33 2.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.169 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 85.6 p -147.32 -52.12 0.2 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.971 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.44 -40.45 21.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.85 17.71 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.766 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 32.9 m -131.53 156.95 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -1.041 . . . . 0.0 110.337 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 1.039 ' HB ' HG22 ' A' ' 46' ' ' ILE . 53.4 t -104.17 133.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.495 -0.753 . . . . 0.0 109.525 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.765 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -112.42 129.34 56.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 -179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 1.05 HG22 ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.25 139.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.575 -0.703 . . . . 0.0 109.921 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.86 ' N ' HD13 ' B' ' 46' ' ' ILE . 3.4 pm0 -158.73 -175.46 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.171 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.41 ' CD1' HG12 ' B' ' 33' ' ' VAL . 1.4 mp . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.2 0.524 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.8 164.87 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.451 -0.781 . . . . 0.0 110.498 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.597 ' HA ' HG22 ' B' ' 36' ' ' THR . 1.9 tm-20 -131.76 146.74 52.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.809 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.33 162.17 39.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.455 ' C ' HG13 ' A' ' 7' ' ' VAL . 2.4 pp -141.21 136.23 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.639 . . . . 0.0 109.861 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.455 HG13 ' C ' ' A' ' 6' ' ' ILE . 35.9 m -148.68 157.49 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 150.4 44.3 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.736 -0.602 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 31' ' ' ASP . 59.8 t -85.85 163.54 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.434 -0.791 . . . . 0.0 109.656 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -88.86 170.27 10.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.504 -0.748 . . . . 0.0 109.695 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -39.71 77.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -96.85 41.61 1.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.501 -0.749 . . . . 0.0 110.812 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 59.4 m-85 51.35 24.84 2.28 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.387 -0.821 . . . . 0.0 111.476 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -78.84 159.57 27.76 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.423 -0.798 . . . . 0.0 109.231 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.63 155.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.417 -0.802 . . . . 0.0 110.681 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.7 m -141.32 113.55 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -78.25 130.79 70.93 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.723 . . . . 0.0 110.03 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' A' ' 21' ' ' VAL . 23.0 Cg_exo -55.79 -173.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.101 1.053 . . . . 0.0 110.605 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.48 -28.41 16.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.539 -0.726 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -59.24 3.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.53 -0.731 . . . . 0.0 110.915 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 18' ' ' PRO . 27.0 m -63.6 -33.76 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -61.97 -37.29 84.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -68.9 -35.26 76.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.576 -0.702 . . . . 0.0 109.232 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -73.33 0.15 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.903 ' HD2' ' CD1' ' B' ' 37' ' ' PHE . 0.7 OUTLIER -60.5 158.63 11.83 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.592 -0.693 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -81.01 -84.12 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.394 -0.816 . . . . 0.0 110.855 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt 53.17 92.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.013 -1.054 . . . . 0.0 110.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -104.13 -170.53 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.695 -0.628 . . . . 0.0 110.818 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.59 126.49 35.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.738 -0.601 . . . . 0.0 110.164 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.1 45.36 15.85 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' O ' HG23 ' B' ' 9' ' ' VAL . 23.8 t70 -112.67 142.93 44.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.988 . . . . 0.0 110.232 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.82 62.86 4.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.608 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.414 HG12 HD11 ' A' ' 48' ' ' LEU . 27.5 m -53.32 155.88 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.43 -0.794 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -110.23 103.06 11.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.69 -0.631 . . . . 0.0 110.66 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.02 110.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.773 . . . . 0.0 108.933 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.589 HG22 ' HA ' ' B' ' 4' ' ' GLU . 47.2 p -128.14 150.42 49.99 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.562 0.696 . . . . 0.0 111.696 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.911 ' CD1' ' HD2' ' B' ' 25' ' ' PHE . 27.4 t80 -124.63 122.53 37.78 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.8 151.41 24.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 110.361 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.29 20.08 9.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.684 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -46.83 7.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.78 -30.27 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 109.859 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . . . 93.06 47.62 3.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' CG ' ' B' ' 47' ' ' GLN . 33.1 m -140.58 159.63 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.538 -0.978 . . . . 0.0 110.368 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.94 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 31.2 t -100.55 133.97 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.42 123.28 49.07 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.132 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.962 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.9 pt -109.17 134.16 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.803 ' CG ' HG12 ' B' ' 43' ' ' VAL . 54.0 tt0 -149.28 165.81 30.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.504 -0.747 . . . . 0.0 110.52 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.208 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.106 0.479 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -132.64 164.94 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.54 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.589 ' HA ' HG22 ' A' ' 36' ' ' THR . 1.9 tm-20 -131.82 146.69 52.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.66 -0.65 . . . . 0.0 109.87 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.25 162.01 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.456 -0.778 . . . . 0.0 110.47 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.456 ' C ' HG13 ' B' ' 7' ' ' VAL . 2.4 pp -141.11 136.21 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.688 -0.632 . . . . 0.0 109.871 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.456 HG13 ' C ' ' B' ' 6' ' ' ILE . 35.5 m -148.6 157.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.453 -0.78 . . . . 0.0 110.56 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 150.42 44.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 110.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 31' ' ' ASP . 59.8 t -85.85 163.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 109.657 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.414 ' N ' HG12 ' B' ' 9' ' ' VAL . 0.6 OUTLIER -88.76 170.14 11.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.582 -0.699 . . . . 0.0 109.813 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -39.78 78.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.702 . . . . 0.0 110.502 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -96.84 41.61 1.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.468 -0.77 . . . . 0.0 110.92 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' B' ' 13' ' ' TYR . 58.5 m-85 51.49 24.7 2.34 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.442 -0.786 . . . . 0.0 111.499 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -78.88 159.41 27.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.396 -0.815 . . . . 0.0 109.094 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.59 155.85 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 0.0 110.687 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.5 m -141.3 113.53 8.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.09 130.99 70.74 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.541 -0.724 . . . . 0.0 110.109 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.402 ' HD2' HG21 ' B' ' 21' ' ' VAL . 22.8 Cg_exo -56.19 -173.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.196 0 O-C-N 123.115 1.061 . . . . 0.0 110.436 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.35 -28.52 16.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.718 . . . . 0.0 110.878 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -59.25 3.03 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.489 -0.757 . . . . 0.0 110.887 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.402 HG21 ' HD2' ' B' ' 18' ' ' PRO . 26.9 m -63.65 -33.58 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -62.1 -37.11 83.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.203 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -69.08 -35.12 76.16 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -73.29 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.911 ' HD2' ' CD1' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -60.58 158.64 11.99 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -81.02 -84.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.362 -0.836 . . . . 0.0 110.856 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 88.0 mt 53.13 92.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.023 -1.048 . . . . 0.0 110.129 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -104.25 -170.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 110.821 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -88.51 126.54 35.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.825 -0.547 . . . . 0.0 110.185 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 45.26 15.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 9' ' ' VAL . 23.7 t70 -112.62 142.83 44.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.95 . . . . 0.0 110.24 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.85 62.95 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.744 -0.597 . . . . 0.0 109.495 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.431 HG12 HD11 ' B' ' 48' ' ' LEU . 28.0 m -53.5 155.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.479 -0.763 . . . . 0.0 110.583 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -110.33 102.95 11.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 110.591 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.84 110.75 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 4' ' ' GLU . 49.6 p -128.12 150.62 49.9 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.645 0.736 . . . . 0.0 111.678 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.903 ' CD1' ' HD2' ' A' ' 25' ' ' PHE . 27.4 t80 -124.77 122.55 37.77 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.81 151.39 24.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.462 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.25 19.97 9.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.72 -46.57 7.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.98 -30.23 7.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.701 -0.624 . . . . 0.0 109.785 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . 0.568 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 93.11 47.49 3.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.803 HG12 ' CG ' ' A' ' 47' ' ' GLN . 33.1 m -140.65 159.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.56 -0.965 . . . . 0.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.962 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 32.4 t -100.49 133.81 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.16 123.23 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 111.317 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.94 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.9 pt -109.3 134.19 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.256 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.787 ' CG ' HG12 ' A' ' 43' ' ' VAL . 54.1 tt0 -149.26 165.81 30.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.683 -0.636 . . . . 0.0 110.611 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.431 HD11 HG12 ' B' ' 33' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.566 -0.709 . . . . 0.0 110.142 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.18 150.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 110.139 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.95 157.34 44.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.604 -0.685 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.56 143.43 20.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.81 119.78 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.557 -0.714 . . . . 0.0 110.544 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.1 -176.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.474 -0.766 . . . . 0.0 110.139 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.71 163.73 29.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.484 -0.76 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG11 ' O ' ' B' ' 28' ' ' LYS . 59.6 t -74.06 166.08 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.56 -0.712 . . . . 0.0 109.928 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' B' ' 29' ' ' GLU . 15.5 m -107.61 -156.64 0.59 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.468 -0.77 . . . . 0.0 110.514 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HA ' ' OE2' ' B' ' 29' ' ' GLU . 8.2 ttp180 -79.09 -52.38 8.28 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.473 -0.767 . . . . 0.0 110.722 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.41 40.07 1.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 110.802 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.755 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 94.2 m-85 50.73 40.14 23.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.345 -0.847 . . . . 0.0 111.227 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.38 153.96 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.19 132.68 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 0.0 110.246 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.49 85.16 2.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.647 . . . . 0.0 109.631 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 23.0 mt -61.0 145.42 89.34 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.62 -0.675 . . . . 0.0 110.273 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 16.4 Cg_exo -61.9 -159.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.0 0 O-C-N 123.338 1.178 . . . . 0.0 110.367 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.11 -21.09 16.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.0 -55.84 29.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -0.882 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.22 -39.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.594 -0.691 . . . . 0.0 109.683 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -63.82 -32.31 73.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.661 -0.65 . . . . 0.0 109.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -54.1 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.56 -60.82 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.647 -0.658 . . . . 0.0 109.641 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.5 OUTLIER -74.07 128.18 34.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.54 -0.725 . . . . 0.0 110.355 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -78.58 96.97 5.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.517 -0.74 . . . . 0.0 110.104 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.5 mt -132.04 78.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.58 -0.7 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.782 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.3 OUTLIER -87.32 -158.67 0.46 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.653 -0.655 . . . . 0.0 110.606 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' B' ' 10' ' ' SER . 37.1 tt0 -87.41 91.62 8.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.696 -0.628 . . . . 0.0 110.31 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.99 47.24 0.31 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB2' HG21 ' B' ' 9' ' ' VAL . 2.2 m-20 -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.985 . . . . 0.0 110.352 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mp -75.19 81.42 2.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.989 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -87.21 154.0 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.97 131.79 41.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.616 -0.677 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.91 131.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.532 -0.73 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.55 147.96 48.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.414 -0.804 . . . . 0.0 111.22 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.513 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 29.6 t80 -119.63 141.43 49.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -110.71 154.12 24.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.756 . . . . 0.0 110.733 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.41 29.11 7.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.024 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 p -117.91 -35.21 3.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.713 . . . . 0.0 110.305 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.29 -65.82 1.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.493 -0.754 . . . . 0.0 110.26 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.32 42.6 0.27 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.73 ' HB ' ' CG ' ' B' ' 45' ' ' LYS . 34.6 m -133.9 156.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.971 . . . . 0.0 109.665 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.829 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 29.2 t -116.36 115.4 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.838 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.746 ' CG ' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -99.94 146.82 26.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.735 -0.603 . . . . 0.0 109.997 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.83 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 12.9 pt -128.74 155.81 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.679 -0.638 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.411 ' OE1' ' CG1' ' B' ' 43' ' ' VAL . 38.9 tt0 -159.95 160.82 33.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.646 -0.659 . . . . 0.0 110.105 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 O-C-N 121.591 -0.693 . . . . 0.0 109.994 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.19 150.9 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 110.113 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.85 157.41 44.39 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.549 -0.72 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.62 143.48 20.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.244 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.79 119.97 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.559 -0.713 . . . . 0.0 110.477 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.35 -177.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.72 163.71 29.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.497 -0.752 . . . . 0.0 110.507 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 28' ' ' LYS . 59.2 t -74.07 166.13 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.599 -0.688 . . . . 0.0 109.904 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 15.4 m -107.69 -156.67 0.59 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.44 -0.787 . . . . 0.0 110.449 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.409 ' HA ' ' OE2' ' A' ' 29' ' ' GLU . 8.3 ttp180 -79.05 -52.46 8.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.47 -0.769 . . . . 0.0 110.663 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.3 39.98 1.11 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.782 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 94.2 m-85 50.86 40.04 23.88 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.321 -0.862 . . . . 0.0 111.218 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.35 154.0 19.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.22 132.78 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.573 -0.704 . . . . 0.0 110.205 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.6 85.17 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 109.609 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.01 145.44 89.36 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.647 -0.658 . . . . 0.0 110.204 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.02 -159.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.986 0 O-C-N 123.347 1.183 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.12 -21.19 16.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.714 -0.616 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.02 -56.01 27.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.339 -0.851 . . . . 0.0 110.366 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -62.06 -39.1 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.576 -0.703 . . . . 0.0 109.7 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -63.89 -32.23 73.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.621 -0.674 . . . . 0.0 109.927 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -54.1 25.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.717 . . . . 0.0 109.645 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.42 -60.95 2.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.614 -0.679 . . . . 0.0 109.654 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.562 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -74.03 128.09 34.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.662 -0.649 . . . . 0.0 110.34 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -78.51 97.05 5.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.559 -0.713 . . . . 0.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 88.6 mt -132.14 78.51 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.572 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.755 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -87.37 -158.58 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.763 -0.586 . . . . 0.0 110.553 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' SER . 37.1 tt0 -87.51 91.81 8.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.648 -0.657 . . . . 0.0 110.238 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.76 47.38 0.32 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.412 ' HB2' HG21 ' A' ' 9' ' ' VAL . 2.2 m-20 -111.12 133.9 53.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.971 . . . . 0.0 110.32 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.15 81.53 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.708 -0.62 . . . . 0.0 110.028 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -87.23 153.97 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.563 -0.711 . . . . 0.0 110.392 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.98 131.78 41.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.576 -0.703 . . . . 0.0 110.21 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.95 131.93 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.583 -0.698 . . . . 0.0 109.566 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.69 148.01 48.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 111.237 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 29.8 t80 -119.69 141.41 49.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -110.75 154.04 24.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.29 29.0 7.19 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.626 -0.672 . . . . 0.0 110.094 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 5.4 p -117.79 -35.23 3.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.28 -65.83 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.23 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.28 42.43 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.746 ' HB ' ' CG ' ' A' ' 45' ' ' LYS . 34.6 m -133.78 156.9 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.977 . . . . 0.0 109.704 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.83 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 30.8 t -116.48 115.28 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.291 -0.881 . . . . 0.0 109.986 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.73 ' CG ' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -99.86 146.78 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.811 -0.556 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.829 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 12.7 pt -128.68 155.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.709 -0.62 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -159.88 160.83 34.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.691 -0.63 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.469 ' N ' ' OE1' ' B' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.063 0.459 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.8 150.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.571 -0.706 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -147.99 116.0 6.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 109.937 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.52 173.96 8.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.47 -0.769 . . . . 0.0 110.641 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.419 HG22 ' HE2' ' B' ' 34' ' ' LYS . 26.8 pt -120.53 130.92 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.685 -0.635 . . . . 0.0 109.894 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' ' 33' ' ' VAL . 33.1 m -131.37 146.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.576 -0.703 . . . . 0.0 110.265 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -103.58 154.21 19.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.39 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.025 ' O ' ' HA2' ' B' ' 30' ' ' GLY . 58.2 t -109.91 142.46 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.584 -0.697 . . . . 0.0 109.58 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.9 p -169.83 -170.52 1.04 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 111.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.93 -86.77 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.697 -0.627 . . . . 0.0 110.984 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.76 55.52 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.061 -1.024 . . . . 0.0 110.579 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HE1' ' C ' ' B' ' 28' ' ' LYS . 71.9 m-85 49.33 47.43 22.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.457 -0.777 . . . . 0.0 111.048 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -112.25 154.15 26.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 110.13 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.92 135.85 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 110.391 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.4 p -108.2 106.87 17.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.782 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.41 126.96 93.0 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.688 . . . . 0.0 109.584 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.86 -77.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.06 1.032 . . . . 0.0 110.645 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.11 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.48 -0.763 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.77 -46.79 86.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.726 -0.609 . . . . 0.0 110.156 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.73 -43.69 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.698 . . . . 0.0 109.343 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.87 -27.66 68.3 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.612 -0.68 . . . . 0.0 110.164 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.04 -39.19 42.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.985 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -79.46 -70.37 0.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.648 . . . . 0.0 109.969 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.972 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.5 OUTLIER -65.65 133.59 51.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.516 -0.74 . . . . 0.0 110.57 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -81.84 87.92 6.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.59 76.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.593 -0.692 . . . . 0.0 109.481 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' C ' ' HE1' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -58.65 168.86 1.07 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.782 -0.574 . . . . 0.0 110.633 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' CE1' ' B' ' 13' ' ' TYR . 0.5 OUTLIER -74.87 72.66 2.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.73 -0.606 . . . . 0.0 110.139 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 1.027 ' HA2' ' O ' ' B' ' 9' ' ' VAL . . . 137.54 45.17 0.08 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.512 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 2.9 m-20 -105.42 147.54 28.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.613 -0.934 . . . . 0.0 110.323 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.32 76.8 5.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.461 -0.774 . . . . 0.0 110.064 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.445 ' O ' HG22 ' B' ' 7' ' ' VAL . 59.0 t -86.65 143.23 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.525 -0.734 . . . . 0.0 110.082 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -111.73 130.59 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.723 . . . . 0.0 110.166 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HA ' HG22 ' A' ' 46' ' ' ILE . 60.4 t -101.95 130.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.625 -0.672 . . . . 0.0 109.498 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 p -129.02 145.01 51.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.54 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 49.8 t80 -121.09 129.73 53.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -107.47 146.9 31.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.426 -0.796 . . . . 0.0 110.774 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 2' ' ' ALA . 28.0 mt-10 -97.94 30.36 3.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.669 -0.644 . . . . 0.0 110.045 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.88 -34.47 3.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.638 -0.664 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -114.66 -42.08 3.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.531 -0.731 . . . . 0.0 110.281 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.52 37.43 4.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.825 HG12 ' HB3' ' B' ' 47' ' ' GLN . 32.7 m -134.61 152.31 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.73 -0.864 . . . . 0.0 109.645 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.961 HG23 ' CE2' ' B' ' 25' ' ' PHE . 56.3 t -99.2 127.35 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 2.1 ttpp -108.5 124.37 50.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.831 -0.543 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.833 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 9.1 pt -117.02 148.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.752 . . . . 0.0 110.447 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.821 ' HB3' HG12 ' B' ' 43' ' ' VAL . 18.3 pt20 -161.53 -171.67 3.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.572 -0.705 . . . . 0.0 110.599 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.061 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . 0.476 ' N ' ' OE1' ' A' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.07 0.462 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.79 150.26 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.589 -0.694 . . . . 0.0 110.09 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -148.16 116.01 6.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.677 -0.639 . . . . 0.0 109.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.65 174.06 8.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.714 . . . . 0.0 110.554 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.414 HG22 ' HE2' ' A' ' 34' ' ' LYS . 27.6 pt -120.57 130.73 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.686 -0.634 . . . . 0.0 109.899 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 33' ' ' VAL . 33.3 m -131.25 146.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.533 -0.729 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -103.5 154.22 19.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 1.027 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 57.7 t -109.95 142.45 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.695 -0.628 . . . . 0.0 109.6 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 84.7 p -169.78 -170.5 1.04 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 0.0 111.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.9 -86.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.721 -0.612 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.7 55.49 1.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.04 -1.038 . . . . 0.0 110.564 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.476 ' HE1' ' C ' ' A' ' 28' ' ' LYS . 71.4 m-85 49.34 47.36 22.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.439 -0.788 . . . . 0.0 111.08 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -112.21 154.22 25.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.161 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.97 135.98 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.624 -0.673 . . . . 0.0 110.314 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 40.5 p -108.31 106.86 17.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.739 -0.601 . . . . 0.0 109.773 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.48 126.91 92.93 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.7 -78.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.091 1.048 . . . . 0.0 110.648 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.74 -37.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.752 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.57 -46.9 85.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.625 -0.672 . . . . 0.0 110.123 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.71 -43.63 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.362 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.94 -27.68 68.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.653 -0.654 . . . . 0.0 110.049 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.05 -39.21 42.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.533 -0.729 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -79.54 -70.32 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.591 -0.693 . . . . 0.0 109.968 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.961 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -65.55 133.52 51.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -0.756 . . . . 0.0 110.563 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -81.88 88.05 6.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.522 -0.736 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.71 76.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 0.0 109.472 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.454 ' C ' ' HE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -58.54 168.74 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.75 -0.594 . . . . 0.0 110.65 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.448 ' N ' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -74.79 72.53 2.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.607 -0.683 . . . . 0.0 110.138 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . 1.025 ' HA2' ' O ' ' A' ' 9' ' ' VAL . . . 137.81 44.85 0.08 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.505 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 3.0 m-20 -105.3 147.54 28.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.405 -1.056 . . . . 0.0 110.362 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.35 76.82 5.91 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.519 -0.738 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 7' ' ' VAL . 57.4 t -86.52 143.13 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.512 -0.742 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.419 ' HE2' HG22 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -111.7 130.57 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' B' ' 46' ' ' ILE . 60.1 t -101.86 130.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 61.2 p -129.1 144.9 51.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.417 -0.802 . . . . 0.0 111.354 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.552 ' CD1' ' CD2' ' A' ' 25' ' ' PHE . 50.1 t80 -121.11 129.86 53.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -107.54 146.88 31.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.656 -0.653 . . . . 0.0 110.823 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 2' ' ' ALA . 28.1 mt-10 -97.99 30.47 3.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.609 -0.682 . . . . 0.0 110.107 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 -34.58 3.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 110.243 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -114.53 -42.17 3.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.501 -0.749 . . . . 0.0 110.319 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.76 37.19 4.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.821 HG12 ' HB3' ' A' ' 47' ' ' GLN . 32.6 m -134.64 152.08 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.824 -0.809 . . . . 0.0 109.676 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.972 HG23 ' CE2' ' A' ' 25' ' ' PHE . 60.0 t -98.95 127.21 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.715 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.2 ttpp -108.26 124.27 50.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.85 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.9 pt -116.92 148.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.535 -0.728 . . . . 0.0 110.464 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.825 ' HB3' HG12 ' A' ' 43' ' ' VAL . 18.4 pt20 -161.18 -171.74 3.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.706 -0.622 . . . . 0.0 110.742 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.672 . . . . 0.0 110.104 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.236 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.77 148.71 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.581 -0.699 . . . . 0.0 109.596 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -140.31 140.2 35.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.898 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.44 161.18 41.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.633 -0.667 . . . . 0.0 109.637 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.23 160.58 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.432 -0.793 . . . . 0.0 110.738 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.45 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.677 -0.64 . . . . 0.0 109.75 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -110.08 151.64 26.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 0.0 110.46 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.08 145.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.647 -0.658 . . . . 0.0 109.649 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 t -172.14 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.535 -0.728 . . . . 0.0 110.741 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.16 -78.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.36 -0.837 . . . . 0.0 111.201 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -162.14 69.18 0.28 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.37 -0.831 . . . . 0.0 110.343 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 52.42 23.94 2.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.271 -0.893 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' C ' HG23 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -109.9 169.84 8.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.48 -0.762 . . . . 0.0 109.629 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 14' ' ' GLN . 58.0 t -146.21 135.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.477 -0.764 . . . . 0.0 110.539 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.35 -174.69 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.617 . . . . 0.0 109.525 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.437 ' CG2' HG13 ' A' ' 21' ' ' VAL . 4.2 mp -138.29 138.48 22.86 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 21.6 Cg_exo -60.3 -164.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.163 1.086 . . . . 0.0 110.271 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.82 -26.41 13.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -65.87 -62.6 1.41 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.498 -0.751 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.437 HG13 ' CG2' ' A' ' 17' ' ' ILE . 9.0 p -60.46 -36.18 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 109.609 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -64.54 -30.16 71.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.62 -0.675 . . . . 0.0 109.255 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -45.41 82.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' B' ' 37' ' ' PHE . 19.7 mmtm -68.76 -71.99 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.671 -0.643 . . . . 0.0 109.27 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' B' ' 44' ' ' VAL . 0.2 OUTLIER -63.12 141.09 58.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.474 -0.766 . . . . 0.0 109.577 179.209 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.39 -83.64 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 110.376 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.5 mt 51.07 77.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.032 -1.042 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.407 ' HA ' ' CE1' ' B' ' 13' ' ' TYR . 1.1 ttpt -105.6 177.25 4.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.449 -0.782 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.83 77.33 0.88 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.573 -0.704 . . . . 0.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.91 56.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.32 170.38 16.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.94 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.56 103.6 7.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.595 -0.69 . . . . 0.0 110.197 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 48' ' ' LEU . 9.4 p -95.08 157.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 110.482 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -108.29 131.28 54.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.608 -0.682 . . . . 0.0 110.191 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 46' ' ' ILE . 57.4 t -122.43 136.63 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.741 . . . . 0.0 109.317 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 p -141.85 147.48 37.25 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.425 -0.797 . . . . 0.0 111.596 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' B' ' 24' ' ' LYS . 27.1 t80 -106.38 137.16 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.51 175.92 6.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 110.9 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.21 36.64 4.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 110.088 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -127.53 -67.02 0.85 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.621 -0.674 . . . . 0.0 110.023 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.6 -38.58 13.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.21 55.87 0.85 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.687 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.1 m -136.48 161.63 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.601 -0.941 . . . . 0.0 110.309 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.644 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 60.3 t -116.08 120.26 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.519 -0.738 . . . . 0.0 109.514 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 17.9 ttmt -109.92 151.53 26.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.752 -0.593 . . . . 0.0 110.799 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.639 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 7.8 pt -134.56 159.58 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.617 -0.677 . . . . 0.0 110.615 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.711 ' HB3' HG12 ' B' ' 43' ' ' VAL . 8.4 pt20 -152.81 164.0 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 110.111 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.451 HD11 ' HB ' ' A' ' 33' ' ' VAL . 1.1 mt . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.457 -0.777 . . . . 0.0 111.237 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.202 0.525 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.78 148.65 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.24 140.22 35.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.447 -0.783 . . . . 0.0 110.924 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.43 161.2 41.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.755 -0.591 . . . . 0.0 109.575 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.2 160.59 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.433 -0.792 . . . . 0.0 110.708 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.43 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.642 -0.661 . . . . 0.0 109.663 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -110.06 151.6 27.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.743 . . . . 0.0 110.479 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.08 145.39 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.656 -0.652 . . . . 0.0 109.71 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.9 t -172.13 -37.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.17 -78.11 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.455 -0.778 . . . . 0.0 111.241 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.16 69.02 0.27 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 110.376 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.407 ' CE1' ' HA ' ' A' ' 28' ' ' LYS . 23.7 m-85 52.62 23.9 2.86 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.343 -0.848 . . . . 0.0 111.003 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.416 ' C ' HG23 ' B' ' 15' ' ' VAL . 1.0 OUTLIER -109.86 169.78 8.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.644 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.416 HG23 ' C ' ' B' ' 14' ' ' GLN . 57.4 t -146.21 135.49 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.38 -174.64 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 109.517 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.439 ' CG2' HG13 ' B' ' 21' ' ' VAL . 4.2 mp -138.43 138.5 22.58 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -60.19 -164.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.151 1.079 . . . . 0.0 110.355 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.85 -26.5 13.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.573 -0.704 . . . . 0.0 110.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -65.79 -62.57 1.43 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.439 HG13 ' CG2' ' B' ' 17' ' ' ILE . 9.2 p -60.45 -36.25 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -64.5 -30.15 71.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -45.38 81.91 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 19.7 mmtm -68.77 -71.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.646 -0.659 . . . . 0.0 109.296 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.501 ' CE1' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -63.1 141.05 58.91 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -72.38 -83.62 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.402 -0.812 . . . . 0.0 110.428 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 85.6 mt 51.05 77.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.055 -1.028 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -105.58 177.27 4.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.182 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.93 77.41 0.9 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.534 -0.729 . . . . 0.0 110.139 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.84 56.88 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.46 170.4 16.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.577 -0.955 . . . . 0.0 110.103 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.46 103.59 7.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.573 -0.705 . . . . 0.0 110.299 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' B' ' 48' ' ' LEU . 9.4 p -95.01 157.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.638 -0.664 . . . . 0.0 110.461 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -108.38 131.23 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.649 -0.657 . . . . 0.0 110.14 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.613 HG22 HG22 ' B' ' 46' ' ' ILE . 60.3 t -122.5 136.56 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.705 . . . . 0.0 109.326 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 8.5 p -141.79 147.52 37.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.396 -0.815 . . . . 0.0 111.479 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.41 ' CE2' ' HB3' ' A' ' 24' ' ' LYS . 26.9 t80 -106.39 137.03 45.1 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.39 175.84 6.1 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.279 -0.888 . . . . 0.0 110.993 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.11 36.51 4.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 110.064 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -127.53 -66.88 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.573 -0.704 . . . . 0.0 110.025 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -90.55 -38.61 13.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.578 -0.701 . . . . 0.0 110.072 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.17 55.92 0.85 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.711 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.1 m -136.54 161.48 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.529 -0.983 . . . . 0.0 110.214 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.639 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.5 t -115.92 120.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.424 -0.798 . . . . 0.0 109.566 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 17.9 ttmt -109.75 151.37 27.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.677 -0.639 . . . . 0.0 110.921 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.644 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 7.8 pt -134.41 159.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.722 -0.611 . . . . 0.0 110.671 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.687 ' HB3' HG12 ' A' ' 43' ' ' VAL . 8.5 pt20 -152.69 164.09 38.41 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 110.123 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' B' ' 33' ' ' VAL . 1.2 mt . . . . . 0 N--CA 1.498 1.962 0 O-C-N 121.391 -0.818 . . . . 0.0 111.31 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.182 0.515 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.96 147.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.593 -0.692 . . . . 0.0 110.152 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' B' ' 36' ' ' THR . 10.3 mt-10 -125.79 135.48 52.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.697 -0.627 . . . . 0.0 109.786 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.69 164.5 38.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.0 110.776 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.35 133.16 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.652 -0.655 . . . . 0.0 109.521 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.37 159.32 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -113.09 158.17 20.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.695 -0.628 . . . . 0.0 109.693 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.58 HG23 ' O ' ' B' ' 31' ' ' ASP . 69.9 t -94.18 147.91 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.54 -0.725 . . . . 0.0 110.172 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.7 t -171.05 -168.81 0.68 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.571 -0.705 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.57 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.717 -0.614 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.14 79.5 0.16 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.01 -1.057 . . . . 0.0 111.563 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 53.14 56.99 6.74 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.314 -0.866 . . . . 0.0 111.433 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -130.26 153.33 48.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.82 . . . . 0.0 110.495 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -123.87 101.48 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.703 -0.623 . . . . 0.0 110.074 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 16' ' ' THR . 6.7 t -74.87 153.99 38.42 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.543 -0.723 . . . . 0.0 110.077 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -98.91 130.99 26.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.564 -0.71 . . . . 0.0 109.789 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.99 -167.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.042 1.022 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.52 -36.51 17.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 110.221 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.55 -43.17 85.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 110.103 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.32 -38.47 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.714 . . . . 0.0 109.64 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -67.87 -41.47 82.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.168 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -67.55 -45.19 76.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 109.916 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.2 -68.68 0.64 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.704 -0.622 . . . . 0.0 109.999 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.6 OUTLIER -70.87 119.78 15.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.594 -0.691 . . . . 0.0 110.272 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.04 108.68 13.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.706 -0.621 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.65 76.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.472 -0.767 . . . . 0.0 109.981 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -97.23 175.35 6.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.632 -0.668 . . . . 0.0 110.011 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.26 125.62 24.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.52 -0.737 . . . . 0.0 109.997 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 20.4 12.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.591 ' O ' HG23 ' B' ' 9' ' ' VAL . 4.9 m-20 -111.83 114.8 27.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 95.93 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.624 . . . . 0.0 110.728 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.13 133.13 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.655 -0.653 . . . . 0.0 109.403 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 165.78 11.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.501 -0.749 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.68 136.15 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.658 -0.651 . . . . 0.0 109.873 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.645 HG22 ' HA ' ' B' ' 4' ' ' GLU . 71.3 p -141.87 146.41 35.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 110.904 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -103.64 140.28 37.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.732 -0.605 . . . . 0.0 109.539 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.33 173.39 6.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.645 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.71 33.97 5.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 110.059 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.5 t -121.65 -63.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 0.0 110.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.37 -35.9 10.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 110.58 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.82 56.97 0.88 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.823 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.2 m -133.25 166.92 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.631 -0.923 . . . . 0.0 110.053 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.537 HG23 ' CE2' ' B' ' 25' ' ' PHE . 47.4 t -119.71 116.6 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.358 -0.839 . . . . 0.0 109.833 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 4.1 ttpt -98.96 139.93 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 110.44 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.516 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.4 pt -131.72 157.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.561 -0.712 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.826 ' HB3' HG12 ' B' ' 43' ' ' VAL . 17.3 pt20 -161.26 168.71 23.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.461 -0.775 . . . . 0.0 110.464 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.539 -0.726 . . . . 0.0 109.568 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.225 0.536 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.03 147.17 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.563 -0.71 . . . . 0.0 110.178 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.645 ' HA ' HG22 ' A' ' 36' ' ' THR . 10.3 mt-10 -125.64 135.6 52.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.69 -0.631 . . . . 0.0 109.75 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.76 164.53 38.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.728 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 87.8 mt -132.49 133.13 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 109.495 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.33 159.31 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.326 -0.859 . . . . 0.0 110.783 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -113.06 158.11 20.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.727 -0.608 . . . . 0.0 109.78 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 31' ' ' ASP . 73.4 t -94.18 147.83 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 110.185 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -171.04 -168.75 0.68 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.361 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.6 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.674 -0.641 . . . . 0.0 110.831 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.13 79.47 0.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.965 -1.084 . . . . 0.0 111.559 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 53.07 57.15 6.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.301 -0.874 . . . . 0.0 111.459 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -130.47 153.23 49.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.332 -0.855 . . . . 0.0 110.586 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.9 t -123.78 101.4 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.763 -0.586 . . . . 0.0 110.082 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -74.83 153.9 38.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 110.075 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 34.1 mt -98.84 130.93 26.59 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.83 -167.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.161 1.085 . . . . 0.0 110.347 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.51 -36.47 17.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.63 -43.05 85.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.607 -0.683 . . . . 0.0 110.168 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.4 -38.44 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.573 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -67.9 -41.52 82.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.736 -0.603 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -67.5 -45.13 76.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.941 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.36 -68.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 109.971 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.537 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -70.87 119.78 15.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.7 -0.625 . . . . 0.0 110.227 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.09 108.75 13.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.627 -0.671 . . . . 0.0 110.327 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.63 76.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -97.25 175.39 6.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.659 -0.651 . . . . 0.0 110.018 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.37 125.74 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 110.017 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 20.42 12.24 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.58 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.9 m-20 -111.77 114.87 28.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.7 95.82 1.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.606 -0.684 . . . . 0.0 110.76 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 64.2 t -94.11 133.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.501 -0.749 . . . . 0.0 109.374 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.37 165.83 11.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.492 -0.755 . . . . 0.0 110.356 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.69 136.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 109.775 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 4' ' ' GLU . 69.8 p -141.91 146.42 35.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.456 -0.778 . . . . 0.0 110.979 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -103.67 140.36 37.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.481 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.34 173.44 6.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.525 -0.734 . . . . 0.0 110.618 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.7 33.76 5.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.675 -0.641 . . . . 0.0 110.027 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 36.9 t -121.48 -63.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.565 -0.71 . . . . 0.0 110.441 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.3 -35.96 10.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.525 -0.734 . . . . 0.0 110.498 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.85 56.87 0.88 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.826 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.0 m -133.25 166.75 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.654 -0.909 . . . . 0.0 110.066 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.531 HG23 ' CE2' ' A' ' 25' ' ' PHE . 47.3 t -119.61 116.64 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.315 -0.865 . . . . 0.0 109.868 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.424 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 4.2 ttpt -99.0 139.84 34.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.578 -0.701 . . . . 0.0 110.419 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.518 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.4 pt -131.65 156.86 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 110.384 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.823 ' HB3' HG12 ' A' ' 43' ' ' VAL . 17.3 pt20 -161.0 168.85 23.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.506 -0.746 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.639 -0.663 . . . . 0.0 109.555 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.046 0.45 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.38 138.18 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.27 152.11 51.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.562 -0.712 . . . . 0.0 109.9 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.25 152.12 32.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.496 -0.753 . . . . 0.0 110.367 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.8 mt -120.11 125.4 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.634 -0.666 . . . . 0.0 109.567 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.54 155.91 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.498 -0.751 . . . . 0.0 110.59 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.46 145.1 38.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.688 -0.632 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.27 130.74 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.605 -0.684 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -170.85 -157.04 0.13 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.498 -0.751 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 mtt85 55.74 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.727 -0.608 . . . . 0.0 111.075 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -150.83 56.39 0.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.096 -1.002 . . . . 0.0 110.561 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.95 38.25 19.73 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.304 -0.873 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.57 176.94 6.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.25 128.58 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.46 -21.49 21.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.331 -0.856 . . . . 0.0 111.49 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.3 mt 59.87 115.32 0.02 OUTLIER Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.718 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.67 175.18 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 122.858 0.925 . . . . 0.0 110.775 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.59 -27.13 61.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.615 -0.678 . . . . 0.0 110.568 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -54.32 46.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.493 -0.754 . . . . 0.0 110.521 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.53 -45.63 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.38 -0.825 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -60.0 -31.39 69.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -48.42 64.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.629 -0.669 . . . . 0.0 109.502 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' B' ' 37' ' ' PHE . 0.0 OUTLIER -65.12 -65.29 0.69 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.686 -0.633 . . . . 0.0 109.514 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.665 ' CE1' HG23 ' B' ' 44' ' ' VAL . 0.6 OUTLIER -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.666 -0.646 . . . . 0.0 110.151 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -73.55 -74.95 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.566 -0.709 . . . . 0.0 109.912 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.4 mm 52.95 84.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.396 -0.815 . . . . 0.0 110.608 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.35 148.57 37.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.632 -0.668 . . . . 0.0 110.379 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -61.69 109.44 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.586 -0.696 . . . . 0.0 110.134 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 55.22 1.31 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' OD2' HD21 ' A' ' 48' ' ' LEU . 3.2 t0 -126.92 158.38 36.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 0.0 110.274 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -92.78 82.95 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.81 156.45 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.825 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' B' ' 5' ' ' GLU . 5.1 tttt -134.17 147.14 50.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 110.25 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 46' ' ' ILE . 48.3 t -127.81 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 0.0 109.664 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.7 p -134.51 155.84 49.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.987 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE1' ' CD1' ' B' ' 25' ' ' PHE . 26.3 t80 -133.97 121.85 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.708 -0.62 . . . . 0.0 109.536 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -99.97 168.8 9.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 110.174 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.53 32.12 5.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 110.009 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 p -117.61 -48.83 2.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 110.139 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.65 -29.64 12.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 110.163 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.91 39.62 11.54 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' B' ' 47' ' ' GLN . 34.0 m -128.3 155.14 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.888 . . . . 0.0 110.327 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.646 HG23 ' CE1' ' B' ' 25' ' ' PHE . 40.2 t -103.01 115.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -100.63 130.01 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.844 -0.535 . . . . 0.0 110.165 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.656 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 8.7 pt -124.45 151.44 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.521 -0.737 . . . . 0.0 110.959 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.561 ' HG3' HG12 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -159.3 -168.98 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.34 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.455 HD21 ' OD2' ' A' ' 31' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.675 -0.641 . . . . 0.0 110.071 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.078 0.466 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.46 138.27 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.573 -0.704 . . . . 0.0 109.998 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -133.3 152.16 51.92 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.649 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.5 mp0 -151.29 152.15 32.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 mt -120.08 125.43 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.592 -0.692 . . . . 0.0 109.647 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.51 155.84 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.752 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.4 145.2 37.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.653 . . . . 0.0 110.036 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 64.9 t -79.27 130.87 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.569 -0.707 . . . . 0.0 109.991 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -171.09 -157.08 0.12 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.611 -0.68 . . . . 0.0 110.089 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 39.5 mtt85 55.75 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.646 -0.659 . . . . 0.0 111.131 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.82 56.36 0.91 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.067 -1.021 . . . . 0.0 110.518 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.9 38.3 19.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.263 -0.898 . . . . 0.0 110.857 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.6 176.95 6.83 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.52 -0.738 . . . . 0.0 111.179 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.24 128.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.52 -21.44 21.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.492 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 68.5 mt 59.85 115.35 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -57.8 175.19 0.47 Allowed 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 122.893 0.944 . . . . 0.0 110.819 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.07 61.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -54.26 47.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.56 -45.69 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -59.85 -31.56 69.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -48.32 64.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.685 -0.634 . . . . 0.0 109.563 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -65.25 -65.19 0.71 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.629 -0.669 . . . . 0.0 109.484 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.646 ' CE1' HG23 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -65.82 164.94 13.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.682 -0.636 . . . . 0.0 110.123 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.59 -74.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.607 -0.683 . . . . 0.0 109.914 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 47.6 mm 52.85 84.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.445 -0.784 . . . . 0.0 110.584 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.39 148.77 37.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.555 -0.716 . . . . 0.0 110.281 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -61.84 109.49 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.594 -0.691 . . . . 0.0 110.098 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 55.15 1.33 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.444 ' OD2' HD21 ' B' ' 48' ' ' LEU . 3.2 t0 -126.91 158.41 36.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.598 -0.942 . . . . 0.0 110.303 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -92.79 82.92 4.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.8 156.43 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 0.0 109.918 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 5.4 tttt -134.16 147.09 50.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.546 -0.721 . . . . 0.0 110.28 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.514 HG22 HG22 ' B' ' 46' ' ' ILE . 47.7 t -127.69 136.11 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.634 -0.666 . . . . 0.0 109.704 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -134.54 155.85 49.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.442 -0.786 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.499 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 26.4 t80 -134.03 121.94 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.705 -0.622 . . . . 0.0 109.468 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -100.07 168.79 9.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.728 -0.607 . . . . 0.0 110.182 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.52 31.97 5.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 74.6 p -117.55 -48.77 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.148 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.67 -29.56 12.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.68 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.82 39.79 11.46 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.561 HG12 ' HG3' ' A' ' 47' ' ' GLN . 34.7 m -128.31 155.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.744 -0.857 . . . . 0.0 110.343 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.665 HG23 ' CE1' ' A' ' 25' ' ' PHE . 41.1 t -103.1 115.39 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -100.22 129.8 46.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.761 -0.587 . . . . 0.0 110.342 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.645 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.8 pt -124.1 151.49 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.518 -0.739 . . . . 0.0 110.983 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.596 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -159.38 -168.96 2.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.783 -0.573 . . . . 0.0 110.348 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.444 HD21 ' OD2' ' B' ' 31' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 109.958 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.053 0.454 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.99 112.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.067 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.38 160.51 14.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.543 -0.723 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.39 148.76 28.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.2 mt -120.32 147.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.638 -0.664 . . . . 0.0 109.777 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 HG13 ' B' ' 33' ' ' VAL . 9.7 p -168.18 161.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.512 -0.743 . . . . 0.0 110.365 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.86 -170.73 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 110.144 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.77 156.01 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.754 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.8 p -168.95 -176.93 2.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.764 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.94 -157.51 0.15 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.521 -0.737 . . . . 0.0 110.765 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -87.98 65.54 8.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.695 . . . . 0.0 110.271 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.41 33.03 14.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.468 -0.77 . . . . 0.0 111.042 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.86 151.37 25.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.702 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.04 140.03 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 16' ' ' THR . 6.6 t -144.77 110.59 5.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 109.891 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.416 HG23 ' HD2' ' A' ' 18' ' ' PRO . 88.3 mt -71.26 142.26 86.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.069 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD2' HG23 ' A' ' 17' ' ' ILE . 30.5 Cg_endo -69.16 179.88 3.09 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.345 1.182 . . . . 0.0 110.465 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.43 43.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.7 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.65 -50.77 72.16 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.11 -36.18 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.267 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.94 -47.67 65.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.312 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -69.33 0.29 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.683 -0.636 . . . . 0.0 109.355 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.67 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.3 OUTLIER -66.41 156.25 35.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.579 -0.701 . . . . 0.0 109.719 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.77 -81.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.494 -0.754 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 25' ' ' PHE . 61.6 mt 50.63 87.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.191 -0.943 . . . . 0.0 110.895 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -124.77 173.0 8.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.727 . . . . 0.0 109.917 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.86 5.66 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 0.0 110.266 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.27 61.6 1.55 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.458 ' HB3' HD21 ' A' ' 48' ' ' LEU . 1.8 m-20 -133.96 138.08 45.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.522 -0.987 . . . . 0.0 110.152 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.81 90.78 8.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.543 -0.723 . . . . 0.0 110.325 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.443 HG13 HG13 ' B' ' 7' ' ' VAL . 7.7 p -97.21 152.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.629 -0.669 . . . . 0.0 109.789 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 151.59 48.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.541 -0.724 . . . . 0.0 110.627 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.0 127.57 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.7 p -127.37 150.11 49.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.497 -0.752 . . . . 0.0 111.367 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.1 t80 -136.23 125.33 24.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.51 -177.68 3.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 0.0 110.532 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -124.24 24.21 8.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.713 -0.617 . . . . 0.0 110.461 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.6 t -119.45 -40.36 2.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 110.072 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.61 -49.6 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 110.128 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.31 43.78 2.49 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' B' ' 47' ' ' GLN . 34.9 m -141.41 156.23 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.576 -0.955 . . . . 0.0 110.032 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.684 HG23 ' CE2' ' B' ' 25' ' ' PHE . 46.6 t -106.23 125.5 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.956 -0.697 . . . . 0.0 109.925 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.579 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -107.83 128.28 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.665 -0.647 . . . . 0.0 110.259 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.498 HG12 ' HB ' ' B' ' 44' ' ' VAL . 22.1 pt -116.76 153.56 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.735 . . . . 0.0 110.356 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.64 ' HB2' HG12 ' B' ' 43' ' ' VAL . 1.6 tm0? -156.26 162.76 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.578 -0.701 . . . . 0.0 110.428 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 31' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 110.166 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.047 0.451 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.95 112.78 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.678 . . . . 0.0 110.03 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.4 160.54 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.44 148.68 28.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.545 -0.722 . . . . 0.0 110.43 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 23.3 mt -120.31 147.73 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.643 -0.661 . . . . 0.0 109.757 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 33' ' ' VAL . 9.6 p -168.25 161.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.423 -0.798 . . . . 0.0 110.356 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.77 -170.65 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 156.03 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.109 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -169.02 -177.02 2.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.482 -0.761 . . . . 0.0 110.454 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.97 -157.54 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.454 -0.779 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -88.02 65.66 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.226 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.5 32.74 14.69 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.0 111.083 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.7 151.41 25.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.553 -0.717 . . . . 0.0 109.759 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.09 140.03 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.584 HG23 ' O ' ' B' ' 16' ' ' THR . 6.8 t -144.67 110.5 5.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.609 -0.682 . . . . 0.0 109.936 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.408 HG23 ' HD2' ' B' ' 18' ' ' PRO . 88.7 mt -71.37 142.33 86.68 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.475 -0.765 . . . . 0.0 110.046 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.408 ' HD2' HG23 ' B' ' 17' ' ' ILE . 30.5 Cg_endo -69.31 179.95 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.393 1.207 . . . . 0.0 110.419 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.34 43.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.107 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -60.8 -50.6 72.8 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.602 -0.687 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.05 -36.3 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.671 -0.643 . . . . 0.0 109.267 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -64.03 -31.97 73.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.641 -0.662 . . . . 0.0 109.587 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -47.54 65.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.668 . . . . 0.0 109.299 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -69.42 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.292 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.684 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -66.37 156.14 35.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.638 -0.664 . . . . 0.0 109.778 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.66 -81.74 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.53 -0.731 . . . . 0.0 110.035 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' B' ' 25' ' ' PHE . 61.8 mt 50.59 87.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.138 -0.977 . . . . 0.0 110.87 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -124.73 172.99 8.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.597 -0.689 . . . . 0.0 109.925 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.82 5.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.5 -0.75 . . . . 0.0 110.314 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 61.45 1.56 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.473 ' HB3' HD21 ' B' ' 48' ' ' LEU . 1.8 m-20 -133.84 138.22 45.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 0.0 110.146 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.9 90.83 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 110.343 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 7' ' ' VAL . 7.8 p -97.24 152.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.0 109.821 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 151.58 48.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 110.669 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.06 127.53 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 18.5 p -127.46 150.04 49.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.818 . . . . 0.0 111.369 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 34.8 t80 -136.25 125.39 24.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.43 -177.74 3.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 110.57 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.28 24.31 8.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.384 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -119.44 -40.51 2.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.48 -49.67 4.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.647 -0.658 . . . . 0.0 110.154 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.41 43.63 2.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.64 HG12 ' HB2' ' A' ' 47' ' ' GLN . 34.8 m -141.31 156.13 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.6 -0.941 . . . . 0.0 110.12 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.67 HG23 ' CE2' ' A' ' 25' ' ' PHE . 46.2 t -106.09 125.54 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.579 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -107.86 128.36 54.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.514 HG12 ' HB ' ' A' ' 44' ' ' VAL . 22.2 pt -116.76 153.57 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.583 -0.698 . . . . 0.0 110.321 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.631 ' HB2' HG12 ' A' ' 43' ' ' VAL . 1.6 tm0? -156.34 162.64 40.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.658 -0.651 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' B' ' 31' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.654 -0.654 . . . . 0.0 110.175 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.101 0.476 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.47 144.38 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.657 -0.652 . . . . 0.0 109.755 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.6 131.08 14.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.508 -0.745 . . . . 0.0 110.306 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.44 173.26 11.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.575 -0.703 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.424 ' C ' HG23 ' A' ' 7' ' ' VAL . 38.9 pt -121.77 159.5 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.642 -0.661 . . . . 0.0 110.286 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.424 HG23 ' C ' ' A' ' 6' ' ' ILE . 63.2 t -147.42 153.12 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.658 -0.651 . . . . 0.0 110.204 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 172.24 6.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.83 149.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.472 -0.767 . . . . 0.0 110.213 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -171.8 -167.65 0.52 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.542 -0.724 . . . . 0.0 110.799 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.81 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.684 -0.635 . . . . 0.0 111.465 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.36 73.94 0.94 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.949 -1.094 . . . . 0.0 111.181 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 49.2 29.08 2.44 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.37 -0.831 . . . . 0.0 111.427 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.01 153.6 21.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.637 -0.664 . . . . 0.0 110.409 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -126.33 151.58 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.61 -0.681 . . . . 0.0 109.842 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -148.15 127.1 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.645 -0.659 . . . . 0.0 110.147 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 84.6 mt -81.26 145.38 55.82 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 0.0 109.942 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 28.6 Cg_exo -58.12 -166.18 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.344 1.181 . . . . 0.0 110.617 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.93 -43.33 8.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.595 -0.691 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -63.71 -44.09 94.63 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.642 -0.661 . . . . 0.0 110.33 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.0 -41.71 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.528 -0.732 . . . . 0.0 109.603 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -65.54 -31.68 72.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.499 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -40.4 75.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.675 -0.641 . . . . 0.0 109.272 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -72.98 -74.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.615 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.3 154.01 14.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.593 -0.692 . . . . 0.0 109.975 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -84.88 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.73 . . . . 0.0 109.853 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.473 HD12 ' HB3' ' A' ' 25' ' ' PHE . 71.0 mt 49.6 86.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.972 . . . . 0.0 110.902 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.25 -177.22 3.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -0.769 . . . . 0.0 110.596 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -83.15 117.57 22.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 0.0 110.104 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.38 38.01 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.27 170.01 9.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.936 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -117.17 72.24 0.83 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.746 . . . . 0.0 110.136 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -64.65 149.37 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 110.398 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.45 156.95 18.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.67 -0.644 . . . . 0.0 110.329 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG23 ' CG1' ' A' ' 44' ' ' VAL . 7.9 p -151.33 133.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.4 p -141.57 145.86 35.6 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.156 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 44.4 t80 -111.47 140.18 46.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -132.81 155.7 48.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 0.0 110.948 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.77 20.02 12.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.239 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -100.94 -27.78 13.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.285 -0.884 . . . . 0.0 109.909 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -127.2 -49.27 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.637 -0.664 . . . . 0.0 110.24 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.42 35.31 3.37 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' B' ' 47' ' ' GLN . 35.3 m -136.89 163.12 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.523 -0.987 . . . . 0.0 110.236 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.803 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 59.5 t -105.0 127.61 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.346 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 27.3 ttmt -112.22 133.71 54.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.771 -0.581 . . . . 0.0 110.217 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.81 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 5.3 pt -125.75 158.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.631 -0.668 . . . . 0.0 110.194 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.665 ' HB2' HG12 ' B' ' 43' ' ' VAL . 5.0 tt0 -153.72 161.31 42.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.668 -0.645 . . . . 0.0 110.351 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.578 -0.701 . . . . 0.0 110.056 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.138 0.494 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.45 144.33 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.759 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.71 131.1 14.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 0.0 110.368 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.41 173.28 11.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.698 -0.627 . . . . 0.0 110.034 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.433 ' C ' HG23 ' B' ' 7' ' ' VAL . 38.4 pt -121.78 159.59 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.624 -0.673 . . . . 0.0 110.324 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.433 HG23 ' C ' ' B' ' 6' ' ' ILE . 62.9 t -147.45 153.16 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.527 -0.733 . . . . 0.0 110.181 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.93 172.19 6.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.705 . . . . 0.0 110.069 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.74 149.23 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 110.237 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.8 t -172.02 -167.64 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.522 -0.736 . . . . 0.0 110.757 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.76 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.663 -0.648 . . . . 0.0 111.454 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.35 73.95 0.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.04 -1.037 . . . . 0.0 111.219 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 49.23 29.17 2.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.315 -0.865 . . . . 0.0 111.396 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.07 153.64 21.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.419 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.34 151.49 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.798 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -148.09 127.03 12.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 110.072 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 85.0 mt -81.08 145.26 56.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.969 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -57.96 -166.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.416 1.219 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.82 -43.49 8.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -63.7 -43.89 95.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.55 -0.719 . . . . 0.0 110.362 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.18 -41.79 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 109.526 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -65.46 -31.78 73.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.6 -0.687 . . . . 0.0 109.462 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -40.48 75.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.668 -0.645 . . . . 0.0 109.334 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -72.96 -74.09 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.609 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.36 154.01 14.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.0 109.97 179.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.3 -84.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 109.887 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . 0.473 HD12 ' HB3' ' B' ' 25' ' ' PHE . 71.8 mt 49.48 86.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.066 -1.022 . . . . 0.0 110.964 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.19 -177.21 3.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.527 -0.733 . . . . 0.0 110.538 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -83.12 117.56 22.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.574 -0.704 . . . . 0.0 110.106 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.26 38.22 4.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.34 170.02 9.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.917 . . . . 0.0 110.184 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mt -117.22 72.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.69 149.33 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.52 -0.738 . . . . 0.0 110.336 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.4 156.9 18.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.597 -0.689 . . . . 0.0 110.364 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.424 HG23 ' CG1' ' B' ' 44' ' ' VAL . 7.8 p -151.34 133.15 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 79.1 p -141.62 145.89 35.56 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.117 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.615 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 44.1 t80 -111.42 140.13 46.26 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -132.75 155.77 48.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.83 20.11 12.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -100.82 -28.04 13.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.795 . . . . 0.0 109.974 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -127.02 -49.25 1.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.706 -0.621 . . . . 0.0 110.246 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.43 35.21 3.39 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 47' ' ' GLN . 35.2 m -136.79 163.1 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.5 -1.0 . . . . 0.0 110.122 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.81 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.6 t -105.03 127.37 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.2 ttmt -111.87 133.55 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.697 -0.627 . . . . 0.0 110.294 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.803 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 5.4 pt -125.54 158.05 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.653 -0.654 . . . . 0.0 110.302 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.641 ' HB2' HG12 ' A' ' 43' ' ' VAL . 4.8 tt0 -153.64 161.36 42.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.716 -0.615 . . . . 0.0 110.32 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.055 0.455 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.77 156.25 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.711 . . . . 0.0 109.759 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -145.52 147.05 31.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.531 -0.73 . . . . 0.0 110.598 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HB2' HG13 ' B' ' 35' ' ' VAL . 1.4 mm-40 -137.81 164.05 29.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.752 -0.593 . . . . 0.0 109.912 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.95 137.93 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.657 -0.652 . . . . 0.0 110.519 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 8' ' ' LYS . 9.9 p -146.15 165.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.575 -0.703 . . . . 0.0 109.736 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' N ' HG22 ' A' ' 7' ' ' VAL . 16.0 tttp -137.07 138.35 40.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.351 -0.843 . . . . 0.0 110.517 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.45 124.96 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.597 -0.689 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 m -168.65 42.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.437 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -139.59 -66.04 0.46 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.605 -0.684 . . . . 0.0 109.457 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.08 46.29 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.752 -0.592 . . . . 0.0 109.995 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' B' ' 29' ' ' GLU . 15.2 m-85 53.42 57.42 6.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 110.803 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 174.71 13.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.463 -0.773 . . . . 0.0 110.81 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.52 145.53 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.753 -0.592 . . . . 0.0 109.693 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 p -110.95 -8.47 14.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 111.368 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.8 mt 59.51 111.6 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.304 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.53 -168.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.039 1.02 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.04 -33.85 26.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 0.0 111.519 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -56.34 -52.43 64.6 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.234 -0.916 . . . . 0.0 110.862 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.22 -47.7 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.393 -0.817 . . . . 0.0 109.593 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HD2' HG21 ' A' ' 27' ' ' ILE . 9.1 tpp180 -58.63 -28.77 65.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.559 -0.713 . . . . 0.0 109.99 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -45.06 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 109.486 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.64 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.598 -0.688 . . . . 0.0 109.952 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.12 169.92 5.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.402 -0.811 . . . . 0.0 110.817 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.47 -73.43 0.38 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.692 -0.63 . . . . 0.0 110.733 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.547 HG21 ' HD2' ' A' ' 22' ' ' ARG . 47.2 mm 55.12 93.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.326 -0.859 . . . . 0.0 110.365 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 139.16 47.79 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.619 -0.676 . . . . 0.0 110.365 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 13' ' ' TYR . 5.4 tt0 -67.58 112.15 4.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.543 -0.723 . . . . 0.0 110.154 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.73 35.44 4.88 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.73 163.98 18.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.579 -0.954 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.3 tp -93.71 107.25 19.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.645 -0.66 . . . . 0.0 110.289 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.9 t -98.72 141.18 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.667 -0.645 . . . . 0.0 109.585 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.75 142.21 46.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.548 -0.72 . . . . 0.0 110.346 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' B' ' 5' ' ' GLU . 12.4 p -131.37 134.27 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.665 -0.647 . . . . 0.0 109.779 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.402 HG22 ' CB ' ' B' ' 4' ' ' GLU . 24.1 p -134.25 146.03 49.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.74 . . . . 0.0 111.208 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -104.16 130.56 51.91 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.47 148.1 24.59 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 110.556 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.21 38.92 1.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.632 -0.668 . . . . 0.0 110.226 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -144.28 -52.74 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.659 -0.651 . . . . 0.0 110.064 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB3' HG22 ' A' ' 43' ' ' VAL . 4.7 mt-10 -83.92 -30.56 26.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.482 -0.761 . . . . 0.0 110.024 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 39.26 29.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' B' ' 47' ' ' GLN . 35.8 m -136.89 158.27 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.921 . . . . 0.0 109.684 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 61.6 t -98.68 130.48 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 109.504 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 15.5 ttmt -110.08 127.21 54.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.877 -0.514 . . . . 0.0 110.415 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.449 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.4 pt -121.98 146.93 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.403 -0.811 . . . . 0.0 110.92 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.545 ' HB3' HG12 ' B' ' 43' ' ' VAL . 17.0 pt20 -143.89 -169.58 3.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.871 -0.518 . . . . 0.0 110.186 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.55 165.13 25.93 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.37 -179.84 8.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.357 -0.839 . . . . 0.0 110.337 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -59.3 -167.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.54 -0.725 . . . . 0.0 109.996 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.8 121.3 12.55 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.146 -0.971 . . . . 0.0 111.585 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -83.57 152.08 13.37 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 N-CA-C 108.748 -1.289 . . . . 0.0 108.748 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -135.56 40.15 2.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.345 -0.847 . . . . 0.0 111.12 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.12 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.135 0.493 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.75 156.3 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.402 ' CB ' HG22 ' A' ' 36' ' ' THR . 7.5 tt0 -145.47 147.13 31.84 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.484 -0.76 . . . . 0.0 110.59 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.4 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 1.4 mm-40 -137.95 163.88 30.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.683 -0.636 . . . . 0.0 109.903 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.84 137.89 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.688 -0.632 . . . . 0.0 110.582 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.417 HG22 ' N ' ' B' ' 8' ' ' LYS . 10.2 p -146.14 165.17 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 0.0 109.725 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.417 ' N ' HG22 ' B' ' 7' ' ' VAL . 16.2 tttp -137.03 138.4 40.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.433 -0.792 . . . . 0.0 110.518 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.46 125.17 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 109.54 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -168.75 42.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.475 -0.765 . . . . 0.0 110.43 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -139.61 -65.99 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.24 46.25 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 29' ' ' GLU . 15.2 m-85 53.44 57.57 6.05 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.492 -0.755 . . . . 0.0 110.814 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 174.78 13.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.451 -0.78 . . . . 0.0 110.822 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.64 145.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.843 -0.536 . . . . 0.0 109.666 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -110.78 -8.56 14.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 111.476 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt 59.55 111.69 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.248 -0.907 . . . . 0.0 110.592 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.76 -168.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.089 1.047 . . . . 0.0 111.324 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.78 -33.72 27.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.654 -0.654 . . . . 0.0 111.6 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -56.62 -52.15 65.96 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.14 -0.975 . . . . 0.0 110.873 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -60.44 -47.63 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.384 -0.823 . . . . 0.0 109.43 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.556 ' HD2' HG21 ' B' ' 27' ' ' ILE . 9.1 tpp180 -58.74 -28.78 66.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.585 -0.697 . . . . 0.0 109.938 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -45.11 80.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.657 -0.652 . . . . 0.0 109.459 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.61 -63.62 1.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.13 169.87 5.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.451 -0.781 . . . . 0.0 110.827 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.41 -73.5 0.38 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.7 -0.625 . . . . 0.0 110.678 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.556 HG21 ' HD2' ' B' ' 22' ' ' ARG . 46.9 mm 55.2 93.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.234 -0.916 . . . . 0.0 110.337 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 139.21 47.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 110.339 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 5.5 tt0 -67.59 112.18 4.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.515 -0.74 . . . . 0.0 110.144 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.61 4.9 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.75 163.89 18.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.715 -0.874 . . . . 0.0 110.047 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.1 tp -93.5 107.19 19.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.614 -0.679 . . . . 0.0 110.354 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 74.2 t -98.85 141.25 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.485 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 142.03 46.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.558 -0.714 . . . . 0.0 110.28 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 5' ' ' GLU . 12.1 p -131.28 134.31 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 24.0 p -134.22 146.12 49.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -104.12 130.46 51.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.26 148.18 24.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.428 -0.795 . . . . 0.0 110.634 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.27 38.86 1.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.656 -0.652 . . . . 0.0 110.284 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -144.1 -52.78 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 110.07 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.525 ' HB3' HG22 ' B' ' 43' ' ' VAL . 4.7 mt-10 -83.82 -30.68 26.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 0.0 110.048 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.9 39.21 28.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 47' ' ' GLN . 35.6 m -136.99 158.14 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.789 -0.83 . . . . 0.0 109.635 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 61.4 t -98.54 130.35 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.314 -0.866 . . . . 0.0 109.555 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.406 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 16.8 ttmt -110.02 127.21 54.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.702 -0.624 . . . . 0.0 110.38 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.46 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.4 pt -121.75 146.93 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.423 -0.798 . . . . 0.0 110.917 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.546 ' HB3' HG12 ' A' ' 43' ' ' VAL . 17.0 pt20 -143.91 -169.57 3.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.855 -0.528 . . . . 0.0 110.197 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.58 165.13 25.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 110.319 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.37 -179.81 8.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.558 -0.714 . . . . 0.0 110.352 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -59.29 -167.15 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.428 -0.795 . . . . 0.0 110.042 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.88 121.6 12.63 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.32 -0.862 . . . . 0.0 111.593 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.86 152.12 12.91 Favored 'Trans proline' 0 C--N 1.323 -0.795 0 N-CA-C 108.623 -1.337 . . . . 0.0 108.623 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -135.57 40.25 2.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 111.004 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.138 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.182 0.515 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.47 134.91 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 109.97 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.721 ' HA ' HG22 ' B' ' 36' ' ' THR . 0.2 OUTLIER -122.76 153.39 39.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.74 . . . . 0.0 110.582 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.04 162.6 41.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.664 -0.647 . . . . 0.0 109.746 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 tt -134.93 154.9 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.566 -0.709 . . . . 0.0 110.703 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.36 159.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 109.973 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -156.32 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.72 . . . . 0.0 110.275 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.122 ' O ' ' N ' ' B' ' 30' ' ' GLY . 49.0 t -143.59 126.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.545 -0.722 . . . . 0.0 109.806 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.87 -169.21 3.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.572 -0.705 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 56.88 -85.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.8 -0.562 . . . . 0.0 111.313 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -152.42 57.73 0.82 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.975 -1.078 . . . . 0.0 110.835 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.008 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 80.3 m-85 50.8 37.38 16.83 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.327 -0.858 . . . . 0.0 111.346 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.45 173.98 6.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.453 -0.78 . . . . 0.0 110.242 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -169.5 141.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.791 . . . . 0.0 110.624 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -108.04 174.47 5.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 109.405 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.9 mm -108.54 133.47 20.6 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.386 -0.821 . . . . 0.0 110.38 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.578 ' HG2' HG23 ' A' ' 21' ' ' VAL . 33.0 Cg_endo -71.36 157.32 57.02 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 O-C-N 123.171 1.09 . . . . 0.0 110.195 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.99 57.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 110.612 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -70.86 -53.49 15.01 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.372 -0.83 . . . . 0.0 110.466 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.578 HG23 ' HG2' ' A' ' 18' ' ' PRO . 98.8 t -59.95 -43.95 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.258 -0.901 . . . . 0.0 109.32 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -59.95 -31.48 69.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.61 -52.57 50.96 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.445 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.53 -68.64 0.67 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.626 -0.671 . . . . 0.0 110.383 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.058 ' CE1' HG23 ' B' ' 44' ' ' VAL . 13.5 t80 -57.96 134.87 56.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.536 -0.728 . . . . 0.0 111.029 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -81.97 123.09 28.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.671 -0.643 . . . . 0.0 109.783 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 27' ' ' ILE . 6.9 tt -166.85 85.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.182 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 1.008 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.4 OUTLIER -95.83 178.28 5.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.294 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.632 ' HA ' HG12 ' B' ' 9' ' ' VAL . 3.5 mt-10 -66.62 135.28 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.65 -0.656 . . . . 0.0 110.606 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 1.127 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 61.16 48.66 84.65 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -106.68 -176.22 3.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -1.019 . . . . 0.0 110.165 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.434 ' HA ' HD13 ' A' ' 32' ' ' LEU . 2.0 mm? -95.9 78.84 3.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.63 -0.669 . . . . 0.0 109.792 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.572 HG21 ' CG2' ' B' ' 9' ' ' VAL . 63.7 t -85.6 116.98 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.35 142.32 32.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.669 -0.644 . . . . 0.0 109.836 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.1 t -138.08 122.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.56 -0.712 . . . . 0.0 109.878 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.707 HG22 ' HA ' ' B' ' 4' ' ' GLU . 68.3 p -140.55 146.79 38.53 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.311 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.421 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 12.0 t80 -105.03 142.54 34.64 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.36 145.07 27.76 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.473 -0.767 . . . . 0.0 110.135 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.56 32.69 2.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.582 -0.699 . . . . 0.0 110.007 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.63 -59.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.588 -0.695 . . . . 0.0 110.077 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -79.99 -30.02 39.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.666 . . . . 0.0 110.163 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.6 43.06 7.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.5 m -137.82 156.44 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.679 -0.894 . . . . 0.0 110.33 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.043 HG23 ' CE1' ' B' ' 25' ' ' PHE . 57.6 t -107.34 121.86 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' HG21 ' B' ' 43' ' ' VAL . 1.2 ttpt -103.67 136.96 42.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.753 -0.592 . . . . 0.0 110.684 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.776 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 42.9 pt -127.5 149.31 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.934 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.74 ' HB3' HG12 ' B' ' 43' ' ' VAL . 10.2 pt20 -151.79 175.1 12.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.0 110.504 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.33 22.76 2.76 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 0.0 110.713 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.8 -175.15 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.28 -0.888 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -138.57 160.31 39.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.606 -0.684 . . . . 0.0 110.098 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -136.6 160.61 65.92 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.666 . . . . 0.0 110.011 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -81.03 67.99 8.46 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.288 1.152 . . . . 0.0 110.059 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -87.42 86.06 7.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.468 -0.77 . . . . 0.0 110.259 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.5 tttt . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.105 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.099 0.476 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.55 134.91 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.543 -0.723 . . . . 0.0 110.022 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' A' ' 36' ' ' THR . 0.2 OUTLIER -122.62 153.42 39.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.558 -0.714 . . . . 0.0 110.653 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -154.14 162.46 41.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.719 -0.613 . . . . 0.0 109.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -134.85 154.85 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.544 -0.723 . . . . 0.0 110.783 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 p -170.33 159.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.686 -0.634 . . . . 0.0 109.891 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.31 -156.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.516 -0.74 . . . . 0.0 110.275 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 1.127 ' O ' ' N ' ' A' ' 30' ' ' GLY . 49.2 t -143.6 126.34 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 109.795 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.78 -169.18 3.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.611 -0.68 . . . . 0.0 110.404 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 56.87 -85.8 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.657 -0.652 . . . . 0.0 111.309 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -152.23 57.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.102 -0.999 . . . . 0.0 110.842 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 1.008 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 81.6 m-85 50.8 37.37 16.8 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.429 -0.794 . . . . 0.0 111.397 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.4 174.13 6.02 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.439 -0.788 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -169.83 141.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.383 -0.823 . . . . 0.0 110.54 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -108.03 174.33 5.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.644 -0.66 . . . . 0.0 109.388 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 42.5 mm -108.35 133.47 20.56 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.587 ' HG2' HG23 ' B' ' 21' ' ' VAL . 32.8 Cg_endo -71.53 157.19 56.74 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 O-C-N 123.304 1.16 . . . . 0.0 110.155 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.95 -20.72 54.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -71.05 -53.41 14.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.363 -0.836 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.587 HG23 ' HG2' ' B' ' 18' ' ' PRO . 86.7 t -59.94 -43.96 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -60.03 -31.38 69.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.77 -0.581 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -65.55 -52.56 51.53 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.705 -0.622 . . . . 0.0 109.481 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -68.4 0.7 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.639 -0.663 . . . . 0.0 110.482 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 1.043 ' CE1' HG23 ' A' ' 44' ' ' VAL . 13.8 t80 -58.21 135.02 57.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.951 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -81.99 123.03 28.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.644 -0.66 . . . . 0.0 109.815 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.631 HG23 ' O ' ' B' ' 27' ' ' ILE . 7.0 tt -166.74 85.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.271 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 1.008 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -95.99 178.19 5.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -0.843 . . . . 0.0 110.311 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.644 ' HA ' HG12 ' A' ' 9' ' ' VAL . 3.5 mt-10 -66.56 135.33 54.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.669 -0.644 . . . . 0.0 110.538 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 1.122 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 61.25 48.67 84.31 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.463 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -106.7 -176.14 2.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -1.009 . . . . 0.0 110.177 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' B' ' 32' ' ' LEU . 2.0 mm? -95.98 78.86 3.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.589 -0.695 . . . . 0.0 109.852 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.565 HG21 ' CG2' ' A' ' 9' ' ' VAL . 64.3 t -85.52 116.98 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.643 -0.661 . . . . 0.0 110.145 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -101.37 142.53 32.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 109.779 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.3 122.12 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.395 -0.815 . . . . 0.0 109.73 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 4' ' ' GLU . 70.5 p -140.54 146.85 38.64 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -0.823 . . . . 0.0 111.269 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.428 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 11.9 t80 -105.11 142.55 34.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.31 145.02 27.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.405 -0.809 . . . . 0.0 110.184 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.6 32.6 2.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.706 . . . . 0.0 109.957 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.61 -59.32 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.702 -0.624 . . . . 0.0 110.065 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -80.11 -30.05 39.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 110.105 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.67 42.97 7.5 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.7 m -137.68 156.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.584 -0.95 . . . . 0.0 110.295 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 1.058 HG23 ' CE1' ' A' ' 25' ' ' PHE . 57.5 t -107.38 121.64 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 43' ' ' VAL . 1.3 ttpt -103.49 136.8 42.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.687 -0.633 . . . . 0.0 110.665 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.754 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 42.5 pt -127.28 149.35 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.767 -0.583 . . . . 0.0 109.99 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.728 ' HB3' HG12 ' A' ' 43' ' ' VAL . 10.2 pt20 -151.66 175.13 12.68 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 0.0 110.495 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.4 22.81 2.74 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.599 -0.688 . . . . 0.0 110.723 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.58 -175.14 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.221 -0.925 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -138.45 160.41 39.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.64 -0.662 . . . . 0.0 110.134 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -136.65 160.54 66.13 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.474 -0.766 . . . . 0.0 109.969 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -81.02 68.24 8.38 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.325 1.171 . . . . 0.0 110.009 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -87.62 86.15 7.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.707 . . . . 0.0 110.226 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 tttt . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 117.818 -1.087 . . . . 0.0 110.108 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.163 0.506 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.75 139.8 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.666 -0.647 . . . . 0.0 109.968 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.14 150.4 42.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.6 -0.688 . . . . 0.0 110.168 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -156.81 161.88 39.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.624 -0.673 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.4 mt -131.25 136.61 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.585 -0.697 . . . . 0.0 110.216 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.69 170.07 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.748 -0.595 . . . . 0.0 109.785 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.69 152.16 35.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.424 -0.798 . . . . 0.0 110.772 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.86 ' O ' ' N ' ' B' ' 30' ' ' GLY . 62.7 t -101.71 136.31 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.74 -0.6 . . . . 0.0 109.591 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.6 p -157.15 -47.01 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.524 -0.735 . . . . 0.0 110.411 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.61 -147.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.652 -0.655 . . . . 0.0 110.182 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.97 60.98 1.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 111.1 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.928 ' CD2' ' O ' ' B' ' 27' ' ' ILE . 27.1 m-85 50.59 32.16 6.47 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.38 -0.825 . . . . 0.0 111.826 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -88.42 174.64 8.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.299 -0.876 . . . . 0.0 110.101 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.11 135.5 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.022 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.2 m -100.61 150.51 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 110.364 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.3 mt -101.7 128.95 27.68 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.584 -0.698 . . . . 0.0 109.67 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.1 158.44 25.66 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.121 1.063 . . . . 0.0 110.72 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.14 77.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.639 -0.663 . . . . 0.0 109.874 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.49 -51.91 56.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.643 -0.661 . . . . 0.0 109.571 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.77 -39.26 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.05 -30.07 70.53 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.68 25.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.603 -0.686 . . . . 0.0 109.433 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -79.62 -63.34 1.44 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.684 -0.635 . . . . 0.0 109.846 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.817 ' CE1' HG23 ' B' ' 44' ' ' VAL . 6.4 t80 -53.53 115.24 1.84 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.268 -0.895 . . . . 0.0 110.695 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.449 ' O ' HD22 ' A' ' 48' ' ' LEU . 12.4 mt-30 -73.77 131.17 41.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.558 -0.714 . . . . 0.0 110.358 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.946 ' O ' ' CD2' ' B' ' 13' ' ' TYR . 6.8 tt -167.56 91.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.64 0.733 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.752 ' HA ' ' CE2' ' B' ' 13' ' ' TYR . 8.3 tttt -99.1 -179.65 4.32 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.262 -0.899 . . . . 0.0 110.997 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.579 ' HA ' HG12 ' B' ' 9' ' ' VAL . 23.5 mt-10 -75.48 127.08 32.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.634 -0.666 . . . . 0.0 109.973 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.842 ' N ' ' O ' ' B' ' 9' ' ' VAL . . . 90.97 26.39 22.11 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.767 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 0.4 OUTLIER -103.74 149.55 24.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.538 -0.978 . . . . 0.0 109.776 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.3 mt -101.43 74.59 1.55 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.695 . . . . 0.0 110.708 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -72.32 151.09 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.426 -0.796 . . . . 0.0 109.569 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -106.61 154.95 20.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.836 . . . . 0.0 111.145 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.695 ' HA ' HG22 ' A' ' 46' ' ' ILE . 8.4 p -145.21 125.83 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.0 p -130.98 146.95 52.54 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.317 -0.865 . . . . 0.0 111.508 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CD1' ' HD1' ' B' ' 25' ' ' PHE . 40.0 t80 -106.49 149.97 26.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -110.07 -167.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.561 -0.712 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.13 -38.71 1.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.7 . . . . 0.0 110.597 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.97 -40.11 12.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.728 . . . . 0.0 110.598 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' A' ' 43' ' ' VAL . 13.8 mp0 -81.66 -37.2 27.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.697 . . . . 0.0 110.537 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.94 26.07 72.11 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.889 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 24.7 m -121.21 149.77 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.447 -1.031 . . . . 0.0 109.661 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.901 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 90.3 t -103.62 129.28 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.418 -0.802 . . . . 0.0 109.675 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.938 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 3.8 ttpm? -109.07 130.96 55.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.217 0.532 . . . . 0.0 109.737 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.903 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 10.8 pt -126.53 145.14 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.73 -0.606 . . . . 0.0 110.086 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.847 ' HB3' HG12 ' B' ' 43' ' ' VAL . 4.0 pt20 -148.96 171.08 16.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 110.303 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 26' ' ' GLN . 1.7 tp -112.03 169.84 8.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.27 57.09 3.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.421 -0.8 . . . . 0.0 110.728 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -101.1 136.22 41.29 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.473 -0.767 . . . . 0.0 110.011 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -122.18 88.1 48.24 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.487 -0.758 . . . . 0.0 111.147 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -63.34 97.41 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.362 1.19 . . . . 0.0 109.807 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.43 92.28 3.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.735 . . . . 0.0 110.379 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.777 179.655 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.05 0.452 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.57 139.95 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.642 -0.661 . . . . 0.0 109.982 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.2 150.57 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.711 -0.618 . . . . 0.0 110.137 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -156.97 161.85 39.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.745 -0.597 . . . . 0.0 109.589 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.26 136.62 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.523 -0.736 . . . . 0.0 110.306 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -126.9 169.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.692 -0.63 . . . . 0.0 109.71 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -117.61 152.04 35.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.518 -0.739 . . . . 0.0 110.787 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.842 ' O ' ' N ' ' A' ' 30' ' ' GLY . 62.8 t -101.59 136.26 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.637 -0.665 . . . . 0.0 109.61 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.4 p -157.23 -46.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.506 -0.746 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.41 ' HB3' ' HG2' ' B' ' 14' ' ' GLN . 0.3 OUTLIER -69.72 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.657 -0.652 . . . . 0.0 110.222 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -75.9 60.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.093 -1.005 . . . . 0.0 111.213 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.946 ' CD2' ' O ' ' A' ' 27' ' ' ILE . 27.0 m-85 50.61 32.09 6.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.364 -0.835 . . . . 0.0 111.902 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.41 ' HG2' ' HB3' ' B' ' 11' ' ' ARG . 17.1 pt20 -88.43 174.56 8.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.307 -0.871 . . . . 0.0 110.207 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.99 135.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.46 -0.775 . . . . 0.0 109.918 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 m -100.58 150.53 22.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.489 -0.757 . . . . 0.0 110.299 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 89.5 mt -101.67 129.0 27.61 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.22 158.52 25.91 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.115 1.061 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.0 77.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -51.65 58.18 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.574 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 83.7 t -62.04 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -66.01 -30.18 70.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -55.59 26.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.708 -0.62 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.61 -63.37 1.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.741 -0.599 . . . . 0.0 109.887 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.802 ' CE1' HG23 ' A' ' 44' ' ' VAL . 6.3 t80 -53.45 115.21 1.82 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.441 ' O ' HD22 ' B' ' 48' ' ' LEU . 12.3 mt-30 -73.83 131.29 41.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.648 -0.658 . . . . 0.0 110.309 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.928 ' O ' ' CD2' ' A' ' 13' ' ' TYR . 6.8 tt -167.64 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.548 0.69 . . . . 0.0 109.557 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.744 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 7.6 tttt -98.99 -179.77 4.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 111.005 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.582 ' HA ' HG12 ' A' ' 9' ' ' VAL . 23.3 mt-10 -75.41 127.12 32.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.678 -0.638 . . . . 0.0 109.961 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.86 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 91.02 26.36 22.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.767 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -103.78 149.44 25.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.972 . . . . 0.0 109.825 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 74.53 1.56 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.656 -0.652 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.44 151.19 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.517 -0.739 . . . . 0.0 109.516 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -106.79 154.93 20.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.337 -0.852 . . . . 0.0 111.141 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.691 ' HA ' HG22 ' B' ' 46' ' ' ILE . 8.2 p -145.17 125.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -130.99 146.97 52.56 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.591 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.575 ' CD1' ' HD1' ' A' ' 25' ' ' PHE . 39.8 t80 -106.46 149.95 26.56 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.9 -167.21 1.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.642 -0.661 . . . . 0.0 110.272 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -130.03 -38.64 1.42 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.633 -0.667 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.05 -40.08 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -0.8 . . . . 0.0 110.604 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.463 ' HB3' HG22 ' B' ' 43' ' ' VAL . 13.6 mp0 -81.77 -37.2 27.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 110.446 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.87 26.29 71.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.938 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 25.5 m -121.32 149.58 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -1.047 . . . . 0.0 109.686 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.903 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 92.3 t -103.62 129.19 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.502 -0.749 . . . . 0.0 109.773 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.889 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 3.8 ttpm? -109.09 130.85 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.783 -0.573 . . . . 0.0 109.833 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.901 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 10.8 pt -126.25 145.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.788 -0.57 . . . . 0.0 110.178 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.844 ' HB3' HG12 ' A' ' 43' ' ' VAL . 3.9 pt20 -149.01 171.02 17.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.247 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.441 HD22 ' O ' ' B' ' 26' ' ' GLN . 1.8 tp -111.9 169.81 8.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 109.721 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.33 57.03 3.79 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.43 -0.793 . . . . 0.0 110.704 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -101.1 136.2 41.34 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.523 -0.736 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -122.25 88.15 48.47 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.468 -0.77 . . . . 0.0 111.076 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -63.39 97.56 0.21 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.325 1.171 . . . . 0.0 109.829 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.48 92.29 3.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 110.348 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.826 179.782 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.166 0.508 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.5 t -122.36 150.69 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.55 -0.719 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.569 ' CB ' HG22 ' B' ' 36' ' ' THR . 1.2 pt-20 -156.27 142.94 18.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.491 -0.756 . . . . 0.0 110.736 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.61 166.86 29.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 109.8 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.0 mt -119.65 126.4 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.478 -0.764 . . . . 0.0 110.226 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.451 HG22 ' N ' ' A' ' 8' ' ' LYS . 12.3 p -127.46 167.3 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.56 -0.712 . . . . 0.0 110.072 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 7' ' ' VAL . 6.9 ttmt -116.29 138.18 51.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.479 -0.763 . . . . 0.0 110.43 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 10' ' ' SER . 59.1 t -78.04 167.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.605 -0.685 . . . . 0.0 109.483 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' B' ' 29' ' ' GLU . 11.5 t -170.2 -66.05 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.33 -0.856 . . . . 0.0 111.164 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . 3.6 mtt180 -58.08 -166.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.612 -0.68 . . . . 0.0 110.765 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -66.56 76.01 0.1 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.674 -0.641 . . . . 0.0 110.801 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 51.84 30.0 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.262 -0.899 . . . . 0.0 111.521 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 11' ' ' ARG . 31.2 mt-30 -89.29 150.61 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.46 -0.775 . . . . 0.0 109.946 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.3 t -121.72 142.56 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 110.693 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.66 132.77 55.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 109.573 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.57 131.25 28.62 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.43 -0.794 . . . . 0.0 109.829 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.04 150.16 74.89 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.044 1.023 . . . . 0.0 110.456 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.61 63.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.548 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -67.29 -45.75 75.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.542 -0.724 . . . . 0.0 109.839 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.8 -41.05 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -65.48 -33.6 76.32 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -42.14 96.77 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -80.45 -68.79 0.65 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.87 ' CE1' HG23 ' B' ' 44' ' ' VAL . 2.5 t80 -64.17 126.1 26.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.721 -0.612 . . . . 0.0 110.596 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.5 112.06 17.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.581 -0.699 . . . . 0.0 109.294 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 27' ' ' ILE . 4.3 tt -154.04 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 121.73 0.776 . . . . 0.0 109.452 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HA ' ' CE1' ' B' ' 13' ' ' TYR . 25.8 mttm -101.51 -170.9 1.89 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.429 -0.794 . . . . 0.0 111.438 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' B' ' 10' ' ' SER . 5.2 tt0 -74.21 139.84 44.67 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.279 0.562 . . . . 0.0 110.785 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.68 28.22 65.67 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.5 159.72 15.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -1.028 . . . . 0.0 110.283 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.34 64.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 110.054 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.409 HG13 HG13 ' B' ' 7' ' ' VAL . 9.9 p -75.01 150.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.743 . . . . 0.0 110.265 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' B' ' 5' ' ' GLU . 32.4 tttt -127.87 136.12 50.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 110.297 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 46' ' ' ILE . 57.8 t -107.69 129.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.665 -0.647 . . . . 0.0 109.824 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.562 HG22 ' CB ' ' B' ' 4' ' ' GLU . 65.4 p -137.88 147.45 44.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.757 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -115.21 144.72 43.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.676 -0.64 . . . . 0.0 109.332 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.35 -174.22 2.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.44 42.01 2.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.561 -0.712 . . . . 0.0 110.085 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.36 -52.29 1.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.56 -0.712 . . . . 0.0 110.56 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -115.41 -61.61 1.72 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.745 . . . . 0.0 110.344 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.32 59.18 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' B' ' 47' ' ' GLN . 32.9 m -140.78 149.54 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.569 -0.959 . . . . 0.0 110.145 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.863 HG23 ' CE1' ' B' ' 25' ' ' PHE . 51.1 t -103.28 133.17 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.392 -0.817 . . . . 0.0 110.128 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 2.8 ttpt -109.42 136.63 48.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.727 -0.608 . . . . 0.0 110.036 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.555 HG22 ' HA ' ' A' ' 35' ' ' VAL . 5.3 pt -131.45 150.25 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.401 -0.812 . . . . 0.0 111.21 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.428 ' HB3' HG12 ' B' ' 43' ' ' VAL . 28.1 pt20 -145.35 -167.9 2.81 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 0.0 109.594 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.61 HD11 HD12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -138.45 -88.88 0.23 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.256 -0.903 . . . . 0.0 111.191 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.54 -172.2 1.19 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.958 -1.089 . . . . 0.0 110.81 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.02 -20.56 4.89 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.628 -0.67 . . . . 0.0 111.31 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 55.51 74.94 0.65 Allowed Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.056 -1.027 . . . . 0.0 111.085 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -81.39 154.89 18.76 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.374 1.197 . . . . 0.0 110.115 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.19 44.42 2.95 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.491 -0.756 . . . . 0.0 110.136 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 118.106 -0.949 . . . . 0.0 109.917 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.026 0.441 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 66.4 t -122.13 150.98 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.654 -0.654 . . . . 0.0 109.652 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.562 ' CB ' HG22 ' A' ' 36' ' ' THR . 1.2 pt-20 -156.65 142.77 18.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.722 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 2.5 mp0 -151.46 166.93 29.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.588 -0.695 . . . . 0.0 109.837 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 61.1 mt -119.58 126.62 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.513 -0.742 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.45 HG22 ' N ' ' B' ' 8' ' ' LYS . 13.9 p -127.64 167.06 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.558 -0.714 . . . . 0.0 110.171 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.45 ' N ' HG22 ' B' ' 7' ' ' VAL . 6.9 ttmt -116.28 138.13 51.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.527 -0.733 . . . . 0.0 110.468 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.465 HG12 ' N ' ' B' ' 10' ' ' SER . 58.7 t -78.1 167.67 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.471 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.511 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 11.2 t -170.21 -65.96 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' B' ' 14' ' ' GLN . 3.6 mtt180 -58.01 -166.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -66.52 76.0 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.66 . . . . 0.0 110.871 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 28' ' ' LYS . 92.0 m-85 51.93 29.89 6.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.433 -0.792 . . . . 0.0 111.52 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' B' ' 11' ' ' ARG . 31.1 mt-30 -89.07 150.64 22.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.99 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.91 142.5 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.618 -0.676 . . . . 0.0 110.676 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.7 p -113.61 132.78 55.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.731 -0.606 . . . . 0.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 59.4 mt -96.62 131.19 28.69 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.585 -0.697 . . . . 0.0 109.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -58.79 150.07 73.5 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 123.079 1.042 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.67 -30.68 63.65 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.474 -0.766 . . . . 0.0 110.496 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -67.3 -45.74 75.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.514 -0.741 . . . . 0.0 109.773 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 65.5 t -62.83 -41.17 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.469 -0.769 . . . . 0.0 109.001 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -65.26 -33.72 76.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.696 -0.627 . . . . 0.0 109.365 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -80.47 -68.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.863 ' CE1' HG23 ' A' ' 44' ' ' VAL . 2.5 t80 -64.42 126.21 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.688 -0.633 . . . . 0.0 110.524 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 112.09 17.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.529 -0.732 . . . . 0.0 109.327 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.638 HG23 ' O ' ' B' ' 27' ' ' ILE . 5.2 tt -154.16 91.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.76 0.79 . . . . 0.0 109.509 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -101.49 -170.92 1.9 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 111.543 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 10' ' ' SER . 5.2 tt0 -74.07 139.75 44.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.799 -0.563 . . . . 0.0 110.868 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.48 28.54 65.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.61 159.76 15.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -1.0 . . . . 0.0 110.238 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.46 64.78 1.88 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.06 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.43 HG13 HG13 ' A' ' 7' ' ' VAL . 10.1 p -75.12 150.74 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.618 -0.676 . . . . 0.0 110.25 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 31.9 tttt -127.82 136.01 50.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.586 -0.696 . . . . 0.0 110.344 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' B' ' 46' ' ' ILE . 58.3 t -107.66 130.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.827 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.569 HG22 ' CB ' ' A' ' 4' ' ' GLU . 65.5 p -137.96 147.32 44.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 110.894 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -115.06 144.67 43.27 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -101.24 -174.13 2.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 110.303 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.47 42.05 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.448 -0.782 . . . . 0.0 110.056 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -123.4 -52.13 1.84 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.526 -0.734 . . . . 0.0 110.525 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -115.61 -61.79 1.69 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.558 -0.714 . . . . 0.0 110.241 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.35 59.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.428 HG12 ' HB3' ' A' ' 47' ' ' GLN . 32.7 m -140.72 149.46 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.621 -0.929 . . . . 0.0 110.13 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.87 HG23 ' CE1' ' A' ' 25' ' ' PHE . 50.4 t -103.2 132.98 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 110.119 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.8 ttpt -109.26 136.52 48.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.658 -0.651 . . . . 0.0 110.135 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' B' ' 35' ' ' VAL . 5.3 pt -131.29 150.11 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.455 -0.778 . . . . 0.0 111.261 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.416 ' HB3' HG12 ' A' ' 43' ' ' VAL . 28.0 pt20 -145.1 -167.8 2.77 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.585 -0.697 . . . . 0.0 109.654 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.553 HD11 HD12 ' B' ' 27' ' ' ILE . 0.3 OUTLIER -138.4 -88.87 0.23 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.238 -0.914 . . . . 0.0 111.337 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.59 -172.25 1.19 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.953 -1.092 . . . . 0.0 110.854 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.03 -20.51 4.91 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.622 -0.674 . . . . 0.0 111.263 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 55.42 74.97 0.64 Allowed Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 121.083 -1.011 . . . . 0.0 111.026 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -81.4 154.97 18.76 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.283 1.149 . . . . 0.0 110.131 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -131.3 44.43 2.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.395 -0.815 . . . . 0.0 110.086 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.911 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.146 0.498 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.2 m -123.64 152.7 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.554 -0.716 . . . . 0.0 109.572 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.495 ' CB ' HG22 ' B' ' 36' ' ' THR . 8.0 pt-20 -144.06 153.91 42.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.783 . . . . 0.0 111.046 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -134.06 147.16 50.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.696 HG23 HD21 ' B' ' 32' ' ' LEU . 89.3 mt -111.28 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 110.677 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.9 t -133.17 151.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.65 12.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.526 -0.733 . . . . 0.0 110.72 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.86 HG23 ' O ' ' B' ' 31' ' ' ASP . 76.4 t -75.45 142.29 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.758 -0.589 . . . . 0.0 109.916 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -172.78 3.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.556 -0.715 . . . . 0.0 110.0 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.3 mtt85 56.58 -86.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.712 -0.617 . . . . 0.0 110.526 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.1 78.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.926 -1.109 . . . . 0.0 109.043 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.79 14.62 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.368 -0.833 . . . . 0.0 109.83 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.06 157.16 26.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.604 -0.685 . . . . 0.0 110.823 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.94 138.47 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.655 -0.653 . . . . 0.0 109.385 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -120.78 152.81 37.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.497 -0.752 . . . . 0.0 110.886 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -97.3 119.59 62.73 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.708 -0.62 . . . . 0.0 109.5 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.21 -174.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.067 1.035 . . . . 0.0 110.622 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.49 25.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.564 -0.71 . . . . 0.0 110.44 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -48.4 42.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 109.982 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.24 -41.63 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.655 -0.653 . . . . 0.0 109.426 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.74 -38.29 81.33 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.558 -0.714 . . . . 0.0 109.69 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -36.02 81.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.596 -0.69 . . . . 0.0 109.757 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -76.45 -69.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.934 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.4 OUTLIER -65.02 149.9 49.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.645 -0.66 . . . . 0.0 109.923 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.88 -80.25 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -0.752 . . . . 0.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' A' ' 25' ' ' PHE . 94.9 mt 50.18 88.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.144 -0.972 . . . . 0.0 110.947 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.637 ' O ' HG11 ' B' ' 9' ' ' VAL . 11.7 tptt -109.34 168.09 9.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.589 -0.694 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -69.35 123.7 21.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.587 -0.696 . . . . 0.0 110.024 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.497 ' H ' ' HB ' ' B' ' 9' ' ' VAL . . . 85.47 37.51 9.63 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.884 ' O ' HG23 ' B' ' 9' ' ' VAL . 2.6 m-20 -115.53 133.03 56.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.528 -0.984 . . . . 0.0 110.193 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HG23 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -69.19 112.25 5.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 48' ' ' LEU . 59.9 t -107.62 151.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.593 -0.692 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -125.0 128.09 48.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.21 128.79 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.483 HG22 ' CB ' ' B' ' 4' ' ' GLU . 69.2 p -136.65 153.0 51.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.257 -0.902 . . . . 0.0 111.872 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 36.6 t80 -124.95 143.79 50.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -117.55 155.96 28.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.438 -0.789 . . . . 0.0 110.894 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -101.37 19.92 16.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.78 -0.575 . . . . 0.0 110.703 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -118.61 -28.48 5.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 110.601 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -105.41 -58.89 1.84 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.402 -0.811 . . . . 0.0 110.296 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.84 33.17 2.68 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' B' ' 47' ' ' GLN . 33.9 m -141.48 162.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.676 -0.896 . . . . 0.0 109.938 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.917 HG23 ' CE2' ' B' ' 25' ' ' PHE . 37.0 t -112.04 123.85 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.33 -0.856 . . . . 0.0 109.981 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 1.5 ttpm? -105.39 150.37 25.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.837 -0.54 . . . . 0.0 109.813 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.885 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 2.7 pp -136.98 155.86 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.833 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.641 ' HB3' HG12 ' B' ' 43' ' ' VAL . 1.8 pt20 -154.98 -174.78 5.13 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.904 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -139.08 25.12 2.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.492 -0.755 . . . . 0.0 110.68 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -164.73 148.09 8.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.347 -0.846 . . . . 0.0 110.348 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -170.38 -42.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.517 -0.739 . . . . 0.0 110.215 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.37 64.8 39.92 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.547 -0.721 . . . . 0.0 110.239 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -60.53 124.34 14.89 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 123.253 1.133 . . . . 0.0 110.5 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -141.85 -44.71 0.35 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.446 -0.784 . . . . 0.0 110.15 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.074 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.155 0.502 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.64 152.73 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.51 -0.744 . . . . 0.0 109.552 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.483 ' CB ' HG22 ' A' ' 36' ' ' THR . 8.0 pt-20 -144.1 153.81 42.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.386 -0.821 . . . . 0.0 111.009 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.87 147.14 51.12 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.658 HG23 HD21 ' A' ' 32' ' ' LEU . 89.2 mt -111.24 116.03 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.739 . . . . 0.0 110.679 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.29 151.15 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.63 163.63 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.399 -0.813 . . . . 0.0 110.707 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 31' ' ' ASP . 69.0 t -75.43 142.18 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.754 -0.591 . . . . 0.0 109.981 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.9 t -159.22 -172.71 3.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.694 . . . . 0.0 109.93 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 56.46 -86.39 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.686 -0.634 . . . . 0.0 110.52 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -175.19 78.47 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.045 -1.035 . . . . 0.0 109.17 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 56.25 49.76 14.68 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.344 -0.848 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -117.08 157.15 26.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.582 -0.699 . . . . 0.0 110.786 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -137.9 138.28 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.746 -0.596 . . . . 0.0 109.459 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.5 p -120.62 152.74 37.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.503 -0.748 . . . . 0.0 110.916 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -97.21 119.56 62.93 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.791 -0.568 . . . . 0.0 109.629 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -58.16 -174.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.06 1.031 . . . . 0.0 110.591 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.55 -29.56 25.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.704 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -48.18 44.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.773 . . . . 0.0 109.99 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.49 -41.5 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.555 -0.715 . . . . 0.0 109.466 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -59.64 -38.28 80.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.564 -0.71 . . . . 0.0 109.712 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -36.08 82.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.57 -0.706 . . . . 0.0 109.639 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -76.51 -69.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.781 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.917 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -65.33 150.0 49.02 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 109.887 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.96 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.538 -0.726 . . . . 0.0 109.906 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' B' ' 25' ' ' PHE . 94.9 mt 50.14 88.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.262 -0.899 . . . . 0.0 110.97 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.638 ' O ' HG11 ' A' ' 9' ' ' VAL . 11.8 tptt -109.4 168.05 9.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.601 -0.687 . . . . 0.0 110.071 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -69.37 123.75 22.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.738 . . . . 0.0 110.077 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.498 ' H ' ' HB ' ' A' ' 9' ' ' VAL . . . 85.64 37.32 9.62 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.6 m-20 -115.61 132.9 56.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.588 -0.948 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -69.01 112.41 5.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.522 -0.737 . . . . 0.0 110.022 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.59 151.15 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.677 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -124.96 127.8 47.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.324 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 m -114.99 128.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.495 HG22 ' CB ' ' A' ' 4' ' ' GLU . 71.3 p -136.53 152.94 51.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 111.863 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.62 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 37.1 t80 -124.83 143.62 50.72 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -117.43 155.84 28.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.482 -0.761 . . . . 0.0 110.868 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -101.46 19.97 16.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.736 -0.603 . . . . 0.0 110.69 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -118.57 -28.7 5.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.358 -0.839 . . . . 0.0 110.616 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -105.36 -58.75 1.85 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.504 -0.747 . . . . 0.0 110.336 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.77 33.22 2.69 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.0 m -141.48 162.69 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.578 -0.954 . . . . 0.0 109.831 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.934 HG23 ' CE2' ' A' ' 25' ' ' PHE . 37.8 t -112.11 123.67 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 0.0 109.922 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.5 ttpm? -105.45 150.08 25.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.713 -0.617 . . . . 0.0 109.874 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.861 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 2.7 pp -136.6 155.96 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.56 -0.713 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.631 ' HB3' HG12 ' A' ' 43' ' ' VAL . 1.8 pt20 -154.92 -174.73 5.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.79 -0.569 . . . . 0.0 110.042 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.439 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.2 OUTLIER -138.97 25.1 2.54 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.436 -0.79 . . . . 0.0 110.713 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.439 HD12 ' O ' ' B' ' 48' ' ' LEU . 0.2 OUTLIER -164.77 148.05 8.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.332 -0.855 . . . . 0.0 110.292 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -170.31 -42.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.51 -0.744 . . . . 0.0 110.164 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.24 64.81 40.99 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.494 -0.754 . . . . 0.0 110.215 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.36 124.3 14.86 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.389 1.205 . . . . 0.0 110.484 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -141.99 -44.57 0.34 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.526 -0.734 . . . . 0.0 110.255 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.054 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.121 0.486 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.96 126.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.596 -0.69 . . . . 0.0 109.848 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.87 147.57 51.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.616 -0.678 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.17 146.38 18.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.708 . . . . 0.0 110.311 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 pt -112.62 150.35 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.63 -0.669 . . . . 0.0 110.218 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.6 m -136.52 150.6 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.625 -0.672 . . . . 0.0 110.267 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -94.06 138.04 32.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.136 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.537 HG11 ' O ' ' B' ' 28' ' ' LYS . 60.6 t -77.04 145.05 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 110.096 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -158.1 -55.4 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.579 -0.701 . . . . 0.0 110.219 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -168.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.666 -0.646 . . . . 0.0 110.033 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -77.93 67.84 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.51 -0.744 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.475 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 93.7 m-85 53.29 45.33 28.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.466 -0.771 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.03 174.24 6.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.488 -0.758 . . . . 0.0 109.53 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -139.36 153.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.678 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 16' ' ' THR . 7.1 t -150.18 115.31 5.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.829 -0.545 . . . . 0.0 109.536 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.1 mt -71.73 143.01 86.55 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.545 -0.722 . . . . 0.0 110.204 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -61.23 -175.81 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.001 0 O-C-N 123.201 1.106 . . . . 0.0 110.216 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.07 -29.96 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 110.199 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.54 -48.26 49.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.539 -0.726 . . . . 0.0 110.012 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.43 -45.42 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.55 -0.719 . . . . 0.0 109.477 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -65.66 -32.31 73.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.666 -0.646 . . . . 0.0 109.513 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -63.61 -36.12 82.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 109.535 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -78.86 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.794 -0.566 . . . . 0.0 109.767 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.864 ' CE2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.47 159.58 6.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -80.72 -82.82 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.731 . . . . 0.0 110.379 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.414 ' O ' ' HE2' ' B' ' 13' ' ' TYR . 45.3 mt 51.28 87.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.167 -0.958 . . . . 0.0 110.519 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' O ' HG11 ' B' ' 9' ' ' VAL . 29.8 mtmt -107.05 -171.45 1.89 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.525 -0.734 . . . . 0.0 110.515 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -79.67 137.01 36.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.478 ' N ' ' HB ' ' B' ' 9' ' ' VAL . . . 58.45 44.09 95.51 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.953 . . . . 0.0 110.113 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.77 2.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.513 -0.742 . . . . 0.0 110.609 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.749 HG13 HD11 ' A' ' 46' ' ' ILE . 64.9 t -67.26 133.64 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 109.218 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -125.07 129.25 49.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.452 -0.78 . . . . 0.0 110.975 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 46' ' ' ILE . 61.7 t -123.72 129.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -138.17 148.38 44.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.375 -0.828 . . . . 0.0 111.235 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.87 ' CE1' ' CE2' ' B' ' 25' ' ' PHE . 47.9 t80 -113.92 135.65 53.75 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.32 162.7 12.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.762 . . . . 0.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.37 32.62 4.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.3 p -118.7 -60.69 1.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 110.102 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -87.03 -50.14 6.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.607 -0.683 . . . . 0.0 110.151 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.61 36.5 2.23 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.805 HG21 ' HD3' ' B' ' 45' ' ' LYS . 35.2 m -133.27 159.68 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -1.01 . . . . 0.0 110.342 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.004 ' HB ' ' CG2' ' B' ' 46' ' ' ILE . 45.6 t -103.23 127.51 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.667 . . . . 0.0 109.403 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.83 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 14.5 ttmt -112.13 125.54 54.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.632 . . . . 0.0 110.571 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.029 ' CG2' ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -113.04 138.66 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.687 . . . . 0.0 109.489 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.838 ' N ' HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -151.08 171.86 16.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.708 -0.62 . . . . 0.0 109.971 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.25 -157.95 0.67 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.564 -0.71 . . . . 0.0 109.761 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 50' ' ' LYS . 1.1 tt -61.8 142.18 57.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.47 -0.769 . . . . 0.0 109.601 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.516 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -101.51 -64.22 1.07 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.424 -0.797 . . . . 0.0 110.995 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -135.85 96.88 12.88 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.435 -0.791 . . . . 0.0 111.348 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HG3' HD22 ' A' ' 49' ' ' LEU . 9.1 Cg_exo -68.84 122.9 9.83 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 O-C-N 123.422 1.222 . . . . 0.0 109.615 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -97.53 54.34 1.18 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.433 -0.792 . . . . 0.0 110.467 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.028 179.724 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.175 0.512 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.76 126.43 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.531 -0.731 . . . . 0.0 109.957 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -129.9 147.63 51.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -158.23 146.22 18.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.562 -0.711 . . . . 0.0 110.321 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.45 150.2 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.567 -0.708 . . . . 0.0 110.195 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.41 150.56 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.488 -0.757 . . . . 0.0 110.254 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.98 138.02 32.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.683 . . . . 0.0 110.2 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 28' ' ' LYS . 59.7 t -77.0 144.93 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.576 -0.703 . . . . 0.0 110.175 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -157.99 -55.46 0.07 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.591 -0.693 . . . . 0.0 110.278 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -168.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 0.0 110.112 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -78.08 67.92 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.717 . . . . 0.0 110.107 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.503 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 93.8 m-85 53.29 45.4 28.56 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 111.184 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -100.18 174.16 6.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.26 153.16 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.401 -0.812 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.574 HG23 ' O ' ' B' ' 16' ' ' THR . 7.2 t -150.22 115.22 5.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.68 -0.638 . . . . 0.0 109.508 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 80.9 mt -71.74 143.11 86.65 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.504 -0.748 . . . . 0.0 110.224 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.3 -175.91 0.15 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 O-C-N 123.1 1.053 . . . . 0.0 110.055 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.08 -29.74 24.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.582 -0.698 . . . . 0.0 110.242 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -71.65 -48.16 49.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.535 -0.728 . . . . 0.0 110.018 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.43 -45.48 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.626 -0.671 . . . . 0.0 109.492 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -65.71 -32.23 73.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.635 . . . . 0.0 109.562 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -63.62 -36.09 82.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.614 -0.679 . . . . 0.0 109.474 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -79.03 -62.62 1.64 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.722 -0.611 . . . . 0.0 109.774 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.73 159.57 6.6 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.735 . . . . 0.0 110.015 179.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -80.69 -82.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.483 -0.76 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' B' ' 25' ' ' PHE . 45.5 mt 51.25 87.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.063 -1.023 . . . . 0.0 110.486 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.537 ' O ' HG11 ' A' ' 9' ' ' VAL . 29.8 mtmt -107.19 -171.35 1.87 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.578 -0.702 . . . . 0.0 110.497 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -79.69 136.98 36.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.485 ' N ' ' HB ' ' A' ' 9' ' ' VAL . . . 58.44 44.15 95.45 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.39 173.67 6.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.595 -0.944 . . . . 0.0 110.142 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.43 65.57 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 110.684 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.744 HG13 HD11 ' B' ' 46' ' ' ILE . 62.1 t -66.95 133.71 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.486 -0.758 . . . . 0.0 109.344 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -125.16 129.27 49.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.487 -0.758 . . . . 0.0 111.04 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.674 HG22 HG12 ' B' ' 46' ' ' ILE . 62.0 t -123.74 129.28 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -138.19 148.42 44.82 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.402 -0.811 . . . . 0.0 111.272 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 25' ' ' PHE . 48.2 t80 -113.92 135.62 53.78 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -104.34 162.62 13.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.596 -0.69 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.34 32.6 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.627 -0.671 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.7 p -118.6 -60.62 1.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.619 -0.676 . . . . 0.0 110.069 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -87.15 -50.1 6.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.41 2.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.83 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 35.3 m -133.25 159.7 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.536 -0.979 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 1.029 ' HB ' ' CG2' ' A' ' 46' ' ' ILE . 45.9 t -103.26 127.51 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.527 -0.733 . . . . 0.0 109.409 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.808 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 14.8 ttmt -112.08 125.32 53.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.671 -0.643 . . . . 0.0 110.552 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 1.004 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -112.79 138.6 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.654 -0.654 . . . . 0.0 109.542 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.832 ' N ' HD13 ' B' ' 46' ' ' ILE . 0.2 OUTLIER -151.04 171.86 16.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.203 0.525 . . . . 0.0 109.916 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.17 -157.9 0.67 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.529 HD23 ' N ' ' B' ' 50' ' ' LYS . 1.0 OUTLIER -61.79 142.13 57.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.37 -0.831 . . . . 0.0 109.633 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . 0.529 ' N ' HD23 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -101.4 -64.33 1.06 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.516 -0.74 . . . . 0.0 111.014 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -135.81 96.8 12.98 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.477 -0.765 . . . . 0.0 111.429 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.445 ' HG3' HD22 ' B' ' 49' ' ' LEU . 9.9 Cg_exo -68.84 122.82 9.75 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.36 1.189 . . . . 0.0 109.688 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -97.41 54.24 1.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.5 -0.75 . . . . 0.0 110.477 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.019 179.63 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -108.79 119.83 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -0.75 . . . . 0.0 109.559 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -120.35 126.61 50.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 0.0 110.876 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.58 152.15 45.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.666 -0.646 . . . . 0.0 109.334 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.93 134.01 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.443 -0.786 . . . . 0.0 110.526 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.49 148.91 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.758 -0.589 . . . . 0.0 109.42 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.59 179.99 3.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.534 -0.729 . . . . 0.0 110.39 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.852 HG21 ' HB3' ' B' ' 31' ' ' ASP . 57.6 t -106.75 165.43 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.614 -0.679 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.444 ' N ' HG12 ' A' ' 9' ' ' VAL . 77.1 p -102.87 -163.64 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.516 -0.74 . . . . 0.0 110.249 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.718 ' HG2' ' OE2' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -102.02 -25.34 13.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.502 -0.748 . . . . 0.0 110.337 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.93 29.85 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 0.0 110.442 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.559 ' HE1' ' HA ' ' B' ' 28' ' ' LYS . 64.4 m-85 52.39 25.81 3.72 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.443 -0.786 . . . . 0.0 110.983 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -104.33 151.28 23.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.515 -0.741 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.93 146.07 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.594 -0.691 . . . . 0.0 110.114 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.5 p -110.72 123.94 51.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.689 -0.632 . . . . 0.0 109.756 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.7 mt -66.39 116.34 32.93 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.743 . . . . 0.0 109.711 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.3 169.17 4.11 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.156 1.082 . . . . 0.0 110.477 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.14 68.34 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.572 -0.705 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.85 -59.83 4.8 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.431 -0.793 . . . . 0.0 110.312 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.91 -40.78 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.379 -0.826 . . . . 0.0 109.22 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.32 -29.97 68.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.717 -0.614 . . . . 0.0 109.549 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -45.66 56.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.65 -69.13 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.661 -0.649 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.685 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.3 OUTLIER -73.44 151.3 41.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.631 -0.668 . . . . 0.0 109.659 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -81.37 -81.28 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 111.209 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 25' ' ' PHE . 15.5 mt 54.49 93.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HA ' ' HE1' ' B' ' 13' ' ' TYR . 0.2 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 0.0 110.453 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.717 ' OE2' ' HG2' ' B' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.82 27.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.711 . . . . 0.0 110.411 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.34 50.9 4.87 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.847 ' HB3' HG21 ' B' ' 9' ' ' VAL . 3.2 t70 -110.06 155.68 21.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.487 -1.008 . . . . 0.0 110.266 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.29 52.34 0.84 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 109.706 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 46' ' ' ILE . 35.9 m -61.12 170.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 0.0 110.404 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.3 122.03 7.5 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.69 144.31 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.557 -0.715 . . . . 0.0 109.141 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.9 p -138.79 150.53 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.218 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.687 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.7 t80 -134.46 147.13 50.34 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -122.04 178.45 4.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.444 -0.785 . . . . 0.0 110.457 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.01 44.26 2.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.9 p -147.18 -52.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.58 -0.7 . . . . 0.0 110.017 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.37 -40.43 21.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.732 -0.605 . . . . 0.0 109.754 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.61 32.96 17.51 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.765 ' HB ' ' HG2' ' B' ' 45' ' ' LYS . 33.0 m -131.61 156.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.05 ' HB ' HG22 ' B' ' 46' ' ' ILE . 56.3 t -104.2 133.81 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.506 -0.746 . . . . 0.0 109.455 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.766 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 0.2 OUTLIER -112.47 129.49 56.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.754 -0.591 . . . . 0.0 110.263 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.039 HG22 ' HB ' ' B' ' 44' ' ' VAL . 0.0 OUTLIER -123.51 139.44 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 109.861 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.862 ' N ' HD13 ' A' ' 46' ' ' ILE . 3.4 pm0 -158.62 -175.33 5.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 110.139 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' CD1' HG12 ' A' ' 33' ' ' VAL . 1.4 mp -107.69 -163.06 0.87 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.19 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.1 tp -61.64 119.73 9.23 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.677 -0.64 . . . . 0.0 110.322 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.42 -168.27 2.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.666 -0.647 . . . . 0.0 109.496 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.0 137.43 46.58 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.397 -0.814 . . . . 0.0 110.13 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -69.79 79.57 0.95 Allowed 'Trans proline' 0 N--CA 1.486 1.033 0 O-C-N 123.248 1.131 . . . . 0.0 110.196 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -61.97 -30.02 70.64 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.743 . . . . 0.0 110.16 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.272 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.202 0.525 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.85 119.9 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.571 -0.706 . . . . 0.0 109.496 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -120.43 126.59 50.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.477 -0.764 . . . . 0.0 110.979 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.51 152.08 45.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.674 -0.641 . . . . 0.0 109.303 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.82 134.04 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.531 -0.731 . . . . 0.0 110.537 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.9 t -137.44 148.96 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.714 -0.616 . . . . 0.0 109.485 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -72.76 179.9 3.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.431 -0.793 . . . . 0.0 110.326 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.847 HG21 ' HB3' ' A' ' 31' ' ' ASP . 58.0 t -106.77 165.55 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.586 -0.696 . . . . 0.0 110.182 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.429 ' N ' HG12 ' B' ' 9' ' ' VAL . 78.0 p -102.92 -163.67 1.01 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.537 -0.727 . . . . 0.0 110.237 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.717 ' HG2' ' OE2' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -102.05 -25.33 13.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.611 -0.681 . . . . 0.0 110.255 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -99.92 29.8 4.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.456 -0.778 . . . . 0.0 110.374 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.583 ' HE1' ' HA ' ' A' ' 28' ' ' LYS . 64.5 m-85 52.35 25.74 3.65 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.463 -0.773 . . . . 0.0 111.005 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.23 151.32 23.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.687 . . . . 0.0 109.883 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.99 146.07 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.601 -0.687 . . . . 0.0 110.159 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -110.77 123.95 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.36 116.28 32.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.29 169.03 4.21 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.143 1.075 . . . . 0.0 110.545 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.08 68.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.572 -0.705 . . . . 0.0 110.227 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.87 -59.88 4.72 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.498 -0.751 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 109.229 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -59.27 -29.97 67.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -45.69 56.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.69 -68.97 0.52 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.635 -0.666 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.687 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -73.68 151.34 40.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.613 -0.679 . . . . 0.0 109.572 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -81.31 -81.4 0.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.754 . . . . 0.0 111.22 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' B' ' 25' ' ' PHE . 15.5 mt 54.66 93.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.044 -1.035 . . . . 0.0 110.049 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.564 ' O ' HG11 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -115.54 -171.96 2.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.612 -0.68 . . . . 0.0 110.436 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.718 ' OE2' ' HG2' ' A' ' 11' ' ' ARG . 5.5 mt-10 -74.85 124.79 27.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 110.358 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.45 50.88 4.86 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.852 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.2 t70 -110.13 155.64 21.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -1.034 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.25 52.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.489 -0.757 . . . . 0.0 109.865 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.604 ' HB ' HD11 ' B' ' 46' ' ' ILE . 35.7 m -60.9 170.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.605 -0.685 . . . . 0.0 110.481 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -151.18 122.19 7.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.685 -0.635 . . . . 0.0 110.141 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 62.8 t -98.85 144.25 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.488 -0.758 . . . . 0.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -138.75 150.66 46.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.419 -0.8 . . . . 0.0 111.151 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.685 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 35.8 t80 -134.64 147.05 50.09 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -121.92 178.54 4.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.457 -0.777 . . . . 0.0 110.485 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.1 44.33 2.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.52 -0.738 . . . . 0.0 110.169 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 85.6 p -147.32 -52.12 0.2 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 109.971 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.44 -40.45 21.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.85 17.71 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.766 ' HB ' ' HG2' ' A' ' 45' ' ' LYS . 32.9 m -131.53 156.95 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -1.041 . . . . 0.0 110.337 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 1.039 ' HB ' HG22 ' A' ' 46' ' ' ILE . 53.4 t -104.17 133.64 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.495 -0.753 . . . . 0.0 109.525 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.765 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -112.42 129.34 56.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 -179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 1.05 HG22 ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.25 139.55 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.575 -0.703 . . . . 0.0 109.921 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.86 ' N ' HD13 ' B' ' 46' ' ' ILE . 3.4 pm0 -158.73 -175.46 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.171 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.41 ' CD1' HG12 ' B' ' 33' ' ' VAL . 1.4 mp -107.64 -163.0 0.86 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 17.0 tp -61.73 119.68 9.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.651 -0.656 . . . . 0.0 110.371 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.35 -168.31 2.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.682 -0.636 . . . . 0.0 109.609 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -81.89 137.35 46.97 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.438 -0.789 . . . . 0.0 110.141 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -69.81 79.8 0.94 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.22 1.116 . . . . 0.0 110.157 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -62.23 -30.01 70.79 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.633 -0.667 . . . . 0.0 110.044 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.307 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.2 0.524 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.8 164.87 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.451 -0.781 . . . . 0.0 110.498 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.597 ' HA ' HG22 ' B' ' 36' ' ' THR . 1.9 tm-20 -131.76 146.74 52.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.646 -0.659 . . . . 0.0 109.809 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.33 162.17 39.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.455 ' C ' HG13 ' A' ' 7' ' ' VAL . 2.4 pp -141.21 136.23 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.639 . . . . 0.0 109.861 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.455 HG13 ' C ' ' A' ' 6' ' ' ILE . 35.9 m -148.68 157.49 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 150.4 44.3 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.736 -0.602 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 31' ' ' ASP . 59.8 t -85.85 163.54 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.434 -0.791 . . . . 0.0 109.656 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -88.86 170.27 10.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.504 -0.748 . . . . 0.0 109.695 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.35 -39.71 77.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -96.85 41.61 1.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.501 -0.749 . . . . 0.0 110.812 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 59.4 m-85 51.35 24.84 2.28 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.387 -0.821 . . . . 0.0 111.476 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -78.84 159.57 27.76 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.423 -0.798 . . . . 0.0 109.231 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.63 155.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.417 -0.802 . . . . 0.0 110.681 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.7 m -141.32 113.55 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -78.25 130.79 70.93 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.723 . . . . 0.0 110.03 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' A' ' 21' ' ' VAL . 23.0 Cg_exo -55.79 -173.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.101 1.053 . . . . 0.0 110.605 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.48 -28.41 16.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.539 -0.726 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -59.24 3.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.53 -0.731 . . . . 0.0 110.915 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 18' ' ' PRO . 27.0 m -63.6 -33.76 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.353 -0.842 . . . . 0.0 109.885 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -61.97 -37.29 84.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -68.9 -35.26 76.65 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.576 -0.702 . . . . 0.0 109.232 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -73.33 0.15 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.903 ' HD2' ' CD1' ' B' ' 37' ' ' PHE . 0.7 OUTLIER -60.5 158.63 11.83 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.592 -0.693 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -81.01 -84.12 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.394 -0.816 . . . . 0.0 110.855 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt 53.17 92.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.013 -1.054 . . . . 0.0 110.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -104.13 -170.53 1.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.695 -0.628 . . . . 0.0 110.818 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.59 126.49 35.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.738 -0.601 . . . . 0.0 110.164 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.1 45.36 15.85 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' O ' HG23 ' B' ' 9' ' ' VAL . 23.8 t70 -112.67 142.93 44.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.988 . . . . 0.0 110.232 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.82 62.86 4.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.641 . . . . 0.0 109.608 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.414 HG12 HD11 ' A' ' 48' ' ' LEU . 27.5 m -53.32 155.88 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.43 -0.794 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -110.23 103.06 11.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.69 -0.631 . . . . 0.0 110.66 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.02 110.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.773 . . . . 0.0 108.933 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.589 HG22 ' HA ' ' B' ' 4' ' ' GLU . 47.2 p -128.14 150.42 49.99 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.562 0.696 . . . . 0.0 111.696 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.911 ' CD1' ' HD2' ' B' ' 25' ' ' PHE . 27.4 t80 -124.63 122.53 37.78 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.8 151.41 24.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 110.361 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.29 20.08 9.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.693 -0.629 . . . . 0.0 110.684 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -46.83 7.69 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.78 -30.27 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.668 -0.645 . . . . 0.0 109.859 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . . . 93.06 47.62 3.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' CG ' ' B' ' 47' ' ' GLN . 33.1 m -140.58 159.63 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.538 -0.978 . . . . 0.0 110.368 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.94 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 31.2 t -100.55 133.97 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.42 123.28 49.07 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.132 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.962 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.9 pt -109.17 134.16 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.803 ' CG ' HG12 ' B' ' 43' ' ' VAL . 54.0 tt0 -149.28 165.81 30.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.504 -0.747 . . . . 0.0 110.52 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -119.37 -41.71 2.7 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.208 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.33 164.12 13.97 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.439 -0.788 . . . . 0.0 110.413 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.63 -171.64 2.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.549 -0.719 . . . . 0.0 109.687 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.28 59.73 8.03 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.804 . . . . 0.0 111.18 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -82.78 121.74 3.32 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.11 1.058 . . . . 0.0 109.922 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.71 -65.88 1.0 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.526 -0.734 . . . . 0.0 110.179 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.412 -179.71 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.106 0.479 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -132.64 164.94 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.54 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.589 ' HA ' HG22 ' A' ' 36' ' ' THR . 1.9 tm-20 -131.82 146.69 52.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.66 -0.65 . . . . 0.0 109.87 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -147.25 162.01 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.456 -0.778 . . . . 0.0 110.47 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.456 ' C ' HG13 ' B' ' 7' ' ' VAL . 2.4 pp -141.11 136.21 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.688 -0.632 . . . . 0.0 109.871 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.456 HG13 ' C ' ' B' ' 6' ' ' ILE . 35.5 m -148.6 157.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.453 -0.78 . . . . 0.0 110.56 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 150.42 44.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 110.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 31' ' ' ASP . 59.8 t -85.85 163.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.439 -0.788 . . . . 0.0 109.657 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.414 ' N ' HG12 ' B' ' 9' ' ' VAL . 0.6 OUTLIER -88.76 170.14 11.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.582 -0.699 . . . . 0.0 109.813 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -39.78 78.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.702 . . . . 0.0 110.502 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -96.84 41.61 1.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.468 -0.77 . . . . 0.0 110.92 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' B' ' 13' ' ' TYR . 58.5 m-85 51.49 24.7 2.34 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.442 -0.786 . . . . 0.0 111.499 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -78.88 159.41 27.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.396 -0.815 . . . . 0.0 109.094 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.59 155.85 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.32 -0.862 . . . . 0.0 110.687 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.5 m -141.3 113.53 8.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.09 130.99 70.74 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.541 -0.724 . . . . 0.0 110.109 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.402 ' HD2' HG21 ' B' ' 21' ' ' VAL . 22.8 Cg_exo -56.19 -173.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.196 0 O-C-N 123.115 1.061 . . . . 0.0 110.436 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.35 -28.52 16.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.718 . . . . 0.0 110.878 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -59.25 3.03 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.489 -0.757 . . . . 0.0 110.887 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.402 HG21 ' HD2' ' B' ' 18' ' ' PRO . 26.9 m -63.65 -33.58 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -62.1 -37.11 83.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.203 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -69.08 -35.12 76.16 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -73.29 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.911 ' HD2' ' CD1' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -60.58 158.64 11.99 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.0 109.344 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -81.02 -84.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.362 -0.836 . . . . 0.0 110.856 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 88.0 mt 53.13 92.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.023 -1.048 . . . . 0.0 110.129 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -104.25 -170.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 110.821 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -88.51 126.54 35.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.825 -0.547 . . . . 0.0 110.185 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 45.26 15.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 9' ' ' VAL . 23.7 t70 -112.62 142.83 44.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.95 . . . . 0.0 110.24 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.85 62.95 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.744 -0.597 . . . . 0.0 109.495 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.431 HG12 HD11 ' B' ' 48' ' ' LEU . 28.0 m -53.5 155.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.479 -0.763 . . . . 0.0 110.583 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -110.33 102.95 11.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 110.591 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.84 110.75 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 4' ' ' GLU . 49.6 p -128.12 150.62 49.9 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.645 0.736 . . . . 0.0 111.678 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.903 ' CD1' ' HD2' ' A' ' 25' ' ' PHE . 27.4 t80 -124.77 122.55 37.77 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -105.81 151.39 24.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.462 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -95.25 19.97 9.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.72 -46.57 7.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.98 -30.23 7.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.701 -0.624 . . . . 0.0 109.785 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.568 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 93.11 47.49 3.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.803 HG12 ' CG ' ' A' ' 47' ' ' GLN . 33.1 m -140.65 159.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.56 -0.965 . . . . 0.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.962 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 32.4 t -100.49 133.81 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.16 123.23 49.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.591 -0.693 . . . . 0.0 111.317 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.94 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.9 pt -109.3 134.19 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.256 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.787 ' CG ' HG12 ' A' ' 43' ' ' VAL . 54.1 tt0 -149.26 165.81 30.81 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.683 -0.636 . . . . 0.0 110.611 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.431 HD11 HG12 ' B' ' 33' ' ' VAL . 0.7 OUTLIER -119.45 -41.46 2.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.566 -0.709 . . . . 0.0 110.142 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.39 164.15 13.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.484 -0.76 . . . . 0.0 110.47 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.65 -171.65 2.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.486 -0.759 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.32 59.73 7.98 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.351 -0.843 . . . . 0.0 111.153 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -82.84 121.81 3.31 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.224 1.118 . . . . 0.0 109.884 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -65.9 1.01 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.477 -0.764 . . . . 0.0 110.185 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.434 -179.705 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.135 0.493 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.18 150.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 110.139 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.95 157.34 44.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.604 -0.685 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.56 143.43 20.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.81 119.78 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.557 -0.714 . . . . 0.0 110.544 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.1 -176.96 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.474 -0.766 . . . . 0.0 110.139 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.71 163.73 29.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.484 -0.76 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG11 ' O ' ' B' ' 28' ' ' LYS . 59.6 t -74.06 166.08 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.56 -0.712 . . . . 0.0 109.928 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' B' ' 29' ' ' GLU . 15.5 m -107.61 -156.64 0.59 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.468 -0.77 . . . . 0.0 110.514 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HA ' ' OE2' ' B' ' 29' ' ' GLU . 8.2 ttp180 -79.09 -52.38 8.28 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.473 -0.767 . . . . 0.0 110.722 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.41 40.07 1.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.481 -0.762 . . . . 0.0 110.802 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.755 ' HE2' ' HA ' ' B' ' 28' ' ' LYS . 94.2 m-85 50.73 40.14 23.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.345 -0.847 . . . . 0.0 111.227 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.38 153.96 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.19 132.68 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.612 -0.68 . . . . 0.0 110.246 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.49 85.16 2.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.647 . . . . 0.0 109.631 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 23.0 mt -61.0 145.42 89.34 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.62 -0.675 . . . . 0.0 110.273 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 16.4 Cg_exo -61.9 -159.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.0 0 O-C-N 123.338 1.178 . . . . 0.0 110.367 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.11 -21.09 16.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.607 -0.683 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.0 -55.84 29.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -0.882 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.22 -39.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.594 -0.691 . . . . 0.0 109.683 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -63.82 -32.31 73.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.661 -0.65 . . . . 0.0 109.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -54.1 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.56 -60.82 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.647 -0.658 . . . . 0.0 109.641 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.5 OUTLIER -74.07 128.18 34.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.54 -0.725 . . . . 0.0 110.355 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -78.58 96.97 5.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.517 -0.74 . . . . 0.0 110.104 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.5 mt -132.04 78.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.58 -0.7 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.782 ' HA ' ' HE2' ' B' ' 13' ' ' TYR . 0.3 OUTLIER -87.32 -158.67 0.46 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.653 -0.655 . . . . 0.0 110.606 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' B' ' 10' ' ' SER . 37.1 tt0 -87.41 91.62 8.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.696 -0.628 . . . . 0.0 110.31 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.99 47.24 0.31 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB2' HG21 ' B' ' 9' ' ' VAL . 2.2 m-20 -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.985 . . . . 0.0 110.352 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mp -75.19 81.42 2.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.643 -0.661 . . . . 0.0 109.989 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -87.21 154.0 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.582 -0.699 . . . . 0.0 110.384 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.97 131.79 41.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.616 -0.677 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.91 131.73 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.532 -0.73 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.55 147.96 48.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.414 -0.804 . . . . 0.0 111.22 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.513 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 29.6 t80 -119.63 141.43 49.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -110.71 154.12 24.31 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.491 -0.756 . . . . 0.0 110.733 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.41 29.11 7.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.672 . . . . 0.0 110.024 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 p -117.91 -35.21 3.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.56 -0.713 . . . . 0.0 110.305 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.29 -65.82 1.15 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.493 -0.754 . . . . 0.0 110.26 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.32 42.6 0.27 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.73 ' HB ' ' CG ' ' B' ' 45' ' ' LYS . 34.6 m -133.9 156.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.971 . . . . 0.0 109.665 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.829 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 29.2 t -116.36 115.4 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.838 . . . . 0.0 110.016 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.746 ' CG ' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -99.94 146.82 26.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.735 -0.603 . . . . 0.0 109.997 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.83 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 12.9 pt -128.74 155.81 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.679 -0.638 . . . . 0.0 110.43 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.411 ' OE1' ' CG1' ' B' ' 43' ' ' VAL . 38.9 tt0 -159.95 160.82 33.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.646 -0.659 . . . . 0.0 110.105 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.85 -67.06 0.87 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.591 -0.693 . . . . 0.0 109.994 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 20.9 tp -91.31 97.16 10.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.559 -0.713 . . . . 0.0 110.191 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.99 -29.29 7.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.58 -0.7 . . . . 0.0 110.166 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 52.57 64.14 7.79 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.516 -0.74 . . . . 0.0 111.044 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -77.46 -157.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.211 1.111 . . . . 0.0 109.852 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 54.3 m95 56.07 76.87 0.26 Allowed 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.411 -0.806 . . . . 0.0 110.351 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.9 tptt . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.197 179.898 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.19 150.9 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 110.113 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.85 157.41 44.39 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.549 -0.72 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.62 143.48 20.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.616 -0.678 . . . . 0.0 110.244 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.79 119.97 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.559 -0.713 . . . . 0.0 110.477 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.35 -177.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -135.72 163.71 29.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.497 -0.752 . . . . 0.0 110.507 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 28' ' ' LYS . 59.2 t -74.07 166.13 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.599 -0.688 . . . . 0.0 109.904 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 15.4 m -107.69 -156.67 0.59 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.44 -0.787 . . . . 0.0 110.449 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.409 ' HA ' ' OE2' ' A' ' 29' ' ' GLU . 8.3 ttp180 -79.05 -52.46 8.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.47 -0.769 . . . . 0.0 110.663 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.3 39.98 1.11 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.782 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 94.2 m-85 50.86 40.04 23.88 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.321 -0.862 . . . . 0.0 111.218 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.35 154.0 19.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.22 132.78 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.573 -0.704 . . . . 0.0 110.205 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -134.6 85.17 2.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 109.609 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 23.0 mt -61.01 145.44 89.36 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.647 -0.658 . . . . 0.0 110.204 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.02 -159.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.986 0 O-C-N 123.347 1.183 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.12 -21.19 16.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.714 -0.616 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -58.02 -56.01 27.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.339 -0.851 . . . . 0.0 110.366 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -62.06 -39.1 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.576 -0.703 . . . . 0.0 109.7 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -63.89 -32.23 73.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.621 -0.674 . . . . 0.0 109.927 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -54.1 25.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.717 . . . . 0.0 109.645 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -64.42 -60.95 2.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.614 -0.679 . . . . 0.0 109.654 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.562 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -74.03 128.09 34.62 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.662 -0.649 . . . . 0.0 110.34 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -78.51 97.05 5.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.559 -0.713 . . . . 0.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 88.6 mt -132.14 78.51 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.572 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.755 ' HA ' ' HE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -87.37 -158.58 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.763 -0.586 . . . . 0.0 110.553 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' SER . 37.1 tt0 -87.51 91.81 8.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.648 -0.657 . . . . 0.0 110.238 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.76 47.38 0.32 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.412 ' HB2' HG21 ' A' ' 9' ' ' VAL . 2.2 m-20 -111.12 133.9 53.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.55 -0.971 . . . . 0.0 110.32 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.15 81.53 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.708 -0.62 . . . . 0.0 110.028 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -87.23 153.97 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.563 -0.711 . . . . 0.0 110.392 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.98 131.78 41.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.576 -0.703 . . . . 0.0 110.21 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.95 131.93 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.583 -0.698 . . . . 0.0 109.566 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 1.8 p -135.69 148.01 48.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.42 -0.8 . . . . 0.0 111.237 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 29.8 t80 -119.69 141.41 49.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -110.75 154.04 24.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.29 29.0 7.19 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.626 -0.672 . . . . 0.0 110.094 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 5.4 p -117.79 -35.23 3.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -116.28 -65.83 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.23 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.28 42.43 0.27 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.746 ' HB ' ' CG ' ' A' ' 45' ' ' LYS . 34.6 m -133.78 156.9 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.538 -0.977 . . . . 0.0 109.704 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.83 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 30.8 t -116.48 115.28 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.291 -0.881 . . . . 0.0 109.986 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.73 ' CG ' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -99.86 146.78 26.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.811 -0.556 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.829 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 12.7 pt -128.68 155.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.709 -0.62 . . . . 0.0 110.365 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -159.88 160.83 34.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.691 -0.63 . . . . 0.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.85 -67.07 0.87 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 20.5 tp -91.3 97.11 10.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.602 -0.686 . . . . 0.0 110.216 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -29.34 7.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 110.13 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.401 ' N ' ' HD3' ' B' ' 52' ' ' PRO . 1.8 tt0 52.57 64.23 7.68 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.516 -0.74 . . . . 0.0 111.001 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' B' ' 51' ' ' GLU . 2.3 Cg_endo -77.47 -157.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.123 1.065 . . . . 0.0 109.852 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 54.2 m95 56.1 76.72 0.27 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.38 -0.825 . . . . 0.0 110.39 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 4.8 tptt . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.234 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' N ' ' OE1' ' B' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.063 0.459 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.8 150.21 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.571 -0.706 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -147.99 116.0 6.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 109.937 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.52 173.96 8.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.47 -0.769 . . . . 0.0 110.641 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.419 HG22 ' HE2' ' B' ' 34' ' ' LYS . 26.8 pt -120.53 130.92 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.685 -0.635 . . . . 0.0 109.894 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' ' 33' ' ' VAL . 33.1 m -131.37 146.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.576 -0.703 . . . . 0.0 110.265 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -103.58 154.21 19.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.578 -0.701 . . . . 0.0 110.39 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.025 ' O ' ' HA2' ' B' ' 30' ' ' GLY . 58.2 t -109.91 142.46 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.584 -0.697 . . . . 0.0 109.58 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.9 p -169.83 -170.52 1.04 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 111.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.93 -86.77 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.697 -0.627 . . . . 0.0 110.984 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.76 55.52 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.061 -1.024 . . . . 0.0 110.579 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HE1' ' C ' ' B' ' 28' ' ' LYS . 71.9 m-85 49.33 47.43 22.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.457 -0.777 . . . . 0.0 111.048 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -112.25 154.15 26.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 110.13 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.92 135.85 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 110.391 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.4 p -108.2 106.87 17.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.782 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.41 126.96 93.0 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.6 -0.688 . . . . 0.0 109.584 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.86 -77.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.06 1.032 . . . . 0.0 110.645 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.11 -37.59 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.48 -0.763 . . . . 0.0 109.446 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.77 -46.79 86.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.726 -0.609 . . . . 0.0 110.156 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.73 -43.69 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.698 . . . . 0.0 109.343 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.87 -27.66 68.3 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.612 -0.68 . . . . 0.0 110.164 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.04 -39.19 42.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.985 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -79.46 -70.37 0.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.664 -0.648 . . . . 0.0 109.969 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.972 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.5 OUTLIER -65.65 133.59 51.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.516 -0.74 . . . . 0.0 110.57 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -81.84 87.92 6.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.59 76.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.593 -0.692 . . . . 0.0 109.481 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' C ' ' HE1' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -58.65 168.86 1.07 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.782 -0.574 . . . . 0.0 110.633 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' CE1' ' B' ' 13' ' ' TYR . 0.5 OUTLIER -74.87 72.66 2.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.73 -0.606 . . . . 0.0 110.139 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 1.027 ' HA2' ' O ' ' B' ' 9' ' ' VAL . . . 137.54 45.17 0.08 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.512 ' H ' ' HB ' ' B' ' 9' ' ' VAL . 2.9 m-20 -105.42 147.54 28.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.613 -0.934 . . . . 0.0 110.323 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.32 76.8 5.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.461 -0.774 . . . . 0.0 110.064 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.445 ' O ' HG22 ' B' ' 7' ' ' VAL . 59.0 t -86.65 143.23 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.525 -0.734 . . . . 0.0 110.082 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -111.73 130.59 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.723 . . . . 0.0 110.166 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HA ' HG22 ' A' ' 46' ' ' ILE . 60.4 t -101.95 130.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.625 -0.672 . . . . 0.0 109.498 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 p -129.02 145.01 51.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 111.364 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.54 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 49.8 t80 -121.09 129.73 53.44 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -107.47 146.9 31.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.426 -0.796 . . . . 0.0 110.774 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 2' ' ' ALA . 28.0 mt-10 -97.94 30.36 3.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.669 -0.644 . . . . 0.0 110.045 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.88 -34.47 3.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.638 -0.664 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -114.66 -42.08 3.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.531 -0.731 . . . . 0.0 110.281 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.52 37.43 4.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.825 HG12 ' HB3' ' B' ' 47' ' ' GLN . 32.7 m -134.61 152.31 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.73 -0.864 . . . . 0.0 109.645 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.961 HG23 ' CE2' ' B' ' 25' ' ' PHE . 56.3 t -99.2 127.35 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 2.1 ttpp -108.5 124.37 50.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.831 -0.543 . . . . 0.0 109.838 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.833 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 9.1 pt -117.02 148.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.752 . . . . 0.0 110.447 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.821 ' HB3' HG12 ' B' ' 43' ' ' VAL . 18.3 pt20 -161.53 -171.67 3.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.572 -0.705 . . . . 0.0 110.599 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.66 124.14 37.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.061 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 49' ' ' LEU . 4.2 tt -169.76 83.52 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.518 -0.739 . . . . 0.0 110.219 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.93 111.6 0.86 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.406 -0.809 . . . . 0.0 110.154 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.9 mt-10 62.18 137.83 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.302 0 O-C-N 121.659 -0.651 . . . . 0.0 110.402 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -87.88 78.15 1.56 Allowed 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 122.952 0.975 . . . . 0.0 110.447 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 51' ' ' GLU . 58.7 m95 -71.16 90.12 0.87 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.486 -0.759 . . . . 0.0 109.833 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.199 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.476 ' N ' ' OE1' ' A' ' 39' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.07 0.462 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.79 150.26 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.589 -0.694 . . . . 0.0 110.09 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -148.16 116.01 6.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.677 -0.639 . . . . 0.0 109.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.65 174.06 8.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.714 . . . . 0.0 110.554 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.414 HG22 ' HE2' ' A' ' 34' ' ' LYS . 27.6 pt -120.57 130.73 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.686 -0.634 . . . . 0.0 109.899 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 33' ' ' VAL . 33.3 m -131.25 146.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.533 -0.729 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -103.5 154.22 19.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.559 -0.713 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 1.027 ' O ' ' HA2' ' A' ' 30' ' ' GLY . 57.7 t -109.95 142.45 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.695 -0.628 . . . . 0.0 109.6 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 84.7 p -169.78 -170.5 1.04 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.281 -0.887 . . . . 0.0 111.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 56.9 -86.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.721 -0.612 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.7 55.49 1.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.04 -1.038 . . . . 0.0 110.564 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.476 ' HE1' ' C ' ' A' ' 28' ' ' LYS . 71.4 m-85 49.34 47.36 22.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.439 -0.788 . . . . 0.0 111.08 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -112.21 154.22 25.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.161 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.97 135.98 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.624 -0.673 . . . . 0.0 110.314 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 40.5 p -108.31 106.86 17.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.739 -0.601 . . . . 0.0 109.773 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.48 126.91 92.93 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.7 -78.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.091 1.048 . . . . 0.0 110.648 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.74 -37.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.752 . . . . 0.0 109.409 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -58.57 -46.9 85.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.625 -0.672 . . . . 0.0 110.123 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.71 -43.63 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.362 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -60.94 -27.68 68.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.653 -0.654 . . . . 0.0 110.049 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.05 -39.21 42.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.533 -0.729 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -79.54 -70.32 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.591 -0.693 . . . . 0.0 109.968 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.961 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -65.55 133.52 51.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.491 -0.756 . . . . 0.0 110.563 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -81.88 88.05 6.36 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.522 -0.736 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.71 76.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 0.0 109.472 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.454 ' C ' ' HE1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -58.54 168.74 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.75 -0.594 . . . . 0.0 110.65 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.448 ' N ' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -74.79 72.53 2.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.607 -0.683 . . . . 0.0 110.138 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 1.025 ' HA2' ' O ' ' A' ' 9' ' ' VAL . . . 137.81 44.85 0.08 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.505 ' H ' ' HB ' ' A' ' 9' ' ' VAL . 3.0 m-20 -105.3 147.54 28.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.405 -1.056 . . . . 0.0 110.362 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.35 76.82 5.91 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.519 -0.738 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 7' ' ' VAL . 57.4 t -86.52 143.13 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.512 -0.742 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.419 ' HE2' HG22 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -111.7 130.57 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' B' ' 46' ' ' ILE . 60.1 t -101.86 130.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.56 -0.712 . . . . 0.0 109.474 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 61.2 p -129.1 144.9 51.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.417 -0.802 . . . . 0.0 111.354 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.552 ' CD1' ' CD2' ' A' ' 25' ' ' PHE . 50.1 t80 -121.11 129.86 53.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -107.54 146.88 31.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.656 -0.653 . . . . 0.0 110.823 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 2' ' ' ALA . 28.1 mt-10 -97.99 30.47 3.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.609 -0.682 . . . . 0.0 110.107 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.02 -34.58 3.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.672 -0.642 . . . . 0.0 110.243 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -114.53 -42.17 3.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.501 -0.749 . . . . 0.0 110.319 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.76 37.19 4.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.821 HG12 ' HB3' ' A' ' 47' ' ' GLN . 32.6 m -134.64 152.08 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.824 -0.809 . . . . 0.0 109.676 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.972 HG23 ' CE2' ' A' ' 25' ' ' PHE . 60.0 t -98.95 127.21 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.715 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.2 ttpp -108.26 124.27 50.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.85 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.9 pt -116.92 148.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.535 -0.728 . . . . 0.0 110.464 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.825 ' HB3' HG12 ' A' ' 43' ' ' VAL . 18.4 pt20 -161.18 -171.74 3.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.706 -0.622 . . . . 0.0 110.742 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.67 124.04 36.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.624 -0.672 . . . . 0.0 110.104 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.586 HD23 ' O ' ' B' ' 49' ' ' LEU . 4.5 tt -169.7 83.45 0.12 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.476 -0.765 . . . . 0.0 110.238 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.89 111.84 0.88 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.461 -0.774 . . . . 0.0 110.106 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.412 ' HB3' ' CD1' ' B' ' 53' ' ' TRP . 1.9 mt-10 62.07 137.76 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.647 -0.658 . . . . 0.0 110.473 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.0 78.21 1.51 Allowed 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 122.896 0.945 . . . . 0.0 110.537 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . 0.412 ' CD1' ' HB3' ' B' ' 51' ' ' GLU . 59.4 m95 -71.08 89.92 0.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.504 -0.747 . . . . 0.0 109.986 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.189 -179.808 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.236 0.541 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.77 148.71 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.581 -0.699 . . . . 0.0 109.596 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -140.31 140.2 35.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.439 -0.788 . . . . 0.0 110.898 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.44 161.18 41.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.633 -0.667 . . . . 0.0 109.637 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -128.23 160.58 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.432 -0.793 . . . . 0.0 110.738 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.45 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.677 -0.64 . . . . 0.0 109.75 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -110.08 151.64 26.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.525 -0.734 . . . . 0.0 110.46 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.08 145.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.647 -0.658 . . . . 0.0 109.649 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 t -172.14 -37.37 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.535 -0.728 . . . . 0.0 110.741 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.16 -78.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.36 -0.837 . . . . 0.0 111.201 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -162.14 69.18 0.28 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.37 -0.831 . . . . 0.0 110.343 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 52.42 23.94 2.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.271 -0.893 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' C ' HG23 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -109.9 169.84 8.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.48 -0.762 . . . . 0.0 109.629 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 14' ' ' GLN . 58.0 t -146.21 135.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.477 -0.764 . . . . 0.0 110.539 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.35 -174.69 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.617 . . . . 0.0 109.525 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.437 ' CG2' HG13 ' A' ' 21' ' ' VAL . 4.2 mp -138.29 138.48 22.86 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 21.6 Cg_exo -60.3 -164.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.163 1.086 . . . . 0.0 110.271 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.82 -26.41 13.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -65.87 -62.6 1.41 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.498 -0.751 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.437 HG13 ' CG2' ' A' ' 17' ' ' ILE . 9.0 p -60.46 -36.18 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.81 . . . . 0.0 109.609 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -64.54 -30.16 71.19 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.62 -0.675 . . . . 0.0 109.255 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -45.41 82.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' B' ' 37' ' ' PHE . 19.7 mmtm -68.76 -71.99 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.671 -0.643 . . . . 0.0 109.27 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' B' ' 44' ' ' VAL . 0.2 OUTLIER -63.12 141.09 58.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.474 -0.766 . . . . 0.0 109.577 179.209 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.39 -83.64 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.377 -0.827 . . . . 0.0 110.376 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.5 mt 51.07 77.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.032 -1.042 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.407 ' HA ' ' CE1' ' B' ' 13' ' ' TYR . 1.1 ttpt -105.6 177.25 4.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.449 -0.782 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.83 77.33 0.88 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.573 -0.704 . . . . 0.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.91 56.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.32 170.38 16.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.94 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.56 103.6 7.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.595 -0.69 . . . . 0.0 110.197 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 48' ' ' LEU . 9.4 p -95.08 157.44 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.687 . . . . 0.0 110.482 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -108.29 131.28 54.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.608 -0.682 . . . . 0.0 110.191 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 46' ' ' ILE . 57.4 t -122.43 136.63 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.741 . . . . 0.0 109.317 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 p -141.85 147.48 37.25 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.425 -0.797 . . . . 0.0 111.596 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' B' ' 24' ' ' LYS . 27.1 t80 -106.38 137.16 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.51 175.92 6.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.353 -0.842 . . . . 0.0 110.9 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.21 36.64 4.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 110.088 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -127.53 -67.02 0.85 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.621 -0.674 . . . . 0.0 110.023 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.6 -38.58 13.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.21 55.87 0.85 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.687 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.1 m -136.48 161.63 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.601 -0.941 . . . . 0.0 110.309 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.644 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 60.3 t -116.08 120.26 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.519 -0.738 . . . . 0.0 109.514 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 17.9 ttmt -109.92 151.53 26.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.752 -0.593 . . . . 0.0 110.799 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.639 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 7.8 pt -134.56 159.58 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.617 -0.677 . . . . 0.0 110.615 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.711 ' HB3' HG12 ' B' ' 43' ' ' VAL . 8.4 pt20 -152.81 164.0 38.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 110.111 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.451 HD11 ' HB ' ' A' ' 33' ' ' VAL . 1.1 mt -149.31 -179.22 6.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.457 -0.777 . . . . 0.0 111.237 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 56.2 160.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 122.022 0.915 . . . . 0.0 112.464 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.29 -152.3 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.81 145.44 30.16 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.243 -0.911 . . . . 0.0 110.257 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -73.02 94.12 0.81 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 O-C-N 123.247 1.13 . . . . 0.0 110.677 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -156.88 77.72 0.89 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.596 -0.69 . . . . 0.0 110.173 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 tptp . . . . . 0 N--CA 1.502 2.143 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.701 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.202 0.525 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.78 148.65 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.719 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.24 140.22 35.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.447 -0.783 . . . . 0.0 110.924 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -155.43 161.2 41.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.755 -0.591 . . . . 0.0 109.575 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.2 160.59 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.433 -0.792 . . . . 0.0 110.708 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.43 161.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.642 -0.661 . . . . 0.0 109.663 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -110.06 151.6 27.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.512 -0.743 . . . . 0.0 110.479 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.08 145.39 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.656 -0.652 . . . . 0.0 109.71 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.9 t -172.13 -37.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -51.17 -78.11 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.455 -0.778 . . . . 0.0 111.241 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -162.16 69.02 0.27 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 110.376 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.407 ' CE1' ' HA ' ' A' ' 28' ' ' LYS . 23.7 m-85 52.62 23.9 2.86 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.343 -0.848 . . . . 0.0 111.003 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.416 ' C ' HG23 ' B' ' 15' ' ' VAL . 1.0 OUTLIER -109.86 169.78 8.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.644 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.416 HG23 ' C ' ' B' ' 14' ' ' GLN . 57.4 t -146.21 135.49 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.465 -0.772 . . . . 0.0 110.505 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -98.38 -174.64 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.646 -0.659 . . . . 0.0 109.517 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.439 ' CG2' HG13 ' B' ' 21' ' ' VAL . 4.2 mp -138.43 138.5 22.58 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -60.19 -164.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.151 1.079 . . . . 0.0 110.355 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.85 -26.5 13.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.573 -0.704 . . . . 0.0 110.422 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -65.79 -62.57 1.43 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.505 -0.747 . . . . 0.0 109.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.439 HG13 ' CG2' ' B' ' 17' ' ' ILE . 9.2 p -60.45 -36.25 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -64.5 -30.15 71.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -45.38 81.91 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 19.7 mmtm -68.77 -71.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.646 -0.659 . . . . 0.0 109.296 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.501 ' CE1' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -63.1 141.05 58.91 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -72.38 -83.62 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.402 -0.812 . . . . 0.0 110.428 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 85.6 mt 51.05 77.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.055 -1.028 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -105.58 177.27 4.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.182 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.93 77.41 0.9 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.534 -0.729 . . . . 0.0 110.139 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 141.84 56.88 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.46 170.4 16.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.577 -0.955 . . . . 0.0 110.103 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.46 103.59 7.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.573 -0.705 . . . . 0.0 110.299 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' B' ' 48' ' ' LEU . 9.4 p -95.01 157.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.638 -0.664 . . . . 0.0 110.461 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -108.38 131.23 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.649 -0.657 . . . . 0.0 110.14 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.613 HG22 HG22 ' B' ' 46' ' ' ILE . 60.3 t -122.5 136.56 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.705 . . . . 0.0 109.326 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 8.5 p -141.79 147.52 37.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.396 -0.815 . . . . 0.0 111.479 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.41 ' CE2' ' HB3' ' A' ' 24' ' ' LYS . 26.9 t80 -106.39 137.03 45.1 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.39 175.84 6.1 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.279 -0.888 . . . . 0.0 110.993 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.11 36.51 4.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 110.064 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -127.53 -66.88 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.573 -0.704 . . . . 0.0 110.025 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -90.55 -38.61 13.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.578 -0.701 . . . . 0.0 110.072 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.17 55.92 0.85 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.711 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.1 m -136.54 161.48 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.529 -0.983 . . . . 0.0 110.214 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.639 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.5 t -115.92 120.11 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.424 -0.798 . . . . 0.0 109.566 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 17.9 ttmt -109.75 151.37 27.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.677 -0.639 . . . . 0.0 110.921 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.644 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 7.8 pt -134.41 159.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.722 -0.611 . . . . 0.0 110.671 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.687 ' HB3' HG12 ' A' ' 43' ' ' VAL . 8.5 pt20 -152.69 164.09 38.41 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.642 -0.661 . . . . 0.0 110.123 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' B' ' 33' ' ' VAL . 1.2 mt -149.32 -179.15 6.84 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.391 -0.818 . . . . 0.0 111.31 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt 56.1 160.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.98 0.895 . . . . 0.0 112.468 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.35 -152.3 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.8 145.35 29.99 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.177 -0.952 . . . . 0.0 110.314 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -72.86 94.1 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.379 1.199 . . . . 0.0 110.729 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 27.1 m95 -156.93 77.82 0.89 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.489 -0.757 . . . . 0.0 110.082 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 tptp . . . . . 0 N--CA 1.501 2.116 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.779 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.182 0.515 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.96 147.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.593 -0.692 . . . . 0.0 110.152 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' B' ' 36' ' ' THR . 10.3 mt-10 -125.79 135.48 52.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.697 -0.627 . . . . 0.0 109.786 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.69 164.5 38.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.0 110.776 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.35 133.16 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.652 -0.655 . . . . 0.0 109.521 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.37 159.32 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -113.09 158.17 20.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.695 -0.628 . . . . 0.0 109.693 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.58 HG23 ' O ' ' B' ' 31' ' ' ASP . 69.9 t -94.18 147.91 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.54 -0.725 . . . . 0.0 110.172 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.7 t -171.05 -168.81 0.68 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.571 -0.705 . . . . 0.0 110.332 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.57 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.717 -0.614 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.14 79.5 0.16 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.01 -1.057 . . . . 0.0 111.563 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 53.14 56.99 6.74 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.314 -0.866 . . . . 0.0 111.433 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -130.26 153.33 48.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.387 -0.82 . . . . 0.0 110.495 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -123.87 101.48 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.703 -0.623 . . . . 0.0 110.074 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 16' ' ' THR . 6.7 t -74.87 153.99 38.42 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.543 -0.723 . . . . 0.0 110.077 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -98.91 130.99 26.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.564 -0.71 . . . . 0.0 109.789 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.99 -167.46 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.042 1.022 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.52 -36.51 17.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.615 -0.678 . . . . 0.0 110.221 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.55 -43.17 85.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 110.103 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.32 -38.47 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.714 . . . . 0.0 109.64 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -67.87 -41.47 82.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.168 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -67.55 -45.19 76.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 109.916 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.2 -68.68 0.64 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.704 -0.622 . . . . 0.0 109.999 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.6 OUTLIER -70.87 119.78 15.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.594 -0.691 . . . . 0.0 110.272 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.04 108.68 13.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.706 -0.621 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.65 76.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.472 -0.767 . . . . 0.0 109.981 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -97.23 175.35 6.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.632 -0.668 . . . . 0.0 110.011 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.26 125.62 24.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.52 -0.737 . . . . 0.0 109.997 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.47 20.4 12.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.591 ' O ' HG23 ' B' ' 9' ' ' VAL . 4.9 m-20 -111.83 114.8 27.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 95.93 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.624 . . . . 0.0 110.728 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.13 133.13 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.655 -0.653 . . . . 0.0 109.403 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 165.78 11.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.501 -0.749 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.68 136.15 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.658 -0.651 . . . . 0.0 109.873 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.645 HG22 ' HA ' ' B' ' 4' ' ' GLU . 71.3 p -141.87 146.41 35.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 110.904 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -103.64 140.28 37.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.732 -0.605 . . . . 0.0 109.539 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.33 173.39 6.38 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.645 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.71 33.97 5.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 110.059 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.5 t -121.65 -63.64 1.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 0.0 110.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.37 -35.9 10.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 110.58 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.82 56.97 0.88 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.823 HG12 ' HB3' ' B' ' 47' ' ' GLN . 34.2 m -133.25 166.92 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.631 -0.923 . . . . 0.0 110.053 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.537 HG23 ' CE2' ' B' ' 25' ' ' PHE . 47.4 t -119.71 116.6 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.358 -0.839 . . . . 0.0 109.833 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 4.1 ttpt -98.96 139.93 33.88 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 110.44 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.516 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 1.4 pt -131.72 157.06 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.561 -0.712 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.826 ' HB3' HG12 ' B' ' 43' ' ' VAL . 17.3 pt20 -161.26 168.71 23.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.461 -0.775 . . . . 0.0 110.464 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.61 -152.3 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.539 -0.726 . . . . 0.0 109.568 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tp -56.38 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.409 -0.807 . . . . 0.0 110.802 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.37 136.57 1.35 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.601 -0.687 . . . . 0.0 109.532 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.406 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -124.47 52.59 5.97 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.625 -179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 51' ' ' GLU . 30.1 Cg_endo -69.24 106.36 1.55 Allowed 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.283 1.149 . . . . 0.0 109.952 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 -63.72 0.68 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.454 -0.779 . . . . 0.0 110.558 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.272 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.225 0.536 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.03 147.17 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.563 -0.71 . . . . 0.0 110.178 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.645 ' HA ' HG22 ' A' ' 36' ' ' THR . 10.3 mt-10 -125.64 135.6 52.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.69 -0.631 . . . . 0.0 109.75 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -154.76 164.53 38.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.728 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 87.8 mt -132.49 133.13 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 109.495 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.33 159.31 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.326 -0.859 . . . . 0.0 110.783 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -113.06 158.11 20.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.727 -0.608 . . . . 0.0 109.78 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 31' ' ' ASP . 73.4 t -94.18 147.83 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 110.185 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -171.04 -168.75 0.68 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.361 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 56.6 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.674 -0.641 . . . . 0.0 110.831 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -168.13 79.47 0.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.965 -1.084 . . . . 0.0 111.559 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 53.07 57.15 6.6 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.301 -0.874 . . . . 0.0 111.459 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -130.47 153.23 49.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.332 -0.855 . . . . 0.0 110.586 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.9 t -123.78 101.4 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.763 -0.586 . . . . 0.0 110.082 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -74.83 153.9 38.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 110.075 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 34.1 mt -98.84 130.93 26.59 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.83 -167.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.161 1.085 . . . . 0.0 110.347 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.51 -36.47 17.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.6 -0.688 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -66.63 -43.05 85.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.607 -0.683 . . . . 0.0 110.168 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.4 -38.44 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 109.573 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -67.9 -41.52 82.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.736 -0.603 . . . . 0.0 110.198 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -67.5 -45.13 76.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.941 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -79.36 -68.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.711 -0.618 . . . . 0.0 109.971 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.537 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -70.87 119.78 15.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.7 -0.625 . . . . 0.0 110.227 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.09 108.75 13.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.627 -0.671 . . . . 0.0 110.327 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.63 76.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -97.25 175.39 6.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.659 -0.651 . . . . 0.0 110.018 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.37 125.74 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 110.017 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.36 20.42 12.24 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.58 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.9 m-20 -111.77 114.87 28.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.7 95.82 1.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.606 -0.684 . . . . 0.0 110.76 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 64.2 t -94.11 133.11 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.501 -0.749 . . . . 0.0 109.374 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.37 165.83 11.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.492 -0.755 . . . . 0.0 110.356 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.69 136.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 109.775 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 4' ' ' GLU . 69.8 p -141.91 146.42 35.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.456 -0.778 . . . . 0.0 110.979 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -103.67 140.36 37.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.684 -0.635 . . . . 0.0 109.481 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.34 173.44 6.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.525 -0.734 . . . . 0.0 110.618 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -122.7 33.76 5.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.675 -0.641 . . . . 0.0 110.027 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 36.9 t -121.48 -63.75 1.29 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.565 -0.71 . . . . 0.0 110.441 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.3 -35.96 10.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.525 -0.734 . . . . 0.0 110.498 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.85 56.87 0.88 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.826 HG12 ' HB3' ' A' ' 47' ' ' GLN . 34.0 m -133.25 166.75 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.654 -0.909 . . . . 0.0 110.066 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.531 HG23 ' CE2' ' A' ' 25' ' ' PHE . 47.3 t -119.61 116.64 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.315 -0.865 . . . . 0.0 109.868 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.424 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 4.2 ttpt -99.0 139.84 34.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.578 -0.701 . . . . 0.0 110.419 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.518 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 1.4 pt -131.65 156.86 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 110.384 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.823 ' HB3' HG12 ' A' ' 43' ' ' VAL . 17.3 pt20 -161.0 168.85 23.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.506 -0.746 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.79 -152.31 0.07 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.639 -0.663 . . . . 0.0 109.555 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 tp -56.31 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.369 -0.832 . . . . 0.0 110.816 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.47 136.53 1.31 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.577 -0.702 . . . . 0.0 109.569 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.412 ' N ' ' CD ' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -124.47 52.58 5.96 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.483 -0.76 . . . . 0.0 110.561 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' B' ' 51' ' ' GLU . 29.9 Cg_endo -69.36 106.4 1.58 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 O-C-N 123.235 1.124 . . . . 0.0 109.879 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.02 -63.59 0.69 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.487 -0.758 . . . . 0.0 110.621 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.258 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.046 0.45 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.38 138.18 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.596 -0.69 . . . . 0.0 110.068 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.27 152.11 51.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.562 -0.712 . . . . 0.0 109.9 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 2.5 mp0 -151.25 152.12 32.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.496 -0.753 . . . . 0.0 110.367 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.8 mt -120.11 125.4 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.634 -0.666 . . . . 0.0 109.567 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.54 155.91 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.498 -0.751 . . . . 0.0 110.59 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.46 145.1 38.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.688 -0.632 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.27 130.74 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.605 -0.684 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -170.85 -157.04 0.13 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.498 -0.751 . . . . 0.0 110.187 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.2 mtt85 55.74 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.727 -0.608 . . . . 0.0 111.075 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -150.83 56.39 0.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.096 -1.002 . . . . 0.0 110.561 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.95 38.25 19.73 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.304 -0.873 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.57 176.94 6.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.25 128.58 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.46 -21.49 21.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.331 -0.856 . . . . 0.0 111.49 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.3 mt 59.87 115.32 0.02 OUTLIER Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.718 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.67 175.18 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 O-C-N 122.858 0.925 . . . . 0.0 110.775 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.59 -27.13 61.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.615 -0.678 . . . . 0.0 110.568 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -54.32 46.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.493 -0.754 . . . . 0.0 110.521 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.53 -45.63 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.38 -0.825 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -60.0 -31.39 69.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -48.42 64.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.629 -0.669 . . . . 0.0 109.502 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' B' ' 37' ' ' PHE . 0.0 OUTLIER -65.12 -65.29 0.69 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.686 -0.633 . . . . 0.0 109.514 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.665 ' CE1' HG23 ' B' ' 44' ' ' VAL . 0.6 OUTLIER -65.78 164.97 13.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.666 -0.646 . . . . 0.0 110.151 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -73.55 -74.95 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.566 -0.709 . . . . 0.0 109.912 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.4 mm 52.95 84.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.396 -0.815 . . . . 0.0 110.608 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.35 148.57 37.4 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.632 -0.668 . . . . 0.0 110.379 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -61.69 109.44 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.586 -0.696 . . . . 0.0 110.134 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 55.22 1.31 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' OD2' HD21 ' A' ' 48' ' ' LEU . 3.2 t0 -126.92 158.38 36.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 0.0 110.274 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -92.78 82.95 4.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.81 156.45 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.825 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' B' ' 5' ' ' GLU . 5.1 tttt -134.17 147.14 50.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.513 -0.742 . . . . 0.0 110.25 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 46' ' ' ILE . 48.3 t -127.81 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.621 -0.674 . . . . 0.0 109.664 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.7 p -134.51 155.84 49.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.987 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE1' ' CD1' ' B' ' 25' ' ' PHE . 26.3 t80 -133.97 121.85 22.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.708 -0.62 . . . . 0.0 109.536 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -99.97 168.8 9.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 110.174 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.53 32.12 5.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.615 -0.678 . . . . 0.0 110.009 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.8 p -117.61 -48.83 2.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.606 -0.684 . . . . 0.0 110.139 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.65 -29.64 12.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 110.163 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.91 39.62 11.54 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' B' ' 47' ' ' GLN . 34.0 m -128.3 155.14 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.691 -0.888 . . . . 0.0 110.327 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.646 HG23 ' CE1' ' B' ' 25' ' ' PHE . 40.2 t -103.01 115.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -100.63 130.01 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.844 -0.535 . . . . 0.0 110.165 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.656 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 8.7 pt -124.45 151.44 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.521 -0.737 . . . . 0.0 110.959 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.561 ' HG3' HG12 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -159.3 -168.98 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.34 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.455 HD21 ' OD2' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -112.82 -74.57 0.63 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.675 -0.641 . . . . 0.0 110.071 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 49' ' ' LEU . 18.6 tp -166.24 140.94 4.45 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.417 -0.802 . . . . 0.0 110.188 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.32 -70.24 0.14 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.462 -0.774 . . . . 0.0 110.45 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -155.19 116.72 2.37 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.448 -0.782 . . . . 0.0 110.346 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.58 88.09 0.28 Allowed 'Trans proline' 0 N--CA 1.486 1.051 0 O-C-N 123.112 1.059 . . . . 0.0 110.478 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -142.53 -46.06 0.32 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.55 -0.719 . . . . 0.0 110.171 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 tttm . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.133 179.905 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.078 0.466 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.46 138.27 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.573 -0.704 . . . . 0.0 109.998 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -133.3 152.16 51.92 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.661 -0.649 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.5 mp0 -151.29 152.15 32.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 mt -120.08 125.43 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.592 -0.692 . . . . 0.0 109.647 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.51 155.84 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.496 -0.752 . . . . 0.0 110.631 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.4 145.2 37.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.653 . . . . 0.0 110.036 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 64.9 t -79.27 130.87 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.569 -0.707 . . . . 0.0 109.991 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -171.09 -157.08 0.12 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.611 -0.68 . . . . 0.0 110.089 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 39.5 mtt85 55.75 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.646 -0.659 . . . . 0.0 111.131 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.82 56.36 0.91 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.067 -1.021 . . . . 0.0 110.518 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 50.9 38.3 19.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.263 -0.898 . . . . 0.0 110.857 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.6 176.95 6.83 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.52 -0.738 . . . . 0.0 111.179 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.24 128.66 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -90.52 -21.44 21.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.451 -0.781 . . . . 0.0 111.492 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 68.5 mt 59.85 115.35 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -57.8 175.19 0.47 Allowed 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 122.893 0.944 . . . . 0.0 110.819 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.07 61.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -54.26 47.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.56 -45.69 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -59.85 -31.56 69.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -48.32 64.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.685 -0.634 . . . . 0.0 109.563 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -65.25 -65.19 0.71 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.629 -0.669 . . . . 0.0 109.484 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.646 ' CE1' HG23 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -65.82 164.94 13.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.682 -0.636 . . . . 0.0 110.123 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.59 -74.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.607 -0.683 . . . . 0.0 109.914 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 47.6 mm 52.85 84.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.445 -0.784 . . . . 0.0 110.584 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -114.39 148.77 37.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.555 -0.716 . . . . 0.0 110.281 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -61.84 109.49 1.26 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.594 -0.691 . . . . 0.0 110.098 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.92 55.15 1.33 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.444 ' OD2' HD21 ' B' ' 48' ' ' LEU . 3.2 t0 -126.91 158.41 36.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.598 -0.942 . . . . 0.0 110.303 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -92.79 82.92 4.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.8 156.43 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 0.0 109.918 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 5.4 tttt -134.16 147.09 50.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.546 -0.721 . . . . 0.0 110.28 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.514 HG22 HG22 ' B' ' 46' ' ' ILE . 47.7 t -127.69 136.11 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.634 -0.666 . . . . 0.0 109.704 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -134.54 155.85 49.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.442 -0.786 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.499 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 26.4 t80 -134.03 121.94 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.705 -0.622 . . . . 0.0 109.468 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -100.07 168.79 9.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.728 -0.607 . . . . 0.0 110.182 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -111.52 31.97 5.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 74.6 p -117.55 -48.77 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.148 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.67 -29.56 12.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.68 . . . . 0.0 110.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.82 39.79 11.46 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.561 HG12 ' HG3' ' A' ' 47' ' ' GLN . 34.7 m -128.31 155.3 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.744 -0.857 . . . . 0.0 110.343 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.665 HG23 ' CE1' ' A' ' 25' ' ' PHE . 41.1 t -103.1 115.39 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -100.22 129.8 46.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.761 -0.587 . . . . 0.0 110.342 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.645 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 8.8 pt -124.1 151.49 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.518 -0.739 . . . . 0.0 110.983 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.596 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -159.38 -168.96 2.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.783 -0.573 . . . . 0.0 110.348 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.444 HD21 ' OD2' ' B' ' 31' ' ' ASP . 0.3 OUTLIER -112.9 -74.59 0.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 109.958 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' B' ' 49' ' ' LEU . 18.6 tp -166.23 140.89 4.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -0.786 . . . . 0.0 110.2 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.28 -70.15 0.15 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.558 -0.714 . . . . 0.0 110.493 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -155.24 116.72 2.37 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.423 -0.798 . . . . 0.0 110.323 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -66.56 88.05 0.27 Allowed 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.129 1.068 . . . . 0.0 110.473 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -142.54 -45.94 0.32 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.603 -0.685 . . . . 0.0 110.261 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 5.9 tttm . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.179 179.861 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.053 0.454 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.99 112.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.067 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.38 160.51 14.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.543 -0.723 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.39 148.76 28.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.551 -0.718 . . . . 0.0 110.323 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.2 mt -120.32 147.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.638 -0.664 . . . . 0.0 109.777 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 HG13 ' B' ' 33' ' ' VAL . 9.7 p -168.18 161.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.512 -0.743 . . . . 0.0 110.365 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.86 -170.73 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 110.144 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.77 156.01 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.754 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.8 p -168.95 -176.93 2.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.764 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.94 -157.51 0.15 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.521 -0.737 . . . . 0.0 110.765 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -87.98 65.54 8.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.695 . . . . 0.0 110.271 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.41 33.03 14.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.468 -0.77 . . . . 0.0 111.042 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.86 151.37 25.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.702 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.04 140.03 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.434 -0.791 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 16' ' ' THR . 6.6 t -144.77 110.59 5.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 109.891 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.416 HG23 ' HD2' ' A' ' 18' ' ' PRO . 88.3 mt -71.26 142.26 86.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.069 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD2' HG23 ' A' ' 17' ' ' ILE . 30.5 Cg_endo -69.16 179.88 3.09 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.345 1.182 . . . . 0.0 110.465 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.43 43.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.579 -0.7 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.65 -50.77 72.16 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.11 -36.18 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.267 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -64.05 -31.99 73.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.94 -47.67 65.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.601 -0.687 . . . . 0.0 109.312 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -69.33 0.29 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.683 -0.636 . . . . 0.0 109.355 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.67 ' CE2' HG23 ' B' ' 44' ' ' VAL . 0.3 OUTLIER -66.41 156.25 35.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.579 -0.701 . . . . 0.0 109.719 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.77 -81.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.494 -0.754 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 25' ' ' PHE . 61.6 mt 50.63 87.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.191 -0.943 . . . . 0.0 110.895 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -124.77 173.0 8.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.727 . . . . 0.0 109.917 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.86 5.66 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 0.0 110.266 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.27 61.6 1.55 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.458 ' HB3' HD21 ' A' ' 48' ' ' LEU . 1.8 m-20 -133.96 138.08 45.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.522 -0.987 . . . . 0.0 110.152 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.81 90.78 8.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.543 -0.723 . . . . 0.0 110.325 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.443 HG13 HG13 ' B' ' 7' ' ' VAL . 7.7 p -97.21 152.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.629 -0.669 . . . . 0.0 109.789 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 151.59 48.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.541 -0.724 . . . . 0.0 110.627 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.0 127.57 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.7 p -127.37 150.11 49.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.497 -0.752 . . . . 0.0 111.367 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 35.1 t80 -136.23 125.33 24.47 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.51 -177.68 3.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 0.0 110.532 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -124.24 24.21 8.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.713 -0.617 . . . . 0.0 110.461 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.6 t -119.45 -40.36 2.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.367 -0.833 . . . . 0.0 110.072 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.61 -49.6 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 110.128 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.31 43.78 2.49 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' B' ' 47' ' ' GLN . 34.9 m -141.41 156.23 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.576 -0.955 . . . . 0.0 110.032 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.684 HG23 ' CE2' ' B' ' 25' ' ' PHE . 46.6 t -106.23 125.5 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.956 -0.697 . . . . 0.0 109.925 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.579 ' HG2' ' HB ' ' B' ' 43' ' ' VAL . 2.4 ttpt -107.83 128.28 54.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.665 -0.647 . . . . 0.0 110.259 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.498 HG12 ' HB ' ' B' ' 44' ' ' VAL . 22.1 pt -116.76 153.56 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.735 . . . . 0.0 110.356 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.64 ' HB2' HG12 ' B' ' 43' ' ' VAL . 1.6 tm0? -156.26 162.76 40.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.578 -0.701 . . . . 0.0 110.428 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -118.52 -66.07 1.11 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 110.166 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 tp -149.3 155.69 40.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.531 -0.731 . . . . 0.0 110.297 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -125.24 139.94 53.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.745 . . . . 0.0 110.052 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -145.13 135.34 11.87 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.548 -0.72 . . . . 0.0 110.275 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -74.23 112.89 3.65 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 O-C-N 123.294 1.155 . . . . 0.0 110.352 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -110.21 51.47 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 110.215 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.2 tttm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.182 179.809 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.047 0.451 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -106.95 112.78 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.678 . . . . 0.0 110.03 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -102.4 160.54 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.44 148.68 28.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.545 -0.722 . . . . 0.0 110.43 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 23.3 mt -120.31 147.73 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.643 -0.661 . . . . 0.0 109.757 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 33' ' ' VAL . 9.6 p -168.25 161.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.423 -0.798 . . . . 0.0 110.356 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.77 -170.65 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 110.172 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 156.03 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.109 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -169.02 -177.02 2.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.482 -0.761 . . . . 0.0 110.454 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.97 -157.54 0.15 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.454 -0.779 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -88.02 65.66 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.226 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 53.5 32.74 14.69 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.386 -0.821 . . . . 0.0 111.083 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -83.7 151.41 25.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.553 -0.717 . . . . 0.0 109.759 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.09 140.03 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.584 HG23 ' O ' ' B' ' 16' ' ' THR . 6.8 t -144.67 110.5 5.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.609 -0.682 . . . . 0.0 109.936 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.408 HG23 ' HD2' ' B' ' 18' ' ' PRO . 88.7 mt -71.37 142.33 86.68 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.475 -0.765 . . . . 0.0 110.046 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.408 ' HD2' HG23 ' B' ' 17' ' ' ILE . 30.5 Cg_endo -69.31 179.95 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.393 1.207 . . . . 0.0 110.419 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.34 43.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.107 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -60.8 -50.6 72.8 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.602 -0.687 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.05 -36.3 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.671 -0.643 . . . . 0.0 109.267 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -64.03 -31.97 73.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.641 -0.662 . . . . 0.0 109.587 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -47.54 65.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.668 . . . . 0.0 109.299 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -69.42 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.292 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.684 ' CE2' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -66.37 156.14 35.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.638 -0.664 . . . . 0.0 109.778 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.66 -81.74 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.53 -0.731 . . . . 0.0 110.035 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' B' ' 25' ' ' PHE . 61.8 mt 50.59 87.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.138 -0.977 . . . . 0.0 110.87 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -124.73 172.99 8.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.597 -0.689 . . . . 0.0 109.925 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.17 117.82 5.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.5 -0.75 . . . . 0.0 110.314 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 61.45 1.56 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.473 ' HB3' HD21 ' B' ' 48' ' ' LEU . 1.8 m-20 -133.84 138.22 45.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 0.0 110.146 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -85.9 90.83 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 110.343 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 7' ' ' VAL . 7.8 p -97.24 152.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.0 109.821 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 151.58 48.57 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.572 -0.705 . . . . 0.0 110.669 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.06 127.53 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 18.5 p -127.46 150.04 49.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.818 . . . . 0.0 111.369 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 34.8 t80 -136.25 125.39 24.55 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.43 -177.74 3.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 110.57 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.28 24.31 8.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.384 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -119.44 -40.51 2.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.48 -49.67 4.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.647 -0.658 . . . . 0.0 110.154 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.41 43.63 2.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.64 HG12 ' HB2' ' A' ' 47' ' ' GLN . 34.8 m -141.31 156.13 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.6 -0.941 . . . . 0.0 110.12 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.67 HG23 ' CE2' ' A' ' 25' ' ' PHE . 46.2 t -106.09 125.54 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.579 ' HG2' ' HB ' ' A' ' 43' ' ' VAL . 2.4 ttpt -107.86 128.36 54.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.652 -0.655 . . . . 0.0 110.199 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.514 HG12 ' HB ' ' A' ' 44' ' ' VAL . 22.2 pt -116.76 153.57 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.583 -0.698 . . . . 0.0 110.321 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.631 ' HB2' HG12 ' A' ' 43' ' ' VAL . 1.6 tm0? -156.34 162.64 40.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.658 -0.651 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' B' ' 31' ' ' ASP . 0.5 OUTLIER -118.4 -66.12 1.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.654 -0.654 . . . . 0.0 110.175 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 tp -149.25 155.72 41.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.569 -0.707 . . . . 0.0 110.27 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -125.33 139.94 53.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.565 -0.709 . . . . 0.0 110.019 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -145.09 135.31 11.87 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.513 -0.742 . . . . 0.0 110.31 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -74.22 113.04 3.69 Favored 'Trans proline' 0 N--CA 1.484 0.919 0 O-C-N 123.175 1.092 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -110.31 51.48 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.575 -0.703 . . . . 0.0 110.228 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 7.2 tttm . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.2 179.869 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.101 0.476 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -92.47 144.38 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.657 -0.652 . . . . 0.0 109.755 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.6 131.08 14.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.508 -0.745 . . . . 0.0 110.306 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.44 173.26 11.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.575 -0.703 . . . . 0.0 110.02 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.424 ' C ' HG23 ' A' ' 7' ' ' VAL . 38.9 pt -121.77 159.5 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.642 -0.661 . . . . 0.0 110.286 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.424 HG23 ' C ' ' A' ' 6' ' ' ILE . 63.2 t -147.42 153.12 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.658 -0.651 . . . . 0.0 110.204 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 172.24 6.94 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.83 149.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.472 -0.767 . . . . 0.0 110.213 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 t -171.8 -167.65 0.52 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.542 -0.724 . . . . 0.0 110.799 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.81 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.684 -0.635 . . . . 0.0 111.465 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.36 73.94 0.94 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.949 -1.094 . . . . 0.0 111.181 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 49.2 29.08 2.44 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.37 -0.831 . . . . 0.0 111.427 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.01 153.6 21.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.637 -0.664 . . . . 0.0 110.409 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -126.33 151.58 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.61 -0.681 . . . . 0.0 109.842 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -148.15 127.1 12.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.645 -0.659 . . . . 0.0 110.147 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 84.6 mt -81.26 145.38 55.82 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 0.0 109.942 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 17' ' ' ILE . 28.6 Cg_exo -58.12 -166.18 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.344 1.181 . . . . 0.0 110.617 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.93 -43.33 8.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.595 -0.691 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -63.71 -44.09 94.63 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.642 -0.661 . . . . 0.0 110.33 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.0 -41.71 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.528 -0.732 . . . . 0.0 109.603 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -65.54 -31.68 72.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.499 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -40.4 75.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.675 -0.641 . . . . 0.0 109.272 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -72.98 -74.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.615 ' CD2' ' CE1' ' B' ' 37' ' ' PHE . 0.4 OUTLIER -58.3 154.01 14.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.593 -0.692 . . . . 0.0 109.975 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -84.88 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.73 . . . . 0.0 109.853 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.473 HD12 ' HB3' ' A' ' 25' ' ' PHE . 71.0 mt 49.6 86.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.972 . . . . 0.0 110.902 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.25 -177.22 3.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -0.769 . . . . 0.0 110.596 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -83.15 117.57 22.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.695 . . . . 0.0 110.104 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.38 38.01 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.27 170.01 9.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.936 . . . . 0.0 110.186 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -117.17 72.24 0.83 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.507 -0.746 . . . . 0.0 110.136 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -64.65 149.37 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 110.398 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.45 156.95 18.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.67 -0.644 . . . . 0.0 110.329 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG23 ' CG1' ' A' ' 44' ' ' VAL . 7.9 p -151.33 133.18 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.4 p -141.57 145.86 35.6 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.156 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' B' ' 25' ' ' PHE . 44.4 t80 -111.47 140.18 46.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -132.81 155.7 48.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 0.0 110.948 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.77 20.02 12.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.653 -0.654 . . . . 0.0 110.239 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -100.94 -27.78 13.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.285 -0.884 . . . . 0.0 109.909 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -127.2 -49.27 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.637 -0.664 . . . . 0.0 110.24 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.42 35.31 3.37 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' B' ' 47' ' ' GLN . 35.3 m -136.89 163.12 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.523 -0.987 . . . . 0.0 110.236 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.803 ' HB ' ' CG1' ' B' ' 46' ' ' ILE . 59.5 t -105.0 127.61 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.346 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' B' ' 44' ' ' VAL . 27.3 ttmt -112.22 133.71 54.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.771 -0.581 . . . . 0.0 110.217 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.81 ' CG1' ' HB ' ' B' ' 44' ' ' VAL . 5.3 pt -125.75 158.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.631 -0.668 . . . . 0.0 110.194 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.665 ' HB2' HG12 ' B' ' 43' ' ' VAL . 5.0 tt0 -153.72 161.31 42.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.668 -0.645 . . . . 0.0 110.351 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.13 38.13 1.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.578 -0.701 . . . . 0.0 110.056 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 23.2 mt -91.97 124.97 36.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.568 -0.707 . . . . 0.0 110.318 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -143.43 -155.16 0.57 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.639 -0.663 . . . . 0.0 109.817 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -58.64 110.25 2.47 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.475 -0.766 . . . . 0.0 110.183 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.07 131.12 26.02 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.147 1.077 . . . . 0.0 110.588 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -150.45 79.63 1.34 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.622 -0.674 . . . . 0.0 109.86 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.349 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.138 0.494 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.45 144.33 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.759 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -149.71 131.1 14.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 0.0 110.368 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -138.41 173.28 11.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.698 -0.627 . . . . 0.0 110.034 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.433 ' C ' HG23 ' B' ' 7' ' ' VAL . 38.4 pt -121.78 159.59 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.624 -0.673 . . . . 0.0 110.324 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.433 HG23 ' C ' ' B' ' 6' ' ' ILE . 62.9 t -147.45 153.16 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.527 -0.733 . . . . 0.0 110.181 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.93 172.19 6.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.573 -0.705 . . . . 0.0 110.069 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.74 149.23 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 110.237 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.8 t -172.02 -167.64 0.5 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.522 -0.736 . . . . 0.0 110.757 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.76 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.663 -0.648 . . . . 0.0 111.454 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -154.35 73.95 0.94 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.04 -1.037 . . . . 0.0 111.219 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 49.23 29.17 2.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.315 -0.865 . . . . 0.0 111.396 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -87.07 153.64 21.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.419 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.34 151.49 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.575 -0.703 . . . . 0.0 109.798 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -148.09 127.03 12.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.57 -0.706 . . . . 0.0 110.072 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 85.0 mt -81.08 145.26 56.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.969 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -57.96 -166.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.416 1.219 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.82 -43.49 8.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.253 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -63.7 -43.89 95.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.55 -0.719 . . . . 0.0 110.362 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.18 -41.79 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 109.526 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -65.46 -31.78 73.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.6 -0.687 . . . . 0.0 109.462 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -40.48 75.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.668 -0.645 . . . . 0.0 109.334 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -72.96 -74.09 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.609 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -58.36 154.01 14.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.509 -0.745 . . . . 0.0 109.97 179.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.3 -84.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 109.887 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . 0.473 HD12 ' HB3' ' B' ' 25' ' ' PHE . 71.8 mt 49.48 86.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.066 -1.022 . . . . 0.0 110.964 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -116.19 -177.21 3.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.527 -0.733 . . . . 0.0 110.538 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -83.12 117.56 22.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.574 -0.704 . . . . 0.0 110.106 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.26 38.22 4.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.34 170.02 9.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.917 . . . . 0.0 110.184 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mt -117.22 72.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.69 149.33 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.52 -0.738 . . . . 0.0 110.336 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -106.4 156.9 18.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.597 -0.689 . . . . 0.0 110.364 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.424 HG23 ' CG1' ' B' ' 44' ' ' VAL . 7.8 p -151.34 133.15 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 79.1 p -141.62 145.89 35.56 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.203 -0.999 . . . . 0.0 112.117 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.615 ' CE1' ' CD2' ' A' ' 25' ' ' PHE . 44.1 t80 -111.42 140.13 46.26 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -132.75 155.77 48.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.351 -0.843 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.83 20.11 12.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -100.82 -28.04 13.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.795 . . . . 0.0 109.974 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -127.02 -49.25 1.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.706 -0.621 . . . . 0.0 110.246 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.43 35.21 3.39 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 47' ' ' GLN . 35.2 m -136.79 163.1 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.5 -1.0 . . . . 0.0 110.122 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.81 ' HB ' ' CG1' ' A' ' 46' ' ' ILE . 60.6 t -105.03 127.37 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.2 ttmt -111.87 133.55 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.697 -0.627 . . . . 0.0 110.294 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.803 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 5.4 pt -125.54 158.05 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.653 -0.654 . . . . 0.0 110.302 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.641 ' HB2' HG12 ' A' ' 43' ' ' VAL . 4.8 tt0 -153.64 161.36 42.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.716 -0.615 . . . . 0.0 110.32 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.18 38.18 1.74 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 110.014 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 24.0 mt -91.87 125.03 36.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 110.406 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -143.43 -155.09 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.561 -0.712 . . . . 0.0 109.824 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.75 110.33 2.55 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.506 -0.746 . . . . 0.0 110.198 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.22 130.99 25.41 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.193 1.101 . . . . 0.0 110.557 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -150.34 79.72 1.35 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.653 -0.654 . . . . 0.0 109.83 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.315 -179.801 . . . . . . . . 1 1 . 1 stop_ save_